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PART ONE: REVIEW OF THE LITERATURE 
CHAPTER 1. INTRODUCTION 
The Italian scholar, Girolamo Fracastoro, in his book De Contagione published in 
1546, distinguished three methods of the spread of infection 1: by direct touching of a 
patient's body, by contact with fomites and at a distance through the air. He described 
infection as being due to the transmission of invisible "seeds" or "germs"; different 
kinds were the specific causes of different diseases; their ability to multiply in 
successive hosts was a necessary attribute for their continued spread. Much of his 
thinking was lost for centuries: another Italian , Agostino Bassi in 1835 showed clearly 
for the first time that micro-organsisms played a pathogenic role, but the germ theory 
of disease was not firmly established until Robert Koch reported his observations with 
Anthrax in 1876 and Koch's postulates were established. 
Preventive measures in infection control owe their origins to the Austrian Ignaz 
Semmelweis who, in 1846, was able to demonstrate that puerperal fever was caused by 
a putrefactive agent transmitted on the hands of doctors when attending patients or 
performing necropsies , and thence to the birth canal when assisting at deliveries. 
Without knowing the nature of the agent responsible , he was able to reduce the 
maternal mortality from 8.3 to 2.3% by instituting a policy of handwashing. 
Within the hospital itself, the development of the techniques of antiseptic and aseptic 
surgery for the prevention of wound sepsis were developed by Joseph Lister in 1867. 
He covered surgical wounds with dressings soaked in carbolic acid to kill any bacteria 
present in them, and to prevent the entry of further bacteria. He also was responsible 
for introducing the disinfection of hands and surgical instruments, and was able to 
reduce the incidence of sepsis significantly in his patients. 
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Despite the advent of antibiotics, nosocomial infections have remained a significant 
challenge, and the emergence of antimicrobial resistance has further complicated the 
problem. Until the 1970s there were no new developments which seemed capable of 
producing any dramatic improvements in the incidence of nosocomial infection; 
techniques of sterilisation and disinfection had advanced considerably, but although the 
incidence of puerperal sepsis and postoperative infection had been reduced to very low 
levels in most hospitals with hygienic control methods, the emerging problem of 
hospital-acquired infection or II nosocomial infection II remained a difficult and 
seemingly insoluble issue. 
With the increasing complexity and invasiveness of medical and surgical procedures 
and, in particular the development of powerful immunosuppressive and antineoplastic 
chemotherapy, the phenomenon of nosocomial infection began to assume still greater 
importance as a cause of morbidity and mortality. 2,3 
It was in patients who were profoundly granulocytopaenic, either due to their disease or 
as part of a conditioning regimen in preparation for bone marrow transplantation, that it 
was first recognised that the gut, the upper respiratory and lower genito-urinary tracts 
formed important reservoirs of potential pathogens which caused nosocomial infections, 
often resulting in major morbidity and mortality. 
During the 1970s, the importance of Gram-negative bacillary carriage as a result of 
impaired colonisation resistance, was demonstrated to be the initial step in the 
pathogenesis of endogenous infection; this carriage is followed by colonisation with the 
potential for progression to infection of other major organ systems_ 
W.G.Johanson in 1969 4,5 was able to show that the very fact of being ill predisposed 
to the oropharyngeal carriage of Gram-negative bacilli. Schimpff in 1972 6 
demonstrated that the route of infection is practically always endogenous in seriously ill 
patients (the patient infects himself after first carrying the identical microorganisms in 
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the throat/stomach or gut.) Le Frock in 1979 7 reported that illness was associated 
with intestinal carriage of Gram-negative bacilli other than the individual's own 
Escherichia coli; healthy people do not normally carry Gram-negative bacilli, other 
than their own E.coli, in their throat or gut, because they are able to resist colonisation 
by these organisms. 
Intensive Care Units (ICUs) represent the single largest identifiable source of infection 
within the hospital 8; among the most frequently observed infections are nosocomial 
pneumonias, post-operative wound infections, urinary tract infections and septicaemias. 
It is estimated that 30 to 50% of all such nosocomial infections are endogenous in 
origin 9. Within the ICU, nosocomial infection causes a threefold increase in mortality 
and considerable additional morbidity, significant! y increasing the costs of 
hospitalisation 10. Daschner 11 estimated from data in the U.S.A. that the average 
nosocomial infection cost $1 800, while a life threatening nosocomial pneumonia could 
cost $42 000. 
The technique of selective decontamination of the gastrointestinal tract, or SDD, owes 
its origins to attempts to reduce the incidence of secondary infection in patients with 
haematological malignancy 12. The theory in broad outline being that the use of broad 
spectrum antibiotics promotes the overgrowth of aerobic Gram negative bacilli and 
yeasts, which are the major pathogens encountered in secondary infection; by 
preserving the normal, predominantly anaerobic flora of the gastrointestinal tract, and 
maintaining normal colonisation resistance, such overgrowth seems to be prevented 
and, with it, the incidence of secondary infection reduced. 
Guiot et al 13 described the successful use of topical and enterally administered 
antibiotics to leukopaenic patients with an almost 50% reduction in the incidence of 
major secondary infection. Other trials confirmed the benefit of this technique, which 
became standard practice in one form or another in most centres treating such patients. 
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If a technique for preserving the normal intestinal flora and eliminating colonisation by 
potential pathogens seemed to work to prevent secondary infection m 
immunocompromised patients, the logical next step was for it to be applied in further 
selected population groups at high risk of nosocomial infection; thus the technique of 
selective decontamination was launched into ICU practice by Stoutenbeek et al 14 in 
the early 1980s, but its efficacy still remains controversial. 
The objectives of this thesis are : 
1) To provide a review of the literature on the significance, pathogenesis, diagnosis and 
management of secondary infections in the Intensive Care Unit. 
2) To present the findings of a study of the technique of selective parenteral and enteral 
antisepsis regimen (SPEAR) in the patient population of the Respiratory ICU at Groote 
Schuur Hospital, aimed at reducing the incidence of secondary infection and , further to 
evaluate the study in terms of the effect of SPEAR on the incidence of secondary 
infection and its influence on the mortality due to secondary infection. 
3) To present the findings of the effect of SPEAR on patient bacterial colonisation in 
the ICU, and to evaluate its longterm influence on the microbial flora of the ICU. 
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CHAPTER 2. DEFINITIONS 
The terminology in this field has evolved over time, and a number of terms are used 
loosely and often interchangeably, for this reason a number of recent publications and 
consensus conferences have been held attempted to achieve uniformity in the definitions 
15,16 
Nosocomial infection and "secondary infection" have come to be synonymous with 
hospital-acquired infection and, by definition, mean the acquisition of infection at 
least 48 hours after admission; although some authorities use a cut- off time of 72 
hours. The intention is that the infection should not have been present, or incubating, at 
the time of admission to hospital. 
In a patient with a previously established hospital-acquired infection , a new episode of 
nosocomial infection should be documented as superinfection. This should involve 
new and different organisms which are cultured from the previously described site of 
nosocomial infection , with a coincident clinical persistence, or deterioration, in the 
patient's condition. 
Infection acquired within hospital during the initial 48 to 72 hour period is thought to 
be community-acquired and already to have been developing on admission to hospital. 
Hospital acquired infections are further designated "early" or "late": "early" infections 
are those that develop within the first 4-5 days of admission and "late" infections are 
those that develop subsequent to this 17. The importance of distinguishing between 
early and late infections is that the aetiological agents responsible may differ in both 
species and antibiotic sensitivity patterns. Usual pathogens such as S.pneumoniae , 
H.influenzae although commonly recognised to cause early infections, may also be 
responsible for late infections. 
With increasing duration of hospital stay , the patient's normal flora is recognised to 
undergo changes, both as the result of antibiotic pressure, and colonisation of the 
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patient by the resident hospital flora. It is well known that the healthy body carries, or 
is colonised by, a flora of commensal organisms, many of which are potentially 
pathogenic if there is a breakdown or breach of the normal defence mechanisms. These 
organisms provide a defence against colonisation by new flora; this resistance to 
colonisation by bacteria is termed "colonisation resistance" l8, l9. The use of 
antibiotics, particularly those that have a broad spectrum of activity, eliminates many of 
the normal commensal flora, thereby creating a more favourable environment for the 
proliferation of organisms. Such organisms may be merely opportunistically 
pathogenic, or intrinsically more pathogenic than the original host organisms. These 
organisms may multiply in an uncontrolled fashion in the altered host environment and 
thus cause infection _at the site they have newly colonised, or, by invasion, may cause 
disease elsewhere. 
There are a series of processes that ultimately result in infection: the attachment of 
potentially pathogenic microorganisms to epithelial cells (eg in the oropharynx), 
proliferation at the site of attachment, invasion, with resulting tissue damage, and then 
possible dissemination to other sites. 
There are three stages 20 in the acquisition of nococomial infection: carriage, 
colonisation and infection. The transition from colonisation to infection is not well 
understood, but with a breakdown in host defences, and the production of inflammatory 
mediators, tissue invasion may develop, resulting in infection. 
Colonisation is the persistence of an organism at a specific site, in the absence of either 
a host response, or adverse effects on the host, and is determined by the culture of an 
identical microorganism from the same site for a minimum of two consecutive samples. 
There is, however, still some controversy as to whether it should be regarded as an 
entirely pathological process, or whether it is a phenomenon not always associated with 
disease. It is regarded by some as the prolonged presence of an organism at a site 
which it does not normally occupy , and against which the host does not mount a 
15 
serious immune response, but it is recognised that an antibody response to commensals 
is made and so this definition is not absolute. 
van Saene l5 defined colonisation in a paper which he presented to the First European 
Consensus Meeting on Selective Decontamination, Paris 1991 as: the presence of a 
potentially pathogenic microorganism in an internal organ that is normally sterile eg the 
lower airways or the bladder. The diagnostic sample should yield fewer than 100 000 
colony forming units per ml. The question still remains as to when the carriage of an 
organism should be regarded as colonisation. van Saene chooses to regard colonisation 
as the state where the same strain of a potentially pathogenic micro-organism is isolated 
from at least two consecutive surveillance samples (saliva, gastric fluid, faeces, throat 
and rectal swab) in any concentration over a period of at least a week. It is evident 
from the above that there is no clear distinction between colonisation and carriage. 
For the purposes of this thesis, carriage means the identification on at least two 
occasions of the same micro-organism. Colonisation means the acquisition of a 
potentially pathogenic micro-organism which can be carried by the host in both 
normally colonised and sterile sites. 
Infection is also a difficult concept to define 21 , as it involves both clinical and 
microbiological diagnoses. It is the presence of microorganisms at sites that are not 
normally colonised eg the blood, or the presence of microorganisms that are not 
components of the normal flora eg Mycobacterium species, but requires, in addition, 
the evidence of a host response to the organism eg pyrexia, leukocytosis, inflammation. 
In the realm of the highly immunocompromised, where such clinical responses may be 
altogether absent, the diagnosis is still more difficult, requiring a high index of 
suspicion, and the early treatment of organisms found at abnormal sites, without any 
clinical features, regardless of the potential pathogenicity of the organism. An organism 
which proliferates excessively, or is present in large numbers, may be also be regarded 
as evidence of infection. 
16 
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The development of infection may arise from either exogenous or endogenous sources. 
Exogenous infections are transmitted from other infected patients, either directly, or by 
means of healthy carriers, or from inanimate or animate sources from the environment; 
infection may occur without the preceding stages of carriage and colonisation. 
Exogenous infection should be almost entirely preventable with the use of strict 
hygienic measures, including handwashing, disinfection and decontamination of 
equipment. 
Endogenous infections are due to organisms carried by the host, which 
opportunistically invade tissues in the presence of compromised or breached host 
defences. These organisms may be community-acquired or hospital acquired and of 
varying degrees of pathogenicity and invasiveness. The main reservoirs for endogenous 
infection are the skin and the gut including the naso and oropharynx and the organisms 
responsible for this type of infection include Staphylococcus aureus, Staphylococcus 
epidermidis and the Enterobacteriaceae, enterococci, yeasts and anaerobes. The flora 
present on admission is involved in primary endogenous infections, while 
microorganisms acquired during hospitalisation are designated "secondary 
endogenous"; such organisms are acquired exogenously from the hospital environment, 
but are called endogenous because oral and gastrointestinal carriage form an essential 
stage in the development of infection. 
Thus the source and type of organisms causing exogenous and endogenous infections 
differ considerably : the epidemic type of diseases eg cholera, typhoid, bubonic plague 
and leptospirosis are all classic types of predominantly community-acquired exogenous 
infection caused by pathogenic organisms, but in the hospital environment 
Staphylococcus aureus, Staphylococcus epidermidis, Acinetobacter spp and other 
potentially pathogenic organisms which are found on hands and fomites, or in fluids or 
feeds administered to patients also become important sources of exogenous infection, 
given the right circumstances. 
With antibiotic use and prolonged hospital stay, aerobic Gram-negative bacilli (AGNB) 
become important colonisers of the gastrointestinal tract and methicillin-resistant 
staphylococci of the skin and oropharynx, thereby assuming importance as potential 
nosocomial endogenous sources of infection. Antibiotic resistance is common, possibly 
as a result of microbial exposure to small quantities of parenteral antibiotics, which 
reach the gut in saliva, bile and mucus. 
The spectrum of organisms encountered in the hospital may differ significantly from 
that in the community depending on the local and hospital antibiotic usage patterns. The 
patient's normal commensal flora begins to resemble that of the hospital within 48 to 
72 hours of admission 7. Even without the use of antibiotics, the patient gradually 
becomes colonised by flora which show a wider spectrum of antibiotic resistance, and 
may also differ in species eg Acinetobacter spp. 
Bone l6 in an editorial on sepsis, and the septic syndrome makes a plea for greater 
precision in the use of terminology in defining infective states. He proposes that the 
term "septicaemia" should be abandoned, because it has been used interchangeably to 
mean both the presence of a blood-borne infection, and a systemic disease caused by 
the spread of microorganisms and their toxins in the circulating blood, and has thus lost 
clarity of meaning. He suggests instead that "bacteraemia" should be used to define 
the presence of viable bacteria in the circulating blood, a syndrome which has a 
positive blood culture as a diagnostic criterion. "Sepsis" should be defined as clinical 
evidence of infection, in the presence of tachypnoea, tachycardia and hypo or 
h yperthermia. 
18 
Such standardisation of, and precision in definitions would be enormously helpful in 
enabling meaningful and easier comparisons between studies, but is unfortunately not a 
reality as yet. 
19 
CHAPTER 3. THE PATHOGENESIS OF NOSOCOMIAL INFECTION 
3.1 The Host 
The healthy individual is able to protect himself from potentially harmful 
microorganisms in the environment by a number of very effective mechanisms which 
are present from birth, and which do not depend upon his having had previous 
experience of the particular organism. Such innate defence mechanisms are non-specific 
and are determined genetically , varying widely among different races (eg the increased 
susceptibility seen in some racial groups to infection with Mycobacterium tuberculosis) 
and to a lesser extent, with the individual. Age, sex, nutritional factors and hormonal 
balance all contribute to this protective mechanism. The acquired immune response 
however, is specific to the organism inducing the disease. 
Mechanical factors such as an intact skin and mucosae act as important physical 
barriers, providing effective protection against non-pathogenic bacteria, and a high 
degree of protection against pathogens. 
Such characteristics as the relatively dry conditions on the skin and the high 
concentration of salt in sweat, are inhibitory or lethal to microorganisms. The 
sebaceous secretions and sweat also contain bactericidal and fungicidal fatty acids, 
which constitute an effective protective mechanism against many potentially pathogenic 
microorganisms. The protective ability of these secretions varies at both extremes of 
life. The nasal secretions and saliva also contain mucopolysaccharides capable of 
inactivating some viruses, and the tears and the mucous secretions of the respiratory, 
alimentary and genitourinary tracts contain lysosyme which is especially active against 
Gram positive bacteria . Fibronectin may facilitate the adherence of certain types of 
organisms , particularly Gram positive microorganisms to the buccal mucosa, and thus 
prevent the adherence of Gram negative organisms 22-24. The acidity of gastric juices, 
vaginal secretions and sweat help to maintain the normal flora of the upper 
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gastrointestinal tract, lower genitourinary tract, and skin. Secreted immunoglobulins 
(eg IgA in the intestinal secretions) have antimicrobial properties. There are a variety 
of other basic polypeptides eg lactoferrin that are derived from the tissue and blood 
cells and which act non-specifically on bacteria, by depriving them of nutritional co-
factors, or in other inhibitory ways 25. 
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The mucous secretions covering the mucous membranes of the respiratory tract act as a 
trapping mechanism; under normal circumstances, the mucociliary escalator serves to 
sweep the secretions containing particulate matter towards the oropharynx, where they 
can be swallowed and destroyed by the powerful acid and enzymes, which are a normal 
constituent of the intestinal juices. The mucus trapping and expulsion by the ciliated 
epithelium, together with the constant desquamation of epithelialised surfaces with 
adherent organisms, facilitate mechanical decontamination 25 . There is also a system of 
surface phagocytosis which operates via the alveolar macrophages in the lungs and the 
epithelial cells in the bladder. The ongoing peristalsis in the gastrointestinal tract helps 
to move organisms and secretions, thereby preventing adherence and overgrowth from 
occurnng. 
Thus the endogenous flora of the healthy individual is the normal flora which is 
dependent for its maintenance on the physicochemical milieu, bacterial interference, 
and epithelial cell adherence. If these mechanisms are intact, colonisation resistance, 
which is determined by the above, will determine whether a patient is colonised by 
potentially pathogenic organisms on admission to the ICU, and the subsequent potential 
for infection. 
Various individual host factors render susceptibility to the development of infection. 
Susceptibility is greatest in the very young and the very old; malnutrition, drug and 
alcohol abuse favour both a greater incidence and severity of infection, and are 
associated with a higher mortality 23 . Metabolic diseases such as diabetes, renal 
disease, collagen vascular diseases, immunological deficiencies, neoplasia, especially 
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haematological, and the hormonal and immunological derangements caused by high 
dose steroid or other immunosuppressant therapy, may all reduce host resistance to 
infection. Infections in such instances may occur with organisms not u~ually regarded 
as being of high pathogenicity eg pneumococci, Candida spp and Klebsiella spp, all of 
which are well-capsulated organisms; there may be a silent invasion due to poor host 
response to pathogens that ordinarily are not highly invasive against healthy tissues. 
Antecedent disease of particular tissues and systems lowers resistance to infection Eg 
chronic skin diseases such as psoriasis and eczema, chronic bronchitis and 
bronchiectasis, rheumatic heart disease and neurological disease. 
It is well recognised that such host factors as age, obesity, the size of the wound, 
wound drainage, duration of operation and the length of stay before and after the 
operation are important factors in the development of wound sepsis. Tissue trauma and 
anaesthesia associated with surgery also alter the host's immunological response and 
resistance to the development of infection 26-28. 
Foreign bodies such as respiratory devices, sutures, indwelling unnary catheters, 
intravenous cannulae, all of which are commonplace in the hospital, may considerably 
add to the risk of infection 29 particularly in the intensive care unit where all of the 
above invasive, monitoring and therapeutic devices are frequently used. The normal 
host defences are breached by the passing of endotracheal tubes, which bypass the 
normal laryngeal, cough and mucociliary escalator defences against aspiration; or 
similarly tracheostomy tubes, which may also facilitate the direct transmission of 
organisms to the lower respiratory tract 29; these devices are the most significant 
factors predisposing to the development of nosocomial respiratory tract infection. 
Central venous catheters breach the skin and may remain in the main venous system of 
the right side of the heart for days at a time; pulmonary artery catheters further are in 
contact with the pulmonary circulation and the right heart valves. Lines placed for 
haemodialysis or peritoneal dialysis are yet a further potential site for organisms to 
penetrate the normally sterile internal environment. Nasogastric tubes may facilitate the 
migration of organisms from the stomach to the oropharynx and thence to the lungs. 
Both endotracheal and nasogastric tubes may block the normal drainage from the 
sinuses thus setting up a site for infection 30. The patients often have underlying 
diseases and may often be receiving aggressive treatment with immune response 
modulating therapy which may further increase their susceptibility to infection. 
3.2 The Organisms 
Pathogenicity, or the ability to initiate disease, requires that the organism possess the 
attributes of transmissibility, infectivity to breach the host's defences and Virulence to 
cause harm to the host. 
There are no specific factors which can be used to measure clinically the ability of a 
microorganism to cause infection. The virulence of a bacterium depends on the 
susceptibility of the host. the interaction of host and bacterium and intrinsic properties 
of the organism such as the presence of fimbriae or a capsule; the site of host/bacterial 
encounter is also important and the size of the bacterial inoculum is a further 
determinant of virulence. 31 
Truly pathogenic bacteria possess properties that enable them to overcome the host's 
defences and infect the tissues of a normal healthy individual. The intrinsic pathogenic 
index (IPI) is the number of infected patients per number of patient carriers and is close 
to one for the high level pathogens including Salmonella species. Such types of 
infection are of more importance in the community. 
Many commensal or non-pathogenic organisms are transmissible from person to 
person, or are derived from the environment and are present on the skin, in the upper 
respiratory tract, the gastrointestinal tract and the lower genitourinary tract, thereby 
constituting the normal bacterial flora of the body. Under normal circumstances, their 
infectivity is low and they do not cause disease, as they are unable to overcome the 
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body's normal defences ; however the balance is a delicate one and many of these 
organisms are able to initiate disease if they are transferred to another site eg aerobic 
Gram negative bacilli are commensals in the gastrointestinal tract but cause infection in 
the urinary tract. Such organisms are designated "potentially pathogenic", having an 
intrinsic pathogenicity index which lies between 0.1 and 0.3. Potentially pathogenic 
microorganisms may cause infection in a subject with impaired defence mechanisms. 
Potentially pathogenic microorganisms most commonly causing community acquired 
sepsis include S.pneumoniae, H. injluenzae, M. catarrhalis, E.coli, S. aureus and 
Candida species. Potential pathogens in the hospital include Klebsiella , Proteus, 
Morganella, Enterobacter, Citrobacter, Serratia, Acinetobacter and Pseudomonas 
species. 
In general , the microorganisms considered as potential pathogens in the community, 
cause infection in a previously healthy individual with intact defences, whereas the 
hospital Gram negative bacilli cause infection in patients with impaired defences due to 
underlying disease. 
The indigenous throat, gut and skin flora including viridans streptococci do not easily 
fit into the definition of potential pathogens , because of their low intrinsic 
pathogenicity. 
The pathogenicity of organisms is determined by their intrinsic properties of virulence, 
adherence, invasiveness and the production of toxins. Bacterial-host cell secretion 
interaction plays a role in the adherence of bacteria to cell receptors, and is important 
in the development of colonisation. The earliest stage of bacterial colonisation is 
bacterial adherence to the epithelium, which is promoted by severe illness, 
malnutrition, intubation , tracheostomy, uraemia, cigarette smoking and ciliary 
dysfunction 22 ,23. 
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Adhesion is a colonisation factor both for pathogens and for organisms of the normal 
flora, but in pathogens may allow the expression of other virulence factors eg both 
commensal avirulent E.coli and toxigenic virulent E.coli can adhere, but the difference 
in outcome of colonisation is toxin production. Todd et aj 24 demonstrated that the 
bacterial adhesion index for Pseu.domonas aeruginosa paralleled the clinical condition 
of the patient, but showed no correlation with intubation or its duration. 
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The host's indigenous flora prevents colonisation by more pathogenic strains - a 
phenomenon called "colonisation resistance" which is achieved by a variety of 
mechanisms including secretion of bacteriocines, and the competition with the 
indigenous flora for nutrients at adherence sites l 8. In the abnormal environment of the 
intensive care unit, organisms which are normally regarded as commensals , or new 
colonisers from the environment, are translocated to new sites where circumstances 
may be favourable for their proliferation, which is often uninhibited and excessive. 
Certain properties of bacteria such as their ability to react with certain components of 
the surface membrane of cells can kill the host cells and result in the haemolysis, 
cytolysis and leukocidal activity which are characteristic of pathogenic staphylococci, 
streptococci and clostridia. The lysis of tissue cells makes extra nutrients available to 
the bacteria, and killing of phagocytes protects the organisms from destruction. The 
specific antigenic character of Gram negative bacteria is determined by the pattern of 
hexoses that compose the lipopolysaccharide molecule. This has an affinity for, and 
tends to become incorporated in, the lipoprotein membrane of tissue cells where it may 
exert its toxic effects by disturbing the function of these membranes. The presence of a 
capsule may confer virulence on bacteria, by enabling them to resist phagocytosis or 
lytic attack and protect them from bactericidal substances in the body fluids. 
Pseu.domonas aeruginosa in natural aquatic systems has been observed to colonise 
available surfaces and proliferate to form adherent biofilms, within which the sessile 
cells grow in a hydrated matrix partially composed of their own uronic acid containing 
alginate hexopolysaccyharides 32. In the catheterised patient, a thick adherent biofilm 
of similar composition from rapidly on the surface of the urinary catheter and confers a 
considerable degree of protection to the organism, protecting the viable organisms 
within this matrix from antibiotics. 
Other protective or aggressive factors that are not toxins, but may contribute to the 
ability of capsulate and non-capsulate pathogens to invade and multiply in the host's 
tissues include: hyaluronidase which permits organisms such as Streptococcus pyogenes 
to penetrate the tissues; coagulase which is a thrombin-like enzyme produced by all 
pathogenic staphylococci which may protect the pathogen by forming fibrin-like 
barriers around the staphylococci and inactivating a bactericidal substance present in the 
serum; fibrinolysins, which by breaking down fibrin barriers may again promote the 
spread of streptococcal infection. There is a host of other depolymerising enzymes such 
as mucinases, proteases etc which may or may not contribute to virulence. 
The route of introduction of the organism to the host is also important eg haemolytic 
streptococci may produce dangerous infection if they are introduced through the skin or 
into the bloodstream, but are likely to be harmless if swallowed. 
Further properties of the bacteria such as the poorly understood adherence mechanisms 
may also contribute to pathogenicity at a specific site. 33 An organism may not be 
observed to have colonised and invaded by the usual means, but on introduction to such 
a site, rapidly sets up infection. 
The use of antiseptics, chemotherapy and aseptic techniques all apply strong selective 
pressure on the hospital flora so that only those that are resistant survive. This may lead 
to the local multiplication of opportunist bacteria in disinfectant solutions or water eg 
Pseudomonas spp , thence contaminating and infecting patients. The widespread use of 
antibiotics produces similar selective pressures so that antibiotic-resistant variants of the 
common bacteria predominate in patients, staff and the environment 34. 
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The consumption of food contaminated with drug-resistant organisms can give rise to 
colonisation of the gut which under the right circumstance may lead to infection. 
After admission to the ICU, acquisition and colonisation by the ICU flora of the 
oropharynx, trachea and digestive tracts occurs rapidly. Kerver et al 35 in a prospective 
study of 39 patients admitted to a surgical ICU, using microbiological surveillance 
cultures, showed that after 5 days in the ICU, the oropharyngeal cavity and the lower 
respiratory tract of 60% of the patients were colonised by ICU acquired organisms. 
After 10 days this figure had increased to 85 % and the colonisation of the remainder of 
digestive tract showed a similar pattern. The predominant pathogens were 
Enterobacteriaceae , Pseudomonaceae and yeasts and were regarded as endogenous 
sources of infection, because of the pattern of acquisition followed by colonisation of 
the gastrointestinal tract. The authors found that the use of systemic antibiotics 
favoured colonisation with these organisms. Patients who became colonised by these 
organisms were found to be highly susceptible to the development of subsequent 
infection. In this study , 75.6% of patients who were colonised by a potential pathogen, 
went on to develop nosocomial infection due to the same organism. Organisms such as 
Acinewbacter baumanii and Pseudomonas aeruginosa, were regarded as exogenous 
causes of lower respiratory tract infection, because such organisms were frequently 
isolated as colonisers and causes of lower respiratory tract infection, without having 
previously colonised the oropharynx. The source of the Acinerobacrer was subsequently 
identified by antibiograms as being the ventilator. Pseudomonas aemginosa was 
identified as coming from disinfected glass thorax drainage systems. In contrast to other 
studies 9, they could not show that similar colonisation of the urinary tract occurred. 
Johanson et al 5 prospectively studied the frequency of colonisation of the respiratory 
tract with Gram negative bacilli, and the relationship of this colonisation to infection, 
in patients admitted to their medical ICU . They demonstrated that 45 % of all 
admissions became colonised, 22 % on the first hospital day, which contrasts with only 
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2 % of normal subjects who are colonised by Gram negative bacilli. Nosocomial 
respiratory infection developed in 23 % of colonised patients, but in only 3.3 % of those 
who were not colonised. The frequency of colonisation of the respiratory tract with 
Gram negative bacilli was 76 % in patients with primary respiratory diagnoses, which 
was significantly higher than for patients with other diseases; suggesting that conditions 
that impair lung clearance may also promote colonisation. They were, however, unable 
to relate the use of inhalational therapy to either colonisation or infection. 
Patients with cardiovascular diagnoses were at significantly less risk of developing 
nosocomial respiratory infections than patients with respiratory diagnoses , 5 % versus 
24 % , drug overdoses (26 % ) and other diagnoses (20 % ) ; the common denominator 
being the presence of an endotracheal tube or coma, the prevalence of colonisation 
increasing as the severity of illness increased. They identified the factors already 
mentioned as risk factors for colonisation, but in addition , the presence of leukocytosis 
or leukopaenia, and sputum expectoration were related to colonisation. While noting 
that patients who were colonised tended to have more protracted stays in the ICU, they 
showed that 22 % of these same patients tended to be colonised on the first day of 
admission, suggesting that colonisation was not only dependent on the duration of stay. 
76% of patients, who were persistently colonised, were colonised on their first day in 
the ICU, but there appeared to be a susceptible subgroup admitted to the ICU, among 
whom colonisation increased for the initial four days following admission, and 
thereafter plateaued. Importantly, they were unable to identify any potential 
environmental reservoirs for Gram negative organisms, except for the isolation of some 
species in the immediate vicinity of the patient, but were unable to determine whether 
this represented contamination from colonised patients, or whether the patients had 
been colonised at source. The previous use of antimicrobial drugs was significantly 
associated with colonisation by Gram negative bacilli: in a subgroup, they showed 
colonisation in 55 % before antibiotic therapy, which rose to 79 % during or after 
therapy. 
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Antibiotics increase the risk of infection by interfering with the normal flora of the 
upper and lower airway, and eliminating the Gram positive organisms and anaerobes; 
thus allowing Gram negative organisms to occupy the bacterial binding sites usually 
filled by the normal flora. There are, in addition properties specific to certain bacteria 
which enhance their ability to bind to epithelial cells, including the presence of a 
capsule, the type of surface appendages, and the nature of exoproducts released by the 
bacteria 1. 
Prior treatment with antibiotics may hasten the advent of such "hospital type" 
pathogens 36_ Meduri 3? reports several studies that demonstrated convincing evidence 
of an increase in the number of potential bacterial pathogens following antibiotic 
therapy. Graybill 38 reported superinfection in 16% of patients with hospital-acquired 
pneumonia, and this represented 45 % of all Gram negative bacillary pneumonias. The 
mortality with primary Gram negative pneumonia was 44 % , but this increased to 60 % 
with Gram negative bacillary superinfection. The colonisation of the respiratory tract is 
of considerable significance in determining both morbidity and mortality. Schwartz et 
al 39 reported that patients who were colonised by Gram negative bacteria one week 
after intubation were four times more likely to develop pneumonia and three times 
more likely to die, than those who were not colonised. 
3.3 The environment 
The spread of infection can occur by a variety of mechanisms. Exogenous infection is 
important, because its spread is potentially preventable by hygienic precautions, based 
on a knowledge of its source and modes of spread. The concentration of patients in the 
ICU, both with and without infection, ensures dissemination of large numbers of 
microorganisms, so that most individuals become rapidly colonised with the 
institutional flora. 
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Those mechanisms operative m the transmission of infection in the hospital 
environment include: the airborne dissemination of infected secretion droplets, which 
occurs either by droplet spray or dried dust containing viable organisms. Droplet spread 
of infection is a danger mainly within the room of its origin, and spread to other rooms 
within the same building is usually slight. The use of moist dressings which prevent the 
wide aerial dissemination of bacteria, which can often be demonstrated to be present 
several hours after the change of dressings , may be helpful 1. 
Air-conditioning plants with contaminated filters can act as maJor reservoirs m the 
dissemination of viruses, Legionella spp. and other organisms , resulting in the 
development of respiratory tract infections which may assume epidemic proportions. 
Special air conditioning systems and the use of laminar flow , have been designed to 
prevent exogenous infection from airborne infected dust and droplet infection in 
vulnerable sites or especially vulnerable patients . 
Modern hospital design should provide the facility for the isolation of patients who are 
either at risk of developing, or who are a potential source of infection . Barrier nursing, 
the segregation of all articles in contact with the patient and hand washing are all 
important in the management of such problems. The incidence of nosocomial infection 
has been shown to be reduced when there is sufficient space between the beds and 
adequate numbers of hand basins are provided 40. 
Most studies confirm that , even with aggressive educational programmes 41 , hand-
washing is still not adequately performed 42 and , compliance with regular hand 
washing in staff of more than 48 % is difficult to achieve. The conversion of an open 
plan ICU to single isolation units was shown to reduce the number of staff-patient 
interactions, but failed to improve hand-washing techniques, in spite of conveniently 
located hand basins; the rate of nosocomial infection , although slightly lower, did not 
even approach statistical significance 43. An improvement in the rate of hand washing 
from 30% to only 48% following patient staff encounters, was shown to reduce the 
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incidence of nosocomial infection considerably in a study with an educational 
programme and motivated staff, reported as recently as 1992 42. In spite of extensive 
education and understanding of the importance of this simple method in preventing the 
spread of infection, handwashing continues to be neglected. 
Fomites may become contaminated with secretions and sedimentation of airborne 
infected dust, and thus act as an important reservoir of infection which may cause 
infection either by direct contact eg touching of bodies as in contact of clothes, hands 
or indirect contact involving an inanimate vehicle of infection such as eating utensils , 
door handles, towels and other fomites. Respiratory tract infections, skin, wound and 
burn infections may all arise in this way. Considerable environmental contamination 
has been shown to result from routine tracheal suctioning using a conventional catheter 
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The faecal-oral route of the spread of intestinal pathogens may be important where 
techniques of food preparation are inadequate, both in the hospital kitchen and where 
enteral or parenteral feeds are produced, but may also come into play where water 
filtration mechanisms break down and when water or other fluids become contaminated 
through inadequate hand-washing and hygienic control methods. 
Important sources of iatrogenic infection are intravenous fluids and medications (either 
for topical or intravenous use) which can easily become contaminated both during 
manufacture and, unless used before their expiry, while awaiting or during use. Careful 
control of each stage in the use of these fluids and agents has helped reduce the 
incidence of infection introduced in this way, but the constant potential for life-
threatening infection to be caused by this means, requires continued surveillance and 
scrutiny of each stage, to guarantee the safety of products designed for use in this way. 
Breakdowns in the sterility of invasive devices eg central venous catheters, intravenous 
cannulae, etc can occur at the time of production : during sterilisation, storage, 
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or at the time of utilisation; when the device is actually in situ and, even subsequently 
while in situ, if the portal of entry is not adequately cared for, and also at removal; 
thus allowing all the above mechanisms to introduce infection directly into the tissues 
or bloodstream. A system of careful checks at each stage is an ongoing necessity to 
prevent breakdown at any stage. 
The migration of organisms in the opposite direction to proposed drainage eg with 
urinary catheters has led to sophisticated valves and "no touch" techniques in an 
attempt to prevent the iatrogenic introduction of infection. 
Central to almost all of the above methods for preventing the spread of infection, are 
the simple techniques of hand-washing, thorough cleaning of the skin before embarking 
on invasive procedures, and the careful handling, storage and maintenance of the 
sterility of fluids , feeds and equipment. Such procedures are facilitated if the design of 
the hospital, ward or theatre permits easy and logical distinction between "clean" and 
"dirty" areas, and if there is a sequential flow in movement from the one to the other; 
something which is always made easier if there is adequate space. 
However, these in turn are all dependent upon high standards of staff training and 
motivation, which is, yet again, contingent upon there being an adequate complement 
of personnel to devote the necessary time to such procedures. This may often appear to 
be tedious and over-ambitious if the staff is over-extended. The bacteriological 
monitoring of staff may be indicated in certain high risk areas, or during outbreaks of 
infection. Alternative duties, or sick-leave, should be prescribed if staff members have 
skin or upper-respiratory tract infections, which can further jeopardise the health of 
those for whom they care. 
Highly topical at present is the spread of diseases such as Hepatitis B and HIV which 
are spread by the contamination or spillage of body secretions and blood products on to 
broken skin, or mucosae, or may be introduced by needle-stick injuries. Both clinical 
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and laboratory staff and patients are at risk from this iatrogenically introduced form of 
infection. The further discussion of techniques of prevention and the handling of 
needles and specimens is beyond the scope of this text. 
All of the above methods of spread and techniques of prevention - which are by no 
means a comprehensive list of the techniques being used in the prevention of exogenous 
infection - have had no impact at all on endogenous infection which, with the generally 
effective control of exogenous infection, is now recognised still to be a major cause of 
morbidity and mortality , and a problem which has been largely ignored. 
The problem of endogenous nosocomial infection is of particular relevance m the 
intensive care unit. As described above, the patient in the ICU provides very fertile 
"soil" for infection to develop, owing to the severity of the underlying disease, the 
effect of broad spectrum antibiotics both on the flora of the patient and the ICU. The 
use of invasive therapeutic and monitoring devices provide easy and obvious portals of 
entry; however, in spite of meticulous attention to sterile techniques and improved staff 
to patient ratios, infection has continued to occur, and the methods of infection control 
have now shifted to the prevention of endogenous or autoinfection, by means of 
selective decontamination of the digestive tract. 
The organisms causing endogenous infection are typically the organism shown to be 
colonising the patient, and thus usually his environment. Mechanisms leading to 
infection are dependent on the properties of the organisms and the breaching of the 
normal host defences described previously. 
3.4 Colonisation 
Colonisation is the persistence of an organism at a specific site, in the absence of either 
a host response, or adverse effects on the host, and is determined by the culture of an 
identical microorganism from the same site for a minimum of two consecutive samples. 
The problem in defining colonisation lies in when and whether it should be considered 
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to be pathological, particularly as abnormal colonisation probably precedes infection. 
As soon as there is host damage or inflammation, colonisation has clearly progressed to 
infection, similarly there are sites where colonisation is abnormal eg the bladder or the 
lower respiratory tract ; however, the colonisation of sites by organisms not normally 
found in those sites eg the presence of hospital-acquired potential pathogens in the 
upper airway is a more difficult "grey area", especially in the immuno-compromised 
patient. 
The normal flora contains only certain organisms owing to a variety of host, bacterial 
and environmental factors which have already been alluded to. Although the flora in an 
individual may change from time to time, and with age, the tendency is for it to remain 
fairly stable, and the relative proportions of organisms found in any individual are 
characteristic of that individual. There are also specific anatomical sites for specific 
organisms, so that cultures of the buccal mucosa will reveal a different spectrum of 
organisms to that in the nasopharynx, even though the areas are contiguous. The 
characteristics of the normal flora include the concept that there may be sterile areas 
contiguous to areas that are massively colonised Eg the upper and lower airways, the 
oropharynx and the stomach. 
Bacterial interference was first described by Louis Pasteur, who noted that if urine was 
contaminated with Anthrax bacilli, the bacilli not only failed to multiply but were 
actually killed. This is an important mechanism for maintaining the normal flora and 
probably results from the production of bacteriocines by the normal bacterial flora, 
which have an inhibitory, or bactericidal effect, on other bacteria. Substrate utilisation 
in a preferential fashion by one species over another, and alterations in the physico-
chemical environment, may be further mechanisms which may produce unfavourable 
conditions for other species to survive. Bacterial adherence is also important in 
determining which type of organisms comprise the normal flora of a particular site; it 
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can be demonstrated that the resident flora adhere readily to the intact surfaces of the 
area in which they are usually encountered. 
The flora in the hospital differs from that in the community and the colonising bacterial 
flora therefore changes gradually following admission to hospital. These changes are 
more pronounced when the admission is to the Intensive Care Unit rather than to the 
general ward, because of a variety of host factors, antibiotic pressure and other factors 
which affect the organisms and the environment. The transference of organisms on the 
hands of staff, leads rapidly to the colonisation of patients by the resident flora. 
Further, the patient's own gastrointestinal flora may become translocated from one site 
where there is normal colonisation, to other sites. 
Gram negative bacilli (AGNB) are found in the oropharyngeal flora of 2-10% of 
normal, healthy individuals and the prevalence of such organisms is no greater in 
healthy hospital personnel than in those who have no hospital contact4. The prevalence 
of these organisms also does not increase in those who are hospitalised for non-medical 
reasons. However, in those who are ill, stressed or aged, the prevalence of colonisation 
by AGNB increases with the severity of their illness45 , 46 and may occur rapidly. The 
colonisation of the trachea and oropharynx of critically ill patients by AGNB is related 
to the underlying disease eg those with cardiac arrhythmias admitted for observations 
show a much lower incidence than those admitted in cardiogenic shock 5 which may be 
due to a variety of host factors or bacterial host interactions. Studies have shown the 
presence of AGNB colonisation of the respiratory tract in over 80% of patients who 
were not colonised pre-operatively. 47 Such colonisation appears to be related to the 
duration of the procedure, and the presence of underlying disease rather than the simple 
introduction of these organisms by the passing of an endotracheal tube. 48 
Alteration in, or loss of, the cell-surface fibronectin layer on the buccal surfaces, due to 
an increase in the proteolytic activity of the oral secretions 49 , may predispose to the 
adherence of Gram negative bacilli, by exposing receptors for bacterial binding -
35 
although the exact mechanism for the increased proteolytic activity is uncertain. There 
is a reciprocal relationship between the cellular binding of Gram positive cocci and the 
AGNB. Thus colonisation of an area is dependant on the host environment specifically 
related to the site, host interactions with the colonising microorganism, the interaction 
with the colonising microorganisms and the flora already present, and certain intrinsic 
properties of the microorganism which favour its colonisation under certain 
circumstances, such as the presence of pili or other adherence mechanisms. 
The micro-environment in which bacteria meet the epithelial cells is also a determinant 
of adherence. Both the protease and mucin components of the respiratory secretions can 
influence whether or not bacteria bind to the epithelial surfaces. Mucins can serve as 
receptors for bacterial binding, and thus have the capacity to competitively inhibit 
binding if they bind to bacteria, rather than to the cells. However. if the mucins attach 
directly to the cellular surface, they may then act as a receptor "bridge" for the 
bacteria, and further increase the capacity of the epithelium to bind bacteria 33. 
Todd et al 24 studied the correlation between bacterial adherence to tracheal epithelial 
cells, and the effect of intubation and its duration, on the acquisition of pneumonia in 
the ICU. They were unable to show any correlation between intubation or its duration 
and the bacterial adhesion index, although an increased adhesion index alone did 
correlate with an increased risk of pneumonia. Using adherence of Pseudomonas 
aeruginosa to the trachea as a model, they showed that the maximal number of 
bacterial receptor sites per tracheal epithelial cell was higher in noninfected subjects; 
which would suggest that an increased adhesion index in patients is not due to the 
creation of a larger number of receptor sites, but rather to a change in the tracheal 
epithelial surface, which alters bacterial binding. They suggested that this change in the 
cell surface which resulted in elevated or augmented bacterial adherence and the 
development of pneumonia, was possibly due to the nutritional status of the patient 
causing alterations in the levels of elastase, secretory IgA, or an altered pH in the 
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airway. They reviewed a number of other factors which also might have been expected 
to alter bacterial adherence, such as smoking, age, sex, whether the patients were fed, 
the method of feeding, the administration of antibiotics, and the presence of renal 
failure, but were unable to demonstrate that any of these factors had an effect on 
bacterial adherence. 
Niederman has shown that tracheal cells are able to bind Gram negative bacteria and 
that Pseudomonas aeruginosa exhibits greater affinity to tracheal than to buccal cells22. 
Further he was able to show that there are host factors which determine this increased 
tracheal adherence to bacteria such as malnutrition, possibly by directly altering the 
ability of the tracheal cells to bind to bacteria 23. There are also bacterial factors which 
help to determine the site of binding . Pseudomonas aeruginosa preferentially colonises 
the lower respiratory tract50, but other Gram negative bacilli show the opposite 
phenomenon: Enterobacrer aerogenes , K/ebsie!la pneumoniae , Escherichia coli, 
Proteus mirabilis and Enrerobacrer cloacae all were shown to preferentially colonise 
the oropharynx when serial paired samples of oropharyngeal and tracheobronchial 
cultures were taken from patients with endotracheal tubes requiring mechanical 
ventilation for chronic cardiac or respiratory disease51 . 
3.4.1 Relationship between Colonisation and Infection 
The contents of the normal stomach are sterile , or have only low counts of oral 
microorganisms , owing to the bactericidal activity of the normally very low pH of 
gastric juice. Other defence mechanisms, as outlined previously. include the protective 
effect of the normal enteric flora , the presence of specific intestinal immune 
mechanisms viz. phagocytic , humeral and cell mediated. However, microbial 
overgrowth has been demonstrated to occur in the stomach of critically ill patients and 
to be a source of bacteria colonising the trachea and respiratory tract . 52. The 
organisms are most commonly AGNB , which can be demonstrated to colonise the 
stomach before they are isolated from the tracheal aspirate . 
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It is well known that aspiration of pharyngeal secretions occurs in up to 70 % of normal 
individuals during sleep and seemingly without ill effect, yet the lower respiratory tract 
remains sterile. The explanation for this must lie with the size of the inoculum, 
bacterial virulence and the intact host defences. 53 
du Moulin et al 54 were able to demonstrate similar organisms when culture of the 
oropharyngeal secretions and gastric aspirates were performed, in patients being treated 
with antacids ; they were also able to show a clear sequence of transmission from the 
stomach to the airway in a high proportion of subjects, with the subsequent 
development of pneumonia caused by AGNB, whereas in those whose flora differed at 
the two sites, pneumonia did not occur. 
There have been a number of studies which have demonstrated that colonisation of the 
stomach is promoted by antacids and H-2 antagonists or an increase in pH 30,54-59. 
There is also a qualitative change in the organisms. with the presence of higher 
numbers of anaerobes and AGNB being isolated.57 At a pH of greater than 4, rapid 
colonisation of the gastric aspirate occurs, predominantly with coliforms and yeasts , 
whereas below 4, significant bacterial growth is rare. 
It is uncertain how the organisms which colonise the stomach in critically ill patients 
initially arrive there. The assumed mechanism is that gastric colonisation follows 
colonisation of the oropharynx; the stomach then acts as a reservoir of bacteria for 
further colonisation. The increased bacterial load eventually overwhelms the lung's 
defences against infection and pneumonia results. The fact that AGNB may first be 
isolated from the stomach , suggests that the organisms may reach the stomach from the 
lower gastrointestinal tract, either because of ileus, or by reverse peristalsis. 
Alternatively the stomach, oropharynx and trachea may all be colonised separately in 
sick patients with diminished host defences, rather than requiring a stepwise 
transmission of organisms from one site to another. 
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Colonisation of the lower airways and pneumonia are more likely after oropharyngeal 
and gastric colonisation, because aspiration of secretions is more likely to involve 
potentially pathogenic microorganisms which have already shown themselves to be 
suited to the abnormal environment of the critically ill patient. 5 Part of the rationale for 
the technique of selective decontamination hinges on this, because if oropharyngeal and 
gastric colonisation are necessary antecedents for the colonisation of the lower airway, 
this and the subsequent development of pneumonia should be preventable by 
elimination of the colonising organisms from these sites. However, it would seem that 
colonisation of the lower airway can occur independently of colonisation of the upper 
airway or either the oropharynx and stomach, in the mechanically ventilated patient 39. 
The aerobiology of inhaled micro-organisms appears to be a major factor in bacteria-
host interaction , and in determining the development of disease. Experiments on mice 
have shown that the response to inhaled Srreprococcus pneumoniae depends on whether 
they are delivered as an aerosol of monodispersed organisms, or as a cloud of 
aggregated bacteria. When bacteria are inhaled in the aggregated form , a smaller 
inoculum has been observed to cause saturation of the pulmonary macrophage system 
and induction of a neutrophil response, than when they are administered in an 
aerosolised form 60. Similar findings were reported by Berendt 3 l who demonstrated 
that the virulence of Klebsiella pneumoniae was significantly less when administered to 
mice and squirrel monkeys by aerosol , than when it was instilled either into the nose or 
trachea. It seems that aggregated bacteria are more resistant to phagocytosis than are 
monodispersed organisms. 
3.4.2 Factors Influencing Colonisation 
The risk factors for bacterial colonisation appear to be the severity of illness, a 
prolonged duration of hospitalisation, prior or concomitant use of antibiotics, an 
elevated gastric pH, azotaemia, the presence of underlying disease of the organ system 
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which becomes infected, and most important of all, particularly m the ICU, the 
presence of invasive devices. 
1) Gastric pH 
The controversy over the role of H-2 blockers/antacids in causing pneumonia in 
critically ill patients has now raged for over 10 years; while increased bacterial 
colonisation of the stomach can clearly be demonstrated in patients receiving such 
therapy 6l, patients at risk of stress ulcers in the ICU setting are already extremely ill 
and thus already at risk of abnormal bacterial colonisation. With altered gastrointestinal 
motility, there is a further predisposition to the development of upper gastrointestinal 
colonisation by AGNB, yeasts or flora more typically found lower down the 
gastrointestinal tract, but it is more difficult to show cause and effect than merely to 
demonstrate an association. 
Craven et al 30 analysed the risk factors for pneumonia and mortality in patients 
receiving mechanical ventilation and showed that pneumonia occurred in 21 % of 
ventilated patients. They identified a number of factors which were individually 
predictive, by univariate analysis, of the risk of developing pneumonia: the presence of 
an intracranial pressure monitoring device, hospitalisation during the winter months, 
the change of the ventilator circuitry every 24 hours rather than every 48 hours and the 
use of cimetidine therapy. This indirect evidence was reported without data on gastric 
colonisation but interpreted to implicate H-2 antagonists as a distinct risk factor for 
pneumonia, which was further associated with a high mortality in the study. 
Tryba 55 reported a prospective randomised double blind trial for the prophylaxis of 
stress bleeding, comparing the efficacy of sucralfate and antacids and showed that 
nosocomial pneumonia developed rn significantly fewer patients who received 
sucralfate. Driks et al 62 found an incidence of nosocomial pneumonia among 
ventilated patients receiving antacids combined with H-2 antagonists of 49%, compared 
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with only 23% in those receiving sucralfate, but surprisingly, in those receiving an H-2 
antagonist alone the incidence of pneumonia was still lower at only 6 % . Although their 
results fell short of statistical significance, they did show that there was less gastric 
colonisation in the sucralfate group. These studies failed to prove that either antacids, 
or H-2 blockers alone, increase the incidence of pneumonia; perhaps because a single 
agent applied in conventional doses does not invariably achieve alkalinisation, whereas 
a combination may be more effective in achieving this, and thus increase the incidence 
of pneumonia. Cook et al 63 performed a meta-analysis of the evaluable studies and 
showed that the incidence of pneumonia was lower in critically ill patients receiving 
antacids and/or H-2 blockers than no stress ulcer prophylaxis at all. With the current 
data, it would seem that the use of sucralfate is associated with a lower incidence of 
nosocomial pneumonia than with agents which raise the gastric pH, but this is an area 
in which funher study is still needed 63,64. The gastric luminal pH is elevated in many 
patients in the ICU who are not receiving any form of stress ulcer prophylaxis. This is 
thought to be due to splanchnic hypoperfusion 62, and the inhibitory effect of hypoxia 
on the energy requiring process for acid generation, and further complicates the 
interpretation of results on drugs designed to alter the gastric pH. 
The incidences of pneumonia reported by both Tryba and Driks (33 % and 16 % ) are 
similar to those normally encountered and the incidence in both studies in the patients 
receiving sucralfate was unusually low (10 and 7%) - suggesting that sucralfate may 
have some other beneficial effect independent of gastric pH. Tryba and Mantey-Stiers 
investigated the antibacterial activity of sucralfate in gastric juice, compared with 
antacids and control, and confirmed that inhibition of the growth of Pseudomonas 
aeruginosa by sucralfate did indeed occur. 59 Other mechanisms are still being 
investigated and include the influence of sucralfate on the production of prostaglandin 
E2, mucus secretion, and mucosal blood flow , which may all serve to maintain the 
integrity of the whole gut mucosa. There is also experimental evidence that sucralfate 
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can reduce bacterial translocation across the intact gut wall, which may also play a role 
in the pathogenesis of nosocomial pneumonia 65. 
2) The Endotracheal Tube 
Mechanical ventilation itself has been viewed as the maJor risk factor for the 
development of nosocomial pneumonia in the intensive care unit, the risk seems to 
increase with the duration of ventilation and appears to be maximal within the first 10 
days of intubation 66. The endotracheal tube serves to connect the patient to the tubing 
of the ventilator. It is thus able to increase the risk and susceptibility of the patient to 
infection through a variety of mechanisms. 
The endotracheal tube by-passes the natural defences of the pharynx, namely the 
epiglottis, the false and true vocal cords, the mucociliary escalator, the non-specific and 
the specific immune mechanisms located in the mucosal walls of the pharynx and 
trachea, and the cough reflex; thus serving to allow the direct introduction of 
potentially contaminated secretions, or condensation from the humidifier or whatever 
foreign matter or biofilm is in its lumen, to the lungs 67, 68. 
The endotracheal tube also acts as a foreign body and, however soft the manufactured 
substance may be, a certain amount of trauma to the pharyngeal mucosa, the larynx and 
the tracheal epithelium is inevitable. By traumatising the epithelium, its properties 
change and the ability of bacteria to adhere to the altered surface, predisposes to 
colonisation by potential pathogens and thus to infection both at the local site and more 
distally in the lungs. 
By breaching the larynx, the cough reflex is abolished and, although this is often so 
poor that it has been one of the indications for intubation, the placement of the tube 
imposes a need for careful suctioning of retained secretions. The secretions from the 
lower airway are often infected and are well recognised to be an important cause of the 
further dissemination of existing infection by the so-called bronchogenic route. Even if 
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the secretions are not primarily infected they serve as an ideal culture medium for 
bacteria to proliferate and need aggressive management by nursing staff and respiratory 
therapists. 
It has been suggested that tracheal suction dislodges biofilm from the tracheal tube and 
carries it into the lungs. Biofilm is a matrix of bacteria and glycocalyx that has been 
shown to build up on the surface of tracheal tubes used for prolonged periods 68. Such 
a mechanism would explain the dissemination of bacteria to the larger airways distal to 
the carina, further dissemination to the smallest airways is thought to be the result of 
this biofilm being broken up and scattered as small contaminated particles by the 
process of mechanical ventilation. The accumulation of biofilm seems to be a time 
related phenomenon - the longer the tube is in situ, the greater the accumulation. 
However there are a number of other factors which influence its formation including 
the quantity of respiratory secretions produced , the frequency of tracheal suction and 
the type of humidification system used. The bacterial colonisation of the inner lumen of 
the tube, seems to be via an endogenous route , because it has been demonstrated to 
occur even with the presence of microbial filters in the ventilator circuit. 69 
There is impairment of the normal swallowing mechanism while an endotracheal tube is 
in place, purely on a mechanical basis, but also depending on the underlying disease for 
which the tube is in place. Swallowing normally plays an important part in the 
mechanical clearing of bacteria and secretions from the naso and oropharynx. It also 
protects against the aspiration of secretions from the pharynx and gastrointestinal tract. 
When swallowing is impaired, there is an increased risk of the pooling of secretions in 
the oropharynx, and of aspiration past the endotracheal tube and into the lungs, 
particularly if the secretions are copious and thus not easily dealt with . Furthermore, 
the flora of the mouth changes with the presence of a foreign body such as an 
endotracheal tube, so that AGNB, yeasts and faecal flora may predominate, increasing 
the infectivity of the secretions. 
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Although the endotracheal tube is designed both to facilitate mechanical ventilation and 
to protect the airway, its ability to protect the airway is not entirely foolproof. If the 
catheter used for suctioning is not sterile, or the technique of usage is inadequate, the 
contaminated upper airway secretions can actually be carried and introduced lower 
down . One of the ways in which secretions may bypass the tube is via the cuff. Part of 
the tracheal toilet performed as routine care in the ICU is regular suctioning down the 
endotracheal tube; however, it is not possible to clean or suction down the sides of the 
tube. The epithelium on the sides of the pharynx and trachea continues to produce 
secretions, and secretions from above may pass down the sides of the tube and thus 
accumulate above the cuff. In order to prevent erosion and pressure necrosis of the 
trachea, it is part of routine nursing care to adjust the pressure on the cuff which may 
involve letting it down somewhat; alternatively, the cuff has a constant slow leak which 
may be increased by coughing or other changes in intrathoracic pressure which alter the 
intra-tracheal diameter. In either event, the net result is that secretions which have 
accumulated around the cuff are allowed to pass directly into the lower airway, thus 
easily introducing a potential source of infection. The application of positive end 
expiratory pressure, which limits the degree of negative intrathoracic pressure, helps to 
prevent aspiration around the cuff. 
The nasotracheal tube is advocated by many because of its stability and the improved 
comfort that it affords the patient. Owing to its natural stability, the patient does not 
require as deep sedation to maintain a secure airway as with an oral tube, and is 
therefore able to be mobilised considerably more actively. It is thought that this active, 
early mobilisation may also be beneficial in preventing the development of pneumonias, 
as well, of course, as deep venous thrombosis, pressure sores etc 70, 7 l. The 
nasotracheal tube tends to ride up and down less than its oral equivalent and thus may 
prevent laryngeal and mucosa! injury through constant chafing which can lead to local 
ulceration and infection , with the obvious risk of seeding farther down the airway. 
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However, its opponents claim that the above are far outweighed by the increased risk of 
sinusitis caused by the obstruction of the sinus orifices in the nose. 
Sinusitis certainly is a well recognised site of, often occult, nosocomial infection, and 
computerised axial tomography (C.T.) scanning of the sinuses in patients with 
nasotracheal tubes does show the presence of mucosa! thickening in a high proportion 
of cases 72 . This however should not be regarded as proof that there is infection in this 
area, and X-rays showing air-fluid levels may actually be of more value. In any event, 
if there is concern , the tube can be withdrawn and replaced. Often if there is 
obstruction, the very act of removing the tube is reported to allow the free drainage of 
accumulated pus, thus resolving the problem. One last advantage of the nasotracheal 
tube over its oral counterpart, is that oral toilet is greatly facilitated which is important 
in preventing excessive oral colonisation from developing, and spilling down the 
pharynx. 
In spite of all the above, emotions run high in individual units all over the world as to 
which placement of endotracheal tube is to be preferred. Part of the problem is 
probably due to there being very little careful analysis in the literature of the relative 
merits of either technique. 
Outbreaks of pharyngeal colonisation with microbes which may lead to infection have 
also been reported from the use of contaminated ventilatory equipment, such as 
anaesthetic equipment, ventilators, and nebulisers for the administration of medication 
and not only due to the endotracheal tube. The ventilator tubing can lead to infection if 
there are breakdowns in the disinfection process eg Pseu.domonas aeruginosa 73 was 
found to contaminate respiratory tubing which did not dry adequately during the 
disinfection process. Initially it was recommended that the tubing should be changed 
every 24 hours to prevent infection, however new evidence suggests that this may 
actually serve to increase the incidence of infection by allowing the spillage of heavily 
contaminated condensate into the tracheobronchial tree during manipulation, and the 
recommendation at present is that the ventilator tubing should be changed every 48 
hours 30. 
One of the main sources of contamination in this setting is the large volume nebuliser, 
such as the Venturi nebuliser, as the aerosolised droplets emitted can deliver large 
numbers of Gram negative bacilli directly to the terminal bronchioles and lead to 
pneumonia. Cascade humidifiers reduce the problem somewhat by allowing the gas to 
bubble through water maintained at a pasteurising temperature prior to delivery, and 
thus preventing the generation of the microdroplets; however, contamination of the 
cascade humidifier can still occur during the cleaning process, or when replenishing the 
water, or if the temperature is inadequate. Modern paper-wick humidifiers (eg Fisher -
Paykel) that humidify at a higher temperature are less likely to become contaminated 
and are now the humidifiers of choice 29,74 . The organisms commonly encountered in 
these circumstances include: Pseudomonas aeruginosa or cepacia, Serratia marcescens, 
Acinetobacter baumanii and Flavobacterium menigosepticum. 
Ventilation may also be carried out via a tracheostomy tube. Although this circumvents 
the problems associated with sinusitis and poor oral hygiene, the problems pertaining to 
the cuff still remain, as the pooling of secretions above it may still occur, and cause 
erosion into the sides of the trachea. There may also be associated wound infection with 
the problem of introduction of organisms from the wound directly into the airway. 
Unfortunately there are again no adequate studies evaluating the place of the 
tracheostomy compared with the endotracheal in the ICU setting specifically. High 
rates of complications and infection rates are published 29, but these report the 
incidence in the general hospital, and thus probably relate to the larger 
otorhinolaryngeal patient population, who have primary laryngeal problems with 
longterm tracheostomies, and are receiving lower grade care in the general ward for a 
different type of disease process. 
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In spite of all the above, it is the severe impairment of airway and pulmonary defence 
mechanisms following the onset of a critical illness that seems to be the most important 
factor in the pathogenesis of pneumonia. 
47 
3) The nasogastric tube 
The presence of a nasogastric tube has been shown to be associated with a higher 
incidence of nosocomial pneumonia 30, which may be due to the adherence of bacteria 
to the foreign material, facilitating their migration from the stomach to the oropharynx, 
and thence to the trachea; the breaching of the oesophageal sphincter may also play a 
role 62, as larger quantities of both gastric and oropharyngeal secretions are aspirated 
with a nasogastric tube in situ. 
By performing cultures of the oropharynx , trachea and stomach before and daily for 5 
days after feeding was begun, Pingleton et al 58 were able to show clearly that 16 of 18 
patients developed tracheal colonisation; of whom 6 had no evidence of preceding 
colonisation at another site. In the other 10 there was evidence of the organisms on 
gastric culture prior to tracheal culture in 5, and of oropharyngeal to tracheal 
transmission in 3. In some, more than one mode of transmission was apparent. 
Nosocomial respiratory infections occurred in 11 of the 18 patients. One of these 
infections was associated with transmission of a gastric organism. They suggested that 
colonisation of the trachea by gastric flora may be associated with enteral nutrition, 
thus resulting in nosocomial respiratory infections. 
The nasogastric tube is placed in the ventilated patient to prevent gaseous distension of 
the stomach, to avoid the problem of aspiration , which is a particular risk in the 
critically ill patient where gastrointestinal motility is often uncertain, and to facilitate 
enteral feeding in patients who are unable to swallow. However, the nasogastric tube 
itself may increase the risk of aspiration. It also acts as a foreign body which may 
increase the risk of oropharyngeal colonisation 75; by impairing swallowing, it may 
encourage the pooling and accumulation of secretions in the mouth; by breaching the 
lower oesophageal sphincter, it may promote gastric reflux , and also acts as a conduit 
up which bacteria may migrate to the oropharynx. The size of the nasogastric tube may 
play a role in determining the likelihood of aspiration and infection. While large bore 
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tubes clearly may cause greater impairment of deglutition and the oesophageal sphincter 
and thereby allow greater quantities of secretions to pass into the lungs, the fine bore 
tubes, which cause less mechanical effect, may themselves migrate into the lungs. 
4) The urinary catheter 
Almost all nosocomial urinary tract infections occur in patients who have undergone 
some form of instrumentation; the commonest form of instrumentation being 
catheterisation, which accounts for about 80% of hospital-acquired urinary tract 
infections 76. The remainder are not associated with urological manipulation and 
presumably arise from haematogenous dissemination, although the exact mechanism is 
uncertain. 
Until the 1950s the urethral catheter system involved drainage into an open container 
with the almost inevitable development of early infectious complications. The 
indwelling urinary catheters in use in the modern hospital and ICU have a closed 
drainage system so that the system remains connected for the duration of 
catheterisation in an attempt to reduce the incidence of colonisation and infection and, 
although there are no studies comparing the two techniques, it would appear that the 
incidence of urinary tract infection has almost certainly been reduced by this 77, with a 
prolongation of the time from insertion to the average time of onset of infection. 
The same mechanisms predisposing to colonisation hold for urinary tract infections, the 
organisms being predominantly the patient's own colonic flora, their source being the 
perineum, vagina with the close proximity of this area to the faecal and lower intestinal 
flora. The majority of infections arise from colonisation of the catheter by the 
introduction, or migration, of organisms from the perineum, which gain access to the 
bladder along the external surface or lumen of the catheter. The tube offers a niche on 
its surfaces for bacteria to develop a microenvironment within a biofilm layer32. This 
glycocalyx covers and secures the bacteria against the mucosal or catheter surface and 
has been demonstrated to be present on drainage bags, catheters, and the uroepithelium; 
it seems to offer protection from antibiotics, host defence mechanisms and even the 
mechanical flow of urine. The biofilm may permit the development of a 
microenvironment in which the organisms may move into the urine, where they are 
measured and detected as bacteriuria. The uroepithelium may allow more easy bacterial 
adherence in catheterised patients which may precede the onset of bacteriuria 78 , in 
addition the bacteria maintain themselves within the urinary tract by interaction with 
the surfaces to which they can adhere by means of specific adhesins, including fimbria 
and pili. 
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Further pathogenic mechanisms may include the inflammation of the bladder and 
urethra from mechanical and chemical irritation, which may also blunt the antibacterial 
function of the polymorphonuclear leukocytes. The organisms may also promote the 
formation of struvite and apatite crystals which can lead to catheter obstruction, 
increased intravesical pressure , transmucosal migration or vesicoureteral reflux of 
bacteria 78. 
Even with meticulous attention to catheter care, the opportunity exists for bacterial 
entry at the external meatus between the catheter and the urethral mucosa. The 
colonisation of this area within 24 hours with hospital type pathogens has been 
demonstrated and once such organisms exceed a certain density, bacteriuria results. 
Even after catheter removal, patients may develop bacteriuria which may be related to 
the presence of pathogens already present in the urinary tract during catheterisation. 
The indwelling catheter system may be opened at two sites once in place: the junction 
between the catheter and the collection tube may be disconnected for irrigation or urine 
collection and bacteriuria may result from this. Alternatively, the drainage tube of the 
collection bag has to be opened periodically and if the lumen of the drainage tube is 
contaminated with bacteria from an unwashed, contaminated jug previously used to 
collect urine from an already infected patient, organisms may enter the drainage bag 
and multiply to high concentrations, persist in the bag and ascend the surface to the 
tubing or be passed into the patient by refluxing urine. 
Unless the organisms are adequately dealt with as they colonise the bladder, they may 
migrate further up the urinary tract to involve the kidneys, where a similar 
microenvironment may be set up with the invasion of the interstitium and the 
development of pyelonephritis. 
The organisms responsible for unnary tract infections in the community are 
predominantly the Enterobacteriaceae; under normal conditions 80% of community 
acquired urinary tract infections are due to Escherichia coli, however in the hospital 
Proteus, Klebsiella and Pseudomonas species as well as Candida and other yeasts 
assume importance with the use of broad spectrum antibiotics, the presence of foreign 
bodies, the possible introduction of the hospital organisms on the hands of staff, as well 
as the common occurrence of stress-induced glycosuria altering the environment. The 
same factors as previously highlighted affecting the colonisation of the hospitalised 
patient operate in this site, so that hospital-type organisms are again encountered. 
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5) Percutaneous Intravascular Devices 
Included in this broad heading are peripheral and central venous catheters, arterial 
lines, pulmonary artery catheters, arterial lines and central lines for total parenteral 
nutrition. Brief mention only will be made of the catheters placed for longterm central 
venous access such as the Hickman catheter, which is not used in our respiratory ICU, 
although the haematologists make extensive use of it for the administration of drugs in 
their patients where access becomes a difficult problem. 
It is estimated that 25 % of all admissions to hospital m the United States receive 
intravenous infusions and that the mortality of patients with primary nosocomial 
bacteraemia is 14 times higher in those patients who develop this complication 
compared with those who have the same primary diagnosis without bacteraemia 79 . 
The types of infection that may result include wound infections, tunnel infections, 
bacteraemia (which may often occur without any local signs), septic thrombophlebitis, 
and infective endocarditis etc.; these infections may then disseminate to other sites with 
the development of metastatic abscesses. 
Bacteria may gain access to an intravascular device at several sites 79,80: the skin 
remains the most important site for potential contamination, however contamination 
may also occur at the junctions of catheter and administration sets, where the spike of 
the administration set is inserted into the fluid container; such contamination may occur 
when the container is initially set up , or whenever the container is changed. The 
container itself may of course be defective and its contents thus contaminated, or the 
sterilisation process may have been inadequate for a number of reasons so that the 
contamination of the infusate has already occurred. The air filter of the container too 
may malfunction and thus allow contamination. The relative importance of these other 
sites has not been assessed. 
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Further portals of entry for contamination include pressure measunng devices and 
transducers, heparinised flush solutions, stopcocks, piggyback IV lines, Y-junctions, 
CVP manometers. Again, handwashing as a preventative measure when handling such 
devices cannot be over-emphasized. 
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The contamination of the infusate has been well shown to be a potential source of 
infection, as the recently much publicised local court cases involving several paediatric 
deaths related to the infusion of intravenous solutions contaminated during admixture 
procedures, have reminded us all of this risk. Different types of solutions support the 
growth of different types of bacteria80, but even distilled water can harbour 
Pseuaomonas cepacia. Klebsiella and Enterobacter species as well as Citrobacter 
freundii and Serratia marcescens are frequently associated with contaminated infusions. 
The routine use of bacterial filters to prevent this extrinsic source of infection is not 
recommended 79 as the incidence of infection has not been shown to be affected and 
the bacteria retained in the filter are still able to produce endotoxin which enters the 
patient along with the infusate. 
The high nutritional value of parenteral nutrition solutions predisposes to their 
contamination by bacterial flora and they may be contaminated both at the industrial 
site of manufacture and also in the pharmacy when then they are reconstituted. They 
form excellent substrates for the growth in particular of Candida albicans, and the 
other Candida species 81 ; Malassezia fwfur is another yeast which is lipid dependant 
and fungaemia has been associated with its growth in lipid emulsions. 
Blood and related products are well-recognised sources of infection from viral and 
other causes but will not be dealt with further, except to mention that platelet infusions 
carry with them a higher risk of catheter related sepsis than other products. 
Contamination at the catheter insertion site is thought to be an important means of entry 
for microorganisms. The hub of the catheter is the portal of entry in over 50% of cases 
and the insertion site is the portal of entry in approximately 50% of instances. The skin 
flora may change owing to the use of antibiotics or the colonisation by hospital type 
organisms which are carried on the hands of the staff 82 , or transmitted indirectly 
through contact with fomites. Any breaks in the skin's integrity also predipose to 
colonisation by other bacteria and increase the likelihood of infection. Colonisation 
around the catheter site may facilitate the ingress of organisms along the external 
surface of the catheter. 
Such factors as the type of dressing may increase the bacterial load around the entry 
site and promote colonisation. The use of semipermeable membranes for dressing the 
site which can be visualised through this has not been shown to reduce the incidence of 
infection over plain gauze dressings although the cost may differ considerably 83. 
Changing the catheter every 48 hours does not seem to alter the infection rate compared 
with daily changes, but a catheter left in situ for more than 72 hours is generally 
thought to be associated with a much greater risk of infection80 although more recent 
studies would suggest that the routine changing of catheters to prevent this is. unlikely 
to reduce the risk if strict standards of asepsis are adhered to84,85. 
The importance of handwashing to prevent the introduction of infection at these sites is 
well known and cannot be over-emphasized, this may be an area where epidemics are 
transmitted on the hands of the staff. Even the cleansing solutions or ointments applied 
to the catheter site to prevent infection may become contaminated and serve to transmit 
infection from patient to patient. The use of such ointments has not been shown to 
reduce the incidence of drip-site infection86. Similarly the removal of the catheter 
needs to be performed with care, including the thorough cleansing of the skin before 
removal, because this manipulation may also result in the showering of bacteria into the 
circulation. 
The composition of the catheter, the presence of thrombus in association with the 
catheter, the nature of the pathogen, the duration of catheterisation, the duration and 
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intensity of bacteraemia and the host's immune status may all determine whether 
infection results80. 
The intensive use of the catheter for pressure monitoring and the taking of samples or 
other manipulation eg for repositioning is also associated with an increased likelihood 
that the catheter may become contaminated. The more frequently any part of the 
administration set is handled and the system entered, the greater the chance that line 
related sepsis may follow87. 
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There are characteristics of the catheter which also determine its potential to cause 
infection80. Certain catheters are more prone to lead to the complication of thrombosis, 
by causing irritation of the intima of the vessel wall and this may initiate a nidus for 
bacterial colonisation and infection. Polyvinylchloride catheters are more rigid and 
thrombogenic than the newer, more flexible silicone elastomer and polyurethane 
catheters which have been shown to be associated with a lower incidence of catheter-
related sepsis. 88 Polyurethane catheters are at present the catheters shown to be 
associated with the lowest risk of infection, followed by silastic, teflon, 
polyvinylchloride and silicone, in that order although doubtless there are new materials 
just around the corner which will be able to improve on those currently available. The 
composition of the catheter may also favour bacterial adherence and thus its 
colonisation by microorganisms eg polyvinylchloride catheters are more easily 
colonised than Teflon catheters. A loosely formed clot quickly forms around the 
intravascular segment of plastic catheters. Clot formation facilitates the colonisation of 
the site by trapping circulating microorganisms. The type of material that is in contact 
with the circulation can determine the thickness and adhesion of the thrombic layer -
polyurethane causes less clot generation than polyvinylchloride 87. Metal catheters also 
have a lower colonisation rate than plastic ones85. All catheters, however, develop a 
fibrin sleeve around them sooner or later, which extends into the vessel and provides a 
potential site for bacterial colonisation. 
The size of the catheter also plays a part in increasing the risk of infection and the 
larger the catheter, the bigger the skin defect and the greater the potential for infection 
to occur. A number of studies also suggest that the use of triple lumen catheters is 
associated with a higher incidence of infection than single lumen catheters although 
this is contraversial. 80,87,89 
The site of the catheter also determines the frequency and likelihood of the 
development of infection; it is well known that femoral catheters become contaminated 
more rapidly than stibclavian or internal jugular central lines because of the 
unavoidable proximity to the perineum; some studies have shown that internal jugular 
lines are more likely to become contaminated than subclavian lines possibly because 
this site is more difficult to keep immobile and sterile 90; similarly central lines 
become contaminated less frequently than peripheral lines. However, a central venous 
line often remains in situ for much longer than a peripheral line and this may result in 
life-threatening complications such as infective endocarditis or thrombophlebitis 
involving the great veins. 
Pulmonary artery catheters are central venous lines which not only enter the great 
veins, but also traverse the tricuspid and pulmonary valves of the heart to enter the 
pulmonary circulation; the risk of infection and the potential for serious complications, 
including bacterial endocarditis, thus is still greater87. 
Arterial lines used for blood pressure monitoring and for the easy taking of specimens 
in patients who are unstable and need repeated blood gas monitoring are frequently 
used in the ICU. Because of the faster flow of the circulation, such catheters are at a 
lower risk of colonisation than venous catheters 8S, although with prolonged placement 
or less than perfect asepsis in insertion or maintenance, there is the risk that they too 
may become infected. Another source of potential contamination is the flush bag and 
transducer set which is reusable and thus brings with it the risk of breakdown in the 
sterilising procedure. 
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The catheters used for total parenteral nutrition often remain in place for much longer 
than other central lines80 , the solutions that they administer are very hypertonic and 
both of these factors increases the tendency to venous thrombosis 81 and infection; 
added to this , the patients who require prolonged parenteral nutrition are often much 
sicker so that their diminished host defences also render them susceptible to infection 
81 _ Guide-lines have been published by the Centre for Disease Control to prevent 
potential complications associated with TPN.91 which include guide-lines for the sterile 
preparation of the solutions, sterile technique in the placement of the line, that the line 
should be firmly secured to prevent movement, that the system should be kept closed 
and where possible dedicated to TPN. 
Studies using antimicrobial creams, heparin or tunnelling of the line have shown 
inconclusive results in preventing infection , although part of the problem is the 
difficulty of diagnosing sepsis related to the catheter site 8l ,90 - the tendency being to 
err on the side of suspicion that the catheter is likely to be responsible and 
overdiagnosis, removing it when there is clinical evidence of sepsis without an obvious 
alternative site . Although it is possible that many catheters are removed unnecessarily, 
this is a practice which should not be changed 8 l, because the complications related to 
sepsis outweigh the risks of replacing the line. Antibacterial cuffs eg with silver 
impregnation , applied to the tunnelled portion of a central line have been shown to 
reduce the incidence of sepsis (Multicenter Trial of an attachable silver-
impregnated subcutaneous cuff for prevention of infection with central venous 
catheters: 27th Interscience Conference on Antimicrobial Agents and Chemotherapy, 
Abstract, New York, October 1987). 
The use of longterm indwelling catheters is mainly confined to patients undergoing 
chemotherapy for haematological malignancy or bone marrow transplantation. Such 
patients are at very high risk of infection , because of their severe immunosuppression; 
however, many centres specialising in the treatment of such patients report surprisingly 
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low infection rates92. The difficulties of deciding when to implicate the catheter 90 in 
infection are still further compounded in such a population. 
A line that is placed electively is associated with a much lower rate of infection than 
those that are placed as emergencies. The reason most probably being that adherence to 
strict skin asepsis is higher in the elective setting 81, 82 , the severity of illness 
necessitating urgent placement also may be contributory by reducing the host's immune 
surveillance and defences. The skill of the operator 85 also is thought to play a role in 
determining the incidence of infection; protocols 8l ,82 which are carefully enforced to 
maintain high standards of asepsis by those responsible can have a major impact on the 
incidence of line related sepsis. Teams of venipuncturists80,82 in the U.S.A. and 
Australia seem to be able to show lower rates of infection than more occasional 
operators. Percutaneously placed lines are associated with a lower incidence of sepsis 
than lines placed by cutdown80,85. 
Haematogenous dissemination of infection from another site 87,90 may result in the 
seeding of organisms on to the catheter. Patients who harbour systemic infections 
before the insertion of catheters are at higher risk of these being colonised by 
haematogenous dissemination 85. The organisms causing this type of catheter related 
sepsis are the organisms responsible for the other site of sepsis and tend to be Gram 
negative bacilli rather than Staphylococci , which are the organisms associated most 
commonly with primary catheter related sepsis 79,80,87.90,93,94_ Coagulase-negative 
staphylococci adhere to plastic catheters more readily than other organisms giving 
them a selective advantage. Pseudomonas species may also cause infection from 
cutaneous colonisation; other organisms occur less commonly. There is a strong 
correlation between the organisms found on the skin and those isolated from blood 
cultures drawn through the catheters90_ 
The same organisms and risk factors as have been described above, pertain to the 
catheters for haemodialysis and peritoneal dialysis, which are used for renal support 
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programmes, and in the ICU in patients with renal failure, and a more detailed analysis 
of this specific area is beyond the scope of this thesis. 
3.5 Bacterial Translocation 
As an alternative to aspiration, there is currently much interest in possible translocation 
of intestinal organisms across damaged intestinal mucosa, as a mechanism for the 
development of infection at distant sites, in particular in the pathogenesis of nosocomial 
pneumonia 95-97. Indirect evidence in support of this mechanism in the pathogenesis of 
nosocomial pneumonia, has been derived from the relatively new technique of gastric 
tonometry, which is used to monitor gut mucosal ischaemia. The development of 
nosocomial pneumonia was found to occur exclusively in those ventilated patients in the 
ICU with gut mucosal injury as determined by gastric tonometry, guiac positive 
nasogastric aspiration, endoscopic evidence of mucosa! injury or bleeding 95 . Gut 
ischaemia, haemorrhagic shock, intestinal obstruction , parenterally administered 
en do toxin, hyperpyrexia, thermal injury, parenteral feeding, the use of an elemental 
diet, cytotoxic drugs, obstructive jaundice, and antibiotics causing Gram negative 
bacterial overgrowth have all been cited as factors thought to promote the translocation 
of viable microorganisms across an anatomically intact intestinal barrier 65. 
The clinical relevance of bacterial translocation still requires further eludication, as 
sequestration of enteric organisms in mesenteric lymph nodes is also observed m 
patients with inflammatory bowel disease, and to a lesser extent, in healthy people. The 
absence of any demonstrable association between multiple organ failure and bacterial 
translocation also leaves some doubt as to the validity of this postulated mechanism. 
Furthermore, selective decontamination ( where the aerobic Gram negative bacilli are 
eliminated from the gastrointestinal tract), has not prevented the development of 
multiple organ failure. These studies also suggest that the majority of nosocomial 
respiratory infections are more likely to be due to colonisation of the oropharynx with 
aspiration, or direct tracheal inoculation,.than to bacterial translocation. 
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The value of postoperative total parenteral nutrition in malnourished surgical patients 
has been controversial, but appears to be justified by the results of recent studies 98 ; 
however, evidence is emerging of the importance to the gut mucosa of enteral feeding 
in supplying nutritional elements not part of TPN (such as glutarnine which is too 
unstable for inclusion in standard solutions, and short chain fatty acids, which are 
produced by the gut anaerobic flora metabolising dietary fibre). While it has been 
shown in human studies that , even after 21 days of glutamine deficient TPN, the 
duodenal mucosa remains intact 99, in animal models, TPN has been demonstrated to 
lead to atrophy of the gut mucosa lOO, and increased bacterial translocation lOl _ 
It is thought that enteral nutrition may actually enhance splanchnic blood flow, 
maintain mucosal integrity and reduce bacterial translocation 102 , although this too is 
not without adverse effects. Enteral feeding neutralises gastric acid and the number of 
Gram negative bacteria has been shown to increase following the institution of this 
form of feeding 58. Contamination of the enteral feeding solution at the time of 
preparation may explain some instances, but a number of mechanisms may be invoked: 
the gastrointestinal motility in the critically ill is often disturbed and, although there 
may not be a paralytic ileus, very often gastric emptying is delayed, reverse peristalsis 
may occur with refluxing of more contaminated lower intestinal contents to the usually 
less contaminated upper gastrointestinal tract, thus predisposing to the colonisation of 
the stomach. The aspiration of feeds and secretions, in varying quantities, is not an 
uncommon occurrence even in normals 53 and occurs still more often in the critically 
ill, particularly in patients with endotracheal tubes or tracheostomies. It has been 
recommended that enteral feeding should be conducted according to more 
"physiological" guide-lines, and intermittently, rather than continuously, to allow 
periods of "natural" sterilisation when the gastric pH may return to lower levels 103. 
The above supposed advantages of enteral feeding have resulted in the placement of 
nasoduodenal or nasojejunal tubes being currently highly favoured, as they may 
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facilitate the earlier institution of enteral feeding in patients with postoperative ileus, 
which tends to affect mainly the stomach and colon. 
3.6 Wound infections 
By breaching the epithelium and thus host defences, all wounds are at risk of 
colonisation and infection in the ways which have been outlined above. The 
pathogenesis of drip-site and other intravenous cannulae-associated infection has been 
dealt with in considerable detail, but more especially with regard to the importance that 
this has in the pathogenesis of bacteraemia and disseminated infection. In this section , 
the pathogenesis of wound infection as relates to the local wound site will be discussed, 
but the prevention of these infections will be dealt with under the section on 
prophylaxis. 
In spite of improved techniques of disinfection and asepsis , wound infections have not 
been eliminated. The efficacy of antimicrobial prophylaxis in certain forms of high risk 
surgery and the importance of its timing have been well established for many years, but 
the optimal timing, choice of antibiotic and the dose still remain to be determined. 
It seems that wound contamination by bacteria is an inevitable phenomenon , but with 
strict techniques of asepsis, wound infection is not a sine qua non. The host's defences 
against infection as previously described can often withstand heavy contamination and 
resist the development of infection. It is when the host's immune defences are 
compromised, such as with diabetes mellitus. malnutrition , obesity and age, or the 
bacterial load or virulence is too great, or the essential homeostatic balance of factors is 
too severely disrupted that infection ensues. 
The presence of traumatised or devitalised tissue , foreign material or haematomas - all 
factors dependant on the severity of the injury and the skill of the operator, predispose 
to infection by providing conditions suitable for bacterial colonisation and infection. 
The direct inoculation of the wound with bacteria may occur from the patient's own 
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skin as more deeply seated bacteria lodging in sebaceous glands and hair follicles may 
persist even after skin disinfection, such organisms may commonly be carried into the 
wound by the scalpel and result in deep wound infection; from the staff Eg the nasal 
carriage of staphylococci is a well recognised reservoir of organisms identified as 
important in wound infections; contaminated surgical instruments or material should 
rarely be a problem, but the presence of already contaminated or infected sites for 
surgery are a common and important risk factor for wound sepsis, particularly when 
the abdomen and especially the colon is entered. 
The importance of airborne infection has been demonstrated by the dramatic reduction 
in postoperative sepsis associated with such "clean surgery" as joint replacements under 
conditions of laminar flow. Even with extreme care, malfunctioning of air-conditioning 
equipment, or the contamination of the fomites, clothing or skin of the staff may 
occasionally result in contamination of the wound. 
Other mechanisms for bacterial colonisation of the wound include the haematogenous 
seeding of organisms to the site from intravenous catheters, or other infected sites; 
however, this is very unusual. Following on from surgery, the drain and irrigation sites 
may rarely become sufficiently colonised by microorganisms to allow contamination 
and infection of the wound to occur. 
The colonisation of the wound by resistant organisms may be enhanced by the 
concomitant use of antibiotics, presumably because the sensitive ones are removed 
which allows uninhibited proliferation - as has previously been described to occur at 
other sites. 
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CHAPTER 4. THE DIAGNOSIS OF INFECTION 
4.1 Nosocomial Pneumonia 
The true incidence and importance of nosocomial pneumonia in the intensive care unit 
are difficult to assess, as the diagnosis of nosocomial pneumonia in a patient on a 
ventilator in the ICU, particularly the patient who already has widespread infiltrates on 
the chest radiograph , is anything but simple 37,104. The clinical parameters of pyrexia 
and leukocytosis may be present for a variety of other reasons , or absent through 
diminished host responsiveness from immunosuppression or severe illness. Purulent 
secretions may be the result of local inflammation caused by the endotracheal tube and , 
similarly, worsening hypoxaemia and a new pulmonary infiltrate on the chest 
radiograph , may be due to a number of other causes. Thus although the clinical features 
are necessary to make the diagnosis , microbiological parameters need to be taken into 
consideration. 
The problem of diagnosis is further compounded in patients with adult respiratory 
distress syndrome (ARDS) from possible unknown and undiagnosed sites of sepsis, 
tissue trauma, fluid imbalance, myocardial depression or dysfunction, or other causes 
of increased capillary permeability - all of which are well known to cause changes on 
the chest radiograph which can be indistinguishable from pneumonia. Andrews 105 and 
co-workers showed that 29 % of cases of ARDS were misdiagnosed as ventilator 
associated pneumonia and that 36% of patients who, clinically were thought only to 
have ARDS , had been misdiagnosed , and were shown at autopsy to have pneumonia. 
The usual triad of a new radiographic infiltrate, fever , and leukocytosis which have 
developed in hospital serves to initiate a diagnostic sequence common to most 
clinicians: the patient's sputum is Gram stained and cultured , simultaneous blood 
cultures are taken , and pleural fluid if present, is examined as another potential culture 
site . A positive blood culture occurs in only 24% of nosocomial pneumonias 
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37,104,106, so that although specific, it is usually unhelpful, and the frequency of 
pleural isolation of a pathogenic organisms is even less common 106. 
The culture of the sputum or tracheal aspirate is also difficult to interpret, as it may be 
colonised by potentially pathogenic microorganisms - 45 % of patients in the ICU and 
80% of intubated patients are colonised by Gram negative bacilli after four days -
which may or may not be causing infection , so that, while giving an indication of the 
colonising flora of the lower airway, it is more difficult to decide whether these 
organisms are the aetiological agent particularly in the intubated, ventilated patient.104 
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Quantitative cultures of tracheal aspirates have been shown by Johanson et al 5 to be of 
no value in distinguishing colonisation from pneumonia. The presence of pus cells in 
the tracheal aspirate, in association with microorganisms, is helpful in suggesting that 
infection may be present , but even this is not diagnostic 107. Torres and co-workers 
l 08 showed the specificity of endotracheal aspiration to be 14 % . 
These diagnostic dilemmas have partially been resolved by the introduction of invasive 
techniques attempting to eliminate the problem of contaminating organisms, particularly 
in the patient who is intubated. 
A recent Consensus Conference on the Clinical Investigation of Ventilator-Associated 
Pneumonia 109 , l 10 highlighted the recognised shortcomings in achieving an accurate 
diagnosis of nosocomial respiratory tract infection in the critically ill, and even 
deficiencies in the term "nosocomial pneumonia". While Johanson 5 had previously 
shown that 50% of patients required 4 days for nosocomial colonisation to have 
occurred, some studies have used either 48 or 72 hours only. It was proposed that 
nosocomial pneumonia should be divided into early-onset ( < 48 hours following 
intubation and ventilation), and late onset ( > 48 hours) 11 1. This is certainly not what 
has previously been understood by the use of these terms, where infections occurring 
within 48 hours were regarded as being community-acquired, 
while infections occurring within the first 5 days were likely to be caused by a 
spectrum of organisms intermediate between those causing either community or 
hospital-acquired infection; infections occurring after 5 days being recognised to be 
largely caused by hospital pathogens. Thus, this definition itself is controversial, and 
may not be widely adopted until the pathogenetic mechanisms are further elucidated. 
The conference also highlighted the fact that risks for the development of pneumonia 
varied among different patient populations within the ICU, which might affect the 
diagnostic approach selected, and the results obtained. A further confounding factor 
was the use of antibiotic therapy prior to microbiological investigation , which might 
result in false negative results by ·preventing the growth of microorganisms, or false 
positives through enhancing colonisation of the lower airway. Chastre 112 had 
previously reported the adverse effects of prior administration of antibiotics on the 
diagnostic accuracy of specimens taken with the protected specimen brush, but there is 
little other documentation in the literature to support this. It was proposed that in the 
future, the prior use of antibiotics and its timing should be recorded and reported, so 
that any potential effects could be more adequately assessed . 
4.1.1 Invasive Diagnostic Procedures 
1). Trans- tracheal aspirate 
The use of the trans-tracheal aspirate for obtaining tracheal secretions is a well 
established, although infrequently used diagnostic technique for obtaining a sputum to 
assist in the microbiological diagnosis of pneumonia in the non-intubated patient. Its 
use is thought to be indicated in cases where no sputum is being produced, where there 
is no clear predominance of a potential pathogen on sputum Gram stain or culture, or 
there has been a failure of response to antibiotic therapy selected on the basis of a Gram 
stain of the sputum. Although there is less contamination of the sputum by 
oropharyngeal organisms in the specimen obtained in this way l 13, a false negative rate 
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for diagnosis of up to 11 % and a false positive rate of up to 21 % due to oropharyngeal 
contamination or tracheobronchial colonisation have been reported, particularly in 
patients with chronic obstructive airways disease 114. 
While this technique is generally accepted as providing a more representative and 
uncontaminated sample of the flora infecting or colonising the lower airway than a 
conventionally obtained sputum sample, it is nevertheless not widely used, because of 
the significant complications that have been associated with the procedure. Well 
recognised complications of this procedure include: haemoptysis , subcutaneous and 
mediastinal emphysema, soft tissue infection, pneumothoraces, and vagal stimulation, 
with the resultant potentially life-threatening complications of bradycardia and 
cardiorespiratory arrest. In the light of the above, the trans-tracheal aspirate should be 
strictly reserved for carefully selected patients who are unlikely to cough violently and 
able to co-operate fully. It should probably not be used at all in the in the critically ill 
patient in the ICU, where 
there is a high prevalence of coagulation abnormalities, impaired levels of 
consciousness, hypoxaemia and hypercapnoea, which predispose to vagal disturbances. 
2) Fibreoptic Bronchoscopy 
The problem of specificity in the diagnosis of nosocomial pneumonia is not resolved by 
the use of fibreoptic bronchoscopy. While the use of this procedure permits aspiration 
of secretions directly from the infected site, and might thus be expected to provide 
greater sensitivity and specificity, contamination of the inner channel of the 
bronchoscope occurs during instrumentation of the upper airway, so that isolates 
obtained by this method are polymicrobial and representative of the microbial flora of 
the oropharynx and upper airway, as shown by Bartlett et al l13. 
Techniques to circumvent this problem, have involved the development of different 
methods of obtaining specimens with protected catheters and brushes. These include: 
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brushes within unplugged sheaths, plugged sheaths (plugged telescoping catheter) and 
double catheter plugged sheaths (protected specimen brush). Similar catheter designs 
have been used for segmental lavage. Guide-lines for the most appropriate and safest 
techniques for the investigation of nosocomial pneumonia, in order to standardise the 
way such procedures are performed and the manner in which the specimens are 
processed, were outlined at the recent Consensus Conference on Ventilator-Associated 
Pneumonia 115 ,116. 
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The most common clinical complication associated with diagnostic fibreoptic 
bronchoscopy in patients receiving mechanical ventilation, is a drop in their arterial 
oxygen saturation which may persist for as long as two hours after the procedure. This 
is particularly common in those in whom it is most difficult to achieve adequate 
oxygenation eg patients with adult respiratory distress syndrome, or in those who fight 
the ventilator during the procedure. The size of the endotracheal tube in relation to the 
size of the bronchoscope is important in limiting ventilation. Other potential 
complications include bleeding following use of the protected specimen brush, 
arrhythmias, transient worsening of pulmonary infiltrates and fever possibly related to 
cytokine release and more commonly associated with bronchoalveolar lavage 115. 
2.1) Fibreoptic bronchoscopy with brushings 
Wimberley et al 117 tested 7 types of brush catheter, in vitro, to determine the optimal 
catheter design for obtaining specimens for bacterial culture which are uncontaminated 
by oropharyngeal flora. Their findings supported the use of a plugged double catheter 
system (protected specimen brush) both in vitro and in nonventilated patients. The 
catheter has been designed with a double-walled cannula and a detachable, 
biodegradable plug at its tip that can be dislodged once the specimen catheter has been 
placed at the site of suspected infection. 
Figure One: The Protected Specimen Brush 
PROTECTED SPECIMEN BRUSH 
XXXX* 
INNER SHEATH BRUSH PLUG 
The technique for protected specimen brush sampling is as follows: the tip of the 
bronchoscope is positioned next to the orifice of the sampling area and the catheter 
advanced 3 cm out of the bronchoscope to avoid collection of pooled secretions on the 
catheter tip. The inner cannula is protruded to eject the distal carbon wax plug into a 
large airway, and the catheter is advanced into the desired subsegment. If purulent 
secretions are visualised, the brush is rotated in them 117. After sampling, the brush is 
retracted into the inner cannula and the inner cannula into the outer cannula, and then 
the catheter is removed from the bronchoscope. A small quantity of brush secretions 
may be smeared into a sterile slide for a Gram stain, the distal portion of the outer and 
inner cannula are separately and sequentially wiped clean with 70% alcohol, cut with 
sterile scissors and discarded. The brush is advanced out and severed with a sterile wire 
clipper into a container with 1 ml of diluent to avoid drying and rapid loss of bacteria. 
The specimen is submitted for quantitative culture within 15 minutes. 
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The use of quantitative bacteriology, previously established in the diagnosis of 
infections of the urinary tract and infections related to indwelling catheter, has been 
applied to the interpretation of bronchoscopically obtained brush specimens in 
ventilated patients. Its use assumes that the bacterial density of pathogens is greater 
than that of contaminants. Quantitative bacteriology has a sensitivity of approximately 
88 % and a specificity of greater than 95 % 112 , l l 8, 119 in the diagnosis of pneumonia. 
There is no general consensus on the cut-off that should be used in quantitative cultures 
to make a diagnosis of true pneumonia l l 8, 120. Prior administration of antibiotics can 
substantially reduce bacterial counts , and even using the cut-off of 1 000 cfu/ml, there 
are still a number of false positive results 121 . The decision as to when to treat is still 
thus not entirely resolved 119. 
Chastre et al 112 however confirmed that quantitative cultures obtained from the 
protective specimen brush in ventilated patients were useful in excluding the diagnosis 
of pneumonia if the culture yielded < 1 000 colony forming units/ml, and that a yield 
of > 1 000 cfu/ml could be used "as a guide for antimicrobial therapy", by comparing 
the results obtained by this method with histologic and bacteriologic examinations of 
pulmonary specimens taken just after death while the ventilator was still working. 
Further studies, using the protected specimen brush in ventilated patients suspected of 
having nosocomial pneumonia because of the presence of a new pulmonary infiltrate 
and purulent secretions, confirmed the value of the quantitative culture technique, but 
reaffirmed the unreliability of clinical evaluation in making this diagnosis 118, 122-124. 
However, using the same technique, Torzillo et al l20 experienced complications of 
pneumothorax in 8 % of cases - a similar incidence to that reported with ultrathin needle 
aspiration 125 , although such complications occurred at an early stage on the "learning 
curve". 
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Ha Pham and co-workers 126 compared the plugged telescoping catheter with the 
protected specimen brush and found the plugged telescoping catheter to be at least as 
accurate in the bacteriological diagnosis (sensitivity and specificity of 100 and 94.8 % 
when excluding uncertain cases and 100 and 82.2 % when all such cases as false 
positives were included), and substantially cheaper. The catheter that they evaluated has 
a single protective sealed sheath in comparison with the protected specimen brush 
which is double-sheathed. They suggest that the protective specimen brush has a high 
specificity but that it is of suboptimal sensitivity in the clinical setting (64.7% in their 
study). Although the technique has been used "blindly", most investigators recommend 
that it should be done under visual guidance, however Ha Pham et al were able to 
demonstrate that blinded sampling with the protected telescoping catheter was as 
accurate as directed sampling via bronchoscopy. 
Bates et al 127 attempted to analyse the microbial aetiology of 198 patients with acute 
pneumonia - both community and hospital acquired, using clinical, radiological and 
microbiological criteria. A diagnosis was only achieved in 50% of patients, despite a 
whole armamentarium of special investigations. The protected specimen brush was 
successful in only 38 % of the patients in whom it was used, a figure which they 
considered highly satisfactory, particularly because confirmation was obtained "in 8 % 
of such cases" where the same organism was isolated from both the brush and blood 
cultures. In those who went on to post-mortem, identification of the pathogen had been 
made ante-mortem in 40 % ; an additional bacteriological diagnosis was made at autopsy 
in 15 % (aspergillosis in one and tuberculosis in two), while the remainder were found 
to have non-infective pathology. Most clinicians would consider this yield unacceptably 
low. 
In patients with bronchial structural abnormalities , who require prolonged intubation, 
or who are receiving antibiotics , the rates of both false positive and false negative 
results with the protected specimen brush may vary between 10 and 30% 126 
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The above clinical studies would certainly support the use of the protected specimen 
brush to obtain the most reliable specimens, short of open lung biopsy, in patients who 
are intubated. The poor sensitivity of the techniques (38-60%) does however limit the 
role of this technique when deciding whether to treat a pneumonia. Fibreoptic 
bronchoscopy with the protected specimen brush is also an expensive and time 
consuming procedure. Similar results with less specificity are obtained with the single 
sheathed, plugged telescoping catheter. 
The recent consensus conference on ventilator-associated pneumonia felt that "the 
literature does not provide criteria to assess the adequacy of a protected specimen brush 
specimen" 115. They recommended that a value of > 1000 colony forming units/ml 
should be considered a significant level for bacterial nosocomial pneumonia; a positive 
Gram's stain is suggestive of pneumonia. but a negative microscopic analysis should 
not be considered definitive for the absence of pneumonia. The main factor 
confounding the interpretation of results was felt to be the effect of prior antibiotic 
therapy, and it was recommended that specimens should be taken prior to the 
commencement of therapy if at all possible, or after therapy had been discontinued for 
at least 48 hours. A patient with pneumonia might have a negative bronchoscopic yield 
if the investigation was performed too early in the infection for the bacterial burden to 
have achieved diagnostic significance; if an unaffected segment was sampled; the 
interval without antibiotic therapy was too short, or the processing of the specimen was 
incorrectly performed. 
2.2) Fibreoptic Bronchoscopy with Bronchoalveolar Lavage 
Bronchoalveolar lavage is another technique which has proved useful and safe for 
diagnosing pulmonary infections both in immunocompromised and immunocompetent 
patients 128. Quantitative culture of bronchoalveolar lavage in baboons with 
nosocomial pneumonia was shown by Johanson to correlate better than telescoping 
plugged catheter specimens with lung culture, suggesting that, in this model at least, it 
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was a more sensitive diagnostic procedure 129. Studies in man suggest that quantitative 
cultures of bronchoalveolar lavage are as reliable as quantitative cultures of telescoping 
plugged catheters for the diagnosis of bacterial pneumonias in mechanically ventilated 
patients 108 and provide a more rapid aetiological diagnosis, as Gram staining of the 
fluid can be performed immediately while the quantitative culture requires 24 to 48 
hours to give a result 121 _ 
Bronchoalveolar lavage is obtained by infusion and aspiration of a sterile physiologic 
solution through a flexible bronchoscope wedged into a bronchial subsegment. The 
amount of fluid injected for the assessment of infectious lung disorders has not been 
standardised , and amounts in various studies have ranged between 100 to 240 ml. At 
least 120 ml are necessary for retrieving secretions from the periphery of the lung 
subsegment 115. When evaluating the results of this technique, the recent consensus 
was that the percentage of retrieved fluid should be recorded , excluding the first 
aliquot; that the presence and degree of haemorrhage should be noted , and that the 
location of the sampling in relation to radiographic infiltrate and presence of 
endobronchial pus should be noted . At least 5 ml of retrieved fluid is necessary for 
adequate microscopic and microbiological analysis. A level of > 10 000 colony 
forming units/ml is currently recommended as a significant level for bacterial 
ventilator-associated pneumonia 115. 
The theoretical advantages of such a technique are that in comparison to the protected 
specimen brush , a larger and more representative area of lung can be sampled which is 
less dependant on the accurate placement of the brush and the quantity of secretions 
obtained is greater and less dilute, there is also much less risk of pneumothorax 128. 
However, contamination with a properly taken protected specimen brush should be 
minimal and 89% of lavage specimens are contaminated in patients without pneumonia. 
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Both techniques have advantages and disadvantages and Chastre et al 121 found them to 
be complementary with the accuracy of the telescoping catheter far outweighing lavage, 
which nonetheless had a place by providing a rapid answer. 
Further studies have been directed to improving the specificity of lavage or reducing 
the invasiveness of the technique to make the diagnosis. Meduri et al 130,131 
performed protected bronchoalveolar lavage through a transbronchoscopic balloon-
tipped catheter with a distal ejectable diaphragm for collecting distal respiratory tract 
secretions with a minimal degree of contamination. The sensitivity and positive 
predictive value of this technique was 100 % and by using a quantitative culture count, 
it was possible to differentiate between patients with and without pneumonia more 
easily than with unprotected bronchoalveolar lavage; the technique was also thought to 
be superior in recovering organisms. In an editorial Johanson 132 welcomed the 
development of this technique with its seeming improved efficacy and specificity, 
particularly as, the broad representation of the microbial flora obtained by 
bronchoalveolar lavage directly from the alveolar surface with the use of this more 
specific technique provided refinement and rapid diagnosis. However, more experience 
with this technique is still required. 
Pugin and co-workers l33 compared bronchoscopically obtained bronchoalveolar 
lavage with quantitative culture which was able to yield a sensitivity of 93 % and 
specificity of 100%, with "blind" lavage sampling - by introducing a catheter blindly 
down the bronchial tree - which yielded results of lower sensitivity of 73 % and 
specificity of 96%. but at considerably lower cost and with greater ease; this degree of 
diagnostic accuracy is still felt to be highly acceptable, especially if same day Gram 
staining provides rapid diagnosis. 
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2.3) Assay of Endotoxin in Bronchoalveolar lavage fluid for the rapid diagnosis of 
Gram negative pneumonia. 
Pugin et al 134 reported recently the use of the limulus assay as a rapid diagnostic 
technique to quantify the endotoxin content of lavage fluid. They demonstrated a 
relationship between the concentration of endotoxin in the lavage fluid and the quantity 
of Gram negative bacteria. While 24 to 48 hours are required for the full 
microbiological processing of bronchoalveolar lavage and protected specimen 
brushings, this assay for endotoxin takes less than 2 hours and is specific and easy to 
perform. The authors suggest that as the causative organisms are likely to be aerobic 
Gram negative bacteria in more than 80% of cases of nosocomial pneumonia, there is 
place for such a technique which should allow the institution of earlier and more 
specific treatment. 
While confirming that the pneumonia is Gram negative in aetiology, however, such a 
technique does not provide any further assistance in the specific aetiologic diagnosis of 
infection, nor in assisting in the choice of an antibiotic. In most instances where a 
nosocomial lower respiratory tract infection was diagnosed , Gram negative organisms 
would naturally form a large part of the differential and cognisance taken of this, when 
selecting a choice of antibiotic cover, while diagnostic results were awaited. The 
absence of endotoxin might potentially of more value in differentiating a staphylococcal 
or fungal pneumonia and might conceivably reduce the use of potentially harmful, or 
nephrotoxic antibiotics such as the aminoglycosides . Whether there is any place for the 
routine assay for endotoxin in the diagnosis of nosocomial pneumonia is doubtful. 
3) "Blind" catheters 
In centres where fibreoptic bronchoscopy is not available, Torres et al l l 9 were able to 
show that the use of the Metras catheter, used for bronchography, which has a radio-
opaque tip and is introduced under radiographic screening, has specificity and 
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sensitivity similar to the plugged telescoping catheter or protected specimen brush, and 
is considerably cheaper. 
4) Percutaneous needle aspiration 
The technique of needle aspiration through the chest wall obviates the potential 
contamination from the upper airway and thus may be highly specific, however its 
sensitivity is dependent on the precise localisation of the involved area and the small 
inoculum volume obtained for microbiologic examination and thus may be much 
lower125. There is also a high risk of life-threatening pneumothorax in ventilated 
patients which considerably restricts its use l04 , l35 , and although the use of ultrathin 
needles seems to · reduce the risk of pneumothorax to a level of 8 % without 
compromising on sensitivity in the study reported by Zavala et al 125 , this incidence is 
still too high for the procedure to have a place as a routine diagnostic modality in 
ventilated patients. 
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5) Antibody- coated bacteria 
Another technique used to distinguish between colonisation of the airway and lower 
respiratory tract infection in intubated patients is to measure the presence of antibody-
coated bacteria. This technique was first pioneered by Winterbauer 106 who 
demonstrated that the detection of antibody coated bacteria in secretions obtained at 
bronchoscopy was 98 % specific and 73 % sensitive for the diagnosis of pneumonia in 
nonintubated patients. Wunderink et al l36 applied this technique to the tracheal 
aspirate in the intubated patient, where it ,vas shown to retain a specificity of 100 % and 
a sensitivity of 43 % ; importantly, patients with chronic bronchitis do not test positive 
by this method. The prior use of antibiotics tended to produce a negative result which 
they postulated to be due to the disruption of the bacterial cell wall affecting antibody 
binding sites. The presence of a positive test may furthermore be predictive of the 
development of a lower respiratory tract infection. 
This technique appears to be still in its infancy and further studies using more rigourous 
diagnostic criteria than the largely clinical ones used by Wunderink are required before 
it can be established as a reliable diagnostic tool in diagnosing nosocomial pneumonia. 
6) Identification of Elastin Fibres 
Salata et al 137 studied intubated patients for evidence of pneumonia and found that 
serial examination of tracheal aspirates for elastin fibres and graded Gram's stains for 
neutrophils, bacteria and intracellular organisms were useful for the early diagnosis of 
nosocomial pneumonia. The presence of elastin fibres preceded pulmonary infiltrates 
by over 24 hours and had a positive predictive value of 100%, a specificity of 73 % , 
and a sensitivity of 52 % for infection. 
The technique of using elastin fibres as a marker for necrotising pulmonary infection 
was first described by Schroeder in 1846, is simple to perform and apparently requires 
little expertise to interpret. The authors suggest that Gram negative pneumonias are 
76 
77 
more likely to be necrotising and cause breakdown, which explains the low sensitivity 
of this technique. Certainly there is much to recommend it in being a useful, non-
invasive, cheap, additional modality which seems to predict the development of 
pneumonia relatively early. 
7) The Radiologic Diagnosis 
Although much emphasis is placed on the value of daily chest radiology in the ICU to 
check line and tube placement, the presence of pneumothoraces. atelectasis , and the 
development and progression of pneumonia or ARDS, this technique is also subject to 
great inaccuracy in the critically ill patient, particularly in the presence of ARDS. 
Despite the inherent inaccuracies associated with the generally poor quality mobile 
anteroposterior film, the presence of a new or changing pulmonary infiltrate on the 
chest radiograph is required as a diagnostic criterion by virtually all studies of 
pneumonia. 
Wunderink et al l38 confirmed that the extrapolation of roentgenographic criteria for 
the diagnosis of nosocomial pneumonia from those employed for the diagnosis of 
community-acquired pneumonia, were as unreliable as the clinical criteria used for its 
diagnosis. They evaluated the diagnostic accuracy of seven roentgenographic signs of 
pneumonia (air-bronchograms, alveolar infiltrates, silhouette sign, cavities, fissure 
abutment, atelectasis, and asymmetric infiltrates superimposed on diffuse bilateral 
infiltrates), in the portable antero-posterior film , obtained in the ventilated patient. The 
last film obtained antemortem in 69 ventilated patients was interpreted by three 
reviewers and the signs were then correlated with the findings at autopsy . Pneumonia 
was found to be present at 35 % of autopsies, but no radiographic sign had a diagnostic 
efficiency of more than 68 % , and the air-bronchogram was the only sign that correlated 
with pneumonia in the total group, and correctly predicted 64 % of pneumonias. They 
found that in patients with ARDS only the clinical parameter of purulent sputum, but 
no roentgenographic feature, correlated with pneumonia. Worsening alveolar infiltrates 
were found to be more commonly due to ARDS than pneumonia. Alveolar 
haemorrhage was detected in 38 % of autopsies, associated with 29 % of multiple air 
bronchograms and 30% of bilateral alveolar infiltrates in patients without pneumonia. 
At the consensus conference on ventilator-associated pneumonia l39 ouide-lines for 
' 0 
the reading of the chest radiograph were proposed. The inherent diagnostic 
shortcomings of the mobile chest film were acknowledged, and it was recommended 
that radiographs should be assigned scores on the certainty of the diagnosis; that serial 
radiographs should be reviewed independently by readers and then a consensus 
achieved. The role of computerised tomography in ventilated patients remains unclear, 
through paucity of reports and limited experience, but should probably be expanded to 
determine the risk benefit ratio. 
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4.1.2 Clinical Application of Diagnostic Procedures 
Nosocomial pneumonia occurs in 0.5 to 5 % of all hospital admissions and is 
responsible for 15 % of hospital deaths; however in the ICU it is still more important, 
as depending on the population of patients , up to 60 % may develop pneumonia 
depending on the severity of their underlying disease 104. 
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Several criteria have been used to establish a clinical diagnosis of nosocomial lower 
respiratory tract infection. Johanson5 et al classified pneumonia as definite when a 
patient had the appearance of a new or progressive infiltrate on the chest X-ray , fever, 
leukocytosis , and purulent tracheobronchial secretions. The diagnosis was probable if 
either the radiographic features or the tracheal secretions were missing. Craven 30 et al 
required in addition to the above , a sputum Gram stain showing more than 25 
leukocytes and less than 10 squamous epithelial cells per low power field, with the 
recovery of a significant pathogen by stain or culture. 
Such criteria in a previously healthy person free of lung disease should indicate 
pneumonia, but as discussed above, in the mechanically ventilated patient many other 
disease processes can obscure or mimic the clinical picture such as chemical aspiration, 
ARDS, atelectasis, pulmonary emboli, lung contusion, haemorrhage, pulmonary 
oedema or rumour. Pneumonia is frequently missed in patients with ARDS, but 
overdiagnosed in patients with respiratory failure from other causes 105,122. 
Sputum analysis by Gram stain has been used in the diagnosis of pneumonia for 
generations, but its diagnostic value in nosocomial pneumonia is limited. Bartlett et al 
140 prospectively studied patients with nosocomial pneumonia using trans-tracheal 
aspirates, pleural fluid and blood for microbiological specimens and showed that, even 
with uncontaminated samples, there was a high rate of mixed organisms obtained with 
more than one potential pathogen. There was an incidence of 10% false positive results 
for Staphylococcus aureus and Gram negative bacilli were recovered from 45 % of 
patients who did not have these organisms growing in the reliable uncontaminated 
specimen. In our own ICU 141 , we reported a diagnostic yield of 48% from sputum or 
tracheal aspirate, 10% from positive blood culture, only 3 % from protected specimen 
brush, with no microbiological diagnosis being achieved in 48 % of cases. Fagon 123 
and others found similar polymicrobial growth in up to 40% of cases in specimens 
taken with the protected specimen brush. This may, in some instances, explain the lack 
of response when treatment of the predominant organism is attempted. Johanson et al 
129 developed the bacterial index to deal with the problem of polymicrobial growth on 
lung homogenates, because many specimens contained multiple organisms. The 
bacterial concentration was expressed as the sum of the logarithmic concentrations of 
the individual species; the bacterial index values of bronchoalveolar lavage were 
linearly related to tissue values. Such a system has been carried over into analysing 
bronchoalveolar lavage systems and although it has not been applied to sputum, it begs 
the question as to which organisms are the significant ones. 
In an attempt to achieve a more accurate and reliable clinical diagnosis of lower 
respiratory tract infection, Pugin et al 142 recently described a "clinical pulmonary 
infection score". They utilised six clinical parameters: 
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Table One: Clinical Pulmonary Infection Score: 
Parameter Normal Slightly Very 
abnormal abnormal 
Points 0 1 2 
Temperature 36.5 - 38.4 38.5-38.9 > 39 or < 36 
White cell 
count > 4 or < 11 < 4 or > 11 
bandforms0.5 I 
I 
Tracheal I I 
secretions* <14 "+" ~ 14 "+" 
purulent 
Oxygenation 
Pa02/Fi02mmHg >240 or ARDS <240 and no 
ARDS 
Chest no 
X-ray infiltrate diffuse localised 
Bacteriology 
semiquant 
0-1-2or3 <l+ pathogenic 
bacteria 
cultured> 1 + 
>1+ 
same 
pathogen 
on Gram 
* The purulence and quantity of tracheal secretions were estimated by the for each 
endotracheal aspiration by the nurses on a score from O to 4 "pluses"; estimation of the 
total volume of secretions per day was calculated by adding together all of the pluses 
recorded over 24 hours. 
Table One: A Clinical Pulmonary Infection Score for determining the likelihood of a 
Pulmonary Infection being a Pneumonia The score has a range from O to 12 points, and 
ventilator pneumonia was diagnosed when the score reached 7 and remained elevated ie 
~ 7 for 3 or more days. (Pugin et al 142). 
Unfortunately the use of such a sc0re does not "guarantee" that the patient will 
unequivocally have nosocomial pneumonia; while it may serve to encourage a 
methodical approach to the diagnosis and alert the clinician to early changes, it would 
not be too difficult to score over 7 and have a site of sepsis elsewhere. 
When the blood culture is positive, it can serve to provide a precise aetiologic agent, 
but its presence in association with a pulmonary infiltrate on the radiograph and 
respiratory failure is not confirmatory proof of pneumonia; Fagon showed an 
extrapulmonary source of the bacteraemia in 58 % with an overall incidence of 
bacteraemia in ventilator associated pneumonia of 24 % 122 
At the Consensus Conference 111 the clinical criteria for a definite diagnosis of 
pneumonia were defined as a new or persistent infiltrate on the chest radiograph, 
associated with purulent tracheal secretions and · one of the following: 1. radiographic 
evidence (preferably CT) of pulmonary abscess and positive needle aspirate culture 
from the abscess. 2. pathogenic evidence of pneumonia on histologic examination of 
lung tissue obtained by open-lung biopsy or at a post-mortem examination immediately 
after death that demonstrates abscess formation or an area of consolidation that 
demonstrates intense polymorphonuclear leukocyte accumulation plus a positive 
quantitative culture of lung parenchyma ( > 10 000 microorganisms per gram of lung 
tissue). When used to confirm the diagnosis of pneumonia made by bronchoscopy, the 
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lung tissue for histological examination and culture should have been obtained within 
three days of the bronchoscopic procedure. 
In the absence of any of the above, a diagnosis of "probable pneumonia" may be made 
if the patient meets the clinical criteria for suspicion of ventilator-associated 
pneumonia, by the presence of new or persistent pulmonary infiltrate, purulent tracheal 
secretions, and demonstrates one of the following: 
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1. the presence of positive quantitative culture of a sample of secretions from the lower 
respiratory tract obtained by a technique that minimised contamination by the upper 
respiratory tract flora eg protected specimen brush, bronchoalveoalar lavage or 
protected bronchoalveolar lavage. 
2. the presence of positive blood culture unrelated to another source and obtained 
within 48 hours before and after respiratory sampling. The microorganism should be 
identical to the organisms recovered from culture of the lower respiratory tract 
secretions. 
3. the presence of positive pleural fluid culture m the absence of previous pleural 
instrumentation. 
4. the presence of pathologic evidence of pneumonia on histologic examination of lung 
tissue obtained by open-lung biopsy or at a post-mortem examination immediately after 
death that demonstrates abscess formation, or an area of consolidation with intense 
polymorphonuclear accumulation and a negative quantitative culture of lung 
parenchyma. 
Criteria for the absence of pneumonia were equally complex 111 _ 
The accuracy of a careful clinical assessment versus the results of protected specimen 
brush culture obtained with bronchoscopy was assessed by Fagon et al in a prospective 
study of patients receiving mechanical ventilation, who had developed purulent tracheal 
secretions and a new infiltrate on the chest radiograph. A team of seven physicians was 
asked to establish the presence, or absence of pneumonia, and to decide on a 
therapeutic intervention based on clinical, radiological and laboratory data and Gram 
stain of the tracheal aspirate. The accuracy of the clinical predictors was 74 % for 
patients with pneumonia, but the therapeutic plans were inappropriate in 58 % , because 
antibiotics were not used, or the organisms responsible were insensitive to the agents 
that were selected 143. 
The endpoints for the definition of infection are important and difficult. Much of the 
difference in incidence in infection quoted in the literature is as a result of this area 
being subjective and unstandardised. The imprecision depends on whether the definition 
is made by a clinician or a microbiologist, how invasively the specimens are taken, and 
the sophistication of the sampling procedure or imaging technique employed. 
The importance of regular microbiological surveillance is not mentioned in any of the 
articles reviewed above, but is doubtless an important factor in deciding whether 
infection is developing , and what the organism is most likely to be. When the tracheal 
aspirate has been relatively clear and uninfected , macroscopically and microscopically, 
with a mixed growth only on culture of surveillance samples, in a patient with no 
evidence clinically of infection , it is not difficult to recognise that pneumonia is 
unlikely to be present. When suddenly the aspirate starts to become purulent and a 
predominant organism is cultured or seen on the Gram stain , in association with a 
clinical deterioration in the patient's condition and no other obvious source of infection; 
the chest is the most likely site of infection. It is reasonable to treat with agents to 
which the organism has been shown to be sensitive, or that the antibiotic profile of such 
an organism is likely to be, considering the local ICU flora. Even when there is no 
radiological evidence of pulmonary infiltrate - what we recognise as a "bronchial 
infection" - such clinical features warrant treatment in the anticipation as, unchecked, 
this bronchial infection will progress into a full-blown pneumonia, with all the 
associated risks of multiple organ dysfunction associated with severe sepsis. 
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A specimen obtained with the protected specimen brush at bronchoscopy, should be 
taken if the pneumonia fails to respond or progresses rapidly , without another cause to 
explain the failure of the underlying disease process to resolve. This should be 
performed under fluoroscopic screening, if the patient is stable enough to be moved to 
such a facility, to confirm accurate localisation and allow transbronchial biopsies to be 
taken, if indicated , with minimal risk of pneumothorax. Bronchoalveolar lavage for 
culture may be performed at the same time. 
In the ICU , techniques such as transthoracic , transbronchial and open lung biopsies are 
generally reserved for immunocompromised patients and for those with suspected 
interstitial or vasculitic lung disease, where it is considered that the potential benefits 
outweigh the morbidity and mortality associated with such invasive procedures. 
Pleural fluid , if present, may be sampled by fine needle aspirate and then drained 
formally in the ventilated patient, rather than by needle aspirate, to obviate the potential 
risk of a pneumothorax . 
Serological screening for the "atypical pneumonias" eg Mycoplasma pneumoniae, 
Legionella pneumophilia and Chlamydia pneumoniae should also be performed where 
there is clinical suspicion, or failure to respond to conventional antibiotic therapy 
occurs. 
The above is our local practice in the investigation of the critically ill patient suspected 
of having a nosocomial pneumonia. It is not specifically designed to be a protocol to 
deal with the investigation of the severely immunocompromised patient, however, this 
is beyond the scope of this thesis. 
The potential toxicity caused by the unnecessary administration of antibiotics, together 
with their cost , as well as the projected costs of unnecessarily treating many patients 
who do not have pneumonia, have been argued to justify the routine use of invasive 
diagnostic techniques , which have been shown to be of high sensitivity and specificity. 
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The place of the protected spec11nen brush remains controversial however, as the 
estimates of cost-saving of antibiotics do not hold true until treatment has been withheld 
for 5 days. Missing only a few cases of pneumonia by this procedure would 
immediately increase costs and worsen the outcome, as delayed therapy, with the 
resultant prolongation of hospital stay, would then have to be added to the cost of the 
procedure. Thus, with the high morbidity and mortality of nosocomial pneumonia, it is 
preferable to err on the side of overtreatment than overbrushing. 
The more discriminating invasive diagnostic tests do however have an important role in 
clinical studies designed to determine the incidence and aetiology of nosocomial 
pneumonia; they also have an invaluable role in evaluating the efficacy of new 
antimicrobial agents and therapeutic strategies, particularly in unblinded studies. 
Nevertheless there are the same drawbacks in their interpretation: the expertise of the 
bronchoscopist. the sophistication and standards of the laboratory, the agreed cut-off 
for the distinction between colonisation and infection by quantitative culture all impact 
on the results, and such information is seldom likely to be provided in the literature. 
The diagnosis of nosocomial pneumonia is elusive, and its incidence at present depends 
on the resources, thoroughness and invasiveness with which the investigator/clinician 
wants to pursue it. The literature therefore needs to be interpreted with some caution 
and scepticism. While the early clinical recognition and diagnosis of infection is 
obviously desirable, and whether it is a bronchial or truly parenchymal infection may 
be unimportant, these questions assume greater significance when evaluating clinical 
trials. At present, the most precise way of achieving a reliable, reproducible, sensitive 
and specific diagnosis may hinge on the trial design - a double-blind study where 
selection bias and diagnostic bias are excluded may provide the best answer. 
4.2 Nosocomial Urinary Tract Infection 
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It is only a matter of time for the catheterised patient to develop an associated 
bacteriuria, but it is slightly more difficult to distinguish between this colonisation and 
the development of true infection. 
The development of bacteriuria depends on the indications for catheterisation to a 
certain extent: those who are catheterised for short-term management show a peak 
incidence at two to four days, and those who are catheterised longterm at three to six 
months or more. Once the catheter is in place, the incidence of bacteriuria is 3-10 % per 
day. 
To establish a diagnosis of urinary tract infection. it is generally accepted that the 
organism concentration should exceed 100 000 colony forming units/ml, which is 
thought to exclude possible contamination of the urine from the urethra, as it is 
virtually impossible to sterilise this area. False positives are caused by contamination or 
incubation of urine before processing. The level of > l 00 000 colony forming units/ml 
applies to the Enrerobacreriaceae only and Gram positive organisms, fungi and bacteria 
with fastidious growth requirements may not ever reach these titres, even when causing 
infection - the concentration being in the range of IO 000 to 100 000/ml. 
The nature of the organism that is isolated often helps to distinguish contamination 
from true bacteriuria; samples with low counts often contain skin contaminants such as 
diphtheroids and staphylococci. which can generally be disregarded. The culture of a 
predominant organism or "pure growth" is more suggestive of infection. A pure growth 
of Enrerobacreriaceae is uncommonly found in low-titre. A mixed culture with more 
than 100 000/ml may be difficult to interpret as it may either represent contamination 
or infection. 
The presence of symptoms is often a good guide to whether infection is present. The 
presence of symptoms is, of course, dependant on the patient being conscious enough 
to be aware of these. The practice of maintaining adequate analgesia, but keeping the 
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patient alert and co-operative, where this is possible, is useful in assisting with the 
diagnosis of urinary tract infection in the ICU. The presence of local or systemic signs 
such as suprapubic tenderness, a change in the odour or clarity of the urine, the 
development of pyrexia, fever and rigors, or loin tenderness may also assist in the 
diagnosis. The presence of symptoms and signs are however notoriously unreliable 
guides to the presence of urinary tract infections, which may be present with or without 
them or, in the case of the "urethral syndrome", present without infection. 
Samples obtained by catheter from uninfected patients should not be able to become 
sufficiently contaminated to demonstrate > l 00 000 organisms/ml and, in an 
asymptomatic patient, such a concentration should be considered indicative of infection; 
the growth of a predominant organism at concentrations between 10 000 and 100 000 is 
of questionable significance, but probably has a 50% chance of indicating infection. 
However. within several days of catheterisation - as is likely in the critically ill - most 
bacteria identified at low concentrations will. over succeeding days , reach the required 
density to qualify as significant. 
Samples taken by suprapubic aspirate should be sterile and the presence of bacteria in 
lower concentration than obtained from a catheter specimen should still be regarded as 
diagnostic of infection. 
The localisation of the site of infection is also problematic. In the presence of loin pain 
and typical symptoms of pyelonephritis, it is not difficult to diagnose that the upper 
urinary tract is involved, but such symptoms may be absent with significant upper tract 
infection. Although a number of tests involving urinary enzymes, antibodies and 
antibody coated bacteria have been devised in an attempt to non-invasively detect the 
presence of renal infection, they are unfortunately unreliable, and at present, only 
ureteral catheterisation can reliably predict the site of infection. 
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The presence of white cells in the urine may help to differentiate bacteriuria from 
infection and more than 10 white cells per high power field is usually indicates the 
presence of infection. There are a number of other conditions which can result in 
pyuria, particularly in the critically ill patient, but in the context of significant 
bacteriuria, this may be a helpful sign. 
4.3 Percutaneous lntravascular Device Related Infection 
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Brun-Buisson et al 90 suggest that there is a continuum between contamination, 
colonisation and infection involving the intra vascular catheter, although ideally the 
catheter should remain sterile. Unfortunately or fortunately , one of the modalities for 
proving or disproving that this is the site of sepsis , involves its removal for culture. 
The clinical syndrome of intravascular device related sepsis includes the presence of 
systemic infection with isolation of an organism of the same species and sensitivity 
pattern, both from the specimen culture obtained from the catheter and from a 
simultaneous blood culture87. If the specimen culture from the catheter is positive, but 
the patient does not show any clinical or laboratory evidence of sepsis , or peripheral 
cultures are negative, or if the organism obtained from peripheral cultures differs from 
organisms grown from the catheter tip, the catheter should be considered to be 
contaminated or colonised. If the type and sensitivity of the organism cultured from the 
peripheral blood match that isolated from another infected site, the sepsis should be 
considered to originate in this other site. 
The clinical detection of intravascular catheter related septicaemia, in the presence of 
bacteraemia occurring in a patient not otherwise at risk for this, may be difficult 90, as 
signs of phlebitis or local inflammation are often absent; the diagnosis can only made 
by the exclusion of other sources. Other pointers to the sepsis being line- related 
include the development of embolic phenomena, the presence of an infection which 
1s characteristically refractory to therapy and which defervesces quite promptly 
removal of the intravascular device 80_ The organisms isolated on blood culture may 
also give some indication of the possible source: Sraphylococcus aureus or epidermidis 
being typically associated with line related sepsis89. 
Confirmatory evidence may often be found in the semiquantitative culture of the 
catheter tip yielding more than 15 colonies of bacteria. Cultures of the catheter tip have 
been reported to be of variable value, but using the semiquantitative culture method, 
the specificity is reported to vary between 76 and 96 % , although there are no 
sensitivity values given by Maki in the report of this technique 144 ,1 45. 
There have been other attempts at bacteriological diagnosis using quantitative culture in 
broth 90, direct Gram staining of the catheter tip, or using blood cultures, taken 
through the catheter, with the isolator technique 146. which allows a quantitative 
estimate of the microbiological burden. 
There have also been reports of false positive results being obtained by pull-back 
samples, obtained through the catheter itself. This may depend on the type of access 
port used and the technique of taking the specimen 145 . Although the method is of 
uncertain sensitivity and specificity, repeated isolation of the same organism by this 
technique should not be disregarded , and is an indication for therapy, or possibly that 
the catheter should be removed89. Further adding to the problem is, that a positive 
result is easily obtained if the removal and processing of the catheter is not done with 
due care to avoid its being contaminated. by inadequate cleansing of the skin or 
handling after removal. 
Culture of the skin site, if this is inflamed or discharging, is used by some 84, if 
positive, as an indication for removal , but this study controversially recommends 
leaving a catheter associated with erythema in situ. 
The interpretation of an isolated positive culture. or sporadic positive blood cultures are 
problematic 94 , and cognisance of the associated clinical status needs to be taken 89. If 
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there is any doubt that intravascular catheter sepsis may exist, the safest policy is to 
provide the most effective treatment by removing it, and establishing the diagnosis by 
both culture of the tip and the clinical response. 
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CHAPTER 5 THE INCIDENCE OF NOSOCOMIAL INFECTION 
The patients in the ICU are the sickest in the hospital, often also being at the extremes 
of life in terms of age, they are subjected to the most invasive support and monitoring 
equipment available; they are also nursed in what is usually one of the most crowded 
locations in the hospital, where they receive more antibiotic therapy during their 
hospitalisation than any other group of patients; the duration of their hospitalisation is 
also often prolonged. All these factors contribute significantly to the increased risk that 
these patients have for developing infection in hospital. 
There are four main sites at which nosocomial infection occurs , viz the urinary tract, 
surgical wounds, the lower respiratory tract and the bloodstream, in that order147. In 
the mid- l 970s in the U.S.A., the overall incidence was estimated to be 5. 23 % of all 
hospitalised patients: 62 % had at least one urinary tract infection , 30% one or more 
surgical wound infections, 17 % nosocomial pneumonia and 7 % bacteraemia; 18 % had 
infection at more than one site. However, when the results of those admitted to the 
Intensive Care Unit are analysed separate I y, the incidence of infection increases 
sharply: the risk of urinary tract and surgical wound infection is five times higher, the 
risk of pneumonia increases twenty-one times in the ventilated patient, and the risk of 
bacteraemia increases sixteen-fold. The estimated overall incidence in our respiratory 
ICU was reported to be 23.6% 148_ 
Differences in the published estimates of the incidence of infection can be explained not 
only by differing diagnostic criteria, but also by differences in methodological analysis: 
the incidence can be reported as the crude ratio of the number of patients developing an 
infection and the number of participating patients 30, 149, or this information can be 
analysed to incorporate the duration of stay during which the patient was exposed to the 
risk of developing infection in which case the values using the Kaplan-Meier analysis 
may be much lower 123, l50_ 
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There are, of course, various sub-groups especially at risk of specific sites of infection, 
so that the incidence varies between different ICUs eg medical, surgical, coronary care, 
neonatal etc., and there are additional risk factors which also determine the likely 
outcome of such infections - nosocomial pneumonia being recognised to be associated 
with a particularly high morbidity and mortality 151 . This chapter provides an 
overview of the incidence of the most important types of nosocomial infection in the 
ICU. 
5.1 Nosocomial Pneumonia 
Nosocomial pneumonia, is the third most common hospital-acquired infection, but is 
associated with the highest mortality 104. A recent ana.lysis of its incidence over a four 
year period showed that it accounted for 14 % of hospital acquired infections with a 
case fatality rate of 33 % 75. By comparing a sampled, individually matched cohort, the 
morbidity as measured by excess hospital stay , was shown to be significantly 
prolonged. 
Only relatively recently have studies of nosocomial pneumonia used techniques for 
· obtaining microbiological specimens that minimise contamination by upper airway 
secretions; the gold standard for the diagnosis of nosocomial pneumonia probably 
remains histological examination and quantitative culture of lung biopsy specimens, but 
techniques such as bronchoscopy with the use of the protected specimen brush , 
bronchoalveolar lavage, or telescoping plugged catheter specimens have gained 
acceptance and have been reported to have a sensitivity and specificity between 70% to 
100% l 19,1 26, l33, using the number of organisms or colony forming units/ml to 
distinguish between colonisation and infection, with more than 10 000 cfu/ml indicating 
infection. It has been suggested that the use of cultures of bronchoscopy specimens 
reduces the estimated incidence of pneumonia in the ICU from 26% to 9% 123, but the 
associated mortality in excess of 70% suggests that such a technique may perhaps be 
too highly specific. 
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Graybill et al 38 , in a classic study in 1973, reported a retrospective analysis of the 
incidence of nosocomial pneumonia in a general hospital . The diagnostic criteria were 
purely clinical, or from the patients' records; using sputum or blood culture for the 
bacteriological diagnosis. They showed that 33 % of secondary pneumonias were due 
to Gram negative bacilli. The study was performed at the time that gentamicin was first 
introduced for clinical use, and interestingly, they did not find a dramatic improvement 
in the outcome following this. The mortality for nosocomial pneumonia, particularly if 
superinfection occurred, being of the order of 50%. 
Bryan et al l52 in 1984 studied episodes of bacteraemic nosocomial pneumonia in the 
general hospital using "standard epidemiologic criteria" for the diagnosis. The 
incidence was 5 % and associated with a mortality of 58 % , although such deaths 
occurred almost exclusively in patients with serious and largely irreversible underlying 
disease. 
Mock et al l53 used an "objective numerical rating system for the assessment of the 
presence or absence of pneumonia on a chest X-ray film" and a positive sputum culture 
to assign patients to either colonisation or pneumonia. They concluded that this was a 
"reasonable" method for separating pneumonic infection, from patients who were 
merely colonised by bacteria. They added a caveat that all sputum pathogens in patients 
in the surgical ICU should be covered with antibiotic therapy, which then allowed them 
to safely conclude that, with the chest X-ray, they were able to diagnose pneumonia in 
over 50% of their patients, with an associated mortality of 32 % . 
An evaluation of the incidence of nosocomial infection in our respiratory ICU showed 
that the incidence of secondary infection was significantly increased in patients admitted 
following multiple trauma . 148, and that patients who were not tracheostomised or 
intubated did not develop secondary infection; however the diagnostic criteria here 
differed from other studies, as a nosocomial infection was diagnosed if infection 
developed 24 hours after admission to the ICU, which may have falsely increased its 
incidence. The definitions of infection were otherwise purely clinical and radiological; 
86.5 % of secondary infections were pulmonary with an overall incidence of 20.4 % for 
nosocomial pneumonia, which is very different from the 50% of the previously 
mentioned study. Unfortunately Potgieter et al were unable to assess the effect that 
secondary infections had on morbidity and mortality, although they speculate that 
infections may have contributed to 17 .5 % of the deaths. 
In a recently published study from Scandinavia, Nielsen et al 154 studied the incidence, 
aetiolgy and mortality of nosocomial pneumonia in their university hospital medico-
surgical ICU. The diagnostic criteria used were clinical and radiological only. The 
incidence of nosocomial pneumonia in the patients who stayed in the ICU for more 
than 48 hours was only 10 % , but they demonstrated that such patients were 
predominantly post-surgical, and required more prolonged intubation and ventilation , 
with a statistically increased duration of ICU stay , as well as a higher mortality of 43 % 
vs 19% in those who did not develop this complication. Again the cause of death was 
difficult to separate from the presence of severe underlying disease in these patients. 
Gram negative Enrerobacceriaceae and Pseudomonas aeruginosa accounted for 43 % of 
cases. Patients treated with H-2 blockers were identified as being at greater risk, as 
were those who were immunosuppressed or had undergone thoracotomy. 
Fagon et al 123 in their studies evaluating the protected specimen brush as the new 
"gold standard'' in diagnosis, found an overall incidence of only 9% for nosocomial 
pneumonia, and showed that this was clearly related to the duration of intubation and 
ventilation with an actuarial risk of 6.5 % at 10 days , which increased to 19 % at 20 
days and 28 % at 30 days. The overall mortality of 71 % in this study is far higher than 
in most reported studies. 
Jimenez et al 149 reviewed the incidence and aetiology of pneumonia acquired during 
mechanical ventilation in their ICU in Barcelona. They also found an increasing 
incidence with increased duration of ventilation: 23 % had developed bacterial 
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pneumonia after 5.6± 1 days, but there were an additional 3 cases who went 
undiagnosed until autopsy, which increased the incidence to 27 % ; the mortality in this 
study was 38 % . The diagnosis of pneumonia in this study was made by a combination 
of clinical and radiographic parameters and then confirmed with cultures and 
pathological findings obtained by protected specimen brush or transthoracic needle 
aspiration. In cases where such investigations were negative, a response to antibiotic 
therapy was used as a diagnostic criterion of pneumonia. They were able to identify the 
causative pathogen in 78 % : by means of the protected specimen brush in 55 % , 
transthoracic needle aspirate in 11 % , when the protected specimen brush had failed, 
and by means of serology, pleural aspirate and blood culture in the remainder. The 
incidence in this study reflects that of a population similar to our own ICU, where there 
are patients with primarily respiratory problems as well as a good representation from 
multiple trauma, post surgical and other miscellaneous categories. The diagnosis is 
reliably made with post-mortem follow-up and probably represents one of the most 
accurate analyses in the literature. In addition, it lacks the potential bias that a study 
designed to evaluate a new diagnostic technique may have. 
An earlier multi -institutional study from Spain l50 found an incidence of nosocomial 
pneumonia of 31 % in the general ICU s; but a bacteriological diagnosis was only made 
in 38 % of these cases, with an associated mortality of 4 7 % . However, no definitions of 
the diagnosis, nor any indication of the diagnostic techniques are provided. 
Langer et al 66 reviewed 724 patients requiring ventilation and similarly confirmed a 
rising incidence of nosocomial pneumonia with prolonged mechanical ventilation from 
5 % after 24 hours , to 68 . 8 % after 30 days ; however, when analysing the same data by 
actuarial life tables , they were able to show that nosocomial pneumonia occurred 
early, with a high and constant rate of acquisition m the first 10 days of 
ventilation, and thereafter its development was rare. This is the only study which has 
analysed the patients in this way, and this data suggests that the acquisition of 
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not necessarily related to duration of admission. In this study, the diagnosis of 
pneumonia was based on clinical and radiographic criteria. The overall incidence of 
nosocomial pneumonia was 23.2 % in those who required ventilation, 26.6% in those 
who were ventilated for more than 24 hours, compared to 7% in those who were not 
ventilated. The overall mortality was 43. 6 % . 
Similar results are reported from yet another centre in Spain 155 , where the incidence 
of pneumonia in 1000 consecutive patients admitted to a medical-surgical ICU is 
reported to be 21.9% after 7.9 days; however, here there were superinfections 
documented, which raised the incidence to '25. 7 % . The diagnosis was made on clinical 
and radiographic criteria and a bacteriological diagnosis was made in 69.1 % by means 
of a variety of techniques including the telescoping plugged catheter, blood culture and 
necropsy. The mortality in the study was reported to be 42 % for those with nosocomial 
pneumonia, which was not very different from the 37 % in those who did not have 
pneumonia. They suggest that pneumonia may not actually increase the mortality in 
critically ill patients , which may be determined by "host factors"and underlying 
disease. However, nosocomial pneumonia clearly prolongs the ICU stay of those who 
survive - in this study the duration of stay was 26.2 days compared with 16.6 days for 
patients with prolonged ventilation who did not develop pneumonia. 
Difficulties occur with interpretation when trying to compare the above data, where 
newly available diagnostic techniques have been used, with the older literature where 
such procedures were not available , although the data was carefully gathered. The 
study in 1979 by Thorp et al l56 in a respiratory ICU used clinical features alone, 
including the purulence of the tracheal secretions. With these criteria, they found an 
incidence of nosocomial respiratory infection of 31. 8 % , which was the most common 
site of infection in their unit; such an incidence would seem to be highly comparable to 
that from more recent studies. That nosocomial infection contributed to morbidity was 
well demonstrated by the fact that over 90% of those who stayed longer than a week 
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had developed a secondary infection. The mortality was found to be 28 % overall - 45 % 
in those with secondary infection which was significantly higher than the mortality of 
19% in those without this complication. 
Daschner et al 9in a study reported in 1982, prospectively analysing the incidence of 
nosocomial infection in a multicentre study of nine intensive care units, reported the 
incidence of nosocomial pneumonia to be only 1 % , with the overall incidence of 
nosocomial infection ranging between only 3% and 27%. Unfortunately the criteria for 
the diagnosis are not as clearly defined in this article, making comparison difficult. 
The patient population in the ICU is not homogeneous. Although the patients are by 
definition critically ill, the nature of their underlying disease, the reason for their 
admission, their age and whether they are elective or emergency admissions , are all 
risk factors which may predispose to the development of nosocomial infection by 
interfering with host defences. Similarly, "clean" ICUs eg cardiothoracic units where 
the patients are elective, postoperative cases, will have different incidences of infection 
from those where all the patients are emergency admissions often with primary 
infective aetiologies such as the medical or respiratory ICU. 
Craven et al IO prospectively studied admissions to both the medical and surgical ICUs 
at a municipal hospital and found the incidence of secondary infection to be 31 % in the 
surgical ICU compared with 24 % in the medical ICU. The overall incidence of 
secondary infection was 28 % . The definition of nosocomial infection was similar to 
that of Potgieter 148, viz. infection 24 hours after admission, and the diagnosis of 
pneumonia was made on clinical and radiological criteria. The incidence of nosocomial 
pneumonia was not significantly different in the two ICU s (being 8 % in the surgical 
and 10% in the medical unit), but the surgical ICU patients tended to develop their 
infections later than the medical patients. The mortality in the two ICUs was 
significantly different being 18 % in the medical ICU compared with 10% in the 
surgical unit, with an overall mortality of 31 % during hospitalisation; however, the 
mortality rate due to secondary infection was not significantly different - 8 % in the 
medical and 6 % in the surgical ICU. 
Brown et al 8 compared the incidence of infection in the medical/surgical, paediatric, 
neonatal, coronary care and cardiac surgery ICUs. Their diagnostic criteria included 
infections which occurred 48 hours after admission; for nosocomial pneumonia the 
criteria were less strict than those of Craven et al, but again clinical and radiological. 
The total infection rates ranged from 1 % in the cardiac surgery ICU to 23.5 % in the 
medical/surgical ICU, and secondary infection rates from 0.8% in the cardiac surgery 
unit to 11.2 % in the medical/surgical unit, with an overall incidence of secondary 
infection in the ICU of 5.8%. The outcome in the medical/surgical ICU was also the 
poorest (36.5% mortality) compared with the paediatric ICU (11.1 %), neonatal 
(10.9%) or coronary care units (22%) for infected patients . Unfortunately, this study 
does not distinguish clearly between community-acquired and hospital-acquired 
infections, when analysing the different sites of infection. 
Chandrasekar et al l5? retrospectively analysed the infection rates in the various ICUs 
in their hospital in Detroit. Their requirement was 48 hours of admission before the 
onset of infection , but again unfortunately they do not specify further the criteria they 
used to diagnose site specific infections. Once again the predominance of urinary tract 
and respiratory infections is seen, with an overall infection rate of 19.2 % in the ICU 
compared with 9.2% in the general ward. Unit specific infection rates were 35% in the 
surgical ICU, 14% in the medical ICU, 30% in the burns unit and 7% in the coronary 
care unit. The distribution of the type or site of infection differed from unit to unit with 
pneumonias most common in the medical and surgical units . Importantly, they were 
able to show a striking significant difference in the mortality between those who 
developed secondary infection and those who did not, as well as increased morbidity; 
however, it is not clear whether those who developed secondary infection actually died 
with it, because of the severity of their underlying disease, or from it. 
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Torres et al 158 assessed the risk factors for nosocomial pneumonia in ventilated 
patients, using strict clinical and radiological criteria, as well as telescoping plugged 
catheter samples to make the diagnosis in cases where other techniques had failed. They 
showed a similar incidence of 24 % , the male predominance encountered in the study by 
Chandrasekar was also demonstrated (70 % ) . The overall mortality was 33 % for those 
who developed nosocomial pneumonia, but admission to a non-cardiac surgery or non-
surgical ICU was associated with a statistically worse prognosis. This finding was 
ascribed to the higher percentage of patients with ultimately fatal disease admitted to 
these units, in comparison with the largely electively admitted cardiac surgery patients , 
as well as the shorter duration of intubation and ventilation in patients following cardiac 
surgery. 
In contrast to most of the above studies where overdiagnosis of pneumonia is likely, a 
population at particular risk for the underdiagnosis of nosocomial pneumonia is that 
with the adult respiratory distress syndrome. Andrews et al 105 showed that 36% of 
cases with nosocomial pneumonia in ARDS had been clinically unrecognised until 
autopsy. 
Montgomery et al l59 analysed the factors causing and contributing to death in patients 
with ARDS. They were able to show a mortality of 68 % compared with 34 % in a 
control group, who were assessed as being at similar risk for the development of 
ARDS, but who did not go on to develop ARDS. Only 16% of the deaths in the ARDS 
group were from respiratory failure, which was usually in a setting of uncontrolled 
sepsis originating in the abdomen; however. when the development of ARDS preceded 
the sepsis syndrome, the lungs , rather than the abdomen, were the usual site of 
infection. They postulate that the necrotic lung tissue associated with ARDS may 
predispose to secondary pulmonary infection, but unfortunately are unable to give 
accurate figures on the incidence of nosocomial respiratory infection in this study. 
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Similar findings were shown in an animal model by Campbell et al 160, who were able 
to show that acquired lung infection superimposed on a model of ARDS was 
responsible for a rapid and marked deterioration of pulmonary function, with a high 
mortality. They again experienced difficulty in making an accurate diagnosis of the 
exact incidence of secondary pulmonary infection in this setting. 
The above review of the incidence of nosocomial pneumonia reported in the literature 
perhaps serves best to illustrate the difficulties encountered when an attempt is made to 
correlate results between institutions. The diagnostic criteria used may include varying 
clinical and radiological techniques and the emphasis, or lack of emphasis, based on 
special invasive procedures to achieve an accurate diagnosis may also substantially 
affect the results. The differing patient populations in different regions, let alone the 
different units even within the same hospital, as well as interindividual variations, make 
the reports of questionable significance when trying to compare results. 
The importance of strict and reliable diagnostic criteria cannot be over-emphasised, not 
only so that such comparisons can more easily be made, but also because this form of 
audit and ongoing evaluation is extremely important in maintaining and improving 
standards of care within an institution. 
5.2 The Incidence of Nosocomial Urinary Tract Infections 
The sheer number of patients undergoing catheterisation of the urinary tract serves to 
make this the most common site of nosocomial infection. The majority of patients in 
the ICU undergo catheterisation of the urinary tract as the catheter is almost essential 
in any patient where accurate fluid balance monitoring is required, where the patient is 
sedated, paralysed or shocked, or to facilitate nursing care of patients who are 
immobile due to trauma. The associated incidence of urinary tract infection might also 
be expected to be higher in the ICU, as, by virtue of their illness, this population is 
recognised to be temporarily immunosuppressed and thus susceptible to infection. 
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About 80 % of all nosocomial urinary tract infections are associated with the use of 
urethral catheters, the remainder follow genitourinary manipulations (5-10% ), or are of 
uncertain aetiology 78. The complications resulting from catheterisation are virtually all 
related to infection, with the exceptions of mechanical trauma or non-bacterial 
urethritis. The definitions of urinary tract infection are somewhat less controversial 
than those for nosocomial pneumonia; usually the isolation of a single organism in 
cultures at a level of > 100 000 organisms/ ml in the presence of clinical symptoms is 
required. Some studies will permit the isolation of multiple organisms if the patient has 
an indwelling catheter, and some studies further require the presence of leukocytes. 
Unfortunately, many of the studies do not specify the diagnostic criteria applied in 
making a diagnosis of urinary tract infection. 
Between 10 and 30% of all patients undergoing short-term catheterisation will develop 
bacteriuria in hospital, with associated fever and symptoms of infection, as compared 
with only 1 % of non-catheterised patients. The incidence of bacteraemia from 
nosocomial urinary tract infection in the catheterised patient is of the order of 1-5 % , 
representing 6-15 % of the total percentage of hospital-acquired bacteraemia, with a 
mortality of 13 % 78. 
Haley et al 161 estimated the frequency of nosocomial infection in 169 526 adult 
patients in 338 general "mainstream" hospitals in the United States during 1975-1976 
by selected patient characteristics. They estimated that 5.23% of the patients developed 
one or more infections in hospital and that 6.62 infections occurred per 100 admissions. 
Of all patients with nosocomial infection, 62 % had at least one urinary tract infection 
and 53 % of all nosocomial infections involved the urinary tract. 18 % of patients had 
more than one nosocomial infection, of whom the percentage of those having more than 
one infection at the same site was 5.6% for the urinary tract, compared with 14.5% for 
surgical wound infection, 1. 9 % for pneumonia and 4.5 % for bacteraemia. 24 % of the 
patients had a urinary catheter placed at some time during their hospitalisation, 21 % of 
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approximately 3% in the ward and 4% in the ICU. All instances of urinary tract 
infection were associated with urethral catheterisation. There is no comment on the 
contribution of urinary tract infection to bacteraemia or mortality. 
Brown et al 8 similarly comparing the incidence of secondary infections in the different 
ICU s within the same hospital , showed an incidence of 50. 8 % for urinary tract 
infections occurring in their coronary care unit, 24. 7 % in the medical/ surgical ICU, 
20.8% in the paediatric ICU and 2.6% in the neonatal unit, with an overall incidence 
of25.8%. 
Craven et al 10 compared nosocomial infection in the medical and surgical ICUs and 
found the overall incidence of urinary tract infection to be 13 % - 15 % in the patients in 
the surgical ICU compared with 10% in the medical ICU, which was statistically 
significant. Of the 700 patients who had a urinary catheter in place for more than 3 
days, 46% developed an associated infection. In this very carefully performed study, 
the authors were not able to demonstrate that infection of the urinary tract was an 
independent risk factor associated with mortality, although any infection was an adverse 
risk factor. 
Daschner et al 9 in their multi-centre European study of the incidence of nosocomial 
infection, found the urinary tract to be the most common site of secondary infection 
(26. 7%) and , with the exception of neonates, virtually all patients with nosocomial 
urinary tract infections had urinary catheters. They then went on to analyse 
retrospectively the risk for secondary septicaemia in patients with nosocomial infection 
by correlating the bacterial species, antibiotic sensitivity of organisms obtained both on 
blood culture and from another infected site. In this way they related 31.5 % of 
secondary septicaemias to urinary tract infections. 
Judging from the number of reports that are to be found in the literature, the incidence 
of urinary tract infections would appear to be of minor interest only, to the intensivist. 
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Its importance is difficult to evaluate accurately for this reason, but, if 31.5% of 
secondary bacteraemias are indeed due to infections arising at this site, it is an area 
which needs to be addressed urgently as deserving of more attention than it has yet 
received. 
5.3 Nosocomial Infections due to Percutaneous Catheters and Primary and 
Secondary Nosocomial Bacteraemias 
The incidence of device-related bacteraemia is uncertain - estimates in the literature put 
the figure for the United States at anything between 25 000 and 200 000 cases per year 
163. The occurrence of such cases depends on the pathogenesis of the infection. and 
these infections may be sporadic or occur in clusters. 
Primary bacteraemias are those in which the microorganism enters the blood at a 
usually undetected site and subsequently goes on to produce metastatic infection; 
however, such infections as meningococcal septicaemia and enteric fever are 
generalised septicaemic states which also qualify as primary bacteraemias. Such 
primary bacteraemias tend to occur in clusters in the community , but form a very small 
proportion of nosocomial bacteraemias. 
Secondary bacteraemia refers to the development of bacteraemia resulting from 
infection at a local site eg pneumococcal pneumonia or acute pyelonephritis, but in the 
hospital setting is most commonly a device related phenomenon. Such bacteraemias 
may occur in clusters due to the spread of the same organism on the hands of health 
workers, or by contaminated equipment or infusates; this type of infection may also be 
sporadic, resulting from the colonisation of a device, particularly if its insertion was 
associated with poor techniques of asepsis, or it is allowed to remain in situ for 
prolonged periods. Maki 80 reported that the incidence of catheter-related septicaemia 
increased from 2 % to 8 % if a catheter was left in situ for more than 48 hours. 
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Forgacs et al 93 identified 468 episodes of bacteraemia in the ICU at St 
Thomas'Hospital, London over a 15 year period, compared with 2754 epsodes in the 
entire hospital. The ICU was thus involved in 17 % of bacteraemias in a population who 
occupied only 1.2 % of the beds in their hospital. 25 % of such bacteraemias were 
community acquired, 75 % developing in the hospital. The mortality from bacteraemia, 
within the ICU, was similar, regardless of whether it was community or hospital 
acquired ; however, the mortality of the primary disease was significantly adversely 
affected by the presence of bacteraemia. The overall mortality for patients in the ICU 
was 13 . 1 % for those without bacteraemia, compared with 60.4 % in those who were 
bacteraemic. Unfortunately , no severity of illness scoring system was used to compare 
the severity of illness in those with bacteraemia with those without , so it is difficult to 
draw further conclusions. 
Similar alarming figures for the mortality associated with nosocomial bacteraemia are 
reported by Quercia et al 79 , who showed a mortality 14 times higher for patients with 
the same primary diagnosis who developed nosocomial bacteraemia compared with 
those who did not. 
A study looking particularly at the incidence of catheter related sepsis with triple lumen 
central venous catheters 89 in an ICU and on the ward, was able to show an 
attributable incidence of only 3 .1 % . 96 catheterisations in 65 patients were studied, and 
the catheters were removed after 5 days , or when infection was suspected. The 
stringent clinical criteria used for the diagnosis of sepsis in this study gives an accurate 
reflection of the incidence of nosocomial catheter related sepsis at this institution, but 
there is an absence of microbiological correlation which , however , unfortunately makes 
comparison with studies where no criteria are specified, or a more microbiological 
basis is used to distinguish between colonisation of a line, isolated unrelated 
bacteraemia, and true infection , difficult. 
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Miller et al 87 in a limited study of only 29 patients and 47 catheter placements using 
similar criteria to the above study by Kelly et al 89, documented an incidence of 
catheter related sepsis of 7 % , with an incidence of contamination of 33 % . Such a value 
correlates well with other studies 84,90, and confirms the prevalence of the problem, 
but unfortunately is too small to contribute further. 
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Brun-Buisson et al 90 designed a study to evaluate a technique of quantitative culture of 
catheter tips in diagnosing catheter related sepsis in the critically ill; to further improve 
comparability, only those catheters which were placed by the internal jugular or 
sublcavian vein were studied. They evaluated 331 central venous catheters obtained 
from 232 medical or post-operative patients, which were used in their ICU over a one 
year period, and removed either at death, when no longer therapeutically necessary, or 
after 10 days. 74% gave no growth and 25.6% grew more than 10 cfu/ml. When 
microbiologic and clinical data were compared , 42 catheters, or 12.7%, were able to be 
classified as contaminated, and 10.8% as definite catheter related sepsis, while 2% 
were classified as colonised from a distant septic focus. It is difficult to make accurate 
comparisons or to draw conclusions when comparing this very careful study with that 
of Kelly et al 89 where the incidence is so much lower. 
Eyer et al 84 randomised 122 patients and 294 catheter placements in a study to 
evaluate three methods of long-term catheter maintenance in a surgical ICU. The 
techniques of microbiological culture were similar to those of Brun-Buisson. They 
reported an incidence of catheter tip colonisation of 3.3% and an associated incidence 
of 13 % to 16 % of catheter related sepsis, with the three techniques under comparison. 
The chance of a patient developing catheter related sepsis was 0.3 % per day per 
catheter, confirming that the risk of infection is a function of time, they were however 
unable to improve this risk by frequent changing of the catheter. 
There is no comment on the association of mortality with catheter related sepsis in the 
above two studies. This aspect was addressed by Smith et al 163 who studied the excess 
mortality attributable to nosocomial bacteraemia in 34 critically ill patients in a medical 
ICU. The study included primary bacteraemias, occurring at least 3 days after 
hospitalisation. The diagnosis of primary nosocomial bacteraemia was made by a 
positive blood culture and the absence of clinical or laboratory evidence of another site 
of infection. In this study, intravenous catheters were not routinely cultured after 
removal, so the incidence attributable to catheter related sepsis is not clear. 384 patients 
without this complication in the same ICU showed an observed mortality of 38 % which 
matched the mortality predicted by the APACHE II score. When the group was 
compared with a subgroup of the control, who matched their APACHE II scores, the 
observed mortality in those with nosocomial bacteraemia was 82.4% which 
significantly exceeded the predicted mortality of 54.1 % for the control group. The 
mortality in this study is far higher than the 60 % recorded by Forgacs93 , but the 
population includes only those with nosocomial bacteraemia which may account for the 
difference; however, the difference in mortality of only 28 % between those who were 
or were not bacteraemic is much less than the 4 7 % reported by Forgacs. The more 
careful matching of severity of illness in the control group in the study by Smith may 
account for this marked difference. 
Clearly the bloodstream is one of the most important sites of nosocomial infection, 
which contributes to, or is the direct cause of a substantially increased mortality. The 
majority of studies indicate that intravenous catheters are the most common culprits in 
causing this, but the difficulty in achieving an accurate diagnosis is possibly as great as 
with nosocomial pneumonias and it is thus impossible to accurately assess the size of 
the problem. 
The use of total parenteral nutrition is an area where infections are recognised to be a 
major cause of morbidity and mortality. The patients who require T.P.N. are often at 
greater risk for the development of secondary infection, because of prolonged ileus, 
severe malnutrition or other underlying reasons which have themselves necessitated the 
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institution of such therapy. The use of T.P.N. is often controversial, as it is often 
thought to cause almost as many complications as it may help resolve. There is 
nevertheless a substantial population of patients in the ICU who receive T.P.N .. 
Unfortunately, most of the studies analysing and reporting the incidence of 
complications related to T.P.N. have looked specifically at high risk subgroups, so it is 
difficult to gain an accurate impression of what the overall risk of infectious 
complications for the lower risk categories might be. 
Detsky et al 164 reported a meta-analysis of patients receiving TPN perioperatively, 
but found that in 11 of the 18 studies the methodology ,.vas so poor that it was difficult 
to draw any conclusions. When taking the methodology into account, they were able to 
show that the risk of complications was such that routine use of TPN for major surgery 
could not be justified, except in certain high risk groups. The incidence of septicaemia 
and other complications varied between O and :25 % . 
The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group 98 studied 
395 malnourished patients undergoing major thoracic or abdominal surgery; the 
patients were randomly assigned to pre and post-operative T.P.N., or to no T.P.N .. 
They demonstrated a statistically increased risk of infection in the T.P.N. group 
(14.1 % vs 6.4%), although the severely malnourished patients had a lower incidence of 
complications - both infectious and non-infectious. They concluded that there was no 
role for preoperative TPN except in the severely malnourished unless there were special 
indications. The infections were not limited to the catheter however, as the majority 
were pneumonias and there is no comment on any correlation between organisms found 
in the lungs and on the catheter tip. The 90 day mortal ity did not differ significantly 
between those who received TPN and those who did not; unfortunately they do not 
specify the cause of death so it is not clear whether those who developed secondary 
infections died from secondary infection or their underlying disease. 
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5.4 The Incidence of \Vound Infections 
Data from the United States 27 suggest that one third of all nosocomial infections are 
surgical wound infections. This complication doubles the postoperative hospital stay 
and the cost per episode, in 1987, was estimated to range between $800 and $1 000, 
although the actual value might have been up to ten times higher than that, if indirect 
costs had also been taken into account. The incidence of wound infection depends on a 
number of variables such as whether the surgery is elective or emergency, and the field 
being entered. Host factors such as the nutrtional status of the patient, and the presence 
of underlying disease, also make it difficult to extrapolate results from one centre to 
another. 
Haley et al l6l reviewed the incidence of nosocomial infection affecting the urinary 
tract, lower respiratory tract, bloodstream and surgical wounds in 338 hospitals across 
the United States. They estimated that of all patients with nosocomial infection, 30% 
had ~ 1 surgical wound infection, and that 40% of infections among surgical patients 
were wound-related. The incidence of wound infection increased approximately linearly 
with the duration of surgery with a 21-fold increase from the lowest to the highest 
categories. There was a 5-fold increase in the incidence of wound infection in patients 
who were mechanically ventilated, which is unfortunately as close as the study comes 
in defining an ICU population. 
The rate of infection varies according to the procedure: less than 3 % for "clean" 
procedures, where there is no violation of aseptic technique and the alimentary, 
respiratory and genitourinary tracts are not entered; the rate increases to 4% for "clean-
contaminated" procedures, where these systems are entered but there is no spillage, and 
rises still funher to 9% when there is gross contamination. For specific operations the 
rate may increase five or more times in certain high risk groups of patients 165. 
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In reviewing this field, it is striking to note the change in philosophy and practice that 
has evolved over the past 30 years. In the 1960s, antibiotic prophylaxis to prevent 
wound infection was frowned upon as something which caused more complications than 
it solved 166 and the fear of inducing resistance amongst bacteria was cited as a reason 
for not even trying to prevent infection in this way; however, during the 1970s the 
number of procedures for which such preventative treatment was indicated, grew 
rapidly. The methods, choice of agents and timing of such administration have since 
then been undergoing repeated analysis, with innumerable reported trials , many with 
design flaws 28 , 165 , 167-178_ Further compounding the problem in evaluating the 
incidence of wound infection, is the fact that the variables which influence the 
incidence of wound infection are often evaluated in terms of techniques which are now 
regarded as obsolete. making the interpretation of any of the data difficult,if not 
impossible. 
In none of these studies is specific reference made to the patient in the ICU, although 
many of the patients undergoing elective clean , major surgery will enter the ICU 
postoperatively. Guidelines for how long such prophylaxis should be continued and its 
effect on cost, morbidity and mortality are thus important. It is equally important to 
gain an indication of the incidence of sepsis as a cause of morbidity and mortality in the 
traumatised patient, who often requires ICU admission and may have a variety of 
wounds - both contaminated and clean. The available literature would suggest that the 
surgical wound is often more susceptible to becoming secondarily infected in the ICU 
than elsewhere , but that such infection per se seldom leads to death. 
A 4 year prospective study from Barcelona 27 looking at the incidence of wound 
infection occurring in clean postoperative wounds. found the incidence to be 3.2 % , 
although this rose to 5. 1 % for emergency surgery, and to 5 .4 % when drains were used. 
The presence of underlying , well-recognised predisposing factors such as diabetes, 
steroid use or carcinoma, raised the incidence still further to 7. 8 % , but age did not 
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seem to affect the infection rate adversely. There were a number of other variables 
which affected the rate significantly: there was up to a ten fold difference in the 
infection rate between different surgeons performing the same operation, the incidence 
of wound infection was 12 % following vascular surgery as compared with 0.6% 
following ophthalmologic surgery. 
The timing of prophylactically administered antibiotics to prevent surgical wound 
infection also has an impact on the incidence 178. Classen et al demonstrated that 
patients who received antibiotic prophylaxis in the two hour period prior to surgery had 
an inciden~e of wound infection of 0.6% for clean or "clean-contaminated" surgery 
compared with those who received antibiotics in the :2-l- hour period prior to surgery, 
where the incidence increased significantly to 3. 8 % . 
Currently there is no reliable data on the attributable mortality to secondary wound 
infection, but its incidence is thought to be very low 165. 
Allgower et al l ?9 reviewed the cause of death in patients with severe polytrauma in 
their hospital and ICU in Basel, in 1980. Prophylactic antibiotics were not used in such 
cases. They showed an overall mortality of 17.6% for 300 such cases, of whom 16% 
died of sepsis. The overall incidence of infection in the 300 patients, using clinical 
definitions only, was 62.6%. 32.3% developed urinary tract infections, 18% 
respiratory tract infections and 12.3% wound infection. They noted a much higher 
incidence of wound infection in the trauma patients - 4 % compared with an incidence 
of 1.5% for clean surgery. 8.3% of the infected patients went on to develop 
septicaemia of whom 65 % died; 8 % of the septicaemias were secondary to traumatic 
wound infection and these patients died. They concluded that the primary injury, the 
lag before therapy and the degree of shock were the determinants of outcome, and that 
the role of antibiotic therapy was questionable. It is interesting to note, when 
attempting to evaluate this study, that in 1980 this unit was not advocating the use of 
prophy~actic antimicrobials for elective orthopaedic surgery either! 
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Goris and Draaisma l 80 retrospectively analysed the cause of death in 89 patients with 
multiple trauma who did not die of burns, primary head injury or isolated fracture of 
the femur. They found that patients dying more than a week after the injury died 
primarily of remote organ dysfunction secondary to sepsis in 88 % , but the role that 
wound sepsis may have played in this is. not discussed. 
Schimpff et al l8l analysed the incidence of nosocomial infection in severely 
traumatised patients admitted to a trauma centre. They showed that the organisms 
responsible for secondary infections in such patients were organisms not regarded as 
pathogenic in patients with normal host defences. They were able to identify a leg 
wound as the source of nosocomial infection in only 1 of 25 patients who developed 
such infections. the remainder being urinary tract infections, pneumonias or catheter 
related bacteraemias. 
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CHAPTER 6 THE AETIOLOGY AND INFLUENCE OF NOSOCOMIAL 
INFECTION IN THE ICU 
The aetiology of secondary hospital-acquired infection is multi-factorial, depending on 
a number of host factors, the site where infection occurs, the organisms responsible and 
their intrinsic properties such as pathogenicity and invasiveness, the size of the 
inoculum of the organism and exposure of both host and organism to an environment 
which suitably predisposes to the development of infection. These factors are often 
inter-dependent and, while it is not difficult to appreciate the association between them, 
it is far more difficult to prove that the relationship is causal. For example , it is well 
recognised that prolonged hospitalisation predisposes to the development of nosocomial 
infection, but nosocomial infection itself prolongs hospital stay and thus it is often 
difficult to distinguish the one from the other, particularly when attempting to interpret 
the literature where all the variables influencing each specific factor are not outlined. 
Such factors apply both in the general hospital and in the ICU. Haley et al 161 
identified the following risk factors for the development of nosocomial infection in the 
general hospital: age, sex, duration of total and preoperative hospitalisation, presence 
of previous community-acquired or nosocomial infection , the type of underlying 
disease, the duration of surgery, as well as treatment with invasive devices or 
immunosuppressive medication. They found that 75 % of the nosocomial infections 
occurred among patients undergoing surgery. 
Craven et al 10 used a multivariate analysis to identify predisposing factors for the 
development of nosocomial infection, when comparing the incidence in the medical and 
surgical ICUs at the Boston City Hospital. They identified a number of variables which 
were associated with the development of infection: age > 70 years, white race, coma 
on admission, an Acute Physiology Score > 20, prior antibiotics , steroids or 
chemotherapy, admission to the Surgical ICU, an ICU stay of > 10 days, or one of the 
following admission diagnoses: head trauma, multiple trauma, neurologic disease, 
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cardiopulmonary arrest, respiratory failure, acute myocardial infarction or pulmonary 
oedema. 
Laboratory values such as a serum urea of ~ 7. lmmol/1, creatinine > 130 mmol/1 or a 
serum bicarbonate of < 20mEq /1 were also univariately associated with a statistically 
significantly increased risk of secondary infection, as were the presence of invasive 
devices such as a urinary catheter, a ventilator, a central line, an arterial line or a 
pulmonary artery catheter. 
Such factors are useful in highlighting a high risk group of patients - at risk of both 
nosocomial infection and death, however, they do not themselves necessarily point to 
the root cause of the problem. Many of the variables merely serve to emphasise the 
severity of the underlying disease, although, in the case of invasive monitoring devices, 
they also may independently add to the risk of infection. 
Such factors as shock, days in the ICU, admission to the surgical ICU, steroid or 
chemotherapy and renal failure were the factors most strongly associated with 
nosocomial infection, not only in Craven' s and Haley's studies, but also in other 
reviews of the incidence and outcome of nosocomial infection , both involving the 
general hospital such as the studies by Gross et al 151 , Bryan and Reynolds 152, the 
elderly as shown in a study by Harkness et al l 82, or specifically in patients in the 
surgical wards as reported by Kinnear, Finch et al l83. It is difficult to decide whether 
these factors cause infection by altering host immunity or merely serve as markers of 
severity of illness. These studies really serve to highlight the importance of the 
associatiqn , rather than to prove cause and effect. 
Craven was able to show that the presence of invasive devices increased the risk of 
infection, and the longer the devices remained in situ, the greater the risk of infection 
became. The duration of ICU stay was also associated with an increasing incidence of 
nosocomial infection, but actuarial life tables were not used to analyse the time 
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relationship to the development of pneumonia in this study. Such analysis,as used by 
Langer et al 66, might have shown that the length of respiratory assistance and the 
associated device-related risk are contributory, rather than the primary cause of 
infection. The analysis of data in this area warrants further evaluation, possibly using 
actuarial life tables, to bring much needed clarity and hopefully some meaningful 
conclusions to this field. 
The incidence of infection occurnng in the different ICUs would suggest that there 
must be particular host factors characteristic of the populations in the different ICUs 
which predispose to the development of specific infections. While it is not difficult to 
understand why wound , or intra-abdominal infection should be more common in a 
surgical ICU, the discrepancy in the incidence of central nervous system infections, 
also reported to be higher in the surgical ICU by Craven ' s group, is more difficult to 
explain. The higher incidence of urinary tract infections was explained by the more 
prolonged placement of such catheters in the surgical patients. 
In spite of the higher incidence of infection in the surgical ICU in Craven' s study, the 
fatality rate was higher in the medical ICU, and the fatality rate due to secondary 
infection was similar in the two units. This poses the question as to whether the patients 
who died, died with , or of, their secondary infections. From the data in this study, it 
would appear that the medical ICU patients were older, more critically ill, with a 
higher incidence of coma, or other neurological disease, acute respiratory failure, shock 
or infection; all these factors would suggest that while doubtless contributing to the 
fatal outcome, most of the patients would ultimately have succumbed, irrespective of 
the development of nosocomial infection. 
The undisputedly poor prognosis that untreated severe community acquired infections, 
requiring ICU admission , are known to have , may have been over-simplistically 
extrapolated to apply to nosocomial infections; the natural history of nosocomial 
infection is much less well established and less easily defined, because of all tj1e other 
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factors which tend to be occurring simultaneously. It is well known that bacteraemias 
with Klebsiella pnewnoniae, and other highly pathogenic aerobic Gram negative bacilli, 
are associated with a much higher mortality in community-acquired infections than 
secondary hospital acquired bacteraemias 184. Might all nosocomial infections be 
rather a manifestation of severe illness than its cause? Similarly, may death not be due 
to the severity of the underlying disease with a \'ariable contribu tion from secondary 
infection, rather than postulating that nosocomial infection is the final common pathway 
and cause of a fatal outcome? There is clearly no one answer to this question, although 
its relevance. when planning expensive :,trateg1es to prevent nosocomial infection, 
needs to be considered. 
Rello et al 155 asked much the same que:,tion in their multi-institutional study in Spain. 
They identified a number of host risk factors which predisposed to the development of 
nosocomial pneumonia in a group of predominantly surgical (76% J and multiple 
trauma patients 09%) : while the list is similar to that of Craven. there are a few 
notable differences: shock. immunosuppre:,:,ion and renal failure showed little 
correlation '.>.:ith the predisposition to cleve!op secondary infection. but steroids, pnor 
trauma or surgery. and coma were close I y associated with nosocomial pneumonia. The 
mortality in the 25. 7 % who developed pneumonia was -+2 % . compared with 37% in 
those who did not develop secondary in r'ection. sugg.esti ng that the role played by 
nosocomial pneumonia in determining a fatal outcome was not of major importance. 
Similar findings were reported by Nielsen cc ,Li !5-+. 
Gross et al 151 noted that 50 ':1 of the no:,o,:om ial infections which were related to 
death in their survey of nosocomial infection throughout a general hospital, occurred in 
the ICU. T hey found that the usual hospital risk factors for infection such as 
intravenous catheters . indwelling urinary catheters and respiratory therapy equipment 
were not present more often in those who died \\ ith nosocomial infections than in their 
counterparts. in whom such infections did nut de\·elop. The use of more invasive 
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procedures, such as one finds in the more acutely ill however, such as intraarterial and 
central venous pressure monitoring devices and nasogastric tubes, appeared to be 
significantly associated with the development of nosocomial infections, and a risk 
factor for death. The findings of this study would again support the theory that 
critically ill patients are at risk of both infection and death, and that while the two 
occur together may indicate an association, it does not necessarily prove cause and 
effect. 
Chandrasekar et al l5? similarly found the acquisition of infection in the ICU to be 
associated with a poor prognosis, with an outcome far worse than that of matched 
controls, but the patients who developed such infections again were noted to have 
greater severity of underlying disease and to have been subjected to more invasive 
procedures. 
6.1 Nosocomial Pneumonia: Aetiology and significance 
Celis et al l85 performed a multivariate analysis of risk and prognostic factors in 129 
episodes of nosocomial pneumonia in 118 non-neutropaenic patients in the general 
hospital. The overall mortality rate for these patients was 36. 6 % . The diagnosis of 
nosocomial pneumonia was made on clinical and microbiological criteria using 
confirmatory fiberoptic bronchoscopy with a plugged telescoping catheter or 
transthoracic ultrathin needle aspiration. Each patient who developed pneumonia was 
paired with an unmatched control subject. Using univariate analysis, 8 factors were 
identified as being associated with a higher fatality rate: age > 60 years, place of 
hospitalisation (medical wards or ICU), ultimately or rapidly fatal underlying 
condition, "high-risk" pathogen, chest X-ray showing bilateral pulmonary involvement, 
shock, respiratory failure and inappropiate antibiotic therapy. The following factors 
were associated with a higher mortality, although this was not statistically significant: 
male patients had a higher mortality than female (39.5% vs 29.4%), chronic lung 
disease w_as associated with a higher mortality (42.9% vs 31.3% for those without it), 
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and a leukocyte count of > 20 000 /cu (42.9% of such patients died compared with 
34.1 % of those whose white cell count was less than 20 000/cu). 
When performing univariate analysis on the data, the presence of a nasotracheal or 
orotracheal tube, depressed level of consciousness , chronic lung disease, thoracic or 
abdominal surgery, a previous episode of aspiration and age > 70 years were factors 
significantly predisposing to the development of pneumonia. However, such variables 
as the place of hospitalisation, smoking status, the presence of a tracheostomy, 
nasogastric intubation or previous antibiotic therapy failed to retain significance after 
adjusting for confounding factors. The same difficulty in further dissecting the problem 
of the role of infection in mortality was experienced. 
Possibly the two most important points to emerge from this very carefully performed 
study are: 1) the importance of appropriate antibiotic therapy - 91.6% of those who 
received inappropriate antibiotic therapy died, and only 25 % of these patients had 
ultminately or rapidly fatal underlying disease; this is also the only prognostic factor 
identified which is amenable to intervention. 2) The relevance of "high-risk" organisms 
in the aetiology of nosocomial pneumonia. 
Similar findings are reported in papers by Torres et al 158, Jimenez et al 149 both 
emanating from the same centre, and, possibly , using the same raw data. 
Leu ' et al 75 attempted to identify the morbidity and mortality attributable to 
nosocomial pneumonia in a general hospital setting. They identified 1 001 consecutive 
episodes of nosocomial pneumonia in 90 l patients, in whom they confirmed the excess 
of previously discussed risk factors, such as the time from admission to the 
development of pneumonia, prior mechanical ventilation, and neoplastic disease were 
all associated with mortality . By multiple regresssion analysis, factors associated with 
increased length of hospitalisation were shown to include post-tracheostomy status, 
ventilation , immunosuppression, nasogastric intubation and prior bacteraemia. By using 
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a sampled, individually matched cohort study they determined the proportion of 
mortality attributable to secondary infection to be 33 % , which was of only marginal 
significance, and the excess hospital stay which they showed to be prolonged by a 
statistically significant seven days. 
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Mosconi et al l 86 studied the risk factors associated with nosocomial pneumonia in 
1475 patients collected from 23 ICUs in Italy, who had no previous history of 
pulmonary infection, without irreversible/ ultimately fatal underlying disease, and who 
stayed in the ICU ~ 48 hours. The incidence of pneumonia was 15 % (220 cases). 239 
patients died, with a mortality which was significantly higher in the patients who 
developed pneumonia (p<0.0001). Multivariate analysis of seven risk factors for 
pneumonia, showed a significantly higher risk in patients with neuromuscular disease, 
impairment of airway reflexes on admission, ~ 24 hours of respiratory assistance, age 
> 60 years and emergency surgery. This study again gives fairly convincing evidence 
of the relationship between impaired airway reflexes, with the associated increased risk 
of aspiration, mechanical ventilation and the development of pneumonia, but, more 
importantly, is extremely convincing that there is a strong relationship between 
nosocomial pneumonia and mortality. It is interesting to note however that no 
relationship between impaired airway reflexes and death could be demonstrated. A 
criticism of this study might possibly be that there is no accurate definition (perhaps 
one is not possible, as it is too subjective) or attempt at quantitation, of impairment of 
airway reflexes, which might only be a reflection of the severity of the underlying 
disease. Severity of illness scores might have been useful in assisting further 
evaluation . Harkness et al l82 in their study of risk factors for nosocomial pneumonia 
in the elderly, similarly found aspiration to be of particular importance. 
6.1.1 Invasive Devices 
The role of respiratory assist devices in the development of nosocomial pneumonia is so 
well established, that it hardly warrants comment. Virtually all of the above-mentioned 
studies have included this as a significant risk factor for the development of pneumonia. 
Cross and Roup 29 in 1981 reported a prospective study of 13 086 patients over 11 
months, of whom 914 had a respiratory assistance device for at least 24 hours, 
specifically to document this risk factor. There were 108 episodes of pneumonia - a 
0. 82 % overall incidence; in those without a respiratory assistance device the risk was 
0.3% (35% of the total hospital associated pneumonia) , versus 1.3% in those with 
endotracheal tubes and respirators (11 % of hospital acquired pneumonias), 25 % with 
tracheostomy (12 % of hospital acquired pneumonia) and 66 % in those with 
tracheostomy and a respirator (9 % of hospital acquired pneumonias). The relationship 
with duration of ventilation was once again convincingly demonstrated in that no 
patient who was ventilated for < 24 hours developed pneumonia, but the risk increased 
significantly after 5 days. 
Deppe et al l 87 evaluated the incidence of colonisation and nosocomial pneumonia 
when comparing closed and open suction systems for tracheal toilet. They found that 
the closed system was, perhaps not surprisingly , associated with a higher incidence of 
tracheal colonisation than the open system in which toilet was more adequate. The 
demographic features and severity of illness parameters were similar for both suction 
catheter systems. However, using clinical and radiological criteria to diagnose 
pneumonia, no difference in the incidence of nosocomial pneumonia between the two 
groups could be found and the probability of survival seemed to higher in those who 
were treated with the seemingly less effective closed system. Unfortunately, although 
this study casts doubt on the previously described pathogenetic mechanisms for the 
development of nosocomial pneumonia, the results need to be interpreted with caution, 
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because the actual number of patients with infections is too small for the conclusions of 
this study to be justified. 
There are no studies particularly evaluating tracheostomised patients in the ICU, who 
have undergone this procedure to facilitate ventilation. Yet , as the above study 
suggested, such patients are recognised to be at particularly high risk of nosocomial 
pneumonia. In the only study of its kind in the literature, Rogers et al 188 documented 
the incidence of, and risk factors for , secondary pneumonia following tracheostomy for 
varying indications, in 139 patients. Pneumonia was diagnosed on clinical and 
radiological criteria. Patients with pneumonia, or at ri sk of pneumonia because of 
mechanical reasons at the time of tracheostomy , were excluded from the final analysis 
of 83 patients. The incidence of pneumonia was 20.5 % , and occurred most commonly 
in the first 8 to 12 postoperative days. Interestingly, the incidence of other infections 
whilst the tracheostomy was present was twice as great amongst those who developed 
pneumonia as in the other patients in the study. The organisms isolated from other 
infected sites , excluding grossly infected tracheostomy wounds, showed a striking 
correlation with the tracheal flora. Patients with central nervous system derangements ( 
encephalitis, brain tumours , strokes, fat embolism, etc) again formed the majority of 
patients requiring tracheostomy who developed pneumonia, whereas patients 
undergoing tracheostomy for facial fractures and upper airway obstruction (idiopathic 
tracheolaryngitis , recurrent juvenile papillomatosis) did not develop pneumonia. 59 % 
of the pneumonias following tracheostomy occurred on the neurosurgical service. The 
overall in-hospital mortality , of the 82 patients studied, was 25.3%; 65 % who 
developed pneumonia died , in whom the pneumonia was thought to be the primary 
cause of death in 64% of the deaths. 
The incidence of pneumonia and other hospital-acquired infections has been shown in a 
number of studies to vary with the type of patients or ICU being studied 8,9 , 157. 
Donowitz et al l62 analysed the differing infection rates in patients belonging to 
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different services who were cared for within the same ICU. They showed that the 
highest rates of secondary infection occurred in patients from the obstetrics and 
gynaecology, orthopaedic and general surgery services. The types of infection also 
varied with the services: the highest incidence of pneumonia and urinary tract infections 
were in the orthopaedic patients. Urological patients had the highest incidence of 
postoperative wound infection and general surgery patients the highest incidence of 
bacteraemia. It is difficult to surmise why this should be, particularly as no patient 
characteristics are given. 
Craven et al 30, in another study in patients who required mechanical ventilation, using 
the populations in the medical, surgical and coronary care ICUs at the Boston City 
Hospital, identified by univariate analysis the following eight risk factors for the 
development of pneumonia and a fatal outcome: the presence of an intracranial pressure 
monitoring device , craniotomy, coma or head trauma, treatment with cimetidine or 
steroids, changing of the ventilator circuitry every 24 hours as opposed to every 48 
hours and admission to hospital during the autumn or winter months. However, when 
stepwise logistic regression analysis was performed on these risk factors, only the 
presence of an intracranial pressure monitoring device, treatment with cimetidine, 
hospitalisation during the autumn/winter and 24 hourly changing of the ventilator 
tubing remained statistically significant. 
The two-fold increase in pneumonia during the winter is difficult to explain; the 
investigators attribute it to infections with agents such as possible prior or concurrent 
viral or Mycoplasma, for which they did not routinely test, and which they postulate 
may have predisposed to bacterial pneumonia by altering nasopharyngeal colonisation 
and host defences. Such a seasonal difference in incidence of nosocomial pneumonia 
has not been reported elsewhere - perhaps it has not been looked for? 
It is certainly easier to understand the increase in incidence attributed to frequent 
changing of the ventilator circuitry, and this study has served to change the policy in 
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relation to this, in most ICUs across the world. The more frequent manipulation of the 
patient, the endotracheal tube, or the ventilator tubing, must frequently and inevitably 
lead to the inadvertent flushing of condensate into the patient, and tend to cause 
increased leakage of bacteria around the endotracheal tube into the trachea, just as 
manipulation of other devices eg the urinary catheter, has been shown to lead to an 
increased incidence of bladder infection. There have been several reports in the 
literature of the dissemination of organisms, particularly Pseudomonas aeruginosa 
causing outbreaks of pneumonia secondary to the contamination of ventilatory devices 
and tubing 73 . 
The population that Craven studied were all at risk for secondary infections on a 
number of criteria mentioned previously. They all had significant underlying disease: 
42 % had chronic cardiovascular disease, 35 % chronic respiratory disease, 32 % were 
alcoholic , and notably 30 % were admitted following a neurological event, 20% 
following cardiopulmonary arrest , 18 % following head trauma. Further 
immunocompromising factors included the fact that 12 % had diabetes mellitus, 8 % had 
malignancies, 9% were bacteraemic, 7% had renal failure and 12% had sustained 
multiple trauma. 46 % of the patients were comatose when admitted to these ICUs. The 
in-hospital mortality of the patients studied was 41 % (including both those who 
developed pneumonia, who formed only 21 % of the patients studied , and those who did 
not). 
The presence of an intracranial pressure monitoring device as an independent predictive 
risk fac tor for the development of nosocomial pneumonia and mortality, is possibly 
synonymous with the finding of Mosconi et al l 86 that neurological disease, 
particularly when associated with impairment of the upper airway reflexes, was the 
most important risk factor for the development of nosocomial pneumonia. However, it 
is difficult to distinguish the independent effect of a single parameter, from a whole 
host of other important factors that clearly must have operated in every patient who 
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required an intracranial pressure monitor. All patients who underwent placement of 
such devices were treated with steroids, and 89 % of them were in coma at the time of 
placement, furthermore 41 % were in shock and 63 % had had a craniotomy, 
presumably under general anaesthetic. As mentioned in the study, further predisposing 
to the development of infection in such patients, was the fact that chest physiotherapy 
and suctioning were avoided to prevent any increase in the intracranial pressure, which 
these procedures might have induced; 52 % of this population were paralysed with 
pancuronium, further hi:1dering the clearing of secretions. 
Similarly, when evaluating the data pertaining to the independent risk of secondary 
infection associated with cimetidine in this study, there are so many other variables in 
operation that possibly no amount of statistical manipulation of the data can definitely 
prove cause and effect. Craven found that 37% of the patients given cimetidine 
developed pneumonia, compared with 18 % of those who received antacids, and only 
8 % of those who received no ulcer prophlaxis. These patients, to a significant extent, 
were the same ones who were already at risk of pneumonia by virtue of their head 
injuries, intracranial pressure monitoring devices ( 41 % of those with intracranial 
pressure monitors received cimetidine) and steroid therapy. 
Unfortunately all studies in the critically ill are, and are likely to be, equally hindered 
by the same problems so that while studies like that of Craven are extremely useful and 
important in encouraging audit of daily practice, and generate important conclusions. 
some of the data must at least be viewed with caution. 
6.1.2 Gastric pH 
Gastrointestinal bleeding is a recognised problem in all critically ill patients as a result 
of "stress ulceration", particularly in those with neurological injury or following burns. 
Cimetidine and other H-2 blockers inhibit the histamine type 2 ·receptors in all tissues, 
including the stomach. The role that histamine may play in initiating and modulating 
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the inflammatory and immune responses to infection is thought to be of importance; 
what the effect of blocking this may be is still not clearly established. Cimetidine may 
also have effects on host cellular and humoral defences, but the data in this area is 
again still not available. 
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Many studies have implicated the incre<J.sed gastric pH as an important factor in the 
pathogenesis of nosocomial pneumonia, whether due to antacids or histamine 
antagonists, because it has been shown to lead to an alteration in the colonising flora of 
the stomach , promoting overgrowth by Gram negative baci lli. The stomach is believed 
to act as a source of organisms which then colonise the respiratory tract 
52,54,56 ,61,62 , 154. Cook et al 63, in a meta-analysis , were unable to confirm that, 
with the available evidence, stress ulcer prophylaxis with agents that raise gastric pH 
increased the incidence of nosocomial pneumonia; the use of sucralfate was, however, 
associated with a lower incidence of secondary pneumonia, when compared to antacids 
or H-2 antagonists. 
While meta-analyses have failed to demonstrate that antacids or cimetidine increase the 
incidence of nosocomial pneumonia, the use of sucralfate has been shown to be 
associated with a lower incidence of nosocomial pneumonia 63. Sucralfate is a weak 
buffer that probably acts through pepsin adsorption , mucosal protein binding and 
cytoprotection, without affecting the gastric pH significantly 189. Tryba et al 59 
demonstrated that in addition to maintaining a low gastric pH, sucralfate also exhibits 
anti-bacterial effects against both Gram positive and Gram negative bacteria, which 
may help to explain its more favourable profile with respect to the incidence of 
nosocomial pneumonia. The efficacy of all three agents in preventing acute stress 
bleeding would appear to be equivalent 55. Although Tryba comments that there were , 
in this study, significantly fewer cases of nosocomial pneumonia in those who received 
sucralfate prophylaxis; such respiratory infections as occurred were of more minor 
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significance, and associated with a lower morbidity and mortality, than those that 
developed in the patients receiving antacids. 
Driks et al 62 reported a study comparing the incidence of nosocomial pneumonia in 
intubated patients treated with sucralfate, antacids or histamine type 2 blockers. They 
found that nosocomial pneumonia occurred twice as frequently among those who 
received agents that raise the gastric pH as in those who received sucralfate. The mean 
duration of ventilation and ICU stay in those who received antacids or H-2 blockers, 
was also more prolonged, this contrasts with the study by Bresalier et al l 89 who did 
not show any difference in morbidity (although there were more side-effects 
experienced in those who received antacids), or mortality between those receiving 
antacids or sucralfate. Although the mortality , in the study by Driks , for the group who 
received antacidsicimetidine was also higher than in those treated prophylactically with 
sucralfate, the authors comment that this may be related to a number of factors such as 
the patients' underlying disease and medical condition and there is insufficient evidence 
to implicate pneumonia alone. They found a lower gastric pH and lower concentrations 
of Gram negative bacilli in the stomach, pharynx and trachea of patients in the 
sucralfate group; importantly, they also noted that Gram negative bacilli were not often 
isolated in the tracheal aspirates of the patients who received sucralfate and who 
developed pneumonia. 
Lacroix et al l90 added fuel to the fire regarding which agent to use for stress ulcer 
prophylaxis with their meta-analysis of studies using antacids and/or cimetidine, which 
have been shown to be as effective in preventing bleeding elsewhere as sucralfate 
55,189: they were unable to demonstrate any benefit in reducing morbidity or mortality 
with the use of any prophylaxis compared with no therapy. 
Possibly the conclusion to draw from the above must be that, while awaiting further, 
better conducted studies to demonstrate conclusively whether any prophylaxis is indeed 
better than none, the motto "not to do any harm" should apply. In high risk cases such 
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as burns, head injuries and patients with liver failure, where enteral feeding is not 
possible, sucralfate should be used in preference to the other agents. However, it 
should be remembered that sucralfate binds to other enterally administered drugs and 
may thus inactivate them, which unfortunately may curtail its spectrum of application 
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6.1.3 Nutrition 
\Vhile enteral feeding is known to be effective prophylaxis against stress ulceration, 
simultaneously providing nutritional support, it is also recognised to elevate the gastric 
pH and may increase the risk of nosocomial pneumonia 62. There are , however, few 
reports in the literature on the risk of nosocomial pneumonia associated with such a 
feeding regimen. 
In a small study from Saudi Arabia, Jacobs et al l03 analysed the effect of continuous 
enteral feeding versus intermittent feeding , on the incidence of secondary pneumonia in 
24 patients in their ICU. They reported an incidence of pneumonia, following three 
days of continuous enteral feeding and mechanical ventilation, of 54 % , in whom they 
documented initial cultures of the pathogenic organism from the stomach, oropharynx 
and then trachea before the pneumonia ensued. The initial cultures from all these sites 
did not grow any organisms. Criteria used for the diagnosis of secondary pneumonia 
were only clinical and sputum culture. Antacids and H-2 blockers were not routinely 
used unless there was evidence of gastrointestinal haemorrhage. The 07h00 gastric pH 
in those receiving continuous enteral feeding was persistently documented at greater 
than 3.5, and 92 % of these patients went on to develop pneumonia , while in the other 
patients who were fed intermittently the incidence of pneumonia was only 9% which 
was highly significant, and they were documented to have an intragastric pH 
intermittently of less than 3.3 (an intragastric pH of <2.7 is bactericidal , while a pH 
~ 3.65 is bacteriostatic within 2 hours). The mortality amongst those who had a higher 
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07h00 gastric pH was 46% as compared with only 18% in those with an intermittently 
lower pH, but this did not achieve significance. 
There must be certain reservations about this study, because the patient sample size is 
too small to be meaningful, and the diagnostic criteria used to diagnose secondary 
pneumonia are poor; nevertheless, it makes compelling reading and is an area which 
requires further evaluation. The philosophy of intermittent feeding must be nearer the 
physiological norm of intermittent meals; the idea of permitting rest periods, so that the 
intragastric pH can fall within the bactericidal range , would appear to be a logical next 
step. 
A further complication associated with nasogastric feeding and which may add to the 
infectious complications associated with it, is the potential for such feeds to become 
contaminated by a break in the cold-chain, or other breaches of hygiene, in the 
preparation and administration of the feed. Although often such infection is more likely 
to manifest with gastrointestinal disturbances, there is the potential for enteral feeding 
to act as a source for respiratory infection , particularly if the load of microorganisms is 
large, or the aspiration cannot be effectively cleared as may occur in patients with 
depressed consciousness 53. 
6.1.4 Bacterial Translocation 
Fiddian-Green et al 95 have also recently published work suggesting that nosocomial 
pneumonia may be the result of bacterial translocation rather than the aspiration of 
contaminated secretions. He showed l 9 l that monitoring of the intramucosal gastric pH 
may provide early evidence of impending gut ischaemia; gastric tonometry has been 
suggested as one of the best ways of detecting early, compensated shock at a stage 
when anticipatory management can improve outcome and prevent complications. The 
possibility of ischaemic mucosa! injury, as demonstrated by gastric mucosal tonometry, 
which appears to be fairly common in the critically ill, may allow the translocation of 
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bacteria and their toxins into the bloodstream and serve as an important cause of 
multiple system organ failure and possibly nosocomial pneumonia. Goris 192 has 
attempted and failed to produce an animal model which would support such a 
mechanism, and there would appear to be little evidence to support this rather attractive 
hypothesis at present. 
6.1.5 The ~licro-organisms 
The aetiology of hospital-acquired pneumonia differs from community-acquired 
pneumonia where the responsible pathogens are recognised to be Streptococcus 
pneumoniae, Haemophilus injluenzae, .vfycopLasma pneumoniae, Legionella spp., 
Chlamydia pneumoniae and a variety of viral agents most commonly, with variations in 
the incidence regionally, with the seasons. and depending on host factors. Legionella 
pneumophila has been linked to outbreaks of pneumonia in hospitals around the world; 
the mode of spread of this organism within the hospital has been shown to be via the 
cooling towers used for the airconditioning plants, and shower heads l 93 . Patients who 
are elderly and immunocompromised are again the most at risk of contracting this type 
of infection, and the mortality for nosocomially acquired Legionnaires' disease is 
reported to be of the order of 33 % , compared with approximately 1 % for community-
acquired disease 69. 
Chlamydia pneumoniae 1s a more recently identified agent of acute respiratory 
infection. Grayston et al 194 in a retrospective survey identified it as the possible 
aetiological agent by postive serology in 10% of 198 cases of pneumonia. In 9 patients 
the infection was thought to have been acquired in hospital; all these patients were in 
the ICU and intubated, having undergone major surgery or su~tained multiple trauma, 
however Bates et al 127 recently identitiecl the TWAR agent in 4% of nosocomial 
pneumonias in the general hospital, and almost 10% of community-acquired cases, so 
that the significance of this agent appears to be becoming more important, as it is more 
actively looked for. 
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With all the caveats of different diagnostic methods and criteria, the pattern of the 
microbial species isolated in association with nosocomial pneumonia reported in the 
National Nosocomial Infection Survey in the U.S. 195 is important in providing a basic 
profile of the spectrum of pathogens. It is interesting to contrast this with the spectrum 
of pathogens in community acquired pneumonia identified in a prospective survey by 
Andrews et al 196. (See Table Two) 
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Table Two: Aetioloey of community acguired pneumonia 196 and nosocomial 
pneumonia 195 
Community-acquired Nosocomial 
Bacterial species % % 
Streptococcus pneumoniae 34 4 
Mycoplasma pneumoniae 18 0 
Influenza A virus 7 0 
Haemophilus injluenzae 6 8 
Chlamydia psirraci 3 0 
Legionella pneumophila 2 0 
Enterobacteriaceae""' * 
Staphylococcus aureus 1 14 
Pseudomonas spp 0 15 
Klebsiella spp* * 14 
Enrerobacter* ""' 10 
Escherichia coli* * 8 
Proteus spp* * 
Morganella morganii * 7 
Providencia swarrii 
Other Streptococci 1 2 
Serratia marcescens 0 6 
Others 3 4 
No organisms 33 0 
The incidence of community acquired pneumonia due to Gram negative organisms is of 
the order of 1 % to 5 % and again, patients who are immunocompromised with diabetes 
mellitus or alcoholism, or liable to aspiration from epilepsy or inebriation are most 
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susceptible to this, as their oropharynx has been shown to harbour a higher percentage 
of these organisms 36. 
The spectrum of pathogens responsible for nosocomial pneumonia in the ICU differs 
considerably from that in the community and even the general hospital 141 , because the 
emphasis in aetiology becomes still more predominantly Gram negative 38 and is more 
often found to be polymicrobial 127. 
Using a baboon model , Johanson et al l9? investigated the accuracy of a variety of 
different techniques to determine the microbiological aetiology of nosocomial 
pneumonia, following prolonged mechanical ventilation. By using a bacterial index 
calculated from the log sum of the colony counts for the individual organisms, they 
found that nosocomial pneumonias were predominantly polymicrobial (in 50 - 87% of 
instances) in the absence of antibiotic therapy. Organisms included in this index 
included those grown at only very low concentrations which might have been 
considered to be merely colonising agents or contaminants in other studies. The 
stipulation of a threshold such as 10 000 cfu/ ml in lavage fluid for any individual 
organism, or bacteraemia, would have yielded a much lower incidence of polymicrobial 
infections. Where there is failure of response to seemingly appropriate antibiotic 
therapy for a single aetiological agent, the possibility of a pol ymicrobial infection 
should nonetheless be considered. 
In their multi-institutional analysis of pneumonias requmng ICU admission , Ruiz-
Santana et al from Spain !SO, contrasted the organisms identified in cases of 
community-acquired and hospital-acquired pneumonia. They showed a similar 
difference in the spectrum of microorganisms: with a 34 % incidence of Streptococcus 
pneumoniae causing community- acquired pneumonia requiring ICU admission, 
compared with only 5.6 % of hospital-acquired cases. 31.1 % of secondary pneumonias 
in the ICU were due to Pseudomonas aeruginosa, compared with 2.1 % of community-
acquired infections. 
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Risk factors for Gram negative airway colonisation include previous antibiotic therapy, 
coma, uraemia, diabetes, advanced age, pre-existing lung disease, smoking, surgery, 
serious illness, malnutrition, gastric acid neutralisation, steroid therapy, and 
instrumentation of the airway either with endotracheal intubation or tracheostomy 5,33. 
The possible predisposition to pneumonia by neutralisation of gastric acid by antacids 
and cimetidine has already been alluded to, as well as the fact that in patients receiving 
sucralfate, the organisms were isolated in lower concentrations , than in the antacid/H-2 
group, possibly due to an independent anti-bacterial property of sucralfate 59 . Driks et 
al 62, attempted to demonstrate that such therapy alters the spectrum of organisms 
causing secondary pneumonia by showing that , in the seven patients who received 
sucralfate and developed ventilator-associated pneumonia, the organisms isolated were 
both fewer and included only mixed Gram negative bacilli in one, and Haemophilus 
injluenzae in another; whilst in the sixteen receiving antacids or H-2 blockers who 
developed this complication , there were 7 cases of mixed Gram negative bacilli , 
including Pseudomonas aernginosa in 5 cases, Escherichia coli in one, Proteus spp in 
two, and Serraria and Enterobacrer in one each. E.coli and Staphylococcus aureus were 
also involved in a further 5 cases. 
du Moulin et al 54 and Atherton and White 52 similarly showed increasing colonisation 
by aerobic Gram negative bacilli in patients treated with antacids, with clear evidence 
of oropharyngeal colonisation and airway colonisation secondary to this. Snepar et al 
6 l showed higher titres of organisms in post prandial gastric aspirates in those taking 
antacids and cimetidine. While they were unable to show any difference in the degree 
of colonisation when comparing antacids with cimetidine, there did appear to be an 
increase in the fasting titres of organisms in those taking cimetidine, compared with 
their pretreatment levels . 
While such evidence is suggestive, it is of course far from conclusive, as the spectrum 
of organisms exactly mirrors that recognised_ to cause secondary pneumonia in the 
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critically ill, and gastric colonisation by such Gram negative bacilli is recognised to 
cause nosocomial pneumonia S6 regardless of the use or type of antacid therapy. 
The majority of nosocomial respiratory infections are thought to be due to colonisation 
of the stomach, oropharynx and trachea by microorganisms , whose growth is promoted 
by alterations in the host defences and environment, and the aspiration of such 
organisms into the lower airway. Many of the above-mentioned risk factors for 
colonisation by Gram negative bacilli are thought to operate by causing alterations in 
bacterial adherence. However, Schwartz et al 39 showed that the pattern of colonisation 
leading to infection differs for different organisms. While oropharyngeal colonisation 
preceded tracheal colonisation and infection for the Enrerobacreriaceae, the 
pathogenesis of tracheal acquistion of non-Enrerobacreriaceae was completely different. 
Although the non-Enrerobacreriaceae formed the minority of organisms isolated in the 
hypopharynx , they constituted about two-thirds of the Gram negative bacilli colonising 
the trachea after intubation or ICU admission. Their appearance in the trachea took 
place without their having been isolated previously in any other site, suggesting an 
exogenous route of acquisition from the environment. 
The Gram negative organisms isolated from patients with nosocomial pneumonia are 
often divided into "endogenous" or "exogenous", according to the presumed origin of 
the organism. Typical exogenous species include Pseudomonas aeruginosa which is a 
common constituent of the flora in the hospital environment, but uncommonly found as 
part of the normal human flora. Escherichia coli which is a common component of the 
normal intestinal flora would be regarded as an endogenous organism. In the ICU, this 
classification falls away somewhat, as the flora undergoes such changes that even 
species regarded as exogenous, such as Pseudomonas aeruginosa, may transiently form 
part of the intestinal flora. 
Bartlett et al 140 studied the bacteriology of nosocomial pneumonia prospectively in a 
general hospital, using microbiological samples taken by transtracheal aspirate, pleural 
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fluid and blood cultures only. The diagnosis of pneumonia was made on clinical and 
radiological criteria. They isolated Gram negative bacilli in 47%, anaerobic bacteria in 
35 % , Staphylococcus aureus in 31 % and Streptococcus pneumoniae in 26 % , but found 
that nearly half the specimens yielded a polymicrobial flora , with more than one 
potential pathogen. The difficulties with achieving an accurate diagnosis of nosocomial 
pneumonia, let alone a microbiological diagnosis , have been discussed previously. This 
study is one of a very few that reports the incidence of anaerobic organisms as potential 
nosocomial pathogens. The problem with obtaining an accurate value for the incidence 
of anaerobic microorganisms as pathogens, is that these organisms are fastidious and 
difficult to culture. There is a problem with obtaining suitable specimens, and getting 
them rapidly enough to the laboratory to yield any growth at all ; furthermore, these 
organisms are all presumed to be sensitive to penici llin or metronidazole, and therefore 
of little interest as they are easily treated , and thus not worthy of further attention. 
The aetiological agents responsible for nosocomial pneumonia vary with the timing of 
such infections lO?_ In cases where the pneumonia occurs within two to four days of 
admission , the organisms resemble more closely those responsible for community 
acquired infections: Sr.reprococcus pneumoniae, Haemophilus influenzae, Moraxella 
catarrhalis all being frequent pathogens. The Enrerobacreriaceae , Acinetobacter spp, 
Serratia marcescens, Pseudomonas spp and Sraphylococcus aureus are isolated as the 
causative organisms with increasing frequency , as the patient 's hospital stay becomes 
more prolonged. Particularly after five days , the isolation of such organisms can be 
anticipated. 
Prior antibiotic therapy , before the onset of pneumonia, was identified by Fagon and 
his group 123 to be the only risk factor with a statistically significant effect on 
mortality. They assessed the risk factors for the development of pneumonia in 52 
patients in whom they were able to prove the diagnosis , and then tried to subdivide 
them according to the aetiological agent responsible. However, they were unable to 
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show much difference between the patients' risk factors in this way, except that 83 % of 
those who died with nosocomial pneumonia had received prior antibiotic therapy 
compared, with only 48 % of those who had not. Previous antibiotic therapy increased 
the probability of being infected by Pseudomonas aeruginosa or Acinetobacter spp. 
100% of those patients who were infected by coagulase-positive staphylococci resistant 
to methicillin had received prior antibiotics. whereas this occurred in only 33 % of those 
staphylococcal infections who had not. The mortality in those who developed 
nosocomial ventilator associated pneumonia was double that of those who did not 
develop this complication. although the frequency of poor prognostic factors such as 
those enumerated in the previously mentioned studies was similar. The mortality for 
those who had received prior antibiotic therapy was 83 % . compared with 48 % in those 
who had not received prior antibiotics. 
As has already been discussed. part of the difficulty in making the diagnosis of 
nosocomial pneumonia lies with the fact that the lower ai rway in intubated patients is 
no longer sterile , and it thus becomes both more important and more difficult, to 
distinguish between organisms that are mere Iv colonisers from those that are actually 
causing infection 113. 
Crouch et al 198 usino a baboon model demonstrated that colonisation of the ~ 
oropharynx occurred within 24 to 48 hours of ins trumentation of the respiratory tract. 
This was followed by aspiration of the colonising organisms into the tracheobronchial 
tree; however, specimens from the lower airway remained sterile for at least 24 hours 
longer than the proximal airway . They showed in the majority of these cases, who all 
received antibiotic therapy, that ,despite the presence of multiple organisms in the 
tracheobronchial secretions, pneumonias were usually due to a single species, selected 
from the orgamsms colonising the more proximal regions. The most common 
colonising orgamsms were Pseudomo11(1.1 aeruginosa, Klehsiella pneumoniae and 
Staphylococcus aureus. 
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Salata et al 137 in their study evaluating the examination of tracheal aspirates for elastin 
fibres, went to great lengths to differentiate between colonisation of the respiratory 
tract and true infection. However, in spite of this, there is a considerable overlap 
between the two groups in their study , which unfortunately detracts from it, by its 
resultant low specificity. They identi tied the pathogens responsible for colonisation and 
infection, and showed a very similar prorik of prevalence; apart from a much higher 
incidence of infection than colonisation by Pse11do111<J1WS oernginosa, and much greater 
levels of colonisation .by yeasts and Srreprococcus species. They reported that 
Pseudomonas aeruginosa and Serrario 111uru'st·e11s accounted for more than 50% of the 
organisms causing infection. while Sruphyloc11cc11s a11re11s and epidermidis accounted 
for a further 28 % . 
When evaluating the Gram's stain and 4 uanti tative tracheal aspirate cultures in 
colonised and infected patients, they found a higher Gram 's stain grading for the 
presence of polymorphonuclear leukocytes and bacteria at the time of development of 
the pulmonary infiltrate in those who developed infection, compared with colonised 
patients with and without a pulmonary infiltrate. They noted that, patients who 
developed definite criteria for pneurnoni::i. frequently demonstrated a rapid and marked 
rise in bacterial colony counts before the appearance of new or progressive pumonary 
infiltrates and clinical manifestations of infection. The importance of this finding is that 
it confirms what one intuitively expects: that by seri al monitoring of the tracheal 
aspirate, one should be able to predict the evolution from colonisation to infection. 
Such serial monitoring should help limit rh -:: number of occasions that it is necessary to 
resort to more invasive diagnostic techn iques. Hov.:ever. as mentioned previously , 
Schwartz et al 39 could not confi rm chi~ rinding for non-Emembacreriaceae Gram 
negative organisms. 
Salata also evaluated demographic. clinical. microbiologic and diagnostic differences 
between those with infection compared with colonisation. No difference between the 
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two groups could be found for age, smoking or alcohol consumption , mortality, 
cardiopulmonary disease, diabetes melllitus, neoplasia, renal failure, hepatic failure, 
previous antibiotic therapy, steroid usage, duration of hospitalisation before intubation, 
or previous episodes of pneumonia. Although the mortality rates were similar, death 
was attributed to pneumonia in 63 % of infections, as opposed to only 9 % of those who 
were merely colonised . The frequency of underlying illnesses was similar in the two 
groups apart from neurological disease which was highly significantly more common in 
those who were colonised. Only longer duration of intubation was associated with a 
greater risk of infection in this study. 
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While different diseases may predispose to colonisation by differing organisms, the 
organisms in different ICUs might also be expected to affect the aetiology of 
nosocomial infection . In their survey of the differing infections occuring in different 
ICUs within the same hospital , Brown et al 8 analysed the different frequencies of 
distribution of the various organisms in the ICUs. They found a fairly uniform 
incidence of Staphylococcus aureus in the different units of approximately 10%, while 
the incidence of Enterobacteriaceae varied from 17.4% in the medical/surgical ICU to 
3. 3 % in the neonatal unit. The incidence of Pseudomonas aeruginosa was again highest 
in the medical /surgical unit at 10.4 %, but similar incidences were recorded in the 
neonatal and paediatric units, the incidence being lowest in the coronary care unit at 
5.9%. The incidence of Haemophilus influenzae was uniformly low: 3.5% in the 
medical/surgical ICU and 1.3 % in the neonatal unit. The overall incidence of 
Enterococcus was 5.6% and the incidence of Candida sp was surprisingly high at 
8. 7%. Such findings are for all infections and not only pneumonias. The incidence of 
primary bacteraemias , skin and wound infections was similar in all units and possibly 
accounts in part for the similarity in the incidence of staphylococcal infections. The 
higher incidence of pneumonias in the medical/surgical unit may be surmised to have 
been due to the Enterobacteriaceae and Pseudomonas aeruginosa which predominated 
there, while nosocomial pneumonias are far less common rn such areas as coronary 
care. 
Chandrasekar et al l5? found a similar distribution of organisms when comparing the 
infections in the medical and surgical ICUs that they studied. 
Craven et al 10 compared the prevailing organisms isolated by the site of infection in 
their medical and surgical ICUs. The infections in the surgical unit were predominantly 
urinary tract infections, bacteraemias and wound infections, while those in the medical 
ICU population were more prone to develop pneumonia. The aetiological agents 
isolated are shown in Table Three. 
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Table Three: The aetiological agents causing pneumonia in different ICU 
populations (Craven 10). 
Medical ICU Surgical ICU 
Gram Negative organisms % I % 
I 
I 
Escherichia coli 7 8 
Klebsiella , Enrerobacrer JO I 38 
Serraria i 
Pseudomonas aeruginosa 16 27 
Other 42 I 40 
I 
I 
Haemophilus ::,pp 9 I 13 
I 
I 
I 
I 
I 
Gram positive organisms % 
I 
C1c 
I 
I 
Sraphylococcus aureus 16 I 19 
I 
Enterococci 0 I 0 I I 
Other srreprococci 18 14 
Candida ') 8 ... 
Other/not identified 5 I 5 I I I 
Some infections had more than one organism isolated. There was a general similarity in 
the organisms isolated in the two units. 
In their multicentre study of nosocomial infections m the ICU, Daschner et al 9 
identified the most common organisms causing pneumonia as being Pseudomonas 
aeruginosa (30 %). Escherichia coli (20 %J. Srnphylococcus aureus (20%), Klebsiella 
pneumoniae (17%), enterococci (9 %), Candida a/hicu11s (6 %) and Serrmia marcescens 
(6% ). The _total of 108 % being due to the po.lyrnicrobial aetiology in some cases. They 
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also identified a differing spectrum of pathogens and differences in their pattern of 
occurrence between the ICUs in this study. They point out that each ICU needs to be 
aware of the prevailing microorganisms in the local environment, and how they vary, 
as this will determine to a certain extent the infection control methods which need to be 
applied. Unfortunately, the definitions of infections and the techniques used to obtain 
specimens are not specified in this study, so that the results must be interpreted with 
some reservations , nevertheless the spectrum closely resembles that from studies where 
these details are mentioned. 
Rello et al l55 assessed the aetiology of nosocomial pneumo111a in 1000 consecutive 
admissions to a medical/surgical IC U. They used more specific diagnostic techniques 
than Craven lO to obtain representative specimens, and their diagnostic criteria were 
much more clearly specified than those of Chandrasekar l 57 or Brown 8. The 
predominant pathogens isolated notwithstanding, \vere Gram negative bacilli in 62.6 % 
although the incidence of Sraphy!ococcus uureus was higher than in the other 
mentioned studies at 23. 2 % . Interest ing I y. they found that patients with underlying 
chronic obstructive airways disease were at greatest risk for colonisation (and 
presumably infection) by Gram negative bacilli. \vhereas neurosurgical patients were at 
greatest risk of Staphylococcal pneumonia. They were unable to explain this 
discrepancy , which has also been reported from elsewhere l 99. 
Espersen et al 200 prospectively studied the incidence of pneumonia (the diagnostic 
criteria of which are not mentioned) due to Sruphy!ococcus cwreus in mechanically 
ventilated patients . They identiried 17 -:ases out of 295 patients ventilated in their 
general ICU . Neurosurgical patients again had a significantly higher frequency of both 
colonisation (27.8%), and infection (25.9%) due to this agent than other categories of 
patients, which they attributed to therapy \,\,'ith hypothermia and steroids. This study is 
however very poorly reported , as they make no attempt to define diagnostic techniques 
or criteria and the overall incidence of pneumonia in their unit is not even mentioned. 
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The accuracy of diagnostic procedure to distinguish between colonisation and true 
infection was the object of studies by Chastre and his group. In a study carefully 
designed only to identify true pathogens, Chastre et al 121 compared the cultures 
obtained by protected specimen brush and bronchoalveolar lavage. While obtaining 
polymicrobial growth by both techniques, they felt able to distinguish between 
colonisation and infection by the number of colony forming units obtained. Fagon et al 
123 using the protected specimen brush as the II gold standard II for diagnosis, isolated 
111 microorganisms associated with 52 episodes of pneumonia. of which 84 were 
cultured in significant quantities to be regarded as significant. 61 % were Gram negative 
bacilli, and 38 % Gram positive organisms. anaerobes accounting for only 1 % . 
Pseudomonas aeruginosa, Acinemhacrer spp and Proreus spp accounted for 63 % of all 
Gram negative bacilli and 39 % of the total organisms isolated. while the most common 
Gram positive organisms were Sraphylococcu.1 aureus and nonpneumoniae streptococci. 
75% of all episodes included at least one Gram negative bacillus and -+8% were due to 
such organisms alone; Pseudomonas aeruginosa and Acinerohacrer spp being involved 
respectively in 31 and 15 % of such cases. Onl y 13 % of patients with pneumonia caused 
by Pseudomonas aeruginosa, Sraphy/ococcu.\ aureus or Acinerohacrer spp survived, 
whereas a statistically significant 31 % of patients with pneumonias due to other 
organisms survived. 
A similar spectrum of pathogens was demonstrated in an earlier study by this group 
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, when they compared specimens obtained by protected specimen brush with lung 
cultures of specimens taken immediately afte r death. The high yield of Acinerobacrer 
spp and Sraphy/ococcu.1· aureus in these studies is rather unusual; as most of the studies 
in the literature give little attention to the importance of these organisms and report 
much lower rates of incidence. Graybill et al 38 in their early study of nosocomial 
pneumonia in the general hospital, attributed 3 % of cases to Swphylococcus aureus 
and, as in many studies, do not even mention identifying Acinemhacrer spp. The more 
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recently reported experience of the French group, however, reflects very closely the 
local ICU spectrum of organisms 14 1 , 148. 
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The differing mortality rates associated with different organisms causing nosocomial 
pneumonia was a phenomenon already described in the ICU by Stevens et al 201 in a 
paper published in 1974, reporting their experience in the late 1960s. Their diagnostic 
techniques included clinical examination, sputum bacteriology and chest radiographs. 
They reported similar findings to later studies: patients with Gram positive pneumonias 
who did not go on to develop Gram negative organisms during the period of symptoms 
and signs involving the lower respiratory tract, had a mortality that did not differ from 
patients without pneumonia; however, they were younger, had less duration of 
prolonged mechanicial ventilation , and lacked other indices of severity of illness (such 
as a low serum albumin , or a large A-a oxygen gradient). The other patients who 
developed pneumonias due to Gram negative organisms had a much higher mortality, 
were older, had a higher proportion of underlying lung disease, more severity of illness 
parameters, and more prolonged ventilation. 
In the following study by Celis et al l85, the incidence of these organisms, using 
specific diagnostic techniques, is again much lower with incidences more representative 
of most reports. In their analysis of risk and prognostic factors associated with 
nosocomial pneumonia, they identified infection with Pseuaomonas aeruginosa, 
Enterobacteriaceae, and other Gram negative bacilli, Streptococcus faecalis, 
Staphylococcus aureus, Candida sp, Aspergillus sp and episodes of polymicrobial 
pneumonia, by a stepforward logistic regression analysis, as independent factors which 
worsened the prognosis. The mortality rate of the polymicrobial episodes was 66.6%. 
For those due to Pseudomonas aeruginosa (sixteen patients) the mortality was 75 % , 
while the mortality was 40% with the Enterobacteriaceae (five patients). However, 
such organisms as Acinetobacter baumanii (one patient), Streptococcus faecalis (two 
patients), Staphylococcus aureus (two patients), Candida sp (two patients) and 
Aspergillus sp (one patient) were associated with a 100% mortality. Although the 
numbers are small, this is one of the few studies that has specifically evaluated the 
prognosis related to individual microorganisms. Organisms such as Streptococcus 
pneumoniae, Streprococcus viridans, Bacreroides .fi'agilis, or Haemophilus injluenzae, 
which more closely resemble community-acquired pathogens, were categorised as "low 
risk", because all patients with pneumonias due to these organisms survived. 
In 60% of the patients in this study. no pathogen was identified, despite extensive and 
invasive diagnostic procedures. probably because only those organisms that were 
isolated from the lmver respiratory tract \Vere accepted to be definitely proven 
pathogens; it is difficult to know how _many of these patients may have had a non-
infectious diagnosis . The outcome in those where no organisms were isolated was 
relatively benign . 
158 Similar results are reported from the same centre in studies by Torres et al 
Jimenez et al l-l-9. 
Silver et al 202 in a study designed to look specitically at nosocornial pneumonia due to 
Pseudomonas aeruginosa, reviewed the records of 34 patients, admitted to their ICU 
over a 2.5 year period. 59 % surv ived the initial episode of nosocomial infection; 
however, half of those who survived the init ial episode went on to develop a recurrent 
episode, and only 50% of these went on to survi\'e hospitalisation; however, 90% of 
those who did not develop recurrent episodes survived. They identified the patients who 
developed recurrent bouts of Pseudomonas as bei ng significantly sicker, as measured 
by the APACHE II and APS scores, more likely to have underlying chronic pulmonary 
disease, younger, and also to have received more prolonged ventilation and to stay for 
longer both in the ICU and hospital. 
The poor outcome reported in this study .. in those with recurrent episodes of infection is 
possibly not unexpected. It might have been easier to assess whether Pseudomonas 
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aeruginosa was "a high risk pathogen", if the outcome and other parameters were 
contrasted with other causes of nosocornial infection in the same unit. It is difficult to 
draw conclusions from this study as it is well known that patients with chronic lung 
disease are at risk of colonisation by P.w.:t((/omorws aeruginosa. Patients with more 
severe underlying disease are also likely to spend longer in the both the hospital and the 
ICU, and those who develop pneumonia will require more prolonged ventilation. Once 
again, it is difficult to be certain which process init-iated the whole course of events. 
Johanson et al 5, in an early study of nosocomial respiratory infections, suggested that 
the pathogenicity of an organism was probably more the result of host factors than the 
result of virulence or invasiveness of the organism. They identified a similar spectrum 
of organisms in both those who were colonised and infected: Klehsiella pneumoniae, 
Escherichia coli. species of Ememhacrer and Pse11domo11as aeruginosa being the most 
commonly isolated organisms. They found that no single bacterial species showed 
exceptional invasive potential, and that the frequency of isolation of a particular 
organism from patients with clinical infection. was similar to its isolation from patients 
who were merely colonised. 
Bryan and Reynolds 152 in their study of bacreraemic nosocomial pneumonia identified 
a similar spectrum of organisms, with a slightly increased mortality in those where the 
blood culture yielded a polymicrobial result. They identified a high incidence of 
underlying disease in those who developed this complication and felt unable to attribute 
death solely to the infection, but rather that it was the culmination of the severity of the 
underlying disease and its inevitable -:onsequence. This rather serves to confirm the 
impression created by Johanson that it is not the vi rulence of the organism, but the lack 
of host responsiveness which determines whether disease develops and what the final 
outcome may be. 
Tran et al 203 in their review of the relat ionship between mortality and a number of 
risk factors, similarly found that underlying disea-s~, particularly the presence of organ 
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failure, was the maJor determinant of mortality. While the severity of underlying 
illness, age, etc, predisposed to sepsis, sepsis alone was not an independent contributor 
to overall mortality. 
The importance of host factors 111 determining outcome is illustrated in a study by 
Seidenfeld et al 204, who studied 129 patients with ARDS (from a variety of causes), 
of whom 29% survived. Necropsy was performed in 51 % of non-survivors. The 
authors did not attempt to differentiate between pri rnary and secondary pneumonia in 
this report. although by implicating colonisation as the main factor to explain the 
predominance of Gram negative infections. there is a suggestion that the majority must 
be presumed to have been acquired in the hospital. 
The difficulty in diagnosing pneumonia in pat ients whose chest radiograph already has 
a diffuse pulmonary infiltrate has been discussed. and the difficulty of making an 
aetiologic diagnosis is well illustrated in this study. No infective cause could be 
identified in 67% of patients who survi,eJ (of whom 24 % were clinically septic), 
compared with only 33 % of non-survivors (in whom there was clinical evidence of 
both pulmonary and non-pulmonary sepsis in 76% ). Two or more organisms were 
simultaneously implicated in 45 % of all the infected patients. 27% of patients with 
pulmonary infections were bacteraemic. 58 % of respiratory infections (both primary 
and secondary) were due to Gram negative bacilli, 12% to Staphylococci, 20% to other 
Gram positive organisms, predominantly enterococci. and 10% to a miscellaneous 
group. Pneumonia associated with the development of ARDS occurred in 22 % of 
survivors. In those who did not survive, pneumonia was found at autopsy in 20%, but 
was thought ciinically to have developed in 53 % as a further complication. The overall 
survival rate for patients with ARDS and pneumonia was only 12 %. 
The authors attribute this poor uut<.:umc: to inadequate tissue penetration by 
aminoglycosides, which are known to penetrate respiratory secretions poorly, and may 
be inactivate~ in the presence of a purulent exudate. When the adequacy of treatment 
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by site and organism was assessed, 70% of pneumonias were considered to have 
received adequate therapy in that they had received the appropriate antibiotic; however, 
the dose may have been inadequate as the outcome in such patients was poor. The 
better outcome in those patients who received inadequate therapy is difficult to explain: 
the authors attribute this to less severe infection, which is possibly a little 
unconvincing. More of the inadequately treated infections were due to Pseudomonas 
aeruginosa, in which Stevens et al 201 previously showed the mortality to be 
unaffected by antibiotic therapy (although their patients did not ha·v'e ARDS). The 
dilemma of whether cause and effect exists in the relationship between pneumonia and 
mortality is still unanswered by this study . which i 11 ustrates all the difficulties 
associated with ARDS. infection and outcome. 
Coalson et al l 60 from the same group did attempt to answer this question in their 
study on the effect of bacterial superinfection on lung function in ARDS in a baboon 
model. They induced acute lung injury by means of intravenous oleic acid infusion and 
demonstrated that in the absence of bacterial superin fect ion. the resultant effect on lung 
function was mild; however in those that went on to develop infection, 80% 
deteriorated and died of complications of their infection. Thus in the presence of lung 
injury, acquired infection, either in the form of nosocomial pneumonia, or infection at 
another site may markedly worsen lung function. The current understanding of the 
septic syndrome and definitions of sepsis and the mediators of multiple organ 
dysfunction. possibly shed greater light on this issue 205 
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6.2 The Aetiology and Significance of Nosocomial Urinary Tract Infections 
Gross et al 151 analysed the incidence of nosocomial infection in the general hospital 
and identified the urinary tract as the most common site for infection and which did not 
appear to lead to death. As in all the other studies looking specifically at this type of 
infection, the presence of an invasive device , the urethral catheter, was the greatest risk 
factor for the development of infection. 
For urinary tract infections. the most common onramsms isolated were Escherichia 
. ~ 
coli, Proreus spp and Pse11domu11os .ipp: Serrwiu spp. enterococci and yeasts, although 
less frequently isolated, were also common . 
Haley et al 16! in their analysis of nosocornial infections occurring in 338 hospitals 
across the U.S.A .• estimated that 61 % of all patients '.vith nosocomial infection had at 
least one urinary tract infection . This study evaluated a large number of the potential 
risk factors for infection at the various sites. but unfortunately did not attempt to look 
at the spectrum of organisms responsible for such infections. Although such data would 
undoubtedly have illustrated a marked variation between centres, such information, 
apart from being interesting, might ha\'e been useful in determining preventive 
methods, if patterns of organisms associated with the various risk factors could have 
been highlighted . The incidence of urinary tract infection. as with infection at other 
sites, was shown to increase with increas ing age. and unlike infection at other sites, 
was more common in women than in men. Such infections occurred more commonly in 
neurosurgical and urological patients. \\ ith orthopaedic and thoracic surgery patients 
showing an intermediate risk of infection. In patients receiving any form of 
immunosuppressive therapy, the risk of contracting a nosocomial infection at the four 
most common sites. viz: bladder. lower respiratory tract. wound and primary 
bacteraemia. was lowest for the urinary tract. The incidence of infection was shown to 
increase linearly with increasing duration of hospital stay, but a prior community-
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acquired urinary tract infection, doubled the risk for the subsequent development of a 
further urinary tract infection. The presence of a urinary catheter was yet again shown 
to be the most important factor for the development of infection: the risk of infection 
without a catheter was 1.4% compared with 9.9% for those with indwelling catheters; 
67% of infections occurred in patients with catheters. The incidence of infections was 
also shown to be higher if the patient was mechanically ventilated, although there are 
obviously a number of factors such as the severity of the underlying disease, etc which 
m~st contribute to this phenomenon. 
Very little has been written about the aetio logy or' urinary tract infections specifically 
pertaining to the ICU. Most of the patients are catheterised for the greater part of their 
duration of stay, either as an adjunct to the management of fluid balance, or to facilitate 
nursing management. which must contribute significantly to the risk of infection in 
these patients. Whether there are indeed organisms that predominantly cause infection 
in the ICU setting is not clear, but the sheer volume of urinary tract infections, and the 
relative ease with which they are usually both diagnosed and treated, as well as the lack 
of many studies to show any relationship between such infections and mortality, has 
made this an area which has not been particularly well studied . 
Urinary tract colonisation and infection in the catheterised patient , both in the general 
hospital and ICU, is often polymicrobial. The organisms best recognised to cause 
urinary tract infection in the catheterised patient are Escherichia coli and Providencia 
sruarrii. The mechanisms for infection of£. wli are the ::idhesin type 1 pilus, which has 
been well studied. and also Tamm-Horsfall protein. For Prm·idencia sruartii, the 
adhesin is MR/K and this is thought to mediate adhesion to the catheter surface itself 
78
. Both these organisms are thus well-suited to colonising and infecting the 
catheterised patient. particularly if such l..'atheterisarion is long-term. 
Other organisms which are common Liropathogens, particularly in patients who are 
catherised for less than a month, include Pseudomonas aerngino.rn, Proteus mirabilis, 
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Morganella morganii and Klehsiel/a p11e1111w11iae . The enterococci and staphylococci 
also may account for a small proportion of bacteriuria 78. More importantly, Candida 
albicans and other yeasts may colonise the bladder and urinary tract in catheterised 
patients, who are immunocompromised by severe illness, have received previous 
antibiotic therapy, or who are diabetic. 
Only 1-5 % of all patients with catheter associated bacteri uria are thought likely to 
develop bacteraemia in the general hospital setting 76. Whether this risk increases in 
the ICU is not known. tvlen 1,,vith catheter associated bacteriuria are at greater risk of 
developing bacteraemia than women. Certain bacteriuric organisms such as Serrmia 
marcescens are also thought more likely to result in bacreraemia than others 76. The 
mortality attributed to bacteraemia from nosocomial bacreriuria is 13 % , although again 
most deaths occur in patients with se\·ere underlying diseases . Even without overt 
evidence of systemic disease, catheter associated bacteriuria is thought to be related to 
an increased risk of death 78. 
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Table Four: The spectrum of organisms isolated from catheter bacteriuria and its 
relationship with the duration of catheterisation ?8 
Organism 
Providencia stuartii 
Proteus species 
Escherichia coli 
Pseudomonas aeruginosa 
Enterococcus 
Morganella morganii 
Klebsiella spp 
Coagulase negative staphylococci 
Other Gram negative bacilli 
Other Gram positive bacteria 
Yeasts 
Short-term 
% 
0 
6 
24 
9 
7 
0 
8 
8 
7 
4 
26 
Long-term 
% 
24 
15 
14 
12 
8 
7 
4 
3 
6 
4 
0 
Daschner et al 9in their multicentre study of infection in ICUs in Europe, reponed that 
urinary tract infections were the most common cause of nosocomial infection. All 
patients who developed urinary tract infections, with the exception of neonates, were 
catheterised. The organisms most commonly isolated in such infections were 
Escherichia coli (28 % ) and the enterococci (22 % ), while other Gram negative 
organisms were Pseudomonas aeruginosa (5 % ), Klebsiella pneumoniae (5 % ), Proreus 
mirabilis (8 % ), Emerobacrer (3 % ), Serratia marcescens (0.5 % ) and a miscellaneous 
group comprising 11.5 % . Candida albicans accounted for only 6 % of isolates, as did 
both Staphylococcus aureus and Sraphylococcus epidermidis. 
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While Donowitz et al l62 reported an increasing incidence of Gram positive infections 
in his study of infections in the ICU, Chandrasekar et al l57 were unable to confirm 
this in their study where Gram negative bacilli predominated. Both these studies noted 
that fungal infections usually followed prolonged antibiotic therapy , but were relatively 
uncommon. 
Craven et al 10 reported a high incidence of urinary tract infections, particularly in 
their surgical ICU. The organisms isolated from the patients in the surgical ICU 
followed much the same pattern as reponed above: Escherichia coli 23 % , Klebsiella , 
Enterobacrer and Serraria species 34 % . Pseudomonas aeruginosa 11 % . other Gram 
negatives 7% (including Cirrobacrer .fi'eundii ); enterococci 7%, other Gram positive 
cocci 5 % (including Sraphyfococcus epidt'rmidis, Bacillus jpecies and diphrheroids), 
and a much higher incidence of Candida than in the other studies mentioned above at 
20%, while in 4% the organism was not identified. The pattern in the patients in the 
medical ICU was virtually the same. apart from a slightly higher incidence of 
Pseudomonas aeruginosa and a lower incidence of Candida species (1 6%). Almost all 
the patients who developed urinary tract infections in both IC Us were catheterised. 
This experience with fungal urinary tract infections is similar to our local experience, 
but the wide discrepancy between the incidence of such infections reported in these 
studies is difficult to explain. 
Brown et al 8 reported that Klebsiel!a. Emerohacrer and Serraria were the most 
common organisms encountered causing nosocomial infections in the four categories of 
ICU in their hospital, followed by Escherichia coli, Sraphylococcus aureus, 
Pseudomonas (all species) and Candida (all species) . Whi le noting the most common 
types of infections and the organisms most prevalent in each unit , they unfortunately 
did not analyse this data according to the site of the isolate. so that the spectrum of 
pathogens causing their 25.8% incidence of urinary tract infections is not clear. 
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6.3 The Aetiology of Nosocomial Bacteraemias 
Nosocomial bacteraemias are largely thought of as device-related infections, and as 
such the staphylococci are well recognised to be the most frequently isolated pathogens, 
accounting for one half to two thirds of all episodes. Although Staphylococcus aureus is 
a common cause, the coagulase negative staphylcocci have more recently become 
increasingly important ; it is thought that they may have a selective advantage in such 
infections, by being able to adhere more aggressively to plastic catheters than other 
organisms. The other pathogens most frequently encountered in device-related 
infections are: Klebsiella spp, Enterobacter spp and Serratia marcescens, although a 
contaminated infusate may also be the cause of such bacteraemias. Pseudomonas 
aeruginosa, Pseudomonas cepacia, Citrobacter freundii may also be isolated in these 
infections; however, they are still more unusual and contamination of the infusate 
should be excluded, if such organisms are isolated. Candida albicans and the Candida 
spp are seen most frequently in patients who have received prolonged therapy with 
broad spectrum antibiotics; and are most commonly encountered amongst patients who 
are receiving total parenteral nutrition. Such infections are thought to arise from 
contamination at the catheter entry site, although there have been reports of fungal 
contamination of the T.P.N. solution 8l _ Bacteraemia due to the Corynebacteria 
species occurs almost exclusively in severely immunocompromised patients, who are, 
or have been , receiving broad-spectrum antibiotics, and who have indwelling 
intravascular devices. 
The most frequent source of the bacteraemia depends on the population that is being 
studied. Eykyn et al l84 in a large study of almost 4000 cases of bacteraemia in 
London, showed that 40% of episodes were community-acquired and 60% nosocomial. 
Nosocomial septicaemias were usually of lesser severity than were the community-
acquired septicaemias. Unfortunately they did not report the actual mortality 
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attributable to septicaemia in this survey, although they noted that the mortality was 
lower for a nosocomial than a community-acquired bacteraemia. 
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The primary site for both community-acquired and hospital- acquired bacteraemia was 
the urinary tract, the second most common site for community acquired bacteraemia 
being the biliary tract. The most common organism isolated was Escherichia coli, 
although its proportion of the total number of causative organisms was lower in hospital 
(20 % ) than in the community (25 % ) . In the general hospital setting, they noted that 
after the urinary tract, intravascular devices were the second most common source for 
bacteraemia; together these two sites accounted for more than 50% of nosocomial 
bacteraemias. Escherichia coli was never associated with infected intravenous lines; 
however, the second most common organism in the hospital setting, Staphylococcus 
aureus (19%), which was isolated almost as frequently as Escherichia coli, was 
detected in almost half the episodes of infected intravenous access sites. Other 
important nosocomial pathogens causing bacteraemia were (in descending order of 
frequency): Klebsiella spp (9%), Pseudomonas spp (8%), coagulase negative 
staphylococci (8%), Proreus spp (5%), and then a miscellaneous assortment of other 
organisms including anaerobes (5 % ) and yeasts (1.5 % ), while the isolates were 
polymicrobial in 11 % . These infections were largely related to instrumentation, either 
of the urinary tract, or more rarely after surgery or other manipulation; the other main 
source being surgical wounds, particularly sternal wounds after cardiac surgery, or 
abdominal wound infections after emergency Caesarean section and hysterectomy. 
Certain underlying diseases were associated with particular isolates in community-
acquired bacteraemias: Escherichia coli was found to occur twice as commonly in 
diabetics as in non-diabetics, Streprococcus pneumoniae was three times more common 
in alcoholics; however, this pattern was not detected in nosocomial bacteraemias. 
Interestingly, Forgacs et al 93 in their prospective study of bacteraemias from the ICU 
in the same hospital , over a remarkable fifteen year period, noted that the most 
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common source of bacteraemic infection in the ICU (66 %) was the intravenous line. 
Despite the previous study by Eykyn , one must conclude that the intravenous line is a 
more important source for bacteraemia than the urinary tract, since 17% of all 
bacteraemias occurred in the much smaller ICU population (1.2 % of the hospital beds). 
Forgacs noted a male predominance of 64.9%, with a mean age of 51.8 years. 25% of 
bacteraemias in the unit, were community-acquired and largely related to pneumococcal 
pneumonia (38. 5 % ) ; 22 % occurred in medical patients and 53 % in surgical patients. 
The pattern of microbial isolates was similar to that encountered in the rest of the 
hospital, apart from a higher incidence of Pseudomonas spp (11 % vs 5.6%)and fungal 
septicaemias (3.8% vs 0.4%). The commonest nosocomial organisms to be isolated 
were staphylococci, and the source of these organisms was an infected intravenous line 
in 66 % of cases. The mortality from bacteraemia in the ICU was 60.4 % compared with 
only 13.1 % in those without bacteraemia. 
Forgacs divided the site of infection into medical and surgical , and while there more 
than twice as many surgical as medical episodes, showed that 40. 8 % of all medical 
bacteraemias were related to intravenous lines, compared with 30.6% of surgical 
bacteraemias; the respiratory tract accounted for 17.5 % of medical and 7.3% of 
surgical bacteraemias, peritoneal dialysis 21.4 % of medical cases and wound infections 
for 32.7% of surgical cases. The urinary tract was the source of only 8.7% of 
bacteraemias in the medical patients and a similar 7. 7 % in the surgical patients. 
The differing effects of an organism depending on the environment and host are 
probably best characterised by Streptococcus pneumoniae. Mylotte et al 206 compared 
the differences between community and nosocomial bacteraemias due to this organism. 
They showed a mortality for community acquired bacteraemia of 26.9% compared 
with community acquired pneumococcal pneumonia with bacteraemia where the 
mortality was 18. 2 % ; however, the mortality of nosocomial pneumococcal bacteraemia 
was significantly higher at 75. 8 % , and the mortality of nosocomial pneumococcal 
pneumonia with bacteraemia was also much higher at 66. 7 % . Patients with nosocomial 
bacteraemia were more likely to have received previous antimicrobial therapy, than 
those with community acquired disease; there were also the usual risk factors associated 
with hospitalisation including sedation, the use of respiratory assist devices. The patient 
population was also older, with co-existing, often ultimately fatal, underlying disease. 
Alcoholism was identified as a risk factor for community-acquired, but not nosocomial 
pneumococcal infection. 
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When reviewing the aetiology of nosocomial bacteraemias, once again the problem of 
cause and effect arises . Haley et al l6l in their study of nosocomial infections in 
hospitals across the U.S.A. , highlighted a number of risk factors for all types of 
nosocomial infection. While convincingly demonstrating an association between 
severity of illness and susceptibility to infection, there was possibly no causal 
relationship between the majority of factors identified , and the infectious complications 
which developed. They estimated that 5. 6 % of all nosocomial infections in the general 
hospital were primary bacteraemias, but that, when such infections were analysed 
specifically among surgical patients who had undergone a surgical procedure, the 
incidence increased to 9 % . These patients experienced 54 % of all bacteraemias, of 
which 45 % were primary and 60 % secondary. As with other secondary infections, the 
risk of infection increased with the patient's age and duration of hospital stay, it was 
higher for men than women , and highest in thoracic surgery patients, but lowest in 
gynaecological patients. The risk for acquiring a nosocomial bacteraemia increased 
10.3 times if the patient received steroids or other immunosuppressive therapy; the risk 
for subsequent nosocomial infection was highest amongst patients who had presented 
with an initial community-acquired or secondarily acquired nosocomial bacteraemia, 
particularly if the infection had been acquired in hospital. The risk for nosocomial 
bacteraemia appeared to be related to the duration of surgery, although this probably 
only gives some indication of the severity of illness, or the likelihood of bacterial 
contamination from complications during surgery, such as spillage or 
ischaemia. The risk of bacteraemia increased sixteen fold in patients who received 
ventilatory support, and 14 % of the bacteraemias developed in the 1 % of patients who 
were mechanically ventilated. This observation is probably just a further indicator of 
severity of disease. There is no comment on the predominant pathogens causing 
bacteraemias in hospitals in the U.S.A .. 
Gross et al 151 found a similar incidence of 9% for nosocomial bacteraemias, in their 
comparative study of the incidence of nosocomial infections in a university and 
community hospital. When death was associated with nosocomial infection, they found 
that more than 50 % of the deaths had occurred in the ICU. There was no specific 
microbial aetiology identified for the bacteraemias. Virtually all patients, with or 
without nosocomial infections, had intravenous catheters placed, but in those who 
developed infections, other more invasive devices were present such as central venous 
catheters, intra-arterial monitoring devices and nasogastric tubes. Yet again , the 
severity of disease necessitating the placement of such devices , may obscure a causal 
relationship ; however, the authors observed that such devices were not present more 
often in patients who developed infections than in those in whom such infections did 
not occur. 
Donowitz et al l62 studied the risk of nosocomial infection in their ICU which 
admitted predominantly surgical patients. They found an incidence of nosocomial 
bacteraemia of 5. 2 % , which was significant! y higher than the incidence in the general 
hospital. Patients from the general surgical service were most prone to this 
compiication , with an incidence of 12 % compared with thoracic surgery, where the 
incidence was only 2 % , or otorhinolaryngology and plastic surgery, where the 
incidence was reported as 0%. These incidences contrast markedly with those of Haley 
et al 161 where the thoracic surgery patients were at highest risk of such infection , but 
we are not given sufficient detail about either patient population to be able to draw 
further conclusions. The organisms most frequently isolated from the blood were 
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Staphylococcus epidermidis, Staphylococcus aureu.s, and Serrratia and Pseudomonas 
spp. 
When comparing the prevalence of infections in the different intensive care units within 
the same hospital, Brown et al 8 identified the neonatal ICU as the intensive care unit 
where primary bacteraemias were most prevalent (14.5% of all infections), with an 
incidence 50% higher than any other unit. There was a significantly higher rate of 
infection in which no pathogen was isolated, and they noted that the high prevalence of 
aerobic Gram negative bacilli encountered in all the other ICU s, was not a feature. The 
mortality attributable to nosocomial bacteraemia in this study was 27% compared with 
6% in non-bacteraemic controls. However, overall only 46% of the infections in this 
study were ICU acquired, and there is no attempt to differentiate the source of the 
pathogens in the analysis. 
Chandrasekar et al 157 do not comment specifically on the incidence of nosocomial 
bacteraemias in their study of nosocomial infections in their various ICU s, suggesting 
that such infections were of only limited importance in terms of incidence and sequelae. 
Daschner et al 9, in their multicentre European review, identified septicaemia as 
causing between 21.8% and 14.2% of all nosocomial infections, the incidence varying 
markedly between centres and for different categories of patients. They found venous 
catheter thrombophlebitis to be associated with a high risk of secondary septicaemias; 
this factor was identified in 77. 5 % of patients who developed this complication . The 
frequency of isolation of the organism responsible for these episodes of nosocomial 
bacteraemia did not vary significantly between the centres: Staphylococcus aureus 
48%, Staphylococcus epidermidis 10%, other Gram positive cocci 10%, Escherichia 
coli 9%, Pseudomonas aeruginosa 7% , Klebsiella pneumoniae 6%, Serracia 
marcescen.s 2 % , Proteus mirabi Lis 3 % , Candida albicans 1 % and other bacteria 4 % , 
accounted for the organisms isolated in Freiburg, while the spectrum was very similar 
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in the Swiss hospitals, excepting for one unit where there was a higher incidence of 
Serratia marcescens. 
Craven et al 10 noted a higher incidence of bacteraemia (8 % ) in their surgical ICU than 
in the medical ICU (5 % ). Nosocomial infections were noted to develop in 48 % of 
those who had a central line placed, 51 % of those with an arterial line and 56% of 
those with a pulmonary artery catheter. The rate of infection was related to the 
duration such devices were in place. The site of the infections in relation to the devices 
however was not specified. Yet again the role of the invasive device as a risk factor for 
infection is uncertain, as it may serve more as an index of susceptibility to infection 
and severity of disease , than as its direct cause. There was a considerable difference in 
the spectrum of organisms isolated in the two units although in both units , 64 % of the 
pathogens were Gram negative. There is no immediately obvious explanation for this 
difference, although the higher incidence of Enrerococci and Enrerobacreriaceae (other 
than E.colz) in the surgical patients might be presumed to be related to bowel surgery, 
or the underlying disease. 
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Table Five: Organisms causing bacteraemia l.Q 
Organisms Medical ICU Surgical ICU 
Gram negative % % 
Escherichia coli 28 17 
Klebsiella, Enrerobacrer 
Serraria spp 12 27 
Pseu.domonas aeruginosa 4 9 
Other 20 11 
Haemophilus injluenzae 0 0 
Gram positive 
Staphylococcus aureus 16 15 
Enrerococci 4 21 
Other streptococci 16 5 
Other Gram positive cocci 0 17 
Candida species 0 5 
The local experience with nosocomial bacteraemia in a respiratory ICU, reported by 
Potgieter et al 148, was limited in that the overall incidence of nosocomial infection 
was only 23.6%, and only 13 % of these infections were bacteraemias, effectively only 
eight patients. In three of these, generalised septicaemia was attributed to an infected 
intravenous line; in one, the infection followed nosocomial pneumonia. There were a 
further eleven patients in whom positive catheter cultures were obtained, but without 
evidence of infection. The incidence of such catheter tip colonisation has not been 
reported in most of the studies assessing the incidence of nosocomial bact~raemia, nor 
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do the definitions make allowance for the often questionable significance of an isolated 
positive blood culture, particularly of an organism such as Staphylococcus epidermidis 
94. Such discrepancies make the drawing of comparisons and conclusions difficult. 
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In a study designed to assess nosocomial bacteraemia, unrelated to colonisation and 
catheter related sepsis within the general hospital, Bryan et al 152 analysed episodes of 
bacteraemia attributed to nosocomial pneumonia over a five year period in four major 
hospitals. Although they acknowledge the difficulty in accurately determining the 
source of the bacteraemia by the epidemiological methods that they used , they argue 
that their findings are in agreement with other studies, and that they were able to 
validate their findings by autopsy in 26 cases. In this way, they identified 1 551 
episodes of bacteraemia in 300 54 7 patients, but of these, only 172 episodes in 168 
patients were attributable to nosocomial pneumonia. A male predominance of 62 % was 
identified. All the patients in whom bacteraemic nosocomial pneumonia developed had 
underlying diseases such as neurologic disease, tumours , chronic heart or lung disease, 
renal failure and alcholism . which would have predisposed to the development of 
secondary infection. The findings of this study indicate that bacteraemic nosocomial 
pneumonia is a complication of the critically ill, but the authors were unable to 
demonstrate cause and effect. The same organism was isolated from both sputum and 
blood in 49 % of instances , Gram positive organisms being isolated from both sites 
more frequently than Gram negative. The mortality was also significantly higher for 
Gram negative bacteraemia (45 %), than for episodes associated with Gram positive 
bacteraemia (26 % ) . 12 % of the blood cultures were polymicrobial, and in such cases 
the organisms were most commonly Staphylococcus aureus, Klebsiella pneumoniae or 
Pseudomonas aeruginosa. These episodes were associated with a greater mortality than 
in those in whom a single pathogen was cultured (68% vs 57%). The same organisms, 
either individually or in combination , were the most common pathogens in patients 
whose death was attributed to nosocomial pneumonia; the authors suggest that 
empirical antimicrobial therapy, in patients suspected of having this complication, 
should include agents effective against these organisms. 
Smith et al 163, in a study designed to evaluate the mortality attributable to primary 
nosocomial bacteraemia in the ICU popuiation, identified Staphylococcus aureus in 
39% of the isolates, Gram negative bacilli in 24% (Pseu.domonas aeruginosa 10%, 
Klebsiella pneumoniae 5 % , E. cloacae 5 % , P. cepacia 2 % , Proteus mirabilis 2 % ) and 
Candida albicans in 15%; Streprococcus sp (10%) , Enterococcus (7%) and 
Staphylococcus spp (5 % ) accounted for the remainder. The spectrum of pathogens 
would suggest that the primary source for these infections would have been an infected 
intravenous catheter. In an attempt to differentiate between the mortality due to the 
severity of the underlying disease from that of the complication, the mortality of these 
patients was matched with a control population of equal disease severity, but without 
this complication; in this way, an excess mortality of 28 % was ascribed to the 
bacteraemia. 
In a large study of 331 catheters, specifically designed to evaluate diagnostic techniques 
for detecting catheter related sepsis by quantitative culture , Brun-Buisson et al 90 
identified the organsisms obtained by this method according to whether they resulted in 
contamination , colonisation or infection. The spectrum was similar to other studies: 
there were 99 isolates of which 54 were thought to be contaminants (34 coagulase 
negative staphylococci, 6 Acinetobacrer spp and a miscellaneous spread of the other 
organisms), 7 isolates were thought to be colonisers only (3 Acinetobacter spp, 1 
Staphylococcus aureus, 1 Proteus spp and 1 other) , there was catheter sepsis, but no 
bacteraemia associated with 18 isolates (5 Sraphylococcus aureus, 8 Staphylococcus 
spp, 1 Pseudomonas aeruginosa, 2 Acinerobacrer spp , 1 Klebsiella spp and 1 Candida 
spp), while there were 20 isolates with catheter-related sepsis and bacteraemia (13 
Staphylococcus aureus, 2 Staphylococcus spp, 2 Klebsiella spp, l Escherichia coli). 
The predominant organisms causing infection were therefore Gram positive cocci with 
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Staphylococcus aureus in 42 % of episodes, followed by Sraphylococcus spp 22 % ; the 
Gram negative bacilli caused 18 .4% of infections, while Acinetobacrer spp and 
Pseudomonas spp were analysed separately, and thought to have caused 13.5% of 
episodes, and Candida 4.5 % . The patients in this study were all critically ill and the 
overall incidence of central venous catheter infection was high at 11 % . The authors 
identified a prolonged duration of catheterisation, the presence of another septic focus, 
or bacteraemia, to be associated with an increased risk of both catheter infection and 
contamination. A significant number of infections in this study were attributed to 
haematogenous seeding of the catheter. which then acted as a metastatic septic focus 
responsible for persistent clinical sepsis and positive blood cultures. Bacteraemia due to 
Escherichia coli and other Gram negative organisms, although common, was thought 
unlikely to result in secondary catheter infection. Most infections occurring either from 
the initial insertion, or subsequent manipulation of the catheter, were due to 
staphylococci. 
Other studies looking specifically at aspects of catheter related sepsis 80,84,87,89 
demonstrated a similar spectrum of pathogens both colonising and causing infection in 
the intensive care unit; the risk factors for colonisation being very similar to those 
already mentioned 85. 
There is surprisingly little specific detail on the septic complications of total parenteral 
nutrition, where infection is acknowledged to be a major hazard 164. One of the earlier 
studies by Ryan et al 8 l identified catheter-related sepsis in 11 % of all patients 
receiving T.P.N .. and 7% of all catheters used for this purpose became infected. There 
was a 2.1 % incidence of fungaemia identified in this study, with 61 % of the organisms 
recovered from confirmed cases of catheter-related sepsis being due to Candida spp or 
Torulopsis glabrara. These patients had all previously received broad spectrum 
antibiotics and half of them had also received steroids. Such factors as the catheter care 
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provided, and the duration of placement of the catheter were important in determining 
whether sepsis occurred. 
In the most recent and comprehensive reviews on the subject 98, infectious 
complications were identified to occur more commonly in those who were borderline or 
mildly malnourished and received T.P.N .. The major infectious complications were 
largely unrelated to the intravenous catheter, generally being postoperative infections 
such as pneumonias, empyemata, abscesses etc and only one death in the 192 patients 
who received T.P.N. was attributed to catheter-related sepsis. 
6.4 The Aetiology of Nosocomial Wound Infections 
Bacterial contamination of a wound is inevitable, even under the most stringent 
conditions of asepsis, with the best use of aseptic technique and the use of laminar 
flow 170. The presence of devitalised and traumatised tissue, haematomas and foreign 
material are all recognised to increase the risk of wound infection, as are host factors 
such as malnutrition, extremes of age, diabetes mellitus, concomitant steroid therapy 
and severe obesity 170. The routes of wound contamination remain largely 
undefined l 8 l. Nasal carriage of staphylococci has been recognised to predispose to the 
subsequent isolation of such organisms from the wound site. Despite adequate skin 
disinfection , the resident flora located in the sebaceous glands and hair follicles is 
largely unaffected, and the organisms are easily carried into the wound by the scalpel. 
Airborne contamination is also recognised to be of importance, although its importance 
relative to direct contamination via hands, skin and surgical instruments is uncertain. 
However, quite remarkably in view of the above preamble, wound infection is the 
exception rather than the rule, although in all the studies reported in the literature, 
surgical patients are at greater risk of nosocomial infection than medical patients. 
In their study of the relationship of death to nosocomial infections in the general 
hospital, Gross et al 151 omitted to specify wound infection as a category in its own 
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right, choosing rather to categorise such infections which were clearly regarded as of 
limited significance only, as part of "other". 
Green et al 175 assessed the increased duration of hospital stay and direct cost 
attributable to post-operative wound infection in a controlled study. They found that 
such infection tended to double the duration of hospital stay, and significantly increased 
the associated costs; however, there was no mortality among any of the patients in this 
study. 
Haley et al l6l in their review of nosocomial infections in 300 major U.S. hospitals, 
identified wound infections as one of the four most important sites. They estimated that 
of all patients with nosocomial infection, 30% had at least one surgical wound 
infection, with 14.5 % having multiple infections at the same site; the risk of a previous 
infection increasing the risk of a recurrence four times. When analysing the nosocomial 
infections in the surgical patients separately, they identified wound infection as the 
cause of 40% of hospital-acquired infections in this group, It was particularly frequent 
in the obstetrical and general surgical patients. Immunosupressive therapy increased the 
risk of infection three-fold, while mechanical ventilation was associated with a five 
times increased risk. There was an almost linear increase associated with increased 
duration of preoperative stay, as well as the duration of surgery. The same phenomenon 
of the severity of underlying disease predisposing to the development of complications 
was encountered, and other host factors such as age, diabetes and other underlying 
disease also appeared to add to the risk of infection at the wound site. 
Haley et al 28 developed a simple multivariate index of patient susceptibility and 
wound contamination, to identify patients at high risk of surgical wound infection. 
Such factors as abdominal surgery, an operation which lasted more than 2 hours, a 
contaminated or dirty-infected operation, or the presence of at least three diagnoses 
were all found to be highly significant risk factors predictive of the development of 
infection. 
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The pathogen responsible for wound infection depends not only on the site of the 
wound, but also on whether the surgery was elective or emergency and whether the 
operation was clean, clean-contaminated, contaminated or frankly dirty. Gil-Egea et 
al27 identified additional risk factors in their large prospective study of infections in 
clean wounds. The drainage of clean wounds significantly increased the incidence of 
infection and the skill of the surgeon accounted for up to a tenfold difference. The 
scheduling of the surgery also affected the chance of infection, with operations 
scheduled last being least likely to lead to infection. The authors explained this 
phenomenon as being due to the fact that longer procedures, which are recognised as 
higher risk, are usually performed first. The microbiology of the wounds showed that 
the causative organisms were 29% coagulase negative staphylococci, 28% 
Staphylococcus aureus, 21 % Enterobacteriaceae, 3% Pseudomonas spp, anaerobes 
comprising the remainder. 
While because of the implied severity of underlying disease, the incidence of wound 
infection might be expected to be higher in the ICU than in the general hospital 
population , Donowitz et al l 62 found no significant difference in incidence between the 
two settings. They assessed the risk for nosocomial infection according to the services 
admitting the patient to the ICU; obstetrical and gynaecology patients were identified as 
having the highest incidence of wound infection (9 % ) compared with 
otorhinolaryngology and medicine where the incidence was O % . The organisms in this 
study were not analysed according to the site at which they were isolated. 
Chandrasekar et al 157 compared the nosocomial infection rates between the different 
patient populations admitted to the different types of ICUs within the same hospital. 
They found a significantly higher rate of wound infections in the ICU compared with 
the ward; however, the data that they used included a burns unit where the overall 
incidence of infection was 30% and , although no further details are provided, the 
authors comment that all post-operative wound infections emanated from this and the 
surgical ICU. Again no analysis according to site of the organisms is provided. 
Craven et al 10 analysed the incidence of nosocomial infection specifically in their 
medical and surgical intensive care units, where they found an overall incidence of 
hospital-acquired infection of 31 % in the surgical ICU compared with 24 % in the 
medical unit. Similar risk factors for the development of infection at this site were 
identified: duration of admission, shock, hospitalisation in the surgical ICU, steroid 
therapy, chemotherapy and renal failure and the use of invasive devices. 25 % of 
surgical patients were infected on admission compared with .i4 % of medical patients, 
but the incidence of wound infections in the surgical ICU was 10% compared with only 
2% in the medical ICU. There were many underlying reasons predisposing the surgical 
ICU patients to wound infection: 21 % of the patients in the surgical ICU were multiple 
trauma patients, 12 % had head trauma, 8 % had intra-abdominal abscesses or trauma 
and such diagnoses did not occur in the medical ICU. There was also a higher 
proportion of patients with gastrointestinal disease (21 % vs 15%) and malignancy (15% 
vs 8 % ). The incidences of diabetes mellitus (18 % in the medical patients vs 12 % )and 
alcoholism (34 % vs 26 % ) were however higher in the medical ICU. The organisms 
causing wound infection in this study are shown in Table Six 
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Table Six: Bacterial isolates causin~ wound infection 
Organisms Medical ICU Surgical ICU 
Gram negative % % 
Escherichia coli 0 17 
Klebsiella, Enrerobacrer, 
Serraria spp 9 29 
Pseudomonas aeruginosa '27 23 
Other 9 20 
Haemophilus influenzae 0 1 
Gram positive % % 
Staphylococcus aureus 36 20 
Enterococci 0 6 
Other streptococci 9 14 
Other Gram positive cocci 18 14 
Candida spp 0 6 
Not identified 9 3 
(The total percentages add up to more than 100 because many of the isolates were 
polymicrobial) 
There was a difference in the organisms causing wound infection in the two ICUs, with 
Staphylococcus aureus being isolated more frequently in the medical ICU. 
Unfortunately the site of the wounds in the medical patients is not specified - possibly 
they were mainly septic intravascular catheter sites? The aerobic Gram negative bacilli 
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formed the large majority of isolates in the surgical ICU. Despite these apparently 
adverse factors, including the type of organisms being associated with complications of 
disease requiring admission to the surgical ICU, the mortality was higher in the sicker 
patients in the medical ICU. 
Daschner et al 9 in their multi-centre study in European ICUs, similarly found 
nosocomial infections to occur more commonly in surgical patients. They identified the 
presence of a surgical wound as the cause of hospital-acquired infection in 5 .2 % of 
instances in Swiss hospitals, compared with 7.3% in Freiburg. The organisms causing 
wound infections in this study were predominantly Gram positive cocci, with 
Swphylococcus aureus in 40%, Sraphylococcus epidem1idis in 8 % , Enterococcus in 6% 
and Group B Srreprococcus in 2 % . Gram negative bacilli were less frequent: 
Escherichia coli 16%, Pseudomonas aeruginosa 12 % , Enrerobacter 2 % , Klebsiella 
pneumoniae 6% , Serraria marcescens 2 % • Proreus mirabilis 4 % , other bacteria 
comprised 2 % , while Candida albicans caused 2 % of infections. Secondary 
bacteraemia was identified as being due to nosocomial wound infections in 4 7 % , which 
demonstrates that such infections should not be too easily dismissed as of minor 
importance only. 
Wound infection in surgical patients resulted in 33 % of all cases of bacteraemia, and 
was identified as the most important site for secondary bacteraemia in surgical patients 
in the ICU by Forgacs et al 93. The most common pathogens isolated from the blood in 
these cases were the Gram negative Enrembacreriaceae accounting for 31 % , 
Swphylococcus aureus 28 % , Pseudomonas spp 7 % , Srreprococcus spp and anaerobes 
31 % , with a variety of unspecified organisms causing the remainder. The authors point 
out that although Staphylococcus was the most common organism causing bacteraemia, 
this was not so if the episode was wound related, unless the infection followed cardiac 
surgery. 
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Infection in the severely traumatised patient forms another important part of the 
spectrum of wound and other infections encountered fairly commonly in the general or 
surgical ICU. The host defence mechanisms in the traumatised patient closely resemble 
those of patients with severe, chronic underlying disease. The patients' susceptibility to 
infection and the spectrum of organisms encountered are thus often different from what 
might be expected in young and previously fit individuals. Almost all infections in this 
category of patients are nosocomial, and related to the multiple invasive procedures 
required to resuscitate and manage these cases. Although such patients almost 
invariably have sustained a variety of wounds, it would appear from the literature that 
the wounds themselves are of fairly limited significance in terms of morbidity and 
mortality. 
Schimpff et al l8l in their review of infections in severely traumatised patients 
admitted to their trauma centre identified a high percentage of nosocomial infections in 
patients who stayed in hospital for more than 48 hours as a result of their injuries. 
There were no infections in those whose stay was shorter than this. In 135 patients who 
developed nosocomial infection, there were 35 bacteraemias, 8 wound infections, 40 
urinary tract infections and 7 peritoneal infections. The most prevalent organisms 
included: Pseudomonas aeruginosa (24%), Candida spp (16%), Klebsiella spp (10%), 
Enterobacter (8%) , Escherichia coli (6%) and coagulase negative staphylococci (6%). 
Nearly 50% of the bacteraemias were due to organisms such as Candida spp, 
staphylococci and Serratia marcescens. The organisms encountered in the secondary 
infections were similar to those previously described as common causes of device 
related infections of the urinary tract, vascular catheter-related or ventilator associated 
infections. Wound infections related to trauma were uncommon in this study. 
Caplan and Hoyt 207 identified infection as the second most common cause of death in 
multiple trauma patients, after head injury. In their survey of 2 348 severely 
traumatised patients admitted to a trauma unit, the incidence of infection was 27%. 
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Overall, 44 % of infections were associated with bacteraemia, and 14 % of 
the infected patients were thought to have died as a result of their infections. 37% of 
patients who developed nosocomial infections had multiple episodes, with 9 % having at 
least four episodes of secondary infection. The most common sites of infection were the 
urinary tract (18 %), pneumonia (15%) , empyema (11 %) , phlebitis (12%) , primary 
bacteraemia (10 % ) , surgical wounds ( 10 % ) , intra-abdominal abscesses (7 % ) , central 
nervous system related (7 % ) , sinusitis (5 % ) and catheter related (2 % ) . Fourteen 
percent of infections and 21 % of bacteraemias were attributed to the use of vascular 
devices. The surgical wound infections were mostly due to coagulase negative 
staphylococci, which also caused IV catheter infections, infections related to chest 
tubes , and intraventricular catheters; however, the isolates from the intra-abdominal 
abscesses , which were usually deep-seated and related to major intra-abdominal trauma 
were polymicrobial , and required extensive surgical drainage. 
Goris et al l80 retrospectively analysed the cause of death in 89 patients who had 
sustained blunt trauma. They found that, in the group who died more than 7 days after 
their injury , death was due to sepsis in 88 % . The only factor which seemed to 
differentiate survivors , with similar severity of injury, was the absence of injury to the 
extremities. Although the exact details of these injuries are not provided, it would seem 
that again it was not the presence of wound sepsis, but rather the associated lack of 
mobility, which resulted from limb injuries, that lead to complications; nosocomial 
pneumonia possibly being the final event. 
Allgower et al 179 again emphasised the importance of early mobilisation to prevent 
complications of nosocomial infection, in patients who had sustained polytrauma. The 
mortality of the patients who developed overt sepsis was 65 % . The main causes of fatal 
sepsis being: nosocomial pneumonia 28% (100% of nosocomial pneumonias were 
fatal), subphrenic abscesses 28 % , wound infections 8 % (these patients sustained major 
injuries with traumatic amputations of legs , and the mortality was 100% ), urinary tract 
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infections 12 % , brain empyema 4 % , the site not being identified in 8 % . They found 
that 4% of post-traumatic wounds became infected, with an incidence of 12.3% of 
trauma patients developing wound infection - an incidence of wound infection which 
was higher than in their surgical patients. Traumatic wounds contrasted with surgical 
wounds in that the incidence of Gram positive and Gram negative organisms isolated 
was similar, whereas in the surgical incisions, the infections were predominantly caused 
by Gram negative organisms. 
Machiedo et al 208 reviewed the patterns of mortality in their surgical ICU. 41 % of 
admissions to their unit followed trauma. The overall mortality rate in the unit was 6%, 
with 37% of the 101 deaths in the study period being due to trauma : 81 % of the deaths 
in the trauma patients were as a direct result of the injury, 19 % dying as a result of 
severe, uncontrolled infection , resulting in septic shock or multiple organ failure. 
However, in the non-traumatic group of patients, 62 % of the deaths were the result of 
sepsis. 
Thus while trauma predisposes to infection which remains a late and important cause of 
morbidity and mortality in these patients, the initial wound infections in themselves are 
not regarded as important sites or sources for the development of nosocomial infection, 
as they are usually easily managed with debridement, the early administration of 
antibiotics and appropriate surgery. 
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CHAPTER 7. THE PREVENTION OF NOSOCOMIAL INFECTION 
Introduction 
The prevention of nosocomial infection within the intensive care unit environment can 
be divided simplistically into the prevention of exogenous.or cross-infection, and the 
prevention of endogenous infection. The importance of nosocomial infection has been 
highlighted in the previous sections dealing borl1 with i rs aetiology, incidence and the 
attributed morbidity and monaiity. The de,·el0pme11t of in:·~ction either by endogenous 
or exogenous mechan isms requires the acqui sit ion or" tile organism. colonisation of a 
susceptible site and the subsequent progress ion co tissue invasion and infection. 
Although many so-callee! "endogenous" infections are though t to be acquired from 
colonisation of the patient's o,vn gastrointestinal tract. the organisms must first have 
been acquired from the hospital environment. Thus. the prevention of the exogenous 
spread of infection should aim to pre\·ent the de\elopment to some extent of both routes 
of infection. 
Under normal circumstances. the endogenous colonising microbial flora consists largely 
of anaerobic organisms, while other organisms such as Moraxe/la cararrhalis , 
Klebsie//a spp. Serraria spp. etc are unable to colonise 111 sufficient quantities for 
sufficiently prolonged periods to cause intectiun. In the cri ticall y i ll patient however, 
all these organisms can cause infection . and i t has been estimated that nosoocmial 
infection is due to endogenous colonisation in 30% to 50% of instances 209. 
Techniques aimed at preventing endogenous infection have included the use of 
disinfectant solutions on skin and muco:i:te. the irrigation of cavities. total gut 
sterilisation in leukopaenic patients. topical antimicrobial prophylaxis and more recently 
selective decontamination of the digesti ve tral."t. 
The control of the immediate environment surrounding the patient 1s important m 
preventing nosocomial infection. It is thought hO\vever that the aerogenous route plays 
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a minor role in the transmission of microorganisms. Techniques such as laminar flow 
are accordingly no longer deemed necessary in the general ICU 209 , although infection 
with airborne microorganisms is still an important consideration in patients with burns 
or extensive open wounds, and in the severely immunocompromised leukopaenic and 
transplant patients. 
The effect of nosocomial infection on patient outcome in the ICU, although not clearly 
established as one of cause and effect, clearly contributes to both morbidity and 
mortality, and thus significantly increases the cost of hospitalisation. Pneumonias, 
septicaemias and wound infections are the most expensive nosocomial infections to treat 
and it is estimated that the average episode of hospital-acquired infection cost between 
$1 800 and $42 000 in the USA in 1986 11 . These infections in the intensive care unit 
setting are thought to be a leading cause of death which should be preventable - at least 
to a certain extent. 
The continuous microbiological surveillance of all patients and infections within the 
hospital is probably not justified, as it requires vast quantities of time, manpower and 
money; however, surveillance with goal-directed objectives is important in identifying 
problem areas and effectively controlling the sources of infection. 
Cost-containment in the area of infection prevention is also extremely important and 
includes the education of all involved in hospital administration and patient care. For 
example, it has been shown to be unnecessary to change dressings within 24 hours of 
an aseptic surgical procedure, as wound infections are not recognised to occur within 
this early period. The use of protective gowns for all entering the ICU is unnecessary if 
the person is not going to be in direct contact with patients. Except for certain 
ventilation systems , improvements in architectural design have not been shown to have 
any effect on the incidence of nosocomial infection 1 l _ However, the importance of a 
spacious and good working environment should not be underestimated, as its influence 
on staff morale is carried over into all aspects of patient care. Even in this important 
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area, there needs to be a guidance and some measure of realism in setting achievable 
targets for reducing the incidence of nosocomial infection. 
7.1 The Infection-Control Team 
Hospital-acquired infection has been recognised to be a problem of sufficient magnitude 
to justify the development of specific infection control programmes. Their aim is to 
minimise the risk of infection to patients, staff and visitors, by maintaining constant 
surveillance. The Centre for Disease Control in Atlanta has established that the efficacy 
of nosocomial infection control depends on the degree of surveillance activity, and 
where such levels increased, the infection rate progressively declined 210. A good 
infection control programme needs a broad multidisciplinary approach with 
consideration of the medical, administrative, economic, legal, social and ethical 
implications. Although cost contraints are foremost in the minds of all concerned with 
hospital management, the medical and ethical aspects must not be allowed to be 
overshadowed. 
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In order to permit efficient, streamlined and economic functioning, most hospitals have 
developed infection control committees, who are responsible for the administration of 
this important problem; such committees may vary depending on the staff structure and 
size of the hospital, as well as the available resources. To ensure maximum co-
operation, such a team needs representation from all sectors involved in any aspect of 
infection prevention. Ideally those participating should be interested, influential within 
the hospital and endued with tact and other socially endearing qualities! In most 
hospitals, the team would consist of clinicians, especially infectious disease specialists, 
microbiologists, epidemiologists, pharmacists, pharmacologists, administrators, nurses 
involved in infection control and surveillance, and infection control practitioners. As is 
often the case, as the size of the committee expands, its efficacy diminishes. 
The existing policies need continuous review by the infection control committee, so that 
problems can be identified and appropriately managed. The infection control committee 
must be required to be accountable to the administration for their findings, and to be 
sufficiently empowered to be able to implement the necessary changes. 
The functions of an infection control team are: 
1) the education of the staff in practices to prevent nosocomial infection, and their 
motivation to carry these out to the best of their ability on a daily basis. 
2) surveillance, investigation and reporting of outbreaks of infection. 
3) the formulation of an antibiotic utilisation and prescribing policy, and the monitoring 
of antibiotic resistance patterns. 
4) the screening and protection of staff and patients from transmissible diseases. 
Daschner 9 reported a 17% reduction in the rate of nosocomial infections in his hospital 
in Freiburg when an infection control programme and team were introduced. Where 
cost constraints limit the scope of such programmes, the high risk areas in the hospital 
must be prioritised. Possibly the area which deserves most attention is the intensive 
care unit. The ICU has the highest rate of nosocomial infection in the hospital , with 
more device related infections than elsewhere, and is where antibiotic resistance most 
commonly originates. 
A recent survey of infection control in the intensive care units in the United Kingdom 
211 showed that in 13 % of the units, there were no isolation facilities, 60 % had fewer 
than one washbasin per ICU bed and some units used open urinary drainage systems. 
While there appeared to be fairly adequate accessibility to microbiologists for advice on 
infection related problems, excessive numbers of specimens were being submitted for 
microbiolgical surveillance, without any co-ordinated response to problems. This study 
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revealed a disturbing lack of awareness of methods of infection prevention and control 
and a need for greater education. 
Education 
It is essential that the importance of preventing and controlling nosocomial infection is 
conveyed to all concerned, by both the visibility and accessibility of the infection 
control team. The participation of the staff in regular meetings at which the guidelines 
for infection prevention can be presented , specific areas of concern highlighted, and 
new aspects of policies in management of procedures or drugs explained , help both to 
educate and motivate all concerned by the creation of a sense of involvement and team 
spirit. 
The results of educational programmes are often disappointing in the carry-over of the 
procedure into the daily practice in the unit 43. It is thought, nonetheless, thQ.t units 
with educational programmes do have lower infection rates than those without any form 
of in-house education, probably by the demonstration that these matters really are of 
concern to all those involved. Constant cajoling does serve as motivation! 
The organisms that cause nosocomial infection are frequently transmitted by the hands 
of the hospital personnel , and hand-washing is considered to be the single most 
important procedure in preventing nosocomial infection. Hand-washing has been 
recommended after contact with every patient by the Centers for Disease Control, 
particularly in the ICU where patients are highly susceptible to nosocomial infection 
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. Hand washing is described as " a vigorous rubbing together of all surfaces of 
lathered hands , followed by rinsing under a stream of water"213. However, adherence 
to recommendations of frequent hand-washing has been demonstrated in several studies 
to be poor, even during studies where there was careful monitoring and motivation of 
the staff 4 1,212 . 
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In controlling an outbreak of nosocomial infection , the team needs firstly the ability to 
identify the reservoirs of colonised and infected patients and the contaminated areas in 
the environment; secondly, to halt the spread of infection by improving handwashing 
and aseptic technique, isolating colonised and infected patients, and eliminating any 
identified common environmental sources for the outbreak. Susceptible patients need to 
be separated and protected if at all possible, while those who are colonised may need to 
be treated, depending on the nature of the pathogen. In many centres, the outbreak of a 
resistant organism has prompted the closure of the unit to new admissions. Finally, 
antibiotic usage needs to be controlled to prevent further resistant strains from 
emerging. 
Surveillance 
Continuing microbiological surveillance is an area of extreme importance. The 
quantification of the problem by this method not only helps in the setting of realistic 
goals and providing feedback for motivation to improve problem areas, but surveillance 
cultures also fulfill an important role, both in the management of the patients in 
intensive care, and in the overall "housekeeping" of the ICU. Surveillance cultures 
may be used to help detect early breakdowns in the general maintenance of hygienic 
standards, air-conditioning , environmental control , sterilisation of equipment, and the 
adherence by staff to aseptic technique and other hygienic precautions. 
From an epidemiological point of view, such cultures may serve to reveal an outbreak 
of resistant microorganisms. However they are more often of value in assisting in the 
determination of the most appropriate antibiotic use, and are helpful in the early 
detection of the emergence of resistant strains. 
Microbiological sampling has become a routine part of patient care in the ICU, usually 
being performed twice or three times weekly in all patients. Samples of tracheal 
aspirate, samples from all wound sites and urine are sent for microscopy, culture and 
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sensitivity from all patients in the ICU on specifically designated days, 
regardless of whether infection is clinically suspected or not. It is possible that with 
routine surveillance cultures, the use of more invasive diagnostic techniques to obtain a 
pathogenic microorganism may be reduced to a minimum. The phemonenon of the 
isolation of a colonising organism gradually becoming predominant on repeated 
samples, and then becoming associated with the presence of pus cells and systemic 
signs of infection, should render further investigation superfluous. The diagnosis of 
nosocomial infection may be pre-empted in this way; so that if infection is clinically 
suspected , clues are already to hand as to where the most likely site of infection may 
be, and what pathogenic organisms and their antibiotic sensitivity patterns should be 
expected, so that therapy can be initiated appropriately and expeditiously. 
It is for this reason that it is important to differentiate between "bronchial" infections 
and "nosocomial pneumonias": there can be no justification for awaiting a deterioration 
in gas exchange and a new radiological infiltrate, when surveillance cultures indicate 
that colonisation by a predominant organism is leading to infection . 
7 .2 Antibiotic policy and the monitoring for drug resistance 
Selection pressure caused by antibiotic use is the main factor responsible for the 
emergence of antibiotic-resistance; the best ways of curbing the spread of antibiotic 
resistance are through the adherence to an antibiotic policy, and preventing and 
controlling outbreaks of infection 2 l 4. 
Part of the duties of an infection control commitee is to monitor the levels of antibiotic 
resistance and antibiotic usage in the hospital; guidelines for the prescribing of drugs in 
the hospital can be formulated from this , in an attempt to curtail further antibiotic 
resistance, contain costs and assist clinicians in selecting the most appropriate 
empirical therapy for nosocomial infections. The development of antibiotic policies, if 
effectively implemented, may , with the use of "drug holidays", over time, allow the 
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reintroduction of agents to which the hospital flora had previously become resistant. 
However, the institution of such policies requires careful follow-up as these therapeutic 
manoeuvres are not always successful, and may promote further antibiotic resistance 
34. With the development of new antibiotics, the problem of resistance has become 
increasingly serious, resulting in a desperate race between the use of higher doses and 
newer antibiotics on the one hand, and the development of resistance on the other. 
Certain organisms have been recognised to be susceptible to the development of high 
level antibiotic resistance; these organisms include methicillin-resistant Staphylococcus 
aureus , high level penicillin-resistant Streptococcus pneumoniae, carbenicillin-
aminoglycoside resistant Pseudomonas aeruginosa and , more recently , aminoglycoside 
resistant Acinetobacter baumanii. 
Weinstein et al 215 reported efficacy in controlling epidemic outbreaks of antibiotic 
resistance by the restriction and rotation of antibiotics , thereby decreasing selective 
pressure for "plasmid outbreaks". They also recommended the careful dosing of 
antibiotics to prevent subinhibitory levels from selecting resistant subpopulations. As 
last resort manouevres they suggested the control of antibiotics which select sensitive 
precursors of resistant organisms eg cephalosporins selecting for Pseudomonas spp, or 
even the total suspension of all antibiotic usage. 
Other techniques for the control of epidemic resistance include the use of prophylactic 
topical antibiotics (vide infra), and the largely experimental use of bacterial 
interference. 
7 .3 Staff and patient screening 
The screening of the personnel in the hospital serves both to improve communication 
and to identify the sources of, and prevent the transmission _of infection either to or 
from , the one to the other. The control and organisation of staff health includes: routine 
chest radiographs, to ensure that staff are not serving as a source of infection, either to 
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their colleagues or patients; education about the need for protective techniques to 
protect against exposure to transmissible and highly infectious diseases and the 
implementation of routine vaccination. A periodic review of the techniques currently 
being employed in treating patients with transmissible diseases is also essential in 
maintaining a healthy, motivated work force. 
7.4 Sterilisation, Disinfection and \Vaste Disposal 
It is not the purpose of this thesis to !·eview the techniques of sterilisation, disinfection 
and waste disposal in any detail; however, although it is often taken for granted, the 
safe performance of these procedures should not be underestimated and is essential to 
the prevention of all nosocomial infections and of extreme importance. 
According to the CDC 21 3, patient care objects can be divided into three categories. 
based on the level of disinfection or sterility necessary for the object. Items which have 
access to the blood such as surgical instruments, intravenous fluids, catheters, irrigation 
fluids etc, for which sterility is required, are termed "critical objects", while those 
objects such as bronchoscopy and gastroscopy equipment, that are only in contact with 
mucous membranes, but require a high level of disinfection, are termed "semicritical", 
and should be kept free of vegetative bacteria. "Noncritical objects" are those such as 
bedpans and electrocardiogram leads, which require a low level of disinfection. It is 
thought that the cleansing of the fomites surrounding the patient once a day is 
sufficient. 
The other well-recognised medium by which infection is spread is through the animate 
environment comprising the hospital personnel, particularly on the hands. While there 
is general agreement on the important role that the animate environment plays in the 
aetiology of nosocomial infections, proper quality control and the maintenance of 
appropriate procedures and techniques should virtually eliminate the inanimate 
enviroment as a potential source for nosocomial infection. 
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In a study by Weber et al 21 6, manual ventilation bags were demonstrated to be a 
source for bacterial colonisation of ventilated patients, particularly by coagulase 
negative staphylococci and Acinetobacrer spp. This study, and others already mentioned 
29,217 serve to highlight the importance of adhering to strict protocols for the 
sterilisation of ventilatory equipment. It also shows how such contaminated equipment 
may serve as a source for colonising the hands of personnel , who may then cross-
transmit such pathogens directly to other patients , or to colonise respiratory or other 
medical equipment. Contaminated equipment can also be a source of nosocomial 
infection , by acting as a direct source for introducing the pathogens into the patient. 
The importance of hand-washing following an y contact with patients , or potentially 
contaminated equipment, and high- level disinfection of ventilatory apparatus between 
patients would appear to be self-evident, but is, nonetheless, worthy of emphasis. 
Cross and Roup 29 prospectively studied the role of respiratory assist devices and 
techniques in the pathogenesis of nosocomial pneumonia. They found the incidence of 
contaminated respiratory devices to be reassuring low, so that they were unable to 
recommend the routine monitoring of these devices while in use . They also did not 
find any positive cultures of nebuliser fluid, however, they did demonstrate a 
correlation between the cultures of respirator effluent , tracheal suction fluid and the 
respirometer, with subsequent nosocomial respiratory infection by the same organism. 
65 % of cases with hospital-acquired pneumonia in this study occurred in patients who 
had used respiratory assistance devices; they also showed that manipulation of the 
respiratory tract greatly increased the risk of infection . Some of the recommendations 
formulated are easier in theory than in practice: the earliest possible discontinuation of 
intubation and respiratory assistance being the most obvious, but most difficult to 
implement. The authors recommended the changing of respiratory tubing at 24 hourly 
intervals, which has since been overtaken by the recommendation of Craven et al 30 
that 48 hourly changes actually reduced the incidence of secondary respiratory tract 
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infections. They also suggested that equipment that cannot be adequately sterilised 
should not be used. 
7 .5 Isolation techniques 
The theory of patient isolation to prevent infection owes its origins to the quarantining 
of patients with contagious diseases . Although the technique of separating infected from 
non-infected patients has persisted, the isolation of patients is mainly confined to those 
with certain categories of highly infectious diseases , highly resistant organisms or more 
commonly as practice to protect the patient from the normal hospital environment. In 
an effort to promote the awareness of both potential susceptibility to and the infectivity 
of all patients , universal precautions in the management of all patients have been 
introduced. By this means it is hoped that the provision of health care can be made both 
safer and more efficient. Handwashing again is of prime importance in all patient 
contact, and the use of protective clothing when in contact with all bodily secretions is 
recommended. Similar attention 1s given to the handling and disposal of all 
contaminated equipment. 
Techniques such as reducing the number of patients in a room . reducing the nurse to 
patient ratio , improving the facilities for hand washing are all recognised to reduce the 
incidence of nosocomial infection. Elaborate forms of protective isolation used in 
combination with antibiotic prophylaxis have been extensively studied 13 and have had 
a significant effect on reducing the incidence of infection in granulocytopaenic patients. 
In general , the use of simple barrier nursing without antibiotic prophylaxis has shown 
no benefit Z l 8. possibly because the infections in these patients are caused by 
microorganisms already colonising the patients at the time of admission. Few infections 
appear to be related to invasive devices or procedures, where an improvement in 
infection control practice could further reduce the incidence of infection. However, in 
patients with burns, the use of a protected environment alone has been demonstrated to 
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have significantly reduced the very high incidence of wound and other infections by 
organisms which are acquired exogenously from the hospital environment 2l9. 
In the general intensive care unit setting, many of the pathogens causing nosocomial 
infection are extrinsically acquired after admission to hospital, often being transmitted 
on the hands of staff or equipment, or caused by invasive devices or surgery. The 
period at which such patients are most susceptible to exogenously acquired infection is 
while devices are still in place , and it is for this reason that environmental control is of 
the utmost importance in the prevention of ICU-acquired infection. 
Weinstein et al 215 reported the use of selected barrier type antibiotic resistance 
precautions to control and prevent the emergence of multiple drug resistant nosocomial 
infections throughout the hospital, following an outbreak of multiply resistant aerobic 
Gram negative bacilli. They highlighted the following mechanisms as being of 
importance in leading to the development of multiply resistant organisms: 
(1) The admission or readmission of patients with pre-existing gastrointestinal, 
genitourinary, respiratory or wound colonisation or infection with resistant strains. In 
their hospital 25 % of aminoglycoside resistant Gram negative bacteria were isolated 
from patients on admission. (2) The transmission of bacteria between persons, often 
indirectly, via transient carriage on the hands of the personnel , or due to environmental 
contamination such as urine measuring devices. (3) Antibiotic pressure, both 
suppressing the sensitive flora with sequential colonisation by more resistant bacteria, 
and selecting a resistant subpopulation of bacteria from a larger sensitive population. 
(4) Other more controversial mechanisms of transmission of mulitply resistant Gram 
negative organisms include food-borne and air-borne contamination. 
Based on the above, they employed the use of the following barrier-type precautions in 
all patients who were colonised with multiply resistant aerobic Gram negative bacilli: 
the use of isolation cubicles with no more than two beds per room and no sharing of 
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such rooms by two patients both with drainage tubes or Foley's catheters; the wearing 
of gloves for all patient or secretion contact, and the allocation of individual urine 
measuring devices to each patient. The wearing of gowns and gloves however, was not 
deemed to be necessary. Such precautions were applied to all patients who were 
identified as persistently shedding resistant bacteria, while cultures were being 
processed from patients admitted or readmitted with a history of colonisation or 
infection with resistant organisms, or in patients with indwelling urinary catheters. 
Klein et al 220 reported a prospective randomised trial of 70 non-immunosuppressed 
patients who required mechanical ventilation in a paediatric ICU, to determine whether 
simple protective isolation, using disposable high-barrier gowns and non-sterile gloves 
could reduce the incidence of nosocomial infection. The number of contacts between 
patients and the ICU personnel and family members was monitored. The protective 
isolation was well accepted by patients and their families; more than 90% of the 
observed contacts with the isolated patients were in compliance with the isolation 
protocol, which seemed to be well tolerated in the majority of instances. The frequency 
of contact with patients by personnel and family was comparable in the two treatment 
groups. 
The definition of nosocomial infection was an infection that was not clinically apparent 
on admission, and required the isolation of a pathogen from a site of culture with 
clinical criteria not specified further but which included fever. 
The 32 patients who were randomised to isolation were comparable in terms of sex 
ratio, age, severity of illness and underlying disease with the 38 who received standard 
care. Nosocomial colonisation by Sraphylococcus aureus, methicillin-resistant 
coagulase negative staphylococci, Gram negative bacilli or fungi occurred in 
comparable numbers of patients in both groups (31 % of those isolated vs 42 % given 
standard care); however, colonisation occurred significantly earlier in those receiving 
standard care. 44 % of the isolated patients and 55 % of those receiving standard care 
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developed nosocomial infections, but 12 patients receiving standard care had multiple 
infections compared with only 1 in isolation. The incidence of infection in the isolated 
patients was not affected by whether they received care in a private room or in the open 
area of the ICU. Those given ~tandard care were febrile for more days in the ICU (21 
days), than the isolated patients ( 13 days). The mortality rate in those who received 
standard care was 13 % compared with 9 % in the isolated patients, but the deaths were 
not considered to be directly related to nosocomial infections in any patients. The use 
of antibiotics and the mean duration of stay in the ICU were also reduced in the 
isolated patients. 
While there may have been some added vigilance in the implementation of a new 
protocol in the treatment of the isolated patients as part of the trial, the authors argue 
that such enthusiasm would have been unlikely to have been sustained for over two and 
a half years. The high rate of observed compliance ,vith maintaining the isolation 
protocol in a busy ICU was seen as contirmation that such precautions could be 
implemented as part of routine prophylaxis; particularly as such a technique did not 
seem to lessen the amount of care and contact that the patients received. 
The reduction in the infection rate encountered in this study was attributed by the 
authors as being largely due to the use of gloves, as compliance with hand washing 
procedures by medical personnel are recognised to be notoriously poor 41,212. Clearly 
further work is needed to assess the cost efficacy of such a technique, its efficacy in an 
adult ICU , and whether gloves alone might suffice in achievi ng the same result. 
A recent study 221 in paediatric wards. found that a significant reduction m the 
incidence and transmission of Respirarory Syncyrial Virus could be achieved by the 
combination of cohort nursing , and the wearing of both gloves and gowns, but that 
none of these prophylactic methods was sufficient alone. 
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The wearing of non-sterile gloves at every contact with mucous membranes, secretions 
and "moist body substances", as an alternative, or in addition to, the difficult to enforce 
hand-washing, has been developed as part of the technique of body-substance isolation, 
should serve to prevent the transmission of microorganisms between patients 42 . Such a 
technique, which should not be confused with universal precautions, adds considerably 
to the cost of patient care. The danger still remains that gloves may provide a false 
sense of security: staff may move from patient to patient without changing gloves, 
handwashing may become neglected and hands can become contaminated through leaks 
in the gloves or when the gloves are removed. 
7.6 The effect of drugs on the immune response and the importance of 
mobilisation 
An area not often addressed in the literature regarding the incidence and management 
of nosocomial infections, is that of the method of patient management within the ICU. 
While it is evident that invasive devices play a major role in promoting the 
development of secondary infection, management 1s often not directed at achieving 
decanulation as quickly as possible. This important aspect of infection prevention 
should be encouraged and, while the ability to judge the correct timing requires 
experience, over-hasty removal of supportive care may compromise patient care or 
necessitate the replacement of devices which have been removed too soon, and should 
be deplored; this balance is often difficult to achieve. 
Techniques of patient care vary markedly between units, depending on the philosophies 
of those in charge. In many ICUs, the ventilation of almost all patients is performed by 
means of an orally placed endotracheal tube. As discussed previously , there are both 
advantages and disadvantages associated with this method of intubation. One of the 
possible disadvantages is that there is poor tolerance of an orally placed tube by an 
awake patient, and, for this reason in the ICUs where this method of ventilation is 
preferred , the patients are kept fairly heavily sedated. There have been several studies 
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recently suggesting that even in awake patients, the recall of the time spent in the ICU 
is scanty and generally neither unpleasant or frightening 222 ; so that the argument that 
the use of sedation is kinder to the patient may not be valid. It would appear that the 
early mobilisation of patients in the ICU reduces the incidence of secondary infection, 
both because the drugs that are used for sedation may themselves exert 
immunosuppressive influences 26 and because with mobilisation 223 , it is often 
possible to wean and extubate patients sooner, and thereby remove the invasive devices 
which are so well recognised as being associated with the development of nosocomial 
infection. 
Seibel et al 70 reported a study in which patients who had sustained blunt multiple 
trauma with fractured femurs were randomised to: immediate internal fixation with 
post-operative ventilation and mobilisation by 30 hours (20 patients), 10 days of 
femoral traction before fixation which was followed by ventilatory support (20 
patients), immediate extubation following fixation and thereafter 30 days of femoral 
traction (9 patients) and a group who were particularly predisposed to the development 
of pulmonary complications (7 patients). The patients were fully comparable on 
admission to the trauma unit in terms of severity of injury and demographic features. 
They found the incidence of "pulmonary failure septic state", which was defined by the 
presence of an alveolar arterial oxygen tension difference greater than lOOmmHg, with 
fever and leukocytosis. in those who underwent 10 days of traction , was doubled 
compared with those who underwent immediate fixation to a statistically significant 
level. In those patients who underwent 30 days of traction , the incidence of pulmonary 
complications was still higher being 3 to 5 times that of those who underwent 
immediate fixation and mobilisation and two patients developed advanced multiple 
organ system failure, many patients having episodes of bacteraemia. The course of the 
patients in the various groups was reported to be radically different in terms of 
magnitude and severity of the pulmonary failure septic state, which was very closely 
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associated with the days of femorcj.l traction. The authors suggested that fat emboli, the 
enforced supine position, increased pain with fracture motion and a large fracture 
haematoma and retained necrotic tissue, probably all serve as reasons favouring early 
fixation. Early surgery to prevent the spiral into multiple organ failure by removing all 
necrotic foci, which serve as potential sources of sepsis, and ongoing sites of cytokine 
release, was thus advocated in trauma patients. Similar findings on the early 
mobilisation of trauma patients have been reported by Goris l80 and Behrman 71 _ 
The enforcement of the supine position can be extrapolated to all sedated patients in the 
ICU. In this position , the weight of the abdominal viscera prevents the efficient 
movement of the diaphragm in those who are not fully ventilated; the presence of 
fractured ribs , abdominal wounds and gastrointestinal distension as well as generalised 
malaise, all inhibit normal deep respiration and promote the development of atelectasis 
and retained secretions. with ventilation-perfusion mismatches. The use of mechanical 
ventilation with positive end expiratory pressure has been designed for this scenario to 
improve gas exchange, and is essential to the management of critically ill patients. 
However, it would appear that mobilisation of the patient to an upright position should 
be attempted as soon as possible, if adequate analgesia without sedation can be 
achieved , so that aspiration can be prevented , with early weaning and removal of all 
the associated "hardware" 223. 
Stevenson et al 26 reviewed the effect of anaesthetic agents on the immune response. 
This is an area in which little work has been performed to date and clearly will need to 
advance as our understanding of immunology increases. While it would appear that 
specific humoral impairment of immunity is more related to the degree of surgical 
trauma than to the specific anaesthetic agent employed, there is nonetheless evidence 
already available which suggests that the use of anaesthetic related drugs may 
significantly affect the host immune response . The prolonged postoperative use of 
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narcotics and other sedating drugs should therefore be avoided unless it is essential for 
patient management. 
There have been in vitro studies demonstrating a decrease in gamma interferon 
following halothane exposure, and a decrease in lymphocyte migration towards 
chemical attractants following exposure to anaesthetic agents. Regional anaesthesia has , 
however, been shown to block the post-operative T-cell impairment associated with 
general anaesthesia. The lysis of tumour cells and the production of alpha interferon by 
monocytes has been demonstrated to be decreased by thiopentone. 
Patients with neurological disease requiring ICU admission are recognised to be at high 
risk of developing secondary infections, because of the loss of upper airway protective 
reflexes predisposing to aspiration, and their usually protracted duration of admission 
and immobility. Beale et al 224 reported 44 cases of Guillain-Barre syndrome admitted 
to the Baragwanath ICU, 43 % of whom received steroids, possibly further contributing 
to their immunocompromised status; the mortality was 18 % and in 62.5 % of those who 
died , the fatal outcome was attributed to respiratory complications and infection. 
Patients with tetanus form another group with neurological disease who require 
prolonged ICU admission , often with sedation and paralysis. In a study from Leeds, 
Edmondson et al 225 reported the course of 100 patients admitted to their ICU. There 
were 8 deaths, 6 of which were attributed to respiratory complications (they cite 
retained secretions, atelectasis and infection as the main problems) associated with the 
prolonged ventilation of a paralysed patient. Trujillo et al 226 reported 233 cases of 
tetanus admitted to their ICU in Caracas , Venezuela; 34.5 % of them developed 
infectious complications and sepsis accounted for 12 of the 26 deaths. 
7. 7 The prevention of nosocomial pneumonia 
Although some hypothesise that ischaemic mucosa! injury with an associated 
translocation of enteric bacteria and toxins may be the m?st important mechanism in the 
191 
pathogenesis of nosocomial pneumonia m the critically ill 95, the aspiration of 
oropharyngeal organisms 36 is still generally believed to be responsible for initiating 
the majority of cases of nosocomial pneumonia, with haematogenous dissemination 
from a distant site or the inhalation of aerosolised bacteria being much less common. 
Other potential, although sometimes controversial risk factors for the development of 
pneumonia in the ICU, have been discussed in previous sections. The association of 
pneumonia with colonisation of the stomach by Gram negative bacilli 56 and the 
enhanced risk for pneumonia associated with the use of antacid or H-2 antagonist 
therapy 227 has been alluded to. Although the last word on this relationship has not 
been said, it would seem reasonable to avoid the use of agents which may increase the 
gastric pH unless the need for them exceeds the potential risks associated with them. 
Pingleton et al 58 and Jacobs et al 103 have demonstrated that enteral nutrition can be 
associated with gastric flora colonising the trachea and causing nosocomial respiratory 
infection; although the frequency with which the gastric flora may contribute to the 
development of nosocomial respiratory infection is uncertain, and this potential source 
for infection should not prevent enteral feeding, it is important that the preparation and 
administration of enteral feeds should be performed in such a manner as to reduce this 
risk, and that the clinician should be aware that the risk exists. 
The Study of the Efficacy of Nosocomial Infection Control (SENIC) in the USA found 
that 3 out of every 4 definite or probable cases of nosocomial pneumonia occured in 
patients who had had surgical operations, being particularly high in those who had 
undergone thoracic and abdominal surgery 228. This association is thought to result 
from impairment of normal swallowing and respiratory clearance mechanisms (by 
instrumentation of the respiratory tract , anaesthesia and the use of narcotics and 
sedatives and pain from the operation) allowing bacteria to enter and remain in the 
lower respiratory tract. 
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In the pre-1970 era, aerobic Gram negative bacilli and Gram positive cocci were each 
reported to account for approximately 40% of instances of nosocomial pneumonia; 
however by 1980 the National Nosocomial Infections Study in the USA reported that 
aerobic Gram negative bacilli were now the cause of 68 % of cases of nosocomial 
pneumonia, with a dwindling incidence of only 24 % of cases being attributed to Gram 
positive cocci. 
The patients at highest risk for the development of nosocomial pneumonia are those 
who have had surgery , or have other conditions which predispose to aspiration l 82, are 
exposed to contaminated respiratory therapy equipment, have aerobic Gram negative 
bacilli colonising the oropharynx, or have impaired immunological function. 
Stoutenbeek et al 229 described three mechanisms by which colonisation of the 
respiratory tract by Gram negative bacilli could occur: from direct contact with 
environmental pathogens such as Pseudomonas aeruginosa (exogenous colonisation), 
colonisation of the oropharynx by the normal resident gastrointestinal flora, usually the 
Enterobacteriaceae (endogenous colonisation) , or lastly colonisation of the 
gastrointestinal tract by environmental pathogens, with these organisms eventually 
extending to involve the upper respiratory tract (secondary endogenous colonisation). 
Efforts to prevent nosocomial pneumonia therefore need to be directed at the above. 
The risk for developing nosocomial pneumonia is dependent on the individual, the 
reason for hospitalisation and the presence of underlying or predisposing factors. It is 
important to identify the high risk patients so that prophylactic measures can be 
targeted at those most likely to benefit: those who are elderly (more than 70) , obese, 
immunocompromised , have underlying chronic obstructive airways disease, a history of 
smoking or abnormal pulmonary function tests; the patient who has a tracheostomy or 
requires prolonged intubation and mechanical ventilation , the patient who is undergoing 
abdominal , particularly upper abdominal, or thoracic surgery are all at greatest risk. 
While unfortunately it is not possible to modify these risk factors by the time patient 
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presents to the ICU, careful preoperative preparation might considerably reduce the 
need for major supportive care postoperatively and its associated morbidity. 
Ventilatory therapeutic strategies have been devised to minimise the risk of nosocomial 
lower respiratory tract infection. The use of physiotherapy, including mobilisation of 
the patient out of bed and into a chair with maintenance of erect posture and the early 
encouragement to walk, the use of breathing exercises, postural drainage, percussion, 
and efforts to stimulate coughing and the mobilisation of secretions are all recognised to 
be extremely important. Early mobilisation and the recent introduction of positive end 
expiratory pressure with physiotherapy are possibly the most important modalities in 
reducing the incidence of post-operative pulmonary complications. The use of 
intermittent or continuous positive airway pressure ventilation is thought to assist in 
maintaining lung expansion and prevent the development of areas of atelectasis which 
may more easily become infected by retention of secretions. 
The humidification of the gases supplied during anaesthesia and whilst receiving 
mechanical ventilation may be important in preventing pneumonia, as the prolonged 
breathing of dry gases dehydrates the respiratory mucosa, impairing ciliary function 
and the respiratory defence mechanisms. The maintenance of a high level of 
disinfection of the ventilatory equipment to prevent contamination and equipment-
related outbreaks of infection, is also of importance. 
The nebuliser is one of the principal reservoirs of infection from contaminated 
respiratory equipment. It can easily become contaminated by the introduction of non-
sterile fluids, air, by manipulation of the nebuliser cup and by retrograde flow of 
condensate and tracheal secretions that collect in the respiratory tubing. Reinarz et al 67 
found that the reservoir nebuliser jet was the source of bacterial aerosols and served as 
a nidus to inoculate the reservoir fluid in which the organisms propagated. The 
organisms isolated from the aerosols varied between institutions, but the major 
· contaminants were all Gram negative and included Pseudomonas spp, Flavobacrerium 
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spp, Here/lea spp, Alcaligine.s ~pp and Achromobacrer .spp. Moiraghi et al found that 
the filling of bubble humidifiers or underwater chest drains with tap water was a 
potential hazard for the development of nosocomial pneumonia due to Legionella 
pneumophila and should be avoided l 93. 
Patients who require endotracheal tubes or tracheostomies for prolonged periods, are at 
high risk for the development of pneumonia for many reasons and the colonisation of 
the oropharynx with Gram negative bacill i in such patients may be as much a 
manifestation of the severity of the under! ying disease. as a risk factor for the 
development of pneumonia. Techniques directed at reducing this colonisation are 
discussed below. 
Simmons et al 228 published the CDC guidelines for the prevention of nosocomial 
pneumonia which, in broad outline, include the follo\v ing : 
1. Perioperative measures for prevention of postoperat ive pneumoma: pulmonary 
function testing in those with pulmonary dysfunction undergoing abdominal or thoracic 
surgery; treatment and resolution of pulmonary infections: efforts to remove pulmonary 
secretions; the discontinuation of smoking by the patient before surgery; the institution 
of pre and postoperative physiotherapy with education about breathing exercises; the 
provision of sufficient analgesia to permit coughing and deep breathing. 
It has been suggested that the indications for the prophylactic measures outlined above 
are restricted to too narrow a category of patients - possibly all surgical patients should 
receive this form of care. 
2. Handwashing after contact with respi ratory secretions , whether or not gloves are 
worn. 
3. Fluids and medications : only sterile fluids preferably in single dose vials should be 
used for nebulisation, and these fluids should be dispensed aseptically. 
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4. The maintenance of in-use respiratory therapy equipment : fluid reservoirs should be 
filled immediately before use and fluid should not be added to replenish partially filled 
reservoirs, without first having discarded the residual fluid; the water that has 
condensed in the respiratory tubing should be discarded and not allowed to drain back 
to the reservoir; the respiratory tubing and breathing circuits should be changed 
between patients, and replaced with sterilised or disinfected ones every 24 hours. 
5. Disposable equipment : No pieces of disposable respiratory therapy equipment 
should be re-used. Re-usable equipment should be sterilised or disinfected to remove all 
blood, tissue , food, or other residue and should be decontaminated before or during 
cleaning. Equipment that touches mucous membranes, breathing circuits (including 
tubing, exhalation valves), medication nebulisers and their reservoirs, venturi wall 
nebulisers and their reservoirs, and cascade humidifiers and their reservoirs should be 
sterilised before use between patients, or at least receive high-level disinfection. 
The internal machinery of ventilators and breathing machines should not be routinely 
sterilised between patients. 
Respirometers and other equipment used to monitor several patients m succession 
should not directly touch parts of the breathing circuit, but extension pieces should be 
used between the equipment and breathing circuit and these should be changed between 
patients; otherwise the equipment should be sterilised between patients. 
Once they have been used for one patient , hand-powered resuscitation bags eg 
Ambubags, should be sterilised or receive high level disinfection before use on other 
patients. 
6. Microbiologic monitoring: In the absence of an epidemic or high endemic rate of 
nosocomial pulmonary infections, the disinfection process for respiratory therapy 
equipment should not be monitored by cultu·res; and routine microbiologic sampling of 
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respiratory equipment while it is in use by one patient is not recommended, because of 
the difficulty in interpreting results. 
7. Patients with tracheostomy: Tracheostomy should be performed under aseptic 
conditions in an operating room, except where there are strong clinical indications for 
emergency or bedside operation. Until the wound has had time to heal or from 
granulation tissue around the tube, "no touch" technique should be used. When a 
tracheostomy tube requires changing, a sterile tube or one that has received high-level 
disinfection should be used under aseptic technique. 
8. Suctioning of the respiratorv tract: There is a risk of cross-contamination and 
excessive trauma with frequent suctioning; this should therefore only be performed 
when needed to reduce substantial secretions , which may be indicated by increased 
respiratory difficulties or easily audible gurgling sounds, and not as a routine 
procedure. Suctioning should be performed using "no-touch" technique or gloves, 
although the gloves need not be sterile. A sterile catheter should be used for each series 
of suctioning. If tenacious mucus is a problem, sterile fluid should be used for flushing. 
Suction collection tubing should always be changed between patients. 
Suction collection cannisters when used on one patient need not be routinely changed or 
emptied. Once they have been changed, reusable suction collection cannisters should be 
sterilised or receive high level disinfection. Unless in short term care units , suction 
collection cannisters chould be changed between use on different patients. 
With portable suction devices, which may discharge contaminated aerosols, high 
efficiency bacterial filters should be used between the collection bottle and vacuum 
source. 
9 Protection of patients from other infected patients or staff: Personnel with 
respiratory infections should not be assigned to the direct care of high-risk patients. 
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Although the role of airborne cross-contamination is controversial and not generally 
thought to be of much importance in the transmission of infection, as organisms are 
rarely isolated at more than three metres' distance from the patient, an outbreak of 
Acinetobacter spp was attributed to this mode of spread recently 230_ 
Cobley et al 44 reported a small study in which total colony counts from air sampling 
before and after tracheal suctioning using either a routine suction catheter or a closed 
suction system were compared . They demonstrated environmental contamination up to 
one metre away from the suction port when the conventional system was used, with the 
obvious implications of contamination of not only the bed linen . but al so equipment and 
staff, with the potential that contaminated secretions may persist as potential sources of 
infection for days and result in cross-infection. This potential mode of spread was 
reported to be reduced with a protected suction catheter, but further large studies need 
to be undertaken to confirm these findings. 
Notwithstanding the efforts at environmental infection control , education about 
handwashing and the rigorous enforcement of antibiotic policies , nosocomial infection 
has continued to be a problem. It has gradually become apparent that, although none of 
the techniques directed at controlling the environment and preventing the exogenous 
transmission of infection should be de-emphasised, the endogenous reservoir of 
organisms harboured by the patient in the ICU is possibly an even more important 
source of secondary infection. Critically ill patients have seriously impaired immune 
defence mechanisms against colonisation and infection , particularly if they are 
undergoing mechanical ventilation. It is thought that colonisation of the oropharynx and 
gastrointestinal tract almost always precedes colonisation and infection of the lower 
airway , urinary tract , and wounds in these patients . 
Further attempts to reduce the incidence of nosocomial infection have therefore been 
directed at protecting the patient against colonisation by potentially pathogenic 
organisms, by maintaini~g the normal flora and eliminating nosocomial colonisers. 
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Such prophylactic strategies have involved the administration of intravenous, topical 
and topical aerosolised endotracheally administerd antibiotics and selective 
decontamination of the digestive tract. 
i)The Prevention of nosocomial pneumonia with intravenous antibiotics 
Mandelli et al 17 reported a multicentre, randomised clinical trial of 1319 patients in 23 
ICUs to prevent the development of ICU acquired pneumonia within the first 4 days 
following admission. which accounted for more than 50% of their overall incidence of 
pneumonia. The patients who were enrolled in the study received either prophylaxis 
with cefoxitin 2g IV 8 hourly for three doses , penicillin G 2 million units IV 6 hourly 
for four doses or no antibiotic prophylaxis at all in the control group. The diagnosis of 
pneumonia was made on the basis of a nev.· radiological infiltrate, clinical parameters 
(including fever , worsening hypoxaemia. leukocytosis and purulent tracheal secretions) 
and microbiological specimens obt.:1.ined by bronchoscopy , if possible, or from the 
tracheal aspirate. 
The overall incidence of pneumonia was 6. 1 % in those who received prophylactic 
therapy compared with 7.2 % in the controls. and no statistically different rates of 
pneumonia or death were found among the groups. They concluded that patients 
without impaired oropharyngeal and upper airway reflexes should not receive 
prophlaxis, and that, even in those at greater risk because of impaired reflexes, the 
evidence of benefit from the use of prophylaxis was not conclusive. Even short term 
prophylaxis was found to alter the resident flora, induce and select resistant species, 
result in toxicity , or alter the clinical manifestations of an incipient infection, without 
resulting in a cure. 
199 
ii)The prevention of nosocomial pneumonia by the use of an antimicrobial 
pharyngeal nonabsorbable paste 
Rodriguez-Roldan et al 23 l reported a prospective study comparing the incidence of 
lower respiratory tract infection in patients requiring longterm mechanical ventilation 
for non-infectious reasons. 28 patients were randomly allocated to receive a 
nonabsorbable paste containing tobramycin, amphotericin B and polymyxin E which 
was topically applied to the pharynx (13 patients), or a control placebo paste (15 
patients). The diagnosis of pneumonia was made on the basis of clinical criteria 
(including fever, purulent tracheobronchial secretions, leukocytosis and hypoxaemia), 
radiological criteria and quantitative tracheal culture. 
There were 3 episodes of tracheobronchitis in those who received the study paste, 
compared with three patients who developed tracheobronchitis and 11 patients who 
developed pneumonia in the placebo group , which was highly significant. No 
difference in mortality between the groups was noted . No alterations in bacterial 
resistance patterns were observed during the short study period. While acknowledging 
the small number of patients in the study, the authors conclude by recommending the 
efficacy of such a regimen in preventing the development of nosocomial pneumonia. 
iii)The Prevention of Gram-Negative Pneumonia using topical aerosolised 
endotracheally administered antibiotics 
Colonisation of the upper respiratory tract by pathogenic bacteria is thought to be the 
initial step in the pathogenesis of nosocomial pneumonias caused by Gram negative 
bacilli; attempts at prophylaxis have thus been directed at preventing colonisation from 
developing. The risk factors for colonisation with Gram negative bacilli are poorly 
understood . 
Valenti et al 45 analysed the factors predisposing to colonisation in the elderly and 
found that the levels of colonisation by Gram negative organisms increased with 
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increasing debility, including the development of incontinence, incapacitation due to 
underlying neoplastic, cardiac or respiratory disease, and immobility. Even in the 
young and otherwise healthy, following an episode of viral upper respiratory tract 
infection, the colonisation of the oropharynx by aerobic Gram negative bacilli has been 
observed to increase from baseline values of between 12 % to 18 % , to levels as high as 
60 % 46, with colonisation by Staphylococcus aureus also increasing to up to 43 % ; it is 
thought that this may serve as a factor predisposing to post-viral bacterial pneumonia. 
Parenterally administered antibiotics do not prevent pneumonia and may actually 
increase the frequency of colonisation of the upper respiratory tract, because while the 
low antibiotic levels achieved by this means of administration in the bronchial 
secretions are sufficient to eradicate the normal colonising flora , they fail to eliminate 
the more pathogenic Gram negative bacilli. 
Topical administration of antibiotics achieves very high levels at the local site , but such 
a form of administration is thought to be associated with a much greater potential for 
the development of antimicrobial resistance. 
Klick et al 232 retrospectively analysed the incidence of nosocomial infection in their 
Respiratory-Surgical ICU over a 30 month period. They found that Pseudomonas 
aeruginosa was the most common respiratory pathogen accounting for 50% of episodes 
of bacterial pneumonia, with a mortality of 75 % compared with only 25 % for other 
bacterial pneumonias; this contrasted markedly with the mortality of only 3.8% in 
patients who did not develop pneumonia. They then monitored 640 patients and the 
ICU environment _ to assess the reservoirs of Pseudomonas aeruginosa; 71 % of the 
sputum or throat swab isolates of the organism were found to have been hospital-
acquired and the only environmental source identified were the sinks. The authors 
accordingly then embarked on a prospective study to assess the efficacy of preventing 
colonisation of the upper airway to prevent the development of pneumonia. They 
monitored the effects of aerosolised polymyxin or placebo , used in 2 month alternating 
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cycles, sprayed 4 hourly into the posterior pharynx and tracheal tube of all of 744 
patients admitted to their unit in a double-blind study. Aerosol treatment with 
polymyxin B had previously been shown not to contaminate the culture media so as to 
inhibit the growth of viable organisms deposited in the plate. 
There was intensive microbiological surveillance performed throughout the study with 
daily culture of tracheal aspirates, and bi-weekly culture of the hand basins. The 
diagnosis of colonisation was the isolation of a new organism from throat or sputum on 
more than one consecutive culture. The overall rate of colonisation with Pseudomonas 
aeruginosa of the upper airway was 5.6%; during the placebo cycles, the upper airways 
of 9. 7% of patients were colonised while during th polymyxin B cycles only 1.6% of 
patients were colonised, and this was statistically significant. The incidence of 
colonisation with other species of organisms sensitive to polymyxin B also declined 
significantly. The organisms resistant to polymyxin B (Staphylococcus aureus, 
Flavobacterium, Serraria and Prmeus spp) were not observed to cause bacterial 
overgrowth as a result of the use of aerosolised polymyxin. Swabs from the 
environment including ventilatory apparatus, following the implementation of daily sink 
decontamination, were only rarely positive. 
The diagnosis of pneumonia was based upon three separate opinions obtained from the 
house-officer, an independent physician and a group of paramedical personnel, and 
classified as "possible" or "probable" using the presence of: "persistent radiological 
evidence of an alveolar infiltrate on more than 2 consecutive days, associated with a 
positive sputum culture for potentially pathogen ic organisms , an elevated alveolar-
arterial oxygen difference while breathing 100% oxygen, an evaluation of the 
temperature course, daily weights, central venous pressure and pulmonary artery 
catheter data. Only "probable" cases were considered. 
The incidence of pneumonia during the study was 18.1 % , 35 .5 % of such cases being 
acquired in the ICU. There were 30 episodes of pneumonia during the placeb9 periods 
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of which 17 (4.6%) were due to Pseudomonas aeruginosa, and 4 of the latter group 
died. 18 patients acquired pneumonia during the cycles when polymyxin was used, but 
only a significantly reduced 3 (0. 8 % ) of these episodes were due to Pseudomonas and 
only 2 patients died. There were 5 cases of pneumonia due to Staphylococcus aureus in 
the polymyxin cycles and only 2 in the placebo which was non-significant. The use of 
systemic antibiotic therapy during the different cycles was similar in both groups. 
Despite this significant reduction in the incidence of pneumonia due to this organism, 
there was no effect on the mortality: 12.2 % in the placebo cycles and 12 % in the 
polymyxin cycles. 
Feeley and other authors from the same group 233 , subsequently reported in the New 
England Journal of Medicine the same year as the above study , the effect of aerosolised 
polymyxin B administered prophylactically to the upper airways of 292 patients in a 
respiratory-surgical ICU over a 7 month period , without the benefit of 2 month periods 
when placebo was used . In neither of these papers is sufficient data about the categories 
of patients or their severity of illness parameters provided; however, these studies were 
performed before the advent of the APACHE II and other scoring systems. The 
definitions used were similar to those in the above-mentioned study. Colonisation by 
Gram negative organisms was observed in 24 % of the patients, and 74 % of the isolates 
were resistant to polymyxin. Previously when alternating cycles were used, there had 
been no difference in pol ymyxin resistance. 14 % were colonised by yeasts , and 16 % by 
Gram positive organisms , most commonly staphylococci. Colonisation of the 
respiratory tract preceded the development of pneumonia by the same organism in 10 of 
the 11 patients who developed nosocomial pneumonia. 
The incidence of nosocomial pneumonia was 3.8%. Although only one of the patients 
studied acquired pneumonia due to Pseudomonas aeruginosa, there were 10 others 
where pneumonia was caused by an organism resistant to polymyxin; there were also 
seven cases of pneumonia due to uncommon , opportunistically pathogenic organisms 
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(Flavobacteria, Serratia spp and Streptococcus faecalis). The overall mortality in the 
ICU was 12 % ; however, the mortality in those who developed nosocomial pneumonia 
was 64 % , which was higher than the mortality associated with this complication prior 
to studies where prophylactic therapy had been used (14 % per annum for the preceding 
7 years, with a mortality of 48% for nosocomial pneumonia). 
Although the use of this prophylactic therapy succeeded with its pnmary aim and 
reduced the incidence of colonisation and infection due to Pseudomonas aemginosa, it 
appears to be a potentially dangerous form of prophylaxis. It resulted in an increase in 
antibiotic resistance to the agent used for prophylaxis, the emergence of infections due 
to organisms seldom regarded as being pathogenic and, according to the authors, a 
trend towards an increasing mortality for hospital acquired pneumonia. 
v) Combined intravenous and topical oropharyngeal antimicrobial prophylaxis 
The efficacy of antimicrobial agents applied topically in the oropharynx and trachea, 
with and without the use of intravenous antibiotics, in the prevention of bacterial 
pneumonia during prolonged mechanical ventilation was assessed by Johanson et al234. 
They used a baboon model and studied 35 cases using a variety of prophylactic 
regimens (6 received no prophylaxis, 4 intravenous polymyxin B and gentamicin, 2 
topical polymyxin B alone, 2 topical polymyxin B and intravenous penicillin , 6 topical 
polymyxin and intravenous penicillin/gentamicin, 4 topical gentamicin and intravenous 
penicillin/gentarnicin, 5 topical gentamicin and intravenous penicillin, and 6 topical 
polymyxin and gentamicin with intravenous penicillin) which were ventilated for 7 to 
10 days and then killed; the presence of pneumonia was determined histologically, and 
segments of lung were cultured. 
They found that most animals that received topically administered gentamicin did not 
achieve measurable serum levels. The antimicrobial resistance patterns of 
oropharyngeal flora isolated from animals receiving prophylaxis with intravenous 
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penicillin and gentamicin did not show any change in sensitivity, but only 20% of 
animals receiving polymyxin B still had organisms sensitive to this agent at days 8 to 
10, compared with 100% in those who did not receive this agent; however, the 
prevalence of polymyxin B resistant organisms increased over time. Organisms resistant 
to gentamicin were present in 71 % of animals receiving topical gentamicin, compared 
with only 37% of animals not receiving topical gentamicin. 
The antibiotic regimens that were judged to be effective by bacteriologic and 
histological criteria were: topical polymyxin B and intravenous penicillin ± intravenous 
gentamicin, topical gentamicin and intravenous penicillin ± intravenous gentamicin, 
and topical polymyxin and gentamicin with intravenous penicillin. 36% of the 
histological samples of those who received these regimens had no histologic evidence of 
pneumonia, 52 % of the lobes being sterile; there being evidence of histologically 
severe pneumonia in 15 % . Intravenous gentamicin had no independent effect on either 
culture or histological findings. All the other regimens were found to be ineffective and 
81 % of the histological samples in this group showed moderate to severe changes, only 
2 % showing no changes, and there were no sterile lobes on culture. 
The pneumonias occurring in those who received no antibiotic prophylaxis were always 
polymicrobial , the most numerous organisms being those that comprise the normal 
oropharyngeal flora of the baboon. Such organisms are penicillin sensitive, and, in 
those to which it was administered , penicillin was extremely effective in eliminating 
these organisms from both the tracheal aspirate and lungs. The sensitivity patterns of 
such organisms were not often tested later during the course of therapy, and the authors 
point out that penicillin resistance might well have occurred and been missed. 
Prophylaxis with topical polymyxin alone resulted in extensive pneumonias with very 
high tissue concentrations of penicillin sensitive organisms and lower concentrations of 
organisms resistant to polymyxin; when penicillin was added, the penicillin sensitive 
organisms were eliminated, and although small numbers of polymyxin-resistant 
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organisms persisted, such therapy was highly efficacious in preventing pneumonia. The 
authors indicate that, with more prolonged ventilation and in the presence of underlying 
disease, the resistant organisms might have resulted in the development of severe 
pneumonia. 
Prophylaxis with intravenous penicillin and gentamicin was ineffective in preventing 
colonisation and pneumonias due to Gram negative bacilli. This was attributed to the 
poor penetration of the bronchial secretions by gentamicin, particularly in the presence 
of pus or an acidic environment. 
Although the numbers in this study were small, on the evidence obtained from 
ventilating 23 baboons for 7 to 10 days, the authors concluded that a combination of 
topical polymyxin B, and/or gentamicin with intravenous penicillin was a highly 
efficacious method of preventing pneumonia. The authors do mention that the cost-
effectiveness of such a regimen, the incidence of pneumonia in the population being 
studied, the incidence of side-effects and the possibility of the development of multiply 
resistant Gram negative organisms all need to be evaluated before embarking on such a 
method as routine prophylaxis for all patients requiring mechanical ventilation, a 
sentiment echoed by Faling 235 in an accompanying editorial. 
While the use of topical aerosolised antibiotics has not gained wide acceptance for 
either the prophylaxis or the therapy of nosocomial pneumonia (v.i.), as a result of 
concern about the emergence of antibiotic resistance , the use of selective 
decontamination where the topical antibiotics are applied to the gastrointestinal tract, 
does not seem to be associated with this problem, and studies evaluating all aspects of 
this method of preventing nosocomial infection have now been carried out for almost a 
decade without any clear answers . This technique is reviewed below. 
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vi)Bacterial adherence mechanisms in the prevention of nosocomial pneumonia 
The initial stage of most bacterial infections is thought to be the adherence of the 
pathogen to an epithelial surface. Johanson et al 4,5,48 established that Gram negative 
bacterial infections are usually preceded by oropharyngeal colonisation, and that this 
colonisation was associated with an elevated adhesion index for the attachment of Gram 
negative bacteria to the patient's buccal epithelium. Todd er al 24 demonstrated that the 
bacterial adhesion index paralleled the risk of patients acquiring bacterial pneumonia 
while in the ICU , although there was no corrdation between th is value and the duration 
of intubation. 
The ability to influence the abnormal colonisation of the gastrointestinal tract, may 
hinge on the understanding of the basic factors that govern normal and abnormal 
bacterial attachment to the upper airway epithelium and techniques to modify this. This 
method of prophylaxis is still in its infancy . as the methods of bacterial adherence are 
unravelled; once the underlying mechanisms are understood. a new direction in the 
prevention of nosocomial infections may open. 
Fibronectin normally covers the oropharyngeal epithelial cell surface receptors for 
Gram negative bacteria. thereby inhibiting bacterial-epithelial cell adherence. In 
patients colonised by Gram negative bacteria. for reasons that are poorly understood, 
fibronectin is digested and stripped away by elastase released into the saliva by 
polymorphonuclear leukocytes. 
It has been noted in tracheostomised patients that higher sputum levels of IgA appear to 
inhibit the attachment of Pseudomonas ueruginosa to the tracheal epithelium 50_ This is 
thought to reflect an inhibitory activity of secretory IgA on the adherence process. The 
release of neutrophil elastase in tracheal inflammation can promote proteolytic 
fragmentation of the IgA, thus leading to enhanced bacterial-epithelial cell attachment, 
with the potential to enhance tracheal colonisation 23. The experiments on the possible 
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effects that nutritional deficiencies might have on bacterial adherence have shown 
conflicting results 23 '48 . 
Clearly the answers are not going to be available for some time, but the prevention of 
colonisation of the respiratory tract by these mechanisms may hold the key to 
preventing nosocomial pneumonia. 
vii) Vaccination 
Mylotte et al 206 found that patients who developed either community acquired or 
nosocomial pneumococcal bacteraemia. had a significant mortality associated with their 
illness. All the patients in their study who developed this complication were eligible for 
vaccination and the majority could have received immunoprophylaxis. It is important 
that such easily administered and accessible modalities of prophylaxis be considered 
early in all at-risk patients and sectors of the community, to reduce the incidence of 
preventable morbidity and mortality . 
7.8 The prevention of urinary tract infections 
The most common site of nosocomial infection is the urinary tract, particularly in the 
catheterised patient. The prevention of such infections is most easily achieved by 
removing the urinary catheter as soon as the patient's condition will permit. If the 
catheter can be removed before bacteriuria develops, this should largely prevent the 
development of infection. The removal of infected calculi. and the rapid recognition of 
obstruction and its treatment. should also assist in reducing the incidence of this 
complication. 
The maintenance of a closed catheter system is also extremely important in preventing 
the transmission of infection. The system should only be opened at the bag drainage 
tube, and the staff should avoid allowing the encl of the drainage tube from touching 
potentially contaminated containers . Urine specimens should be obtained without 
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opening the catheter-collection tube junction. Education in the techniques of catheter 
care and the collection of urine samples is essential for effective prophylaxis. It has 
been suggested that the urinary catheter should receive much the same attention as an 
open wound. Techniques such as handwashing between patients, the use of gloves , and 
attempts to segregate infected or catheterised patients from the others may all be 
helpful. 
Patients with indwelling catheters used to receive meatal care with soap and water or a 
povidone-iodine solution once or twice a day; however, studies comparing these two 
forms of meatal care with a group of patients who received no meatal care 
demonstrated a higher level of bacteriuria in those in the treatment group 236. Thus 
this form of preventative care has been abandoned . Methods of catheter irrigation using 
antiseptic solutions have not been shown to be effective in reducing catheter associated 
bacteriuria. 
There have recently been reports of the use of silver-coated catheters, which have been 
shown to postpone the development of bacteriuria 237. Although more expensive to 
use, it is thought that such catheters may rapidly pay for themselves in patients likely to 
require more prolonged catheterisation, by reducing antibiotic usage. Further studies on 
the efficacy of these catheters are needed before they are widely adopted . 
Daschner 9 strongly advocated the use of suprapubic catheterisation in the intensive 
care unit. The rationale for this mode of catheterisation being that the concentration of 
bacteria on the anterior abdominal wall is considerably less , and thus that this should 
reduce the incidence of bacteriuria. This technique has not gained wide acceptance 
however, possibly because it is perceived as being too invasive. 
The use of antibacterial substances in renal and bladder urine may also prevent the 
development of bacteriuria. The majority of patients with indwelling catheters will 
already be receiving antibiotics for their underlying diseases or procedures , during, but 
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not because of catheterisation. It has been shown in some comparative studies 237-239 
that the use of antibiotics is associated with a lower incidence of bacteriuria, and the 
use of antimicrobial prophylaxis has also been shown successfully to postpone the 
development of this complication 239, although it does not prevent it. The prophylactic 
use of antibiotics is however, not generally recommended, because of their potential to 
promote the emergence of antibiotic resistance, the problems that may be caused by 
side-effects, as well as the additional cost involved. 
The regular monitoring of urine samples of all patients in the ICU assists in the 
recognition of the development of colonisation, bacteriuria and infection. If an 
organism is detected to be present in high concentrations and pure growth on repeated 
samples, the removal and replacement of the catheter may be prudent, in anticipation of 
the development of infection. If colonisation of the new catheter occurs rapidly, 
treatment should be instituted. 
In some centres , colonisation of the catheter or bladder by yeasts , which may occur 
quite commonly in patients receiving broad spectrum antibiotic therapy, and who are 
immunocompromised by critical illness, is treated with the early institution of 
Amphotericin B bladder washouts, to prevent the development of systemic fungal 
infection. 
Once bacteriuria has developed , its consequences may extend to involve other patients, 
by contaminating the periurethral area with faecal bacterial flora, the surfaces of the 
catheter system, the collection containers, as well as the skin of the patient; these may 
all serve as potential sources for the contamination of the hands of personnel, and thus 
the transmission of bacteria to other patients. This may lead to the development of 
outbreaks of nosocomial bacteriuria, often due to resistant organisms. The use of 
surveillance cultures should reduce this problem , by allowing its early recognition and 
the institution of appropriate control measures. 
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7.9 The prevention of vascular-catheter related sepsis 
It is estimated that over 25 % of patients hospitalised rn the USA will receive 
intravenous infusions 79, yet microbial contamination of this method of administration 
of drugs, nutritional solutions and blood , can result in serious illness and death. Almost 
half of all the nosocomial infections identified by Daschner 9 were procedure- or 
device-related, the majority being causally attributed to vascular and urinary catheters; 
Craven and many others 10,80,85 have shown that the risk of nosocomial infection is 
associated with the duration such devices are kept in place. In their study of 
bacteraemia in the ICU, Forgacs et al 93 identified the surgical patients as being at 
greater risk of this complication, than the medical patients; 31 % of episodes were 
attributed to intravenous line sepsis. The mortality for patients who develop nosocomial 
bacteraemia, whether related to vascular access devices or other sources, is 
significantly higher than in patients who do not develop this complication, and thus this 
is yet another important area where effective prevention is needed. 
The potential for the administration of intravenous infusions to cause infection extends 
from the techniques used in their preparation; the manufacture and use of the 
administration sets; through hand-washing and care of the entrance wound site; the 
techniques used for the maintenance and replacement of catheters, as well as the criteria 
used for deciding on catheter replacement. Techniques aimed at preventing such an 
array of potential sources thus need to be directed at ensuring that sterility and aseptic 
technique are maintained at each stage. and that the possibility that infection originating 
from this site is constantly considered. 
Olson et al 240 recently published the results of a study evaluating various techniques 
of central venous catheter replacement in sheep . They convincingly demonstrated that 
the replacement of a catheter by using a guidewire over an existing catheter, the 
replacement of a catheter while a potentially in_fected catheter was still in situ, or the 
administration of antibiotics through an infected catheter were all ineffective in the 
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prevention, or eradication, of sepsis. These techniques were associated with a high 
incidence of endocarditis, septic pulmonary emboli and pneumonitis, as well as the 
presence of organisms within the vessel wall at the site of the catheter, at autopsy. They 
demonstrated that the organisms produce a slime-enclosed, antibiotic-resistant biofilm, 
which allows the organisms to both colonise the catheter and to then become detached 
to cause septic embolic dissemination. Only in the sheep where the removal of the 
initial catheter was followed by a 48 hour catheter-free interval and the subsequent 
insertion of a new catheter at a new site, was colonisation and infection of the second 
catheter prevented. These results are in direct conflict with those of Eyer et al 84 where 
no differences in the infection rates were found when the following three techniques of 
catheter maintenance were assessed: a routine weekly change of all longterm central 
venous catheters, the weekly change of the catheter over a guidewire using the same 
site, or the use of a new site and replacement of the catheter only when clinically 
indicated. It may be that the protocol for maintaining strict asepsis of the catheter site, 
the removal of catheters in cases where skin sepsis and positive blood cultures 
developed, or sepsis without another source occurred, allowed the earlier detection and 
prevention of catheter-related sepsis than an animal-model might permit. The clinical 
relevance of Olson's study needs further evaluation. 
Also of importance was the observation by Olson 240 that, despite the presence of 
heavily contaminated central venous catheters, daily peripheral blood cultures failed to 
yield bacteria. This finding confirmed the clinical studies 92 of Hickmann catheters in 
patients with malignancies, where virtually all catheters were shown to be colonised by 
mixed populations of yeasts and bacteria, but in fewer than 5 % were positive blood 
cultures obtained . The colonisation of the surface of the catheter by biofilm bacteria, 
therefore seemingly does not necessarily precede the development of overt bacterial 
infection, and, while it is essential to minimise the potential for infection, it is not yet 
certain that the removal of biofilm-colonised central venous catheters will reduce the 
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risk. Further studies will be needed to establish the conclusions from this study and the 
the clinical application of these important observations will need to be addressed. 
Techniques of catheter insertion including the avoidance of cut-downs , which are 
associated with a higher rate of infection 80, and the use of percutaneous methods of 
insertion where possible, avoiding the unnecessary use of central lines, and if a central 
line is needed siting it preferably in the jugular or subclavian rather than in the femoral 
position, should help to reduce rate of sepsis. The cannulation of the lower limbs is 
also recognised to be associated with a much higher incidence of complications and 
should be avoided if at all possible 80. 
Patients who harbour systemic bacterial or fungal infections before the insertion of 
catheters are recognised to have higher subsequent colonisation rates of these catheters 
80, and, although often little can be done about this at the time of insertion, the shortest 
duration of insertion of the catheter, and the constant awareness of this potential risk 
for a further site of sepsis, need to be borne in mind. The loosely organised clot that 
forms around the intravascular catheter may seve as a trap for circulating 
microorganisms, and microscopic examinations have shown organisms deep within 
such thrombi. Microorganisms from anatomically distant sites of infection such as 
tracheostomies, the urinary tract or surgical wounds may become established on the 
cannula tip, in the absence of recognised bacteraemia. Such secondary bacteraemias are 
most frequently caused by Escherichia coli , although this organism is only rarely 
isolated from the catheter tip. 
Manipulation of . the catheter is associated with a far higher incidence of colonisation 
and infection 80_ Catheters removed because of phlebitis. leakage or infiltration also 
appear to have an increased incidence of culture positivity. Thus the irrigation or other 
manipulation of occluded, infiltrated or leaking catheters serves to provide a focus for 
introducing contamination and potentiating a focus for the development of bacteraemia, 
as well as dislodging small thrombi, some of which may be infected. Manipulation of 
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virtually every component of the intravenous delivery system may reult in 
contamination of the system. The addition of medication, injections of medications into 
the tubing, administration of blood products, the introduction of stopcocks, transducers, 
manometers and other devices into the line, the change of the bottles and administration 
sets and the use of the system to obtain blood samples are all potential risk factors for 
contamination to occur. However, while the additional manipulations likely to be 
associated with increased availability of venous access with a triple lumen central 
venous catheter, compared with a single lumen catheter system, might have been 
expected to increase the incidence of infectious complications this has not been shown 
to be significantly different by Miller et al 87. 
Factors known to decrease the incidence of sepsis associated with peripheral 
intravenous cannulae, include aseptic insertion, daily inspection and removal at 48 
hours, or earlier in the presence of thrombophlebitis. The use of an effective, 
uncontaminated skin disinfectant during insertion is imperative, as the microorganisms 
found on the catheter tip are most commonly representative of the cutaneous 
micro flora. 
Iodine containing skin disinfectants have been shown to be highly effective as they are 
bactericidal, fungicidal and sporacidal. If used in a solution of 1 % mixed in either 
water or 70% alcohol, their efficacy is maintained while skin bums should not occur. 
Before the application of the disinfectant, the site should be thouroughly cleaned and all 
foreign, organic matter that might interfere with the bactericidal activity of the 
disinfectant should be removed. Aqueous bezalkonium chloride should not be used for 
skin disinfection, as it is ineffective against some Gram negative organisms and 
contaminated solutions have been implicated in outbreaks of Pseudomonas spp and 
Enterobacrer spp septicaemias 80_ There is no evidence that shaving of hair from the 
site of cannula insertion is helpful; the flora of the skin has little relation with the 
presence of hair and methods used to clean the skin are sufficient also to clean the hair. 
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The micro-abrasions that are produced during shaving are thought to alter the cutaneous 
flora, and if hair removal is desired, the use of a depilatory is recommended 80_ 
The skill and experience of the venipuncturist are inversely proportional to the number 
of infected catheters 85. The development of dedicated teams of venipuncturists, and a 
strictly enforced intravenous access protocol by nursing staff, was shown to reduce 
significantly the incidence of intravenous cannula related sepsis compared to catheters 
inserted by resident medical staff 82 . Collignon et al comment that the single most 
important factor identified in reducing the incidence of catheter related sepsis was daily 
or even twice daily inspection of the intravenous site by the IV team. The 
implementation of careful and reliable hand-washing by all who deal with the catheter 
cannot be over-emphasised. Possibly this aspect is also more reliably performed by a 
dedicated team. 
The colonisation of the site of insertion of the catheter is recognised to be one of the 
major sources of catheter-related infection. Reports of the use of a silver-impregnated 
subcutaneous cuff, for the prevention of infection with central venous catheters have 
been encouraging, and have shown significant reductions m the incidence of 
colonisation around the catheter site (Multicentre trial of an attachable silver-
impregnated subcutaneous cuff for prevention of infection with central venous 
catheters, Maki D.G., Cobb L., Garman J.et al, 27th Interscience conference on 
antimicrobial agents and chemotherapy). 
The topical application of both antibiotics and antimicrobials has also been attempted to 
prevent this source of colonisation and infection. There have been controlled trials that 
have shown that the application of a topical polyantimicrobial agent such as bacitracin, 
neomycin and polymyxin to the catheter insertion sites provided an element of 
protection against catheter-related infection 80,83. Catheters treated with antibiotic 
ointment have also been reported to be less likely to be associated with septicaemia, but 
such studies have been too small for reliable conclusions to be drawn. The use of 
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antibiotic ointments has not been widely adopted as prophylaxis, because its efficacy 
was not well established in all studies, and it was noted that its use promoted the 
emergence of antibiotic resistant strains, as well as altering the flora isolated from the 
cannula tips. Most investigators have also found that the administration of systemic 
antibiotics has little effect on the incidence of positive cannula cultures 80. With 
regular changing of catheters, the entire problem should be sufficiently minimised to 
make such forms of prophylaxis unnecessary. 
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Maki 83 reported an evaluation of four dressing regimens for the prevention of 
infection with peripheral intravenous catheters. The regimens included: sterile gauze 
which was replaced every other day, gauze, a transparent polyurethane dressing and an 
iodophor-transparent dressing. Cutaneous colonisation of the insertion site, 
contamination of the catheter hub, moisture under the dressing and prolonged 
catheterisation were all shown to be significant risk factors for catheter-related 
infection. While the iodophor dressing did not adhere as well as the others, moisture or 
blood accumulated more frequently under the transparent dressings than under gauze. It 
was not shown to be cost-effective to redress peripheral venous catheters at periodic 
intervals, and the use of either sterile gauze or a transparent dressing was recommended 
that could be used and left on until the catheter was removed. This recommendation 
was not designed to conflict with at least daily inspection of the catheter-insertion site, 
however. 
In the same article, Maki 83 reported that 19 % to 28 % of hubs of the peripheral venous 
catheters were contaminated at the time of removal. Although the hub was 
contaminated in only half of the infected catheters, this contamination was significantly 
associated with catheter-related infection. There are, however, no studies reported in 
which the relative importance of this site of contamination has been compared with 
infection via the cutaneous site. 
Evidence is accumulating that the synthetic material of which an intravascular device is 
made plays an important role in the pathogenesis of device-related infection - by 
determining whether the material provides a suitable surface for bacterial adherence by 
pathogenic organisms such as coagulase negative staphylococci or yeasts. lntravasular 
catheters made of teflon are more resistant to microbial adherence than catheters made 
of polyvinylchloride or polyethylene, and appear less prone to become colonised and 
cause bacteraemia 83. Siliconised catheters are thought to be less thrombogenic than 
polyethylene catheters, but at autopsy , a fibrin sleeve was found to have formed on 
both types of catheters within 24 hours of insertion. The use of heparin bonded to the 
catheter material appears to reduce the incidence of thrombosis, and the systemic 
administration of low dose heparin is also recognised to reduce clotting on intravenous 
catheters. The use of metal needles is associated with a lower incidence of colonisation 
than that encountered with plastic catheters 85 , but the obvious drawbacks with loss of 
flexibility and the potential to puncture the vessel if not completely immobilised have 
limited their widespread application. It is thought that the lower rate of colonisation 
observed with the use of steel scalp vein sets may be due to the smaller bore being less 
traumatic to the vessel, although the fact that they tend to infiltrate the tissues rapidly 
and thus require more frequent replacement may also be important. 
The majority of intravenous infusions are manufactured and sterilised by 
pharmaceutical companies; the quality control in such plants is usually strictly 
enforced, as the vast medico-legal consequences of contamination are a sufficient 
enough incentive. Nonetheless, contamination of infusates still does occur, due to 
contamination either during manufacture, industrial sabotage, or defective containers. 
Outbreaks of nosocomial infections secondary to intravenous fluids becoming 
contaminated during manufacture in the USA were identified as being due to organisms 
such as E.cloacae and E. agglomerans adhering to the elastomer liners of caps in 
previously unopened bottles, introduced during the manufacturing process. An outbreak 
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of Pseudomonas thomasii in London was traced to the use of deioinised, distilled water 
manufacture in the pharmacy; it was discovered that when used for cooling bottles of 
parenteral fluid and other sterilised fluids in the hospital's rapid-cooling autoclave, that 
the water often remained on the rubber stopper beneath a foil seal and entered the bottle 
when the closure was manipulated 80. 
There may be breakdowns in the storage procedure of the fluid before it is 
administered, either at the site of manufacture, or at the place of administration. The 
method of preventing such infections is ongoing surveillance, and the maintenance of 
the strictest quality checks at each stage. The centralisation of mixing of all additives to 
solutions for administration within the hospital should help to reduce the incidence of 
contamination, as well as avoid the potential for drug incompatibilities and prescribing 
errors. However, if contamination should occur under these circumstances, the 
potential to expose a far larger number of patients to contaminated solutions exists. The 
solutions would also be more likely to be stored for longer periods before 
administration, thereby further increasing the potential for contaminants to proliferate. 
The relative merits of either system are not clearly established. 
Unfortunately, clusters of contaminated infusion related bacteraemias and deaths 
continue to be reported , particularly in highly susceptible populations such as the very 
young or old, the highly immunocompromised or the critically ill. 
Quercia et al 79 reported a double blind prospective study to determine the level of 
contamination associated with the admixture (except TPN) and administration of 
intravenous fluids, and whether intravenous filtersets were able to prevent bacteraemia. 
They evaluated 70 patients and found that 14.1 % of real filtersets and 11.3 % of the 
placebo filtersets were contaminated with microorganisms. Overall, 42.9% of all 
patients in the study were found to have extrinsically contaminated intravenous 
adminstration sets on at least one occasion. Coagulase negative staphylococci were the 
most commonly isolated organisms and it was demonstrated that this organism was 
particularly suited to adhere to the plastic cartridge of all the filter sets. In 13 patients, 
(10 with placebo) the contamination of the filterset was associated with clinically 
significant bacteraemia. It was thought that the level of contamination of the filtersets, 
whether true or placebo, was probably a conservative reflection of the overall level of 
contamination of the intravenous fluids being administered. There was no evidence that 
the use of three-way extension sets increased the level of contamination. 
In sharp contrast to the above, Maki 83 commented that the extrinsic contamination of 
intraveous fluid has been shown to be a very rare cause of nosocomial bacteraemia in 
the USA, and that it is therefore unnecessary to replace delivery systems routinely, 
more frequently than every 48 to 72 hours: he recommended that the infusion set be 
changed each time the catheter was replaced. 
The composition of the fluid also determines its potential for contamination. The 
administration, or reflux of blood into the infusion system , may provide sufficient 
nutrients to broaden the spectrum of pathogens capable of proliferation, and it is 
generally recommended that infusion sets should be replaced after the administration of 
blood products. Although reports of clinical infection following the administration of 
blood are rare, 1 % to 6% of individual donor units have been reported to be 
contaminated in the USA 80. Malaria, cytomegalovirus infection, hepatitis and the 
human immunodeficiency viruses have all been transmitted by blood transfusions, 
despite careful screening; leukocyte transfusions have transmitted malaria and 
toxoplasmosis. It is thought that the rate of infection is low because of the small size of 
inocula, intrinsic antibacterial properties of the blood , refrigeration of the blood 
products, and the awareness of the necessity of prompt infusion of such products 
following their delivery from the blood bank. The infections that have been reported 
have been caused by organisms that are able to proliferate at 4°C such as 
Pseudomonads and coliforms. The risk of infection with the administration of platelets 
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is higher, as these are pooled from several donors and often stored at a higher ambient 
temperature to prolong viability. 
To minimise the risk of infection being caused by transfusion, blood products should be 
administered as soon as is possible after delivery, and the entire blood-administration 
set should be removed and replaced after completion of the transfusion. If sepsis is 
suspected, empirical antibiotic therapy should include broad cover against Gram 
negative bacilli. 
The highly nutritious solutions used in total parenteral nutrition are particularly at risk 
for contamination. The catheters used for supplying TPN are often left in place for 
weeks at a time, which may further contribute to the associated high risk of infection. 
Most investigators have found that fungi , particularly Candida spp, are responsible for 
a remarkably large proportion of septicaemias complicating TPN - up to 54% in a 
survey by the CDC 80_ This has been attributed to the generally poor condition of 
patients requiring such therapy for prolonged periods - usually such patients are 
immunocompromised , malnourished, receiving broad spectrum antibiotic cover, and 
possibly steroids or immunosuppressants. The use of topical antimicrobials or occlusive 
dressings which alter the microbial flora of the skin, and provide a moist environment 
at the line insertion site , may also promote fungal colonisation. 
Goldman 91 published guidelines for infection control in TPN, which, in slightly 
modified form , may be summarised thus: 1. TPN should only be initiated when 
clinically indicated by the patient's clinical requirements , and should be balanced 
against the well-recognised and significant risks for infection inherent in such therapy. 
2. The administration of TPN should be under the supervision of a physician and a 
team of health care professionals who are responsible for the insertion, administration, 
and maintenance of the TPN, and are also fully conversant with the management of 
potential complications. 3. The TPN solution should be prepared using sterile or aseptic 
technique, when possible under a laminar flow hood. Once prepared the solution should 
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be stored at 4°C or infused immediately. Studies have demonstrated that Candida spp 
proliferates very rapidly in TPN fluid prepared with casein hydrolysates , and fluids 
containing these compounds should be discarded if they have not been used within 12 
hours. Synthetic solutions are not associated with this problem and can be used for 24 
hour administration. 4. Catheters should be placed , delivery systems maintained, and 
fluid administered according to strict aseptic technique with a carefully developed and 
approved hospital protocol. 5. The catheter placement should be considered to be a 
surgical procedure, performed with the use of drapes , gloves, and appropriate skin 
disinfection. 6. The catheter should be securely anchored to prevent irritating 
movement and to avoid the potential for bacteria to enter through the puncture site. 7. 
The catheter site should be regularly inspected and disinfected. 8. To avoid unnecessary 
contamination, the catheter should not be used to measure the central venous pressure 
or to administer blood products or "piggy-back" medications, and manipulation of the 
line should be kept to a minimum. 9. The administration set should be closely inspected 
to check for cracks in the tubing and bags. The infusate should also be discarded if 
there is evidence of turbidity or precipitate . 10. Other theoretical preventative measures 
of unproven value include: the routine application of antiseptic cream to the site of 
catheter insertion , routine changes of dressings, and skin preparation with antiseptics , 
routine use of semipermeable membrane dressing materials routine use of in-line 
membrane filters, use of silicone or other less traumatic , less thrombogenic catheters, 
use of heparin-locked catheters , or low dose heparin infusions, tunneling of the catheter 
to increase the anatomic distance between catheter insertion and point at which the 
catheter enters the vessel. 11. The TPN system should be immediately considered and 
removed if there are signs of infection and there is no other obvious site of infection. 
The use of perioperative total parenteral nutrition was highlighted in the multicentre 
study reported by the Veterans Affairs Group 98; their conclusion that its use is only 
justified in patients who are severely malnourished or who have other specific 
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indications, if carefully applied, should go a long way to preventing unecessary 
morbidity and mortality from the associated infectious complications . 
7.10 The prevention of wound infections 
Despite the advances in aseptic technique, the contamination of the surgical wound is 
inevitable, and the ability of the tissues to contain the contaminating bacteria depends 
o'n the existing local and systemic immune responses. Although there is often very little 
that can be done to modify them, host risk factors such as age , nutritional status, the 
severity of illness, the site of surgery. the number of surgical procedures, cigarette 
smoking, diabetes and steroid therapy are all recognised risk factors for the 
development of wound infection 28,!69,241 . The role of the anaesthetist and surgeon 
in preserving and enhancing what host defences are present is important 170. Surgical 
wound infection is an important cause of morbidity, doubling the duration of hospital 
stay and considerably adding to costs, although the associated mortality, while 
unknown, is thought to be low 175. 
An effective infection control programme is essential to the prevention of wound 
infection. A surveillance system is needed to identify foci of infection and analyse the 
organisms responsible and their resistance patterns; in this way clusters of infection can 
be rapidly recognised and steps taken to prevent outbreaks. Gil-Egea et al 27 reported 
that the provision of periodic information on infections rates to the various surgical 
services, was associated with a decrease in the infection rate over time. 
The use of asseptic technique, hand washing , effective skin decontamination, laminar 
flow and, post-operatively, the prevention of potential haematogenous seeding from 
other infected sites such as vascular catheters , are all important in the prevention of 
wound infection. The skill of the surgeon and the duration of the surgery are also 
factors which determine the likelihood of postoperative wound infection, as are such 
222 
factors as the presence of foreign material, traumatised or devitalised tissue, and 
haematomas 179. 
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The classification of wounds into clean, clean-contaminated and contaminated has been 
discussed previously, but its relevance has been lost to some extent by the development 
and use of perioperative antimicrobial prophylaxis, which has succeeded in dramatically 
reducing the incidence of wound infections. Of the studies that compared antibiotic 
prophylaxis with a placebo or non-antibiotic control, a literature review in 1983 
demonstrated benefit with prophylaxis in more than 80% I66. However, the margin of 
benefit is small for minor procedures, and the enormous potential costs involved as 
well as the emergence of antibiotic resistance and side effects, need to be 
considered 177. 
Kaiser l 66 recommends the use of the following "interventional" manouevres to reduce 
the risk of surgical wound infection: 
a)pre-operatively: the preoperative avoidance of antibiotic usage, with minimum 
duration of preoperative hospitalisation, the elimination of nasal carriage of 
Staphylococcus aureus, and the treatment of remote sites of infection. 
b )intra-operatively: careful skin disinfection, strict adherence to aseptic 
technique, the maintenance of high flow of filtered air, the irrigation of wounds with 
antiseptic solutions and the minimal use of drains, catheters and intravascular lines. 
c)postoperatively: the maintainenance of adequate tissue perfusion, oxygenation 
and nutrition, should also be of value in reducing the incidence of wound sepsis. 
There appears to be an "incubation period" for the development of wound infection 173: 
once bacterial contamination of the wound has occurred there is an interval during 
which the bacteria are extremely susceptible to antibiotic administration; however, once 
the bacteria have become established within the wound, they become resistant to the 
use of antimicrobial prophylaxis. Thus the timing of the administration of prophylactic 
antibiotics is crucial, and for most procedures the administration of the antibiotic with 
the induction of anaesthesia is seen as the most convenient and efficacious moment 177. 
The duration of antimicrobial prophylaxis has also been a matter of controversy, and 
the pharmacokinetics of the agent used need to be considered when determining the 
time of administration and future dosing intervals. 
Classen et al 178 recently demonstrated that prophylactic antibiotics are most effective 
if given during the two-hour period before the surgical incision, but that the infection 
rate increased if antibiotics were administered earlier than this, or post-operatively. 
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The selection of a prophylactic regimen depends upon the spectrum of infecting 
pathogens, and the prevailing degree of antimicrobial resistance within the hospital. 
The site and nature of the surgery to be undertaken also need to be considered when 
deciding on the most appropriate agents. Not all surgical procedures require the use of 
antimicrobial prophylaxis 167,169,176,177, but should be categorised preoperatively 
according to risk determined by the operative procedure and the state of the host. 
Patients at high risk of infection, or in whom the consequences of infection would be 
disastrous, should be selected to receive prophylaxis 167, 174. Although guidelines do 
exist for most surgical procedures, it is important that the regimen be individualised 
and tailored to the most recently available surveillance data from the particular hospital 
17 l, 176,177. It needs to be remembered that the most prevalent contaminating 
organism does not necessarily correlate with the most likely infecting organism. 
Neurosurgery: The evidence for the efficacy of antimicrobial prophylaxis is not well 
established 169, although many surgeons continue to use anti-staphylcoccal 
prophylaxis. 
Cardiac surgery:In order to prevent the significant mortality rate associated with the 
development of prosthetic-valve endocarditis in the initial period of insertion, 
antimicrobial prophylaxis has become standard practice , despite the studies evaluating 
this form of prophylaxis being inadequate; again, the prophylactic regimen should be 
directed at preventing staphylcoccal infection. 
Peripheral vascular surgery: wound infection may result in failure of revascularisation, 
and thus its prevention is extremely important; controlled studies have demonstrated a 
reduction in postoperative infection with the use of first generation cephalosporins. 
However, the use of prophylactic antibiotics is not warranted for vascular procedures 
on the upper limbs, or in carotid artery surgery. 
Orthopaedics: open fractures require therapeutic rather than prophylactic antibiotics, 
but in joint replacement surgery their efficacy has been confirmed. 
Urology: patients with sterile urine are not generally recommended to require antibiotic 
prophylaxis, but if bacteriuria is present prior to surgery, this should first be treated, 
or , if this is not possible, pre-operative therapy should be continued during the 
operation. 
Biliary tract surgery: antibiotic prophylaxis has been demonstrated to be of benefit in 
high risk cases , such as patients with acute cholecystitis, in the elderly, or those with 
obstructive jaundice, or common duct stones. The agents of choice should cover the 
Enterobacteriaceae , but whether prophylaxis should be extended to include cover 
against Enterococcus and Bacteroides spp is not certain. Gastroduodenal surgery: the 
use of prophylactic antibiotics has been shown to reduce postoperative wound infection 
in the presence of diseases which decrease gastrointestinal motility , or acidity, or in the 
presence of bleeding , obstruction or malignancy; a first generation cephalosporin 
provides adequate prophylaxis. 
Colorectal surgery: support for the use of prophylactic antibiotics here has precluded 
studies of their efficacy in this field; mechanical bowel preparation is insufficient alone, 
but should form part of the regimen for elective surgery . Intravenous antibiotics have 
been shown to be far more efficacious in preventing postoperative infection , than orally 
administered combinations. 
Gynaecology: the incidence of infectious complications depends on the surgery 
and the route employed , being higher following an abdominal hysterectomy than when 
the vaginal route is used . Infections of the female genital tract are usually 
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and include anaerobic organisms, however, antimicrobial prophylaxis which does not 
include anaerobic cover has been shown to be effective: agents such as penicillin, 
ampicillin and the first generation cephalosporins are all effective. 
The cephalosporins have been selected as the agents of choice for most surgical 
prophylaxis, because of their antimicrobial spectrum which covers the skin flora and 
the normal gastrointestinal flora, as well as their relative lack of toxicity. One of the 
major, recognised disadvantages associated with the use of surgical wound prophylaxis 
has been the increasing emergence of multiply-resistant infecting pathogens. The 
cephalosporins have been the antibiotics most commonly used for wound prophylaxis, 
and the concern has therefore largely focused on cephalosporin-resistant organisms. 
Cefazolin has been used in the United States most commonly 166, but failure to 
maintain adequate tissue levels throughout surgical procedures, which is thought to 
result in higher rates of infection, has lead to the introduction of agents with longer half 
lives. Oral agents are also effective in colon surgery , maxillofacial and reconstructive 
surgery, and are much less expensive than the use of routine parenteral antibiotics; both 
oral cephalosporins and newer agents such as the quinolones have been used 
successfully (Rohwedder R., Cerisola J.A., Chavanne J.M. et al. Perioperative 
antibiotic prophylaxis with a single oral dose of 750mg ciprotloxacin in maxillofacial 
and plastic or reconstructive surgery. June 1992, Poster at International Society of 
Infectious Diseases Conference, Nairobi). 
The semisynthetic penicillins have been used as prophylactic agents in clean procedures 
including onhopaedic, vascular and cardiac surgery. The frequency of penicillin allergy 
has probably prevented these agents from assuming a more important role in general 
prophylaxis. The widespread use of vancomycin in clean surgery has not been adopted 
because of adverse reactions, cost and concern that this might potentially lead to 
resistance to this "last reson agent". The use of aminoglycosides in combination with 
beta-lactam antibiotics have not been adopted as first line prophylaxis, because of 
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concern about toxicity, the duration of effective tissue levels, which has not been 
clearly established, and their broad spectrum of activity. The use of metronidazole for 
colorectal and gynaecological surgery in combination with an antibiotic active against 
aerobic Gram negative bacilli has become one of the mainstays of prophylaxis, 
although its superior efficacy over the cephalosporins has not been established 166,174. 
Surgical wound infections are increasingly being reported to be caused by methicillin-
resistant Staphylococcus aureus, methicillin and cephalosporin-resistant coagulase 
negative staphylococci, cephalosporin and gentamicin-resistant Gram negative badlli 
and fungi. Colonisation and infection with these multiply resistant bacteria is thought to 
follow exposure of the patient to the hospital flora, transmitted on the hands of the 
hospital personnel, and it is for this reason that it is recommended that patients 
undergoing elective surgery should have the shortest duration of preoperative admission 
possible. 
The concomitant use of antibiotics has been thought to enhance the colonisation process 
by resistant organisms once exposure has occurred , by altering colonisation resistance. 
It is not certain what the effect of such changes of the colonising flora on the incidence 
and types of infection is likely to be. It is still felt that appropriately administered 
prophylaxis can actually result in less total antibiotic use and a shortened hospital stay 
l66. The selection of resistant pathogens should not preclude the appropriate use of 
antimicrobial prophylaxis , but rather serve to discourage the use of prolonged therapy 
with multiple agents. 
The patient with multiple trauma requiring ICU admission, should be recognised to 
have a marked impairment in host defenses and should be treated in much the same 
way as the highly immunocompromised 241 . The use of empirical, prophylactic 
antibiotic therapy is not generally recommended 207, although in the critically ill 
patient, it is often difficult to resist adding an antibiotic for a presumed, but as yet 
unidentified site of sepsis; again in such cases, the use of surveillance cultures are 
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extremely helpful. The organisms causing nosocomial infections in such patients are 
generally aerobic Gram negative bacilli, Staphylococcus epidermidis and Candida 
albicans 181; the importance of reverse isolation, hand washing and scrupulous aseptic 
technique in preventing infection in such patients cannot be over-emphasised 
7.11 Antimicrobial prophylaxis for Endogenous Infection 
The use of antimicrobial prophylaxis , beyond the confines of perioperative prophylaxis, 
is an emotive area, generally regarded with scepticism and fear that the widespread 
resistance of organisms to antibiotics might be induced in this way. "In clinical use, 
antimicrobial prophylaxis usually combines inefficiency with unproved efficacy" 242 . 
Nonetheless, possibly aided and abetted by the pharmaceutical industry, there is 
constant research and exploration into new indications and areas where the prophylactic 
administration of antibiotics might have a role. 
Shapiro et al l 68 reported in the late 1970s that about 10 % of all hospitalised patients, 
in some randomly selected short-stay general hospitals in Pennsylvania, received 
antimicrobial prophylaxis , either for surgical on nonsurgical procedures; this use of 
antibiotics amounted to 30% of the total antibiotic usage , and was largely 
inappropriate. 
In the early 1980s, Jackson 242 reviewed the indications for antibiotic prophylaxis in 
nonsurgical high risk patients. He stated that the prevention of nosocomial acquisition 
of urinary tract infection, pneumonia, catheter sepsis and cutaneous infections by 
antibiotic prophylaxis was ineffective, yet within three years of this article, Stoutenbeek 
14
,
243 had reported dramatic benefit in preventing just such infections with the use of 
selective decontamination; and this method of antimicrobial prophylaxis within the ICU 
has gained increasing popularity and acceptability ever since. Clearly an answer to the 
existence of a role for antimicrobial prophylaxis must lie somewhere between these two 
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opinions - largely still to be determined by carefully controlled clinical studies to 
determine indications, and contraindications, in this still very controversial area. 
The experience with antibiotic prophylaxis is fairly extensive, but largely unevaluated, 
owing to poorly conducted studies . While there are theoretically enormous potential 
benefits to be derived, these are often difficult to prove. Such therapy is often given to 
large numbers of patients accepting a low rate of efficacy, because the drug is cheap 
and safe to administer, or in the hope that it might prevent, or at least delay, the 
development of infection. If infection does occur in the face of prophylaxis, a number 
of explanations can immediately be provided : including host factors, the endogenous 
and nosocomial flora. so that it is often very difficult to separate the subjective and 
objective data. Clinical and economic values rather than true efficacy thus often 
ultimately may determine whether antimicrobial prophylactic policies are adopted. 
Jackson commented cynically that prophylaxis is consistently most efficacious, or fails 
least frequently. when the exposure to an unusual risk of infection is brief. Where the 
required duration for efficacy is limited. a broad spectrum of potentially pathogenic 
organisms can be inhibited and prophylaxis may appear to have been successful. 
The potential adverse effects of antimicrobial prophylaxis on the host include: an 
alteration of the normal host flora due to selective pressures with the loss of natural 
antibiosis and colonisation resistance, leading to colonisation by an abnormal flora, 
often containing resistant strains which may predispose to bacterial and fungal 
superinfection. There may be other more uncommon side-effects such as the 
development of pseudomembranous colitis from Closrridium d{fficile overgrowth, 
idiosyncratic reactions and vitamin deficiencies . Where the benefit of the regimen is 
difficult to prove, the added costs, particularly if prophylactic drugs are prescribed on a 
large scale are yet another disadvantage . The possibility for increasing numbers of 
resistant organisms to colonise and cause infections in patients who are not receiving 
prophylaxis , particularly if the benefit of prophylaxis is unquantified and uncertain, is 
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one of the major areas of concern with this form of therapy, and is thought to be more 
likely if the regimen is used generally, for prolonged periods, and is not of 
demonstrable benefit. 
It is thus recommended that the indications for antimicrobial prophylaxis should be for 
extremely limited periods only. if the aim is to cover procedures or exposure to disease 
(such as would more commonly be encountered in the community), that prophylaxis for 
disease prevention, such as for bites or following contaminated trauma, should be 
continued for a period of 24 hours to not more than 5 days to a week , and that more 
prolonged regimens should only be used in high risk , immunocompromised patients. 
The regimen should ideally be used only in areas where sepsis is likely to result in 
significant morbidity and mortality , and the use of topical antibiotics or other practices 
that might promote the emergence of Gram negative organisms, should be avoided. 
Infection preve_ntion was initially most vigorously studied in the immunocompromised 
haematological patients, because infection has long been recognised to be the major 
cause of death in these patients , often sadly even in the presence of a "cure" for the 
underlying condition. The use of protective isolation and laminar flow was developed 
in the 1960s and was found to be expensive, cumbersome and difficult to maintain from 
a logistical point of view, as well as from the patient's psychological viewpoint. 
Virtually all patients who were treated with protective isolation also received 
prophylactic oral non-absorbable antibiotic therapy to eliminate the faecal flora. It 
gradually became apparent that the greatest impact on the incidence of life-threatening 
infection was not the environmental protection, but the suppression of the 
gastrointestinal flora, which promoted the development of infections due to Gram 
negative bacilli. 
The choice of agents suitable for use in a prophylactic regimen depends on the 
organisms that are most likely to cause infection, the prevailing flora and their resistant 
patterns in the area where prophylaxis is to be applied ; as well as the potential costs 
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and likely effects that may result from this method of antibiotic usage. The 
development of superinfection, whether from therapeutic or prophylactic use of an 
antibiotic, amounts to failure; this complication has frequently been noted to follow the 
administration of penicillin, streptomycin, meth icillin, tetracycline, ampicillin and 
chloramphenicol 12. The species causing superinfection are most commonly the 
endogenous Enrerobacreriaceae, Pseudomonaceae or fungi. 
The phenomenon of colonisation resistance was noted initially in patients undergoing 
treatment for haematological malignancy 244 . where it was observed that the use of 
broad spectrum antibiotics was more likely to result in the problem of superinfection. 
The normal bacterial flora colonising the gastrointestinal tract, which is largely 
anaerobic, is easily eliminated by the use of such broad spectrum drugs and its 
protective effect which has been shO\vn to prevent the overgrowth of other more 
potentially pathogenic aerobic bacteria and yeasts , is thus lost. The anaerobic flora of 
the digestive tract, particularly the Gram positive anaerobic flora, plays a major role in 
the ecological. flora-associated colonisation resistance by colonising mucus and the 
mucosa. The anaerobic flora in the lumen is thought to be largely derived from the 
flora associated with the mucosa. The primary composition of the indigenous flora is 
,4-
thought to be dependent on diet .,_ ) . 
As discussed previously, the indigenous flora is thought to hinder colonisation by 
foreign bacteria. by blocking receptor sites. Nutrition for the enteral flora is obtained 
from the host. and mucus is thought to be of specific nutritional value to these 
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organisms - ; the indigenous flora may also possess specific enzymes for the 
digestion of nutrients of host origin which non-indigenous flora lack. Significant 
differences in the anaerobic colonising flora between individuals have been found, and 
these interindividual differences may determine the degree of colonisation resistance by 
that individual. 
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Le Frock et al 7 demonstrated that the aerobic faecal flora also undergoes changes 
during hospitalisation, even without the administration of antibiotics, radiation or 
surgery: on admission the most common aerobic bacteria were noted to be Escherichia 
coli, but this was gradually replaced by Klebsiella, Proteus and Enterobacter spp. 
Wells et al 19 demonstrated that the aerobic and facultative bacteria also have a role in 
colonisation resistance, and assist both in preventing gastrointestinal colonisation by 
potential pathogens, and in confining such pathogens to the lumen of the intestine. 
van der Waaij 244 further demonstrated that there were marked differences in the 
colonising flora of normal human volunteers and in patients with acute leukaemia. He 
suggested that the leukaemics might have a "lower quality" of indigenous flora thus 
predisposing to colonisation by potential pathogens. Attempts at enhancing colonisation 
resistance have been attempted by the implantation of anaerobic bacteria by oral 
inoculation, however, such attempts have not been successful. The other technique 
directed at preserving colonisation resistance and maintaining or improving the 
anaerobic indigenous flora is selective decontamination of the digestive tract (SDD); 
however, while the potentially pathogenic aerobic Gram negative bacilli and yeasts may 
be largely eliminated by SDD, Gram positive infections still continue to occur, because 
they share sensitivity patterns with the indigenous flora that determines colonisation 
resistance. 
Gorbach et al 18 has demonstrated that agents which do not inhibit the anaerobic 
species , only minimally decreased its proportion of the intestinal flora in normal 
volunteers , but they were unable to confirm that colonisation resistance was directly 
related to this anaerobic component. It has also not been convincingly demonstrated 
that agents which exert effects on both aerobic and anaerobic species actually promote 
the overgrowth of drug-resistant species. The phenomenon of colonisation resistance 
has remained somewhat controversial because it is argued that, if its relevance were 
absolute, the selection of resistant microorganisms should not occur 246 with the use of 
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a single agent, such as cotrimoxazole, designed to suppress the gut flora but preserve 
its anaerobic component. Clasener 12 suggests that colonisation resistance can be 
simply measured if it is assumed that its reduction leads to an increase in the 
concentration of aerobes in the faeces. Following the administration of antimicrobial 
agents , overgrowth of resistant organisms has been demonstrated in normal human 
volunteers receiving tetracycline, ampicillin , clindamycin, ceftriaxone, and 
moxalactam. Cotrimoxazole, however, was not fou nd to cause overgrowth of resistant 
microorganisms except for occasional enterococcal overgrowth . Since 1977, successful 
infection prophylaxis in leukopaenia has been reported in placebo-controlled studies of 
oral cotrimoxazole, oral cotrirnoxazole plus erythromycin . polymyxin E plus 
neomycin , and polymyxin E plus both neomycin and nalid ix ic acid. 
7.11.1 The Selection of Agents for Antimicrobial Prophylaxis for Endogenous 
Infection 
With careful selection of an antibiotic regimen it is possible to eliminate the major 
potentially pathogenic . . microorgani sms (Emerohacreriaceae , Pseudomonaceae, 
Staphylococcus aureus and Candida and other yeasts) in patients with an increased 
susceptibility to infection , without affecting colonisat ion resistance. Indeed, there is 
such a wide variety of agents avai lable for the treatment of most infections, that it 
should be possible to select both prophylactic and therapeutic agents which do not 
affect colonisation resistance. 
It is thought that the development of bacterial overgrowth. or the presence of high 
concentrations of potentially pathogenic microorganisms in the faeces, particularly if 
they are resistant , may be related to the development of subsequent infection. Failure of 
the prophylactic . regimen is always easi ly explained by the presence of a gap in the 
spectrum of activity of the · antimicrobial agents used. as microorganisms able to 
colonise the gastrointestinal tract will continue to do this in the face of prophylaxis, 
provided that they are not sensitive to the agents used . However, the number of 
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organisms colonising the gut should not increase exponentially if the limiting flora and 
colonisation resistance has been preserved. 
1) Trimethoprim and sulphamethoxazole 
The combination of trimethoprim-sulphamethoxazole was discovered to prevent 
infections due to Pneumocysris cari~ii in children, and the use of cotrimoxazole for the 
prevention of this infection in those who are at risk, and able to tolerate the drug, is 
well recognised. However, this antibiotic combination has also been used with 
considerable success in the prophylaxis of other infections; this is because the 
sulphonamides have not been observed to promote the overgrowth of potentially 
pathogenic microorganisms, although canc!idal colonisation of the gastrointestinal tract 
may occur. Cotrimoxazole should be used in combination with another antibiotic to 
prevent the selection of resistant bacteria, as colonisation with Gram negative 
organisms, while greatly reduced , is not eliminated. Some studies have noted that the 
Gram negative organisms that emerged were fully resistant to this agent; with the 
addition of polymyxin E however, this problem appears to be able to be overcome. One 
of the deficiencies of this drug is its lack of activity against Pseudomonas aeruginosa, 
and part of the rationale for combination therapy with polymyxin is to provide cover 
against this important nosocomial pathogen. 
The risk of colonisation and infection by Candida a/bicans appears to be promoted by 
the use of cotrimoxazole, so that antifungal prophylaxis should be administered in 
conjunction with it. Amphotericin B has been found to be more effective than 
ketoconazole at preventing overgrowth by yeasts. The oral administration of topical 
antibiotic and antifungal preparations may be all that is required. The oral 
administration of cotrimoxazole in combination with such a preparation both 
decontaminates the gastrointestinal tract and provides systemic prophylaxis. 
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Cotrimoxazole has gained acceptance as an effective agent for long term prophylaxis 
against infection in leukopaenic patients. However allergic reactions and toxicity, 
usually due to the sulpha component, are not infrequent, and it has been reported that 
its use may prolong the neutropaenic period following the administration of cytotox.ics 
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2) The Cephalosporins 
The cephalosporins are thought to be potentially damaging to colonisation resistance , as 
they exhibit activity against the anaerob ic flora. Cefotaxime is an unusual beta-lactam 
antibiotic in that only 1 % is excreted in the bile. Superinfections following its use are 
also thought to be uncommon. The effect of parenteral cefotaxime on the faecal flora 
has been extensively studied , however in both patients, and volunteers, and has 
demonstrated at least partial elimination of the Enrerobacreriaceae without the 
emergence of resistant strains. For the above reasons cefotaxime is frequently selected 
as the parenteral agent of choice in regimens of selective decontamination for 
mechanically ventilated patients. It is administered as part of the initial therapy to 
achieve early elimination of potentially pathogenic flora. 
3) The Polymyxins 
Polymyxin B and E may be regarded as therapeutically equivalent. Resistance is 
reported to develop infrequently in originally susceptible bacterial species , and systemic 
toxicity following oral administration has not been reported , although parenteral 
administration commonly results in nausea and vomiting. Their oral administration has 
been demonstrated to achieve complete selective decontamination within a period of 
three days , compared with intervals as long as 7 to 9 days for nalidixic acid and 
cotrimoxazole. When used alone, a dose of 800mg daily is required because of marked 
inactivation of the drugs in the gastrointestinal tract; however , in combination therapy , 
the dose may be reduced to 400mg/day. 
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The polymyxins are effective against most Gram negative bacilli, except Proteus spp. 
to which they are intrinsically resistant, and for this reason they are most commonly 
used in combination with neomycin, tobramycin, nalidixic acid, cotrimoxazole or 
norfloxacin. 
4) The Aminoglycosides 
The use of oral neomycin has become established in preoperative bowel preparation for 
gastrointestinal surgery, often in combination with metronidazole; it has also been used 
for more prolonged periods to eliminate Proreus spp from the intestine of patients in 
hepatic coma. The drug is recognised to have a direct adverse effect on the intestinal 
mucosa, increasing gastrointestinal transit time. Its oral administration may lead to 
ototoxicity. With experimental use in mice, colonisation resistance has been shown to 
be affected, even at doses which fail to completely decontaminate the intestine. 
In a study comparing the effects of the oral administration of aminoglycosides to 
achieve decontamination, only the use of tobramycin was not associated with a 
simultaneous disturbance in colonisation resistance. The disadvantage of tobramycin 
over neomycin is that the former is considerably more expensive. The combination of 
tobramycin and polymyxin appears to be satisfactory in achieving selective 
decontamination both in leukopaenic and mechanically ventilated patients, although its 
decontaminating spectrum , if used alone, is too narrow 12. 
5) The Quinolones 
Nalidixic acid, given as therapy for unnary tract infections, has been observed to 
promote the emergence of resistant strains of Gram negative bacilli in the faeces of up 
to 5 % of all patients receiving this form of therapy. However, if combined with 
polymyxin alone, or polymyxin and neomycin, such resistance was not found to occur. 
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Side effects of therapy with the quinolones include manifestations of central nervous 
system toxicity, including seizures and intracranial hypertension have been reported in 
children, while other areas of potential toxicity such as crystalluria, cartilage damage 
and DNA damage have not yet been shown to be of clinical importance 247 . The newer 
generation of quinolones are generally thought to be safe and well tolerated, with a 
profile similar, or possibly even superior to that of other classes of antibiotics. 
Norfloxacin and the other newer quinolones have been used in selective 
decontamination regimens both in leukopaenic and mechanically ventilated patients. 
Norfloxacin is particularly suited for enteral decontamination, as it is cheap and poorly 
absorbed from the intestine. These drugs do not affect colonisation resistance, are 
rapidly effective in suppressing the gut flora and have not been associated with the 
rapid development of resistance. They have much lower MICs and undergo much less 
inactivation in the faeces. While effective elimination of the Enterobacteriaceae from 
the gastrointestinal tract can be achieved with such agents without disturbing the 
anaerobic flora, resistant coagulase negative staphylococci and increased faecal 
concentrations of Candida albicans have been detected in some patients 246. 
The quinolones have a superior spectrum of activity compared to cotrimoxazole, in that 
they are active against Pseudomonas aeruginosa, however, they lack activity against 
Pneumocystis carinii. 
6) The Macrolides 
The oral administration of either erythromycin or clindamycin has been found to 
eliminate the Enterobacteriaceae from the faeces of volunteers, without promoting the 
overgrowth of resistant organisms. In studies in mice, orally administered erythromycin 
did not affect colonisation resistance. In studies where the drug has been 
administered long term, for the prevention of acne or Legionella pneumophila 
infections, or in immunosuppressed renal transplant patients, there has not been 
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resistant organisms m the faecal flora 12 . The combination of erythromycin and 
cotrimoxazole has been used in leukopaenic patients, but the frequently experienced 
gastrointestinal intolerance associated with the use of this agent has limited its 
widespread use, as success depended on perfect compliance. Erythromycin is also noted 
for drug interactions. 
7) Antifungal Agents 
Neither nystatin nor amphotericin B has any antibacterial activity, and these agents 
therefore do not exert any effects on microbial colonisation resistance. The use of these 
agents requires that there should be a few hours of exposure to the site to be 
decontaminated for this to be achieved, and the use of an adhesive paste or lozenges is 
therefore preferable to an oral solution , when attempting to decontaminate the 
oropharynx. Amphotericin B is preferred to nystatin, because it shows a more 
favourable ratio between the dose given and faecal concentrations achieved, has lower 
MICs for Candida and is also more palatable. 
Ketoconazole does exhibit antibacterial activity against a number of bacterial species, 
and might thus be expected to affect colonisation resistance; it is also sufficiently 
absorbed following oral administration to be able to achieve a systemic effect. In 
studies with leukopaenic patients it has been shown to be more successful at preventing 
fungal infections than the use of oral nystatin or amphotericin B, but following bone 
marrow transplantation this benefit was lost, presumably because of the poor 
gastrointestinal absorption. 
In selecting an antibiotic for the treatment of an infection, the preservation of 
colonisation resistance as far as is possible should also be considered. Although it is 
difficult to find an alternative to the penicillins, some of the cephalosporins including 
cefotaxime, cefaclor, ceftazidime and cephradine would appear to have less effect on 
the anaerobic flora and may perhaps be substituted. It is thought that none of the 
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aminoglycosides, when administered intravenously has any effect on colonisation 
resistance. The quinolones are thought to be relatively safe, but should not be given to 
children. Metronidazole is thought to exert much less effect on colonisation resistance 
than clindamycin and is the drug of choice for anaerobic infections. 
7.11.2 Selective Decontamination of the Digestive Tract 
Unit acquired infection of all types increases with the duration of stay in the ICU, and 
may exceed 80% in those who remain in the unit for more than 5 days 156. Once a 
cycle of induced suppression of host defences. sepsis and organ failure is established, 
conventional management has been recognised often to be inadequate, with the 
consequent high mortality associated with multiple system organ failure. While urinary 
tract infections, septicaemia and soft tissue infections are all common, it is the 
respiratory tract that accounts for the highest proportion of secondary infection, 
although there are many difficulties associated with its definition and diagnosis. 
It is often difficult to distinguish between infections present on admission and those 
acquired within the unit, because infection may be subclinical, incubating or masked by 
other pathology. As previously discussed, it is customary to differentiate between 
primary infections, which are usually accepted as those occurring within the first 48 
hours after admission, and which are considered to have been present or latent on 
admission (and thus often due to a different spectrum of organisms), and secondary 
infections, which manifest after 48 hours. These infections are of interest, because with 
optimal management, they are considered by many to be potentially preventable. 
It was assumed that such infections were mainly exogenous, that is, acquired directly or 
indirectly from the other patients, the attending staff or the environment, and many of 
the techniques, which form an integral part of patient care, are designed to prevent 
such infections from developing. However, although the pathogenesis of infection in 
the ICU is both variable and complex, most unit infections are now thought be 
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endogenous, with the patient's own oropharynx, stomach and more distal 
gastrointestinal tract serving as the principal sources of infection. Such endogenous 
organisms are, however not the primary endogenous colonisers such as Streptococcus 
pneumoniae, Haemophilus influenzae, Moraxella catarrhalis which colonises the upper 
respiratory tract, Staphylococcus aureus and Escherichia coli which colonises the gut in 
healthy people in the community, but rather "secondary endogenous" organisms, or 
colonisers from the hospital bacteria. While a wide range of organisms may be 
involved in colonising and causing endogenous infection, certain groups of aerobic 
Gram negative bacilli (particularly Escherichia coli, Klebsiella spp, Proteus spp, 
Enterobacter, Serratia spp and Pseudomonas species, and less commonly Acinetobacter 
spp, although in some centres this is emerging as the most prominent, problematic 
organism) constitute the main problem. These organisms often show abnormal patterns 
of colonisation of the oropharynx and gastrointestinal tract, reflecting both the 
outgrowth of indigenous strains and colonisation with hospital strains of these 
organisms. Oropharyngeal colonisation with Gram negative bacilli is strongly 
associated with the subsequent development of respiratory tract infections, with more 
than 75 % being preceded by oropharyngeal colonisation with the same organisms 
4
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248. Wound, and urinary tract infections are also related to preceding gastrointestinal 
colonisation and the presence of indwelling catheters or instrumentation 4,5,30, 156. 
More than 50% of all patients admitted to the ICU are already colonised with the 
pathogen that subsequently causes their nosocomial infection 43. While anaerobic 
organisms may be important in sepsis present on admission, they are seldom 
encountered as a cause of unit acquired infection. 
Experience with granulocytopaenic patients 12, 13 first demonstrated that this 
pattern of infection might respond to selective decontamination of the digestive 
tract, where non-absorbed antibiotics are used to eliminate, or greatly reduce, the 
numbers of aerobic Gram negative bacilli and yeasts in the gastrointestinal tract, 
thereby reducing the risk 
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of endogenous infection, while retaining the normal anaerobic flora; thus maintaining 
colonisation resistance against overgrowth with drug-resistant strains. 
The first application of this technique to the ICU was in 1984 by Stoutenbeek and his 
group from Groningen in the Netherlands, 14,243 who described the use of a 
prophylactic regimen combining parenteral cefotaxime, and an enteral regimen of 
polymyxin E, tobramycin and amphotericin B, applied to the oropharynx and stomach. 
The enteral decontamination regimen was known as "selective decontamination", or 
SDD, while the addition of a parenteral agent gave the regimen the acronym of 
"SPEAR" for selective parenteral and enteral antisepsis regimen. The intestinal 
decontamination was applied for the duration of the patient's stay, while the 
cefotaxime, which has negligible effects on the anaerobic flora of the gastrointestinal 
tract, and is thus unlikely to hamper colonisation resistance , was given for the initial 
few days only. The cefotaxime was thus used as a supplement to the intestinal 
decontamination, at a stage before the full effect of intestinal and oropharyngeal 
decontamination was established, while it was still possible for subclinical infection 
acquired before, or at admission, to be incubating, and during which intubation and 
other invasive procedures were most likely to be performed. The use of the cefotaxime 
was independent of the usage of any other antibiotics, which might be indicated for the 
treatment of clinically or microbiologically diagnosed infection. 
The results of the initial studies of selective decontamination (SDD) were most 
encouraging and showed dramatic reductions in the incidence of colonisation by aerobic 
Gram negative bacilli (AGNB) and yeasts, with an associated fall in the infection rate; 
some studies even reporting reductions in the mortality rate for selected groups of 
patients. If the incidence of secondary infection could be reduced, it followed that the 
costs entailed in the treatment of such infections (prolongation of ventilation, ICU stay, 
additional drugs, etc) would be avoided and the additional costs involved in the 
administration of prophylactic antibiotics, with the associated increase m 
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microbiological surveillance, would easily be justified as cost-saving. Of course, if the 
technique could be demonstrated to improve mortality in the ICU, its use would be 
justifiable at any price. 
It was thought that by reducing the bacterial load in the gastrointestinal tract, and thus 
the transfer of endotoxin to the bloodstream 96, selective decontamination might be 
able to prevent the development of multiple organ system failure . If this mechanism 
held true, its effects on the mortality in the ICU could be remarkable. Polymyxin E 
which is used in many of the decontamination regimens , is recognised to bind to 
endotoxin , and might be partly responsible for this effect , which has not yet been 
convincingly proven. 
The studies of selective decontamination have been performed on different ICU 
populations, using a variety of techn iques both in terms of medication and study 
design. While the initial studies were flawed by small patient populations, historical 
control groups , and post-hoc patient stratification , the results were so promising that 
there has been a flurry of studies from numerous ICUs , particularly in Europe. These 
studies have looked at various types of ICUs and high risk sub-populations, in an 
attempt to establish where and whether this technique really has a role, and to assess 
the benefits to the patient in terms of morbidity, mortality and cost. 
Although the decontamination regimens were primarily designed to have an effect on 
endogenous infections, some centres 229 also reported a beneficial secondary effect on 
the bacterial flora of the ICU , with a consequent reduction in the incidence of 
exogenous infection. Still other centres 3,249,250 have reported success in using the 
technique to eradicate multiply-resistant organisms from the ICU. 
There has been continued concern however, that there is enormous potential for such a 
technique to exert selective pressures promoting antibiotic resistance, thereby 
promoting the emergence and overgrowth of organisms resistant to the antibiotics used. 
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There have, to date, been no reports in the literature on the microbial flora and its 
sensitivity patterns following prolonged use of this technique; however, a large part of 
the costs involved in using selective decontamination are incurred in the microbiology 
laboratory, where extensive and ongoing surveillance samples and cultures are 
performed to monitor the effects on the bacterial flora until the possible effects are fully 
known and understood. 
The following is a review of the available literature of the trials to date on selective 
decontamination. While meta-analyses have reported many of these studies in terms of 
the methodology used, this review analyses the studies according to the populations 
studied. 
1) ~Iultiple Trauma 
One of the areas where it has been suggested that conventional perioperative 
antimicrobial prophylaxis may cause more problems than it solves, is in patients with 
multiple trauma. There is concern that, apart from not being effective, it may induce 
the emergence of resistant bacterial strains, making the treatment of nosocomial 
infections, if and when they arise, more difficult. However, once a serious infection 
has developed in the patient who has sustained multiple trauma, multiple organ failure 
easily develops and the outcome, even with appropriate and adequate antibiotic therapy 
may often be fatal l 80. 
Selective decontamination which aims at selectively eliminating the Gram negative 
bacilli and maintaining the normal anaerobic flora, thus preserving the normal 
colonisation resistance to potentially pathogenic nosocomial bacteria, might thus be 
expected to circumvent the problems of antimicrobial prophylaxis, but nonetheless 
reduce the incidence of secondary infection in these patients. The studies of SDD which 
have shown the most positive results have indeed been in groups of patients admitted to 
the ICU because of multiple trauma; however, there are a number of methodological 
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problems with the most widely quoted studies, so that the results need to be interpreted 
with caution until more definitive studies become available. 
In one of the earliest studies of selective decontamination in the ICU, STOUTENBEEK ET 
AL 14 assessed the effect of selective decontamination on colonisation and infection 
rates in multiple trauma patients. The study was not blinded, no placebo was used and 
the control group was historically gathered. The patients included in this study were all 
severely injured with Injury Severity Scores of approximately 34. 122 patients who 
stayed in the ICU for more than 5 days and required mechanical ventilation were 
investigated, including a control group of 59 patients who were retrospectively gathered 
and who had received no antibiotic prophylaxis. In these patients the infection rate was 
reported to be an astonishing I y high 81 % . They found that most infections in the 
control group were due to endogenous organisms and that, after two weeks in the ICU, 
more than 80% of patients were colonised. There were 63 patients who received SDD 
over a 12 month period, and in this group the infection rate was dramatically reduced 
to only 16%. The regimen used was topical Polymyxin E, Tobramycin, Amphotericin 
B, applied to the oropharyngeal cavity and enterally, and systemic cefotaxime which 
was continued until the patient was demonstrated to be free of potentially pathogenic 
microorganisms. 
As part of the same study, the authors separately reported , as a prospective open study 
243, the same two groups which they compared with two other regimens: a third group 
where enteral decontamination alone was performed in 17 patients, however here no 
difference in the infection rate compared with the control was demonstrated. In a fourth 
group of 25 patients, both intestinal and oropharyngeal decontamination were 
performed. In this fourth group they showed that while the incidence of secondary 
colonisation and infection with Gram negative bacilli was significantly reduced, early 
infections with Gram positive organisms were unaffected. It was only in those patients 
who received both systemic and enteral oropharyngeal and intestinal decontamination 
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that the incidence of early and late infections was significantly reduced. The definitions 
of microbial carriage states were carefully specified in this study, and similar 
definitions have since been employed by a number of other trialists : Colonisation was 
the presence of the same species of potentially pathogenic microorganism in an organ 
system for more than 3 days without signs of infection. Possibly more controversially, 
exogenous infection was defined as infection caused by potentially pathogenic 
microorganisms isolated from the site of infection, but without previous colonisation of 
the digestive tract; whereas endogenous infection was infection caused by 
microorganisms that had first colonised the digestive tract. 
The definitions for site specific infection possibly account for the initially high infection 
rate, as they show a considerable microbiological weighting with minimal emphasis on 
the clinical presentation and status of the patients - and. in the absence of the patient 
when analysing an historical group of patients. such weighting might well have lead to 
an overdiagnosis of nosocomial infection. Respiratory tract infection was diagnosed on 
the basis of purulent sputum and dense growth in bacteriological cultures from the 
tracheal aspirate. The diagnosis of lower respiratory tract infection was made on 
physical and radiological signs of pulmonary infiltration, fever and leukocytosis. 
Unfortunately such a definition is rather too vague to be reliable. Urinary tract 
infection was diagnosed by culture of more than 100 000 organisms/ml from catheter 
specimen of urine. Wound infection was diagnosed on the basis of signs of 
inflammation, a purulent discharge from wounds and a positive Gram's stain, and 
culture. Septicaemias were recorded only if bacteriologically confirmed, but while 
specifying that to diagnose a Staphylococcus epidermidis bacteraemia, two positive 
blood cultures were required, again no further clinical parameters for any type of 
septicaemia were specified. 
In the control group, 41 % of patients were colonised by Staphylococcus aureus on 
admission, but this gradually disappeared during their ICU stay, while there was a 
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simultaneous increase in colonisation with Gram negative potentially pathogenic 
microorganisms. Early pneumonia ( < 48 hours) with Staphylococcus aureus, 
Streptococcus pneumoniae and/or Haemophilus influenzae was found to occur in 44 % 
of these patients. Secondary colonisation of the oropharynx and trachea with Gram 
negative bacilli followed by pneumonia occurred in 20 % , and the overall incidence of 
respiratory tract infections was 59 % . 
Only 24 % of the group who received SDD were colonised by Sraphylococcus aureus 
on admission, and the colonisation by all organisms was reported to decline during 
their ICU stay, with no secondary colonisation occurring. The high initial colonisation 
rates in both groups were explained by the rapid acquisition and colonisation by 
potentially pathogenic microorganisms following trauma, as a result of increased 
adherence, impaired oral defence mechanisms and a high exposure to the Gram 
negative organisms already colonising other patients in the unit , or in the food. The 
differences in the initial colonisation rates between the two groups were thought to be 
due to the fact that the initial enrollment specimens in the control group were taken the 
morning after admission, whereas those in the SDD group were taken immediately on 
admission. 
The incidence of pneumonia during the ICU stay was 59% (20% were secondary 
infections) in the control group, of which 95 % of the organisms were endogenous, 
while in the SDD group, the incidence was only 8%, and 57% of the organisms were 
endogenous. The incidence of other types of infection was also reduced. 32 % of the 
control group developed urinary tract infections, 97% of which were due to 
endogenous organisms, but there was only one urinary tract infection which was not 
due to an endogenous organism in those who received SDD. Similarly, there was a 
42 % incidence of septicaemia in the control group of which 70 % were due to 
endogenous organisms compared with only a 3 % incidence in the SDD group in whom 
none of the episodes were due to endogenous organisms, specifically there were no 
episodes of Gram negative septicaemia. The incidence of wound infections was 25 % in 
the control group, 88% of which were endogenously acquired, compared with only 4% 
in the SDD group in whom 100% of the organisms were endogenous. Further 
interpretation of these figures is difficult, because the site specific infections are not 
reported as primary and secondary. 
The effectiveness of the SDD regimen in eliminating Gram negative organisms from 
the gastrointestinal tract is extremely well demonstrated in this study, as is the 
increasing colonisation by these organisms in the control group , and the alterations that 
occur in the normal gastrointestinal flora during hospitalisation in the ICU. The initial 
samples 14 from the oropharynx in both groups showed a high level of colonisation by 
potentially pathogenic microorganisms (63 % in the control and 41 % in the SDD 
group), and while this persisted and increased in the patients in the control group (86% 
colonised by day 15 and 81 % at day 21), by day 15 such organisms had been 
eliminated in those who received SDD, and such eradication continued at day 21. A 
similar pattern was seen in the samples taken from the rectum, although at both sites by 
day 21 there were only 6 patients in either limb of the study. While there are also tables 
provided which show a significantly lower number of potentially pathogenic 
microorganisms in isolates from the tracheal aspirate and urine, only the total numbers 
are provided, so that the effect with time of the decontamination regimen on these sites 
is not apparent. Later studies do not comment on the ability of selective 
decontamination to reduce the incidence of urinary tract infections, but concentrate 
almost exclusively on the prevention of nosocomial pneumonia. 
The authors also found that with the implementation of SDD in their unit, a reduction 
in the contamination level of the ICU environment was achieved, without special 
cleansing procedures; this in itself was thought to have partly accounted for the 
dramatic reduction in the infection rate brought about by SDD. Importantly, the 
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emergence of resistance against the prophylactic topical and systemic antibiotics used 
for SDD, was not observed. 
However, in spite of this dramatic reduction in the infection rate, the mortality is not 
commented upon in the initial study 14. In the later report of the same study 243, 8 % 
of the control group died in whom 59 % had developed respiratory tract infections, 20% 
of which were nosocomial; 12 % who had received intestinal decontamination alone, 
also with an overall incidence of 59% of respiratory tract infections, and an 18% 
incidence of secondary respiratory tract infections died; 4 % who received 
oropharyngeal and intestinal decontamination died, and in these patients the overall 
incidence of respiratory tract infections was a similar 52 % , but there were no 
secondary acquired infections; the mortality was 0% in those who received both enteral 
and parenteral decontamination. and these patients had only an 8% overall incidence of 
respiratory tract infections, with again no secondary infections. 
Unfortunately, no attempt was made to address the problem of whether such deaths 
could be attributed to secondary infection. The low overall mortality, and the 
nonspecific diagnostic criteria used to diagnose lower respiratory tract infections, 
however, do cast doubt on the incidence and severity of the secondary infections in this 
study. The figures correlate poorly with other studies previously reported. It is difficult 
to accept that an infection rate of 81 % can be associated with a mortality of only 8 % in 
patients with an injury severity score of 34, further casting doubt on the diagnosis. 
The costs of selective decontamination were not commented on in either of these 
papers, however in a further paper (Stoutenbeek C.P. , et al A novel approach to 
antibiotic prophylaxis in multiple trauma patients. Actualites en anaesthesie 
reanimation, Librairie Aruette, Paris, 1986: 381-391) devoted to the same multiple 
trauma patients the authors justify the use of the technique thus: "more expenses have 
to be made for the oral non-absorbable antibiotics and the intensive bacteriological 
monitoring. The costs of systemic antibiotics are comparable with a conventional 
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antibiotic policy. The costs of SDD + bacteriological monitoring amounts ± 8 % of the 
total ICU costs/patient. The savings are shortening of ICU stay, less need for isolation 
rooms, simplification of the care of the patients, less disposables, more survivors." 
Considering that the average costs of hospitalisation in an ICU as long ago as 1983, 
when this study was performed, were estimated by the same group 229 to be$ 8116 or 
$ 1365 per day or$ 22326 per survivor, whether such comments are indeed justified by 
the data provided, may be left to the reader to decide. 
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MIRANDA ET AL 229 reported, using the same patient data (although the figures are not 
presented), that the need for patient isolation because of severe infection was decreased 
by 90%, which they attributed to a 50% drop in the rate of nosocomial infection. Their 
practice was to isolate patients with persistent discharge of infected material, or those 
who were "resistant to treatment". As a result of being able to reduce the number of 
isolation rooms, the number of nurses, as well as the use of disposable equipment, 
which helped with cost-saving. 
They found that the positive bacteriological samples taken from potentially 
contaminated sources in the ICU environment were reduced to 10 % during the 
administration of SDD, compared with 100% previously. Of the organisms isolated, 
the Pseudomonaceae were the commonest in the ICU environment (60%), compared 
with the general ward, where the Enterobacteriaceae accounted for 92 % . The surgical 
ward and, indeed the home environment, were found to be far more heavily 
contaminated than the ICU. They concluded from this that the routine hygienic 
precautions were not sufficient to remove contamination, and that the colonisation of a 
person, with normal colonisation resistance, had no correlation with the contamination 
of the environment. In the patient who has lost his normal colonisation resistance 
however, the contamination of the environment exerted a direct influence on the 
potential for colonisation with nosocomial bacterial flora. 
With the use of SDD, there was an associated 12 % increase in admission capacity to 
the ICU. The authors conclude by daring to suggest that architectural design and 
"special care facilities" will cease to be of high priority in infection control in the ICU 
as a result of SDD. 
BOLAND, SADLER, STEWART ET AL from Charleston, West Virginia, reported a 
prospective double blind study of SPEAR in multiple trauma patients, using parenteral 
cefotaxime, or intravenous placebo for the first 72 hours, and oropharyngeal and 
enteral decontamination with polymyxin E, tobramycin, and nystatin, or placebo 
(poster ICC, Berlin 1991) to assess the efficacy of this technique in preventing 
ventilator associated pneumonia. 
The diagnosis of ventilator-associated pneumonia was made by a positive sputum 
culture for bacteria, a temperature > 38°c, a white cell count of more than 10 900/ml 
and a persistent infiltrate and/or a blood culture identical to the sputum culture. No 
further definitions were provided. 
Patients who were considered to be likely to require ventilation for more than 5 days 
were selected on admission to the ICU and randomised; 70 patients were entered and 
41 were evaluable (22 received placebo and 19 received SPEAR). The patients were 
fully comparable in terms of age, sex and APACHE II (20.6 SPEAR vs 16.3 control). 
No injury severity score was provided. The duration of ICU stay was significantly 
shorter in the placebo group (11 days vs 18.6). 10 (53%) patients who receive SPEAR 
developed ventilator-associated pneumonia, compared with 15 who received placebo 
(68 % ) and , in this subgroup, the patients were again fully comparable and the patients 
in the control group still showed a significantly shorter requirement for ICU care. The 
mortality rate in this study is not provided. 
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The organisms identified as causing respiratory tract infection were: Staphylococcus 
aureus (control 3, SPEAR 3), Haemophilus influenzae (control 3, SPEAR 1), and 
aerobic Gram negative bacilli (control 6, SPEAR 5). 
While the number of patients in this study is unfortunately too small, the study design 
is the ideal way to assess any technique. The overall incidence of nosocomial 
pneumonia of 61 % (although no time interval for its definition is specified) is 
sufficiently high for a significant reduction with the use of SPEAR to have been 
anticipated. The definitions and the effect on colonisation and resistance patterns 
presumably could not be provided in the abbreviated poster form. The fact that this 
study failed to achieve the desired result is explained as being due to a spectrum of 
organisms insensitive to the agents used in the decontamination regimen, and also to 
primary tracheal colonisation. 
2) :Multiple trauma with thoracic injury 
Patients admitted with thoracic injuries requiring intensive care therapy for more than 5 
days, with an injury severity score 25 l of more than 25, were enrolled by VAN SAENE 
ET AL 252 in Groningen. 63 patients, who received an oral antibiotic programme of 
polymyxin E, tobramycin, and amphotericin B (administered to the oropharynx as a 
methylcellulose paste to the buccal mucosa, as an enteral solution down the nasogastric 
tube, to the vagina and to any gastrointestinal stomata), parenteral prophylaxis with 
cefotaxime for four days to eliminate potentially pathogenic colonising community-
acquired bacteria, were reported. Colonised or infected wounds were treated with a 
local disinfecting solution which was also used to rinse out peritoneal, pleural or 
mediastinal cavities, where there was colonisation or infection. 
They reported that the oropharynx was free of potentially pathogenic organisms within 
3 days, the alimentary tract within 10 days and that "secondary colonisation was 
virtually prevented in all patients". Only 16% of the patients developed infections, 
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which were largely of the lower airways, compared with the previously observed 81 % 
infection rate in the same unit, obtained by retrospective analysis 14. 
The episodes of infection were all "primary endogenous infections" caused by 
organisms that the patients were carrying on admission to the ICU, half being 
community-acquired, the remainder Enrerobacteriaceae or Pseudomonaceae. 
Cefotaxime cured all these infections easily, which is remarkable in view of the fact 
that 2 of the patients had Staphylococcus epidermidis septicaemias and three were 
reported to have lower airway infections due to Sraphylococcus aureus. The resistance 
to the antibiotics used was reported to be low - less than 3 % for pol ymxin E (including 
Proteus spp), less than 1 % for tobramycin, and less than 4% for cefotaxime; since the 
implementation of the oral decontamination regimen, no outbreaks of multi-resistant 
organisms had been encountered. 
While these results are most encouraging, there are several problems with the 
interpretation of this study, because it is uncontrolled and unblinded. The definitions of 
infection were not specified, which makes interpretation difficult, particularly when 
comparing results with a retrospectively calculated rate of infection of 81 % , which 
would seem to be inordinately high. No time limits, for the study or the gathering of 
data for antibiotic resistance profiles, are specified, so that it is difficult to assess 
whether antibiotic resistance might still have developed. 
3) The Surgical ICU 
KERVER ET AL 253 from Utrecht, reported a prospective randomised study of 96 
patients admitted to their surgical ICU, who required mechanical ventilation and 
hospitalisation, within the ICU, for more than 5 days. Approximately 25 % were 
trauma patients, 25 % non-elective abdominal surgery, the remainder being admitted 
following vascular, thoracic and elective abdominal surgery. The patients were 
randomly allocated to a control or study group who received oropharyngeal and enteral 
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decontamination with polymyxin E, tobramycin and amphotericin B, as well as 
parenteral prophylaxis in the form of cefotaxime for 5 days. This regimen was 
discontinued as soon as the cultures of the oropharynx and trachea revealed no 
microorganisms. The two groups were fully comparable in terms of age, sex 
distribution, and APACHE II score (15.1 control versus 14.6); however, the average 
duration of stay in the control group was not significantly prolonged at 20.1 versus 
14.6 days. This study again found that colonisation of the oropharynx, respiratory and 
digestive tracts was reduced by the use of this regimen, while colonisation by Gram 
negative bacilli, which started at 30% in both groups increased throughout the duration 
of stay in those in the control group (51 % at day 7 in the control versus 2 % in the 
study patients). There were 107 infections in the 47 patients in the control group 
compared with 42 in the 49 in the study group and infections due to Gram negative 
bacilli were significantly reduced in the study group. The mortality due to secondary 
infection was significantly less in the study group. 
The criteria used for diagnosis of infection included a number of features of multiple 
organ dysfunction, of which 3 were required for the diagnosis; however, the localising 
signs for the site of infection were not clearly specified for the respiratory tract where 
lower respiratory tract infection was diagnosed from "clinical and x-ray findings of 
pulmonary infiltration". 
The incidence of secondary infection rn this study was extremely high: 81 % in the 
control group compared with 39 % in the study group. The incidence of secondary 
lower respiratory tract infections was significantly lower in the study group where only 
6 infections occurred in comparison with 40 in the 47 controls. A significant 
reduction in infection was also encountered with catheter related infections, and 
intra-abdominal infections; however, the incidence of urinary tract infections, 
phlebitis and wound infections was similar in both groups. Bacteraemias were 
significantly reduced rn the 
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study patients, and occurred in 30% of the study patients compared with 57% of the 
control group. 
The spectrum of pathogens causing the infections differed significantly between the two 
groups: 40 infections (37%) in the control group were due to 75 isolates of Gram 
negative bacteria, compared with only 6 infections caused by 8 isolates in the study 
group. The organisms most commonly isolated were Pselldomonas spp (17 vs 3), 
Enterobacter (11 vs 1), Escherichia coli (9 vs 0), Klebsiella spp (9 vs 1) and 
Acin.erobacrer spp and Haemophillls infl11e11:.ae which caused l infection each in the 
study group. 
There were 45 infections (42 % ) due to Gram positive infections in the control group 
compared with 28 (67%) in the study group. Sraphylococcus epidennidis being the 
most common Gram positive organism in both groups. The effect of the 
decontamination regimen on the possible emergence of multiply resistant bacteria was 
not studied. 
The number of antibiotic units administered parenterally to the control patients was 
1407 compared with 1352 in the study patients. but whether this included the 
prophylactic cefotaxime is not specified. -+O of the 47 patients in the control group were 
treated with parenteral antibiotics on admission to the ICU as part of a short 
prophylactic or therapeutic regimen, although the number of patients infected on 
admission was not significantly higher in the control group ( 51 % versus 69% in the 
study group). There was "no statistically significant difference in the use of parenteral 
antibiotics on admission" - a fact which is not surprising considering that part of the 
SDD regimen was the use of a parenteral agent for 5 days following admission. The 
effect on the colonisation rate by this extensive usage of antibiotics at admission is 
uncertain, however, the authors had previous! y demonstrated to their satisfaction that 
colonisation with Pseudomonaceae and £11rerohacreriaceae could not be prevented by 
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parenteral antibiotics, and they use this fact to ascribe all benefit in the reduction in 
colonisation in the SDD group to the topical, enteral, decontamination regimen. 
The overall mortality in the control group was 32 % and in the study group 28.5 % . 
Without specifying the means used to decide how death was attributed to secondary 
infection, the authors ascribed 8 of the 15 deaths in the control group to secondary 
infection, compared with only 2 of the 14 in the study group. 
This study satisfies criticisms levelled against other studies in that the control patients 
were concurrent. The reduction in colonisation of the gastrointestinal tract and trachea 
is impressive and, although in an unblinded study there is always the potential for bias 
in the interpretation of results, the more than 50% reduction in the incidence of 
secondary infection, even with a non-specific definition of lower respiratory tract 
infection, is convincing. The incidence of secondary infection , even with the use of 
selective decontamination is still far too high and raises the question as to how 
stringently the diagnostic criteria were applied, or what the hygienic standards in this 
unit must be. An incidence of secondary infection of 39 % after the successful 
introduction of a prophylactic regimen , m addition to perioperative antimicrobial 
prophylaxis, should surely be dealt with by the urgent development of an infection 
control team , and other techniques besides the use of still more antibiotics, to address 
the root cause of an extremely large problem. 
The reduction in mortality due to secondary infection however, possibly needs to be 
defined more carefully, as this is one of the few studies which has reported this type of 
benefit from SDD, and the evidence for this is not convincing with the limited data 
provided. 
Kerver et al 35 had previously published a prospective analysis of the incidence of 
colonisation and infection in 39 patients admitted to their surgical ICU. The incidence 
was similar to that in their study of selective decontamination, with 74 % of the patients 
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developing secondary infection: 66.6% developed nosocomial pneumonia, 28.2 % 
developed catheter-related bacteraemia, 17. 9 % wound infections. Again the infection 
rate in these patients is unlike any other studies reported where there was no underlying 
motive to demonstrate the efficacy of a new technique or drug (cf Donowitz et al 162 
where the highest incidence of wound infection in any subgroup of surgical patients in 
the ICU was 9 % ) . This enormous discrepancy in the incidence of secondary infection is 
neither addressed nor explained in either of their studies. 
PuGIN ET AL 142 from Geneva, performed a randomised, placebo-controlled, double 
blind study of oropharyngeal decontamination without systemic prophylaxis, in their 
surgical ICU, to assess the efficacy of the regimen in preventing ventilator-associated 
pneumonia. 79 patients were randomised, but 27 were withdrawn because the duration 
of intubation was less than 48 hours. The regimen evaluated comprised oropharyngeal 
polymyxin B, neomycin and vancomycin. or placebo. which were administered 6 times 
daily to the oropharynx in 52 evaluable patients. The patients were assessed as being at 
high risk of acquiring ventilator associated pneumonia because of their requirement for 
prolonged ventilation; the average duration of ventilation was from 3 to 34 days (mean 
10 days). Patients who had received organ transplantation were excluded from the 
study. 
They demonstrated a significant reduction in the incidence of tracheobronchial 
colonisation by Gram negative bacteria and Scaphylococcus aureus. The incidence of 
pneumonia was also significantly reduced (16% vs 78 % p < 0.0001) in the first 12 
days of ventilation. This was attributed to interruption of the "stomach to trachea" route 
of colonisation. 
The definitions of pulmonary infection used in this study were still unsatisfactory, 
although more comprehensively reliable than many of the other studies reviewed. A 
scoring system was applied with a range from O - 12, ventilator associated pneumonia 
being_ diagnosed on a score· of 7 or greater for 3 or more days. However, using this 
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scoring system it would still be possible to diagnose pneumonia, either without any 
septic focus, or without the lungs being the site of sepsis, in a colonised patient. 
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In patients not receiving intravenous antimicrobial prophylaxis, the incidence of 
ventilator-associated pneumonia was significantly higher in the placebo group (11 of 12 
vs 2 of 11 patients, p < 0.0017). Aerobic Gram negative bacilli were isolated in 92 % of 
the 25 cases of pneumonia and in 28 % there were associated Gram positive cocci. The 
organisms causing "early" pneumonia differed from the late onset pneumonias, 
resembling more closely the organisms associated with community-acquired infections. 
The 25 patients who received the decontamination , and the 27 placebo patients were 
fully comparable in terms of age, sex, APACHE II (15.8 vs 14.7), duration of ICU 
stay (12.8 days vs 14.7), days of study (11.8 vs 13.9), days of ventilation (9.6 vs 
10.7), antacid therapy, and mortality (28% vs 26%). Two patients had to be withdrawn 
from the study because of heavy colonisation by yeasts, (one developed oral 
candidiasis, another candidaemia) but they both received placebo. There was no 
difference between the two groups in the number of patients receiving, and the duration 
of, antibiotic prophylaxis, although systemic antibiotics were prescribed less frequently 
in those who received the decontamination regimen. 
15 identical strains of aerobic Gram negative bacilli were found first in the stomach and 
subsequently in the trachea, and 8 of these were later implicated in cases of pneumonia. 
Three strains of Klebsiella spp were first found in the trachea. The route of colonisation 
by Staphylococcus aureus was found to differ from that of aerobic Gram negative 
bacteria, in that colonisation of the trachea occurred as the primary event; colonisation 
of the stomach by this organism was not demonstrated at all. The route of colonisation 
of yeasts resembled that of the Gram negative bacilli , and the rate of colonisation was 
higher in those who received the active regimen. The rate of colonisation by yeasts was 
sufficiently high for the authors to recommend the inclusion of oral nystatin, in the 
future use of their regimen. 
Parenteral antimicrobial prophylaxis was not routinely used in this study and in both 
groups only 56% received specific IV antibiotics. The incidence of early-onset 
pneumonia was decreased by the active oropharyngeal decontamination regimen alone. 
The authors felt that cefotaxime, which has been the most commonly utilised antibiotic 
in decontamination regimens, was not suitable for routine use, because different 
antibiotics were indicated for different conditions, and the spectrum of activity against 
Gram positive and anaerobic organisms with this agent is limited. They also felt that 
the use of a parenteral agent had not been convincingly proven to be an effective 
component in decontamination regimens, and also that the optimal period for such 
prophylaxis had not been established. A strict antibiotic policy which reduced the total 
use of parenteral antibiotics to a minimum was advocated as the best way of preventing 
superinfections due to resistant strains. No new antibiotic resistance or cross-infections 
between patients of the study population, or other ICU patients were detected for the 
duration of the study, which was only conducted over a seven and a half month period. 
The causes of death were similar, with 7 patients dying in each group: 3 active and 5 
control patients from sepsis and multiple organ failure , 2 active and 1 control from 
ARDS and multiple organ failure, 1 in each group from cerebral failure and one patient 
in the active group from cardiac failure. While the mortality for patients with similar 
severity of illness in the ICU is generally estimated to be between 30 and 40 % , the 
mortality rates in this study were similar for both groups at 28 % . The numbers of 
patients in this study are too small for a significant reduction to have been expected, as 
the authors estimated that 376 patients would have been required in each limb to have 
an 80% chance of seeing a 10% reduction. 
This study is unfortunately too small , and was conducted over too short a period, to 
provide conclusive results on the benefits and disadvantages of selective 
decontamination. Although the reduction in colonisation and ventilator-associated 
pneumonia is extremely impressive, an incidence of 78 % in those who received the 
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control regimen is surprisingly high , particularly when compared with the incidence of 
secondary infection previous! y reported from this centre in Daschner' s meta-anal yis of 
nosocomial infection in Europe 9. It is nonetheless interesting to note that such benefit 
could be achieved without decontaminating all patients in the ICU simultaneously, 
which is so vigorously advocated by Ledingham, van Saene and Kerver. 
HARTENAUER ET AL 254 performed a prospective, consecutive, non-randomised, cross-
over controlled study in two surgical ICUs in their hospital in Munster, Germany. The 
methodology of this study was extremely complex; patients in each unit who were 
expected to require intubation for ~ 3 days and to remain in the ICU for ~ 5 days 
were included. In this way 200 patients were enrolled. The study was deliberately 
designed to prevent a carry-over effect frorri altering the entire microbial flora, and thus 
masking the effect of the decontamination regimen. In the first unit, 50 suitable patients 
received the decontamination regimen during the first 6 months, while a further 61 
received a control paste and suspension over the subsequent 6 months to ensure 
identical nursing care procedures. In the second unit, there were 49 patients who 
comprised the control group in the first 6 months, followed by 40 patients who were 
given the decontamination regimen over the ensuing 6 months. All patients were given 
cefotaxime for the first 4 days of their hospital stay. The oropharyngeal and enteral 
decontamination regimen comprised a paste and suspension of polymyxin E, 
tobramycin and amphotericin B. All patients in this study received stress ulcer 
prophylaxis with cimetidine and pirenzipine; patients with head injuries received 
triamcinolone. 
Colonisation with Gram negative bacilli was significantly reduced with the SDD; 
aerobic Gram negative bacilli accounted for 18. 9 % of the surveillance strains isolated 
in the test group, compared with 35.6% in the control group. The differences between 
the two groups were especially pronounced for tracheobronchial and oropharyngeal 
samples, and in the period from day 4 to day 14. 
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The definitions of infection were clinically based. Bronchopulmonary infection was 
diagnosed by the finding of a new infiltrate on the chest radiograph, purulent 
tracheobronchial secretions, and one of the following: positive physical signs, hyper or 
hypothermia, leukocytosis or leukopaenia, and a decrease in arterial partial oxygen 
pressure. Such a definition could once again be criticised for excluding bronchial 
infections which would not be evident on the radiograph, and for being too broad so 
that non-infective conditions could be mis-diagnosed as infection. No attempt was made 
to distinguish between primary and secondary infections in this study, which makes 
interpretation and extrapolation of the data more difficult. 
The patients in the control and test limbs were comparable m terms of age, sex, 
duration of stay. duration of mechanical ventilation and severity of illness scores. 
The incidence of lower respiratory tract infec tions was significantly (p < .001) reduced 
from 45% to 10% in both units. with 46 episodes due to 65 organisms occurring in the 
control group compared with only IO episodes due to 10 organisms in the test group. 
No episodes of bronchopulmonary infection in the test group were caused by aerobic 
Gram negative bacilli, compared with 75 % in the control group. The pathogens 
responsible for the episodes of bronchopulmonary infection in the test group were: 
Staphylococcus aureus (3), coagulase negative staphylococci (2), Legionella 
pneumophila (4) and Candida a/bicans (I), this patient was colonised by Candida in 
the oropharynx , trachea and gastrointestinal tract before admission to the study, had 
repeated postoperative haemorrhages and died of multiple organ failure). 
The incidence of urinary tract inr·ections was reduced in the study patients from 16.4% 
to 10% in the one unit. and significantly from 35 % to 8.2 % in the other. The incidence 
of infections caused by Gram negative bacilli was greatly reduced in the test patients. 
The incidence of septicaemias. wound infections and catheter related infections did not 
differ between the two groups. and there were three cases of Candida albicans 
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septicaemia in the test group which were considered to be failures of the 
decontamination regimen. 
There was no significant difference in mortality between the two groups ( 47 .5 % control 
vs 38% test, and 42.5% vs 30.6%). There were apparently fewer patients suffering 
from bronchopulmonary infections in the test group at the time of death, but, 
considering the small number of respiratory infections diagnosed, this must have been 
the case for the entire duration of ICU admission. The mortality rate is high in this 
study, APACHE II scores are not provided, but the acute physiology scores and ISS 
values are extremely high (APS 9-10 , and ISS 39). The authors raise the question as to 
whether infection really is a contributor to mortality. 
Surveillance samples were monitored for the development of antibiotic resistance, 
particularly aerobic Gram negative bacterial resistance to polymyxin E and tobramycin. 
Specimens taken on admission and 1 week later showed similar sensitivity patterns and 
for the one year period of the trial, no emergence of resistance of aerobic Gram 
negative bacilli to polymyxin or tobramycin was detected. Resistance-pattern analysis 
for oxacillin, cefotaxime and tobramycin was used to investigate whether the number of 
multi-resistant coagulase negative staphylococci increased with the prophylactic 
regimen. 24.3 % were found to be resistant to all three antibiotics, and a bacteria-
related comparison between test and control groups showed significantly (p < 0.001) 
greater numbers of resistant coagulase negative staphylococci in the test group, 
although when copy strains (isolates from the same patient with the same sensitivity 
profile on different occasions) were eliminated from the analysis, the distribution of 
coagulase negative, resistant staphylococci was equal in all groups, and there was no 
overall increase. 
AITCHISON, VAN DEN ENDE, VAN RENSBURG AND OPPERMAN from the University of 
Natal , reported their experience with SPEAR in a surgical ICU (poster, ICC , Berlin, 
1991). This was a prospective, consecuti_ve study in which 50 control patients who met 
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enrollment criteria of endotracheal intubation for more than 4 days and duration of ICU 
stay of > 5 days were conventionally managed, the following 50 patients were treated 
with a regimen of oropharyngeal and enteral decontamination using tobramycin, 
polymyxin E and amphotericin B, and systemic cefotaxime for the first 4 days 
following admission. 
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The patients in both limbs were fully comparable in terms of age, sex, number of 
patients with organ system failure (48 in each group), the number admitted following 
trauma (30 in each group), the ISS was 30...+ in the SPEAR group compared with 25.4 
in the control, the APACHE II score was 19 in both groups. 
Pneumonia was defined as the clinical manifestation of sepsis with purulent sputum, 
containing pus cells and a new radiological infiltrate. 
Microbiological surveillance samples showed initially high rates of colonisation (60-
70 % ) with AGNB in both groups , which declined in the trachea and stomach in those 
who received SDD, although the rectal colonisation remained unaltered. 
The overall incidence of pneumonia was statistically reduced in the patients who 
received SPEAR: 30% vs 66%. The incidence of pneumonia occurring after 4 days was 
24.4% in the SPEAR group, compared with a significantly higher 65% in the control 
group, although the incidence of pneumonia occurring after 21 days was a similar 30% 
in both groups. While aerobic Gram negative bacilli were implicated in 96 % of 
pneumonias occurring in the control group. only 53 % of episodes in the SPEAR group 
were due to these organisms; however. the incidence of both colonisation and infection 
due to oxacillin-resistant Staphylococcus aureus increased in the patients who receive 
SPEAR, and 53 % of pneumonias in this group were caused by this organism compared 
with only 13.6% in the control group. The incidence of vascular catheter related sepsis 
was also reduced in the SPEAR group: 6 % vs 22 % . There was no effect on duration of 
stay or mortality, even with subgroup analysis ( 48 % SPEAR vs 52 % control). 
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The definitions and the use of a historical control group make the interpretation of this 
study difficult. It is noteworthy that in spite of the use of this regimen, there was no 
effect on mortality. The high incidence of infection in both groups was clearly reduced 
by the use of SPEAR, which seems to have had an influence on colonisation patterns. 
The rapid emergence of resistant staphylococci with the use of SPEAR is of concern, 
but unfortunately no further data on its possible effect on the resistance patterns of 
other organisms is provided. 
CERRA ET AL 255 reported a prospective double-blind , placebo controlled study of 
selective decontamination using enteral norfloxacin and nystatin in forty-six patients in 
their surgical ICU in Minnesota, to assess whether this technique was able to reduce the 
incidence of nosocomial infection and produce an associated reduction in the incidecne 
of adult respiratory distress syndrome. Criteria for inclusion in the study were that the 
regimen should be initiated within 48 hours of ICU admission, that the patient should 
have an anticipated duration of ICU stay of more than 5 days, and that the patients 
should be hypermetabolic, but without evidence of progressive multiple organ failure. 
The active and placebo groups were fully comparable for age , sex, liver and renal 
function indices on admission; their durations of ICU admission were also similar (18 
± 3 days in the active vs 20 ± 4 days in the placebo group). 
Broad definitions of nosocomial infection were used, however, the double blind nature 
of the study would have eliminated potential bias in the diagnosis of infection. There 
were 22 infections in 12 of the 25 patients in the active group compared with 42 
infections (p =0.0002) in 15 of the 21 patients in the placebo group. There was a 
reduction in the incidence of both nosocomial pneumonias (14 vs 23 p = 0.025) and 
bacteraemias (5 vs 12 p = 0.025) in the patients who received the active regimen, for 
all classes of microorganisms; however, the distribution of nosocomial organism types 
and infections were similar in both groups (8 in the active vs 16 placebo Gram positive 
infections, 8 vs 13 Gram negative infections and 6 vs 13 fungal infections). 
The authors comment that there was no emergence of any resistant organisms detected 
during the study, but the exact duration over which the study was conducted is not 
specified, so that the potential for such drug-resistance to emerge or be detected is 
uncertain. The results of surveillance cultures were not provided other than stool 
cultures which did show some reduction in aerobic Gram negtive bacillary load, 
although no effect on Candida spp was demonstrated. 
The 47% reduction in the incidence of nosocomial infection was not accompanied by a 
reduction in mortality, nor was there a significant reduction in the incidence of multiple 
organ failure or ARDS. The APACHE II score and other indices of severity of illness 
were not provided, making extrapolation to other studies difficult. 
Unfortunately, the small number of patients in this study, the excessively high 
incidence of secondary infection and the use of a less standard regimen make the 
interpretation of these results difficult. 
4) Special High Risk Groups 
a) Liver Transplantation 
Gram negative and Candida! infections have been noted to occur in up to 50% of 
patients undergoing liver transplantation. The source of such infections is thought to 
relate most frequently to the flora colonising the gastrointestinal tract. The use of 
selective decontamination, which has been shown to reduce the incidence of secondary 
infection in patients with multiple trauma, cirrhosis, and leukaemia by eliminating this 
potential reservoir of pathogens, might well also be expected to be of benefit in this 
group of patients. 
WIESNER 256, while acknowledging the flaws in their trial , reported the satisfactory 
experience of his group at the Mayo Clinic with this technique in an uncontrolled, 
unblinded study, in which 145 patients undergoing orthotopic liver transplantation were 
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enrolled. The selective decontamination regimen used included polymyxin E, 
gentamicin and nystatin, in a suspension that was administered four times a day. This 
regimen was commenced three days before the liver transplant, and on the day of the 
transplant systemic prophylactic antibiotic therapy including cefotaxime and tobramycin 
were given for 48 hours. Postoperatively, the enteral decontamination was continued 
and oropharyngeal decontamination was also performed while the patient required 
mechanical ventilation. 
Wiesner reported in this study that the incidence of Gram negative bacterial and 
Candidal infections encountered early after liver transplantation was very low, with 
only 42 major infections occurring in 37 patients; Gram negative organisms were only 
cultured from five of these patients. There was only one patient who developed 
systemic Candidiasis. The infections included 26 primary bacteraemias, 10 
bacteraemias associated with another infectious site, 10 intra-abdominal abscesses, 5 
hepatic abscesses, 5 cases of peritonitis, 5 episodes of pneumonia, and 1 episode of 
meningitis. Five deaths were associated with sepsis. three of which were bacterial, but 
only one was Gram negative, and two deaths were due to fungal sepsis. Because the 
SDD regimen does not cover Gram positive infections to any great extent, infection 
with Staphylococcus coagulase negative strains and Srrepwcoccus group D strains 
emerged as important pathogens; however, without quoting other sources, the author 
seems satisfied that the incidence was similar to that of other studies in this group of 
patients, where SDD is not used. 
b) Acute Hepatic Failure 
Several features of acute liver failure and its management can account for the high 
incidence of infection associated with this condition, including impaired cell-mediated 
and humoral immunity. Bacterial and fungal infections, in particular, are common 
complications of acute hepatic failure, and contribute significantly to morbidity and 
mortality. In recent studies 257,258, bacterial infection was reported in 80% of patients 
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and 32 % of these had concurrent fungal infections. Infection contributes to early 
mortality and late infection is responsible for death in up to 20 % , so that much of the 
great effort and cost invested in the successful early treatment of these patients, is 
negated by the complication of late infections. 
WILLIAMS and his group from King's College Hospital , London , (unpublished data: 
First European Consensus Conference of Intensive Care Medicine, December 1991) 
conducted a prospective, open controlled randomised study to evaluate the efficacy of 
selective parenteral and enteral decontamination (SPEAR) in the prophylaxis of 
secondary infections in 84 patients admitted with acute liver failure to their liver centre 
from November 1990 to May 1991. 
All patients admitted with liver failure , with greater than grade II coma and staying in 
the unit for more than two days were included , although patients already receiving 
antibiotics on admission were excluded. The regimen comprised: Cefuroxime 1.5g 8 
hourly , IV for 5 days , and a suspension of Polymyxin E , Tobramycin and 
Amphotericin B applied four times a day to the oropharynx in a paste, and 
nasogastrically. All patients also had Mupirocin 2 % ointment applied to the anterior 
nares four times a day to eradicate carriage by Staphylococcus aureus, and 
Clotrimazole 10 % vaginal cream was applied on admission to all female patients. 
Patients were allocated to one of two groups on admission: an infected group who were 
randomised to receive SPEAR (group 1), or IV antibiotics alone (group 2); or a non-
infected group who were randomised to receive SPEAR (group 3) or no antibiotic until 
clinically indicated (group 4). 
Of the 84 patients, 23 reached a coma gra_de III, and 61 a coma grade IV. The acute 
liver failure was due to paracetamol in 57 patients , virus related in 19 and due to other 
causes in 8. Renal failure developed in 42 % . There were 43 deaths (51 % ), and 49 % of 
these were related to sepsis. Although death due to sepsis was less frequent in those 
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who received SPEAR (7 deaths) than in those who did not (14 deaths), the difference 
did not achieve statistical significance. 
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In the infected group: 17 patients in Group 1, and 17 patients in Group II, there was no 
difference in the number of episodes of infection that occurred , 15 in each group. 
However, in the non-infected group, there was a significant difference in the number of 
infection episodes: 13 in the 23 patients in Group III and 28 in the 27 patients in Group 
IV (p < 0.004), including a significant difference between early ( < 3 days) and late 
infections (late > 4 days): none in Group III and 9 in Group IV. There were no 
bacteraemias in Group III and five in Group IV which was also statistically significant; 
chest infections occurred in 2 patients in Group III and 10 in Group IV, which was also 
significant. There was a significant difference in the incidence of fungal infections in 
the groups receiving SPEAR compared with the other groups. Emergence of drug 
resistance during the trial period was not observed. 
The study would thus seem to provide convincing evidence of the efficacy of the 
regimen in reducing the incidence of secondary infection in this high risk population. 
However, when the numbers in the various groups are broken down , the size of the 
study becomes so small, that it loses much of its significance. Furthermore, the 
evidence would suggest that apart from the impact on fungal infections, cefuroxime is 
probably as efficacious as the entire SPEAR regimen. 
c) Oesophageal Resection for Carcinoma 
TETTEROO ET AL 2S9-26l prospectively randomised 181 patients, undergoing elective 
thoracic surgery for resection of carcinoma of the oesophagus , into those who received 
conventional therapy with perioperative antibiotic prophylaxis alone, and those who 
were treated , in addition , with selective decontamination (using a similar regimen to 
van Saene applied to the oropharynx , stomach and parenterally). The rate of infection 
prior to the trial , in a retrospectively selected cohort of patients without distant 
metastases (using perioperative antimicrobial prophylaxis with cefamandole and 
metronidazole) , was found to be: 21 % for pneumonia, 5 % for urinary tract infections, 
7% for septicaemias, with a mortality of 5 % . 
67 patients were excluded, either because oesophageal resection was not performed or 
because of non-compliance with the regimen; eventually 114 patients were included in 
the study. The selective decontamination was commenced on the day of hospital 
admission and continued until day 10. Once again no defi nitions for site specific 
infection are provided; however, the authors felt able to report both a significant 
reduction in colonisation by aerobic Gram negative bacilli and the number of secondary 
(acquired > 48 hours after admission) postoperative respiratory infections due to these 
organisms, in those who received SDD (51 infections in 32/56 controls versus 18 
infections in 12/56 in the test group). This benefit was only sustained in those who 
remained in the ICU for less than four days. 
The organisms causing the infections were largely endogenous in both groups (83 % test 
group, 73% controls). In the control group 54% of infections were due to aerobic 
Gram negative bacilli (Pseudomonas spp , Proreus spp , Klebsiella spp , Enterobacter 
spp, Acinetobacter spp. Citrobacrer spp and Escherichia coli), 41 % were Gram positive 
cocci (Staphylococcus aureus, epidem1idis, and Enterococcus). 5 % being due to Gram 
negative diplococci (Neisseria spp and Branhamella spp). In the test patients, aerobic 
Gram negative bacilli accounted for only 15 % of infections and the Gram positive cocci 
85 % . Following discontinuation of the SDD regimen , there were a further 12 infections 
in 4 patients in the test group , including 3 respiratory tract infections. and half of these 
infections were Gram negative or mixed. 
In the 26 patients who stayed in the ICU for more than 4 days, the reduction in 
infectious complications and the number of respiratory infections in those receiving 
SDD was not significant. The number of urinary tract infections was similar in both 
groups, which they attributed to instrumentation of the urinary tract. There was no 
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difference in duration of ICU stay in those who received conventional therapy versus 
those who received SDD, and the mortality was also unaffected. 
While this study again showed benefit in the reduction of predominantly respiratory 
tract infections with the use of SDD, there are again limitations with the interpretation: 
the study was not blinded, the definitions of infection were not carefully specified and 
the benefit was only for a circumscribed period of four days in the ICU. As most 
studies on nosocomial infection in the ICU only assess the prevention of infections that 
occurred after 3 to 5 days , because infections prior to that may have been already 
incubating and SDD regimens may not yet have fully taken effect, the benefits shown 
in this study really only amount to a more effective perioperative antibiotic prophylactic 
regimen. 
d) Multiple Organ Failure: Combined Acute Renal and Respiratory Failure 
McCLELLA,'oiD ET AL 262 assessed the efficacy of selective decontamination m 15 
patients with severe combined acute renal and respiratory failure , who required both 
mechanical ventilation and renal replacement therapy for at least 5 days. They 
compared the efficacy of a standard decontamination regimen using polymyxin E, 
tobramycin, and arnphotericin B and systemic cefotaxime, with a control group of 
patients gathered retrospectively from the preceding 12 months with approximately 
matched severity of illness scores. The average APACHE II score in the SDD group 
was 21 + 6 while in the control group it was 16 ± 5, with similar sepsis scores of 14 
and 15. While 83 % of the control population developed definable infections, the 
incidence was only 33 % in the SDD group, which was just statistically significant; the 
incidence of respiratory tract infections was reduced most with only 1 patient in the 
SDD group developing an infection at this site. compared with five in the control 
group. The incidence of urinary tract infections was lower in the SDD group ( 13 % vs 
50% ), although this did not achieve statistical significance. The incidence of wound 
infections, bacteraemias and other types of infection was identical in both groups. 
269 
270 
The organisms causing the infections were different, with Gram negative bacteria and 
fungi again causing significantly more infections in the control group. They found that 
yeasts were the commonest organisms to be isolated in both groups. Coagulase negative 
staphylococci appeared more frequently in the patients treated with SDD, colonising 
40% of patients at some time, compared with 25% of the controls. These organisms 
were observed to colonise the respiratory tract in four patients and the abdominal 
wounds of two others receiving SDD. The authors rightly comment on the concern that 
this arouses in a group at high risk of staphylococcal septicaemia, because of the use of 
IV dialysis cannulas and intra-cardiac catheters. 
In spite of the reduction in infection with the use of SDD, the mortality in the two 
groups was virtually identical: 42 % in the control versus 40% in the SDD group. The 
authors nevertheless felt that, irrespective of which group the patients belonged to, the 
mortality was causally related to infection: 73 % of the patients with definite infections 
died, compared with 42 % of those who had no infections. This was not of statistical 
significance. 
There are a number of problems with the interpretation of this study. Firstly, the 
number of patients studied is too small , as there were only 7 of 15 patients with 
infection in the SDD group, compared with 17 infections in only 12 patients in the 
control group. The use of a historical control group and the unblinded , uncontrolled 
nature of the study further detract from these results. The definitions of infection 
provided are extremely inadequate (respiratory infection: purulent tracheal aspirate with 
a dense growth on bacteriological culture), so that the reported reduction in infections 
is, in fact, uninterpretable. The authors reference their definitions to papers by 
Stoutenbeek et al, but unfortunately the definitions used there were also unsatisfactory. 
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e) Patients with Burns 
MACKIE, VAN HERTUM, SCHUMBERG ET AL from the Netherlands reported their 
experience with selective decontamination in patients with burns (poster presented at 
the ICC, Berlin, 1991). 31 consecutive patients with > 30% body surface area burns 
or inhalational burns were treated with intravenous cefotaxime for the initial 4 days and 
SDD, using oral tobramycin, amphotericin B and polymyxin E, as well as a paste 
which was applied to the buccal cavity in those with inhalational burns. These patients 
were compared with a historical control group of 33 patients with similar severity of 
burns, who had been treated conventionally . Patients who were admitted more than 24 
hours after the burns , or who died within 24 hours of the burns, were excluded from 
both groups. All patients were treated in single bed isolation areas with strict barrier 
nursing. 
Both groups were comparable in terms of age , sex, mean percent of body surface area 
of burn (control:43.9, SDD: 45 .6) , mean percent full-thickness burn (control:23.5, 
SDD:20. 7), and inhalational injury (control: 14 , SDD: 10). 
The definition of respiratory tract infection was: physical signs on auscultation, 
concurrent fever > 38.5 C, purulent sputum, new infiltrate on chest x-ray, and positive 
sputum culture. Colonisation was defined as the identification of potentially pathogenic 
microorganisms from any bacteriological culture. 
The authors reported a marked reduction in colonisation by Gram negative bacilli in the 
SDD patients. Pseudomonas aeruginosa was virtually eradicated from gastric, faecal 
and urine cultures and the Enrerobacreriaceae were virtually eliminated by the second 
week. There was however an increase in gastric colonisation with Staphylococcus 
aureus and yeasts. The colonisation of the wounds by Gram negative bacilli was also 
reduced, although the wounds of 9 of the 31 patients treated with SDD became 
colonised by Pseudomonas aeruginosa. 
The incidence of infections was lower in the SDD treated patients: respiratory tract 
infections occurred in 6.5% compared with 27.3%; septicaemias in 3.2% vs 24.2%. 
Although the data was not provided, the reduction in respiratory infections was 
particularly marked in the patients with inhalational injury. The authors comment that 
they were impressed by the general well-being of the patients who received SDD. The 
use of antibiotic therapy was less with 48.4 % requiring intravenous antibiotics in 
addition to SDD, compared with 78. 8 % in the control group. While the duration in 
ICU and the duration in hospital were identical in both groups, the mortality was 
significantly lower in the SDD group: 3.2% vs 21.2%. 
While the reports on the effects of selective decontamination in this study on a specific 
high risk subgroup are most encouraging, they must be interpreted with a certain 
amount of caution, because of the small size of the study population, the use of an 
historical control group, and the inadequate definitions of colonisation and infection. 
The significant difference in mortality between the two groups is striking and further 
study in burns patients with such a technique is clearly warranted, although the 
emergence of Staphylococcal infections and colonisation which may be promoted by 
such a regimen, might possibly suggest that alternative agents might be better suited to 
a population such as this. 
0 The Immunocompromised Patient 
GUIOT ET AL 13 from Leiden, Holland. m 1981 reported a study of "selective 
antimicrobial modulation of human microbial flora". This study was performed in 39 
granulocytopaenic patients ( < 100 granulocytes/ml, associated with bone marrow 
failure), admitted to the isolation ward of their hospital for more than 7 days, because 
of their high risk of infection. 14 patients also with bone marrow failure, who were 
admitted to the hospital, but could not be accommodated in special isolation areas, and 
received only conventional therapy, were used as a control group. 
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Therapy for the underlying haematological disorders included: vincristine, doxorubicin 
and cytarabine in 15 patients as remission-induction therapy for acute myeloid 
leukaemia, and 11 patients underwent bone marrow transplantation for acute myeloid 
leukaemia, acute lymphocytic leukaemia or severe aplastic anaemia. 13 patients with 
aplastic anaemia were treated with anti-thymocyte globulin. In the control group, there 
were 11 patients treated with the same remission induction regimen for acute myeloid 
leukaemia, and 3 patients with aplastic anaemia who received androgens or 
corticosteroids. 
The decontamination regimen used consisted of: a nasopharyngeal spray of gentamicin 
used 4 times daily, an ointment of amphotericin B, neomycin, and polymyxin B applied 
to the oropharynx, and used as a toothpaste, an enteral solution of neomycin, 
amphotericin B, polymyxin B and nalidixic acid given 4 times daily. The skin was 
washed with either povidone-iodine soap or water containing chlorhexidine on alternate 
days and the prepuce or vulvo-vaginal area was treated with a cetyl-based cream 
containing the same compounds used for oropharyngeal decontamination. If there was 
macroscopically persistent Candida albicans in the mouth , a gentian violet solution was 
used. Persistent potential skin pathogens were treated with silver sulfadiazine. 
In 15 patients the complete regimen was not followed for short periods, because of 
nausea during chemotherapy or suspected hypersensitivity to the nalidixic acid. 
The first 6 patients who were given the decontamination regimen were nursed in strict 
protective isolation with sterile food in laminar down-flow isolators, while the isolation 
measures in the subsequent 13 patients were down-graded gradually and in the last 20 
patients, the patients were allowed to leave their isolation areas for short periods, to eat 
food with a low bacterial level and to have limited contact with non-sterilised dry and 
clean articles. The control patients were not nursed with laminar flow and received 
normal hospital food. 
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In both groups of patients, antibiotic therapy was not instituted until "infection was 
seriously suspected or proven". The definitions of site specific infections were not 
specified. 
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7 of the patients admitted to the treatment group, were admitted to the hospital with 
minor infections (clinical infection of skin or mucosae without deep extension), of 
whom 2 died of septicaemia unrelated to the site of admission infection. 5 patients were 
admitted with major infections (pneumonia or pyelonephritis) and two died before 
therapy had been started. The hospital acquired infections included 6 localised oral 
infections due to anaerobic flora, and 6 major acquired infections of which 5 started as 
skin infections and one patient died from a combination of infection and bleeding. The 
decontamination regimen was not completely successful in the patients who were 
infected on admission, and there appeared to be a good correlation between patients 
who remained persistently colonised by potentially pathogenic aerobic Gram negative 
bacilli and those who developed major infections. 
In the control population, the patients were older, but their mean duration of 
granulocytopaenia was shorter. There was no difference in the number of minor 
infections, while the incidence of major infections was substantially higher (78 % vs 
36%) in the control group, if patients with acute myeloid leukaemia were compared. 
More fatal infections occurred (35 % vs 19 % ) and it was thought that the number of 
days of fever due to underlying infection was higher. 
This study was performed before selective decontamination had been introduced to the 
ICU, and at a stage when the diagnosis of pneumonia was less refined. The small 
number of patients, the nature of the underlying diseases and associated therapy, the 
poor choice of a control · group (we are not told why it was elected not to treat these 
patients as aggressively as those who were isolated) all make this study unsuitable to 
draw adequate conclusions of the efficacy of an extremely elaborate technique of 
decontamination. 
5) The General (Medical/Respiratory) Intensive Care Unit 
LEDINGHAM ET AL 263 reported a study of selective decontamination (using a standard 
oropharyngeal and enteral regimen of polymxin E, tobramycin and amphotericin E), 
with systemic cefotaxime, in 324 patients. He used an historical control group of 161 
patients and a test group of 163 patients in an unspecialised medico-surgical ICU. The 
diagnostic categories of the patients were : ± 38% post-surgical , 25% medical, 14% 
trauma, 7% drug overdose, 2% shock and 14% sepsis. The two groups were 
comparable in terms of demographic features, diagnostic categories and severity of 
illness. 
Definitions of infection in this study were based on a sconng system. For all 
categories, two temperature spikes of greater than 38.5°c, a white cell count of more 
than 12 000 or less than 4 000 cells/ml , which scored one point each, were used; in 
addition criteria, from the infected system were required. For a respiratory infection, 
additional criteria were purulent sputum, a new pulmonary infiltrate on chest 
radiograph, an increase in the inspired oxygen fraction of 15 % to maintain 
oxygenation; in order to make a diagnosis of respiratory tract infection, three criteria 
out of the potential five just enumerated were required. 
The results of microbiological surveillance samples all showed a similar pattern, with 
aerobic Gram negative bacilli being isolated from gastric aspirate, oropharynx, tracheal 
aspirate in 8-25 % of patients on admission. This proportion increased in the control 
group until the third or fourth day and then remained stable at 30-45 % ; however, in the 
SDD group, the values decreased and stabilised by day four at a value of less than 
10% . The surveillance samples of rectal swabs also showed a marked reduction in the 
SDD, but not in the control group, although 20% of the SOD group remained positive 
at day ten. In both groups less than 5 % of urine samples yielded significant growth of 
Gram negative bacilli. Coliform bacilli were the most common group of aerobic Gram 
negative bacilli to be isolated (80-90 % ) in b~th groups, except tracheal aspirates in the 
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SDD group, where Pseudomonas spp comprised 31 % of the 42 isolates. The isolation 
of yeasts also decreased during the initial four days in the SOD group, but changed 
little with time in the control group. No increase in the incidence of drug resistance to 
the agents used for the regimen was encountered during the use of SDD. 14% of all 
tested clinical isolates of aerobic Gram negative bacilli, Serraria spp and Acinewbacter 
spp were resistant to cefotaxime (excluding Pseudomonas species which was regarded 
as always resistant); 15 % of isolates were resistant to polymyxin E (mostly Proteus 
spp) and 3 % (all Serraria 5pp) weie resistant to tobramycin. 
The incidence of secondary infections in the SOD group was -t.0% of that in the control 
group, with 24% of the control group being classified as infected compared with 10% 
of the SDD group. The number of episodes of infection was 37 in the control group 
and 13 in the SDD group, with 73% and 77% respectively being bacteriologically 
confirmed. The reduction in infection with SOD applied to all categories of infection 
excepting intra-abdominal (where there was only one episode), but was most striking 
for respiratory tract infection. where there was a six-fold reduction. Aerobic Gram 
negative bacilli accounted for 45 % of the isolates in respiratory tract infections in the 
control group, compared with only 17% of all isolates from infected sites in the SDD 
group. While there was no evidence of primary infection predisposing to secondary 
infection in the SDD group , in the control group those who were infected on admission 
had a lower incidence of secondary infection. possibly because they received adequate 
antibiotics. 
The overall mortality in the t\VO groups \vas almost identical: however, when the 
subgroups were analysed separate! y, a statistical I y significant reduction in the mortality 
for multiple trauma patients was seen, although the number of patients in either limb 
was small (6 deaths out of 23 trauma admissions in the control group, compared with 0 
deaths in 18 admissions during SOD). There was also a reduction in the mortality for 
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patients with a duration of stay in excess of 7 days ( 12 /35 in the controls versus 5/39) 
and mid-range APACHE II scores (18/31 versus 12/40). 
The authors acknowledge the difficulties associated with attempting to interpret a 
prospective study using consecutive control and study groups , but argue that concurrent 
controls might have presented still greater difficulty , because the regimens might in 
themselves affect the bacterial ecology of the unit. The marked difference in the results 
of surveillance samples would also have made blinding , if the clinicians had been 
permitted access to these results , impossible. Nonetheless, an unblinded study with 
post-hoc stratification to detect at-risk groups who benefit, is not the ideal way to assess 
the efficacy of a novel therapeutic regimen. The Lancet , which carried the original 
article, also subsequently published an extensive correspondence on the subject (June 
18, 1988 pages 1388-1390) which included similar criticisms of the analysis. 
The authors explained that their results differed from other studies in the overall 
incidence of infections, because they chose to separate primary and secondary 
infection. Part of the problem in evaluating this study and many others is that, although 
differentiating between primary and secondary infections (secondary being defined here 
as developing > 48 hours after admission), the duration of stay before the infection 
occurred is not sufficient! y carefully specified . While it is probable that infections 
occurring after 48 hours might have been due to nosocomial pathogens, a cut-off for 
evaluating the incidence after the SDD regimen had taken effect - in this study after 4 
days - might have provided more convincing evidence that the SDD regimen was 
responsible for this. Indeed , when interpreting the data on mortality , they point out that 
many patients died within the initial three days of admission , and therefore SDD cannot 
be considered to have been a factor. 
UNERTL ET AL 264 in 1987 reported their expenence with a topical regimen of 
decontamination applied to the nose , oropharynx and stomach in longterm ventilated 
patients in their general ICU in Munich, Germany . They conducted a randomised, 
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controlled trial over 7 months in 39 patients : 20 untreated patients were used as a 
control population and 19 patients formed the treatment group who received polymyxin 
B, gentamicin and amphotericin B, administered 6 hourly in a saline solution into the 
nose, oropharynx and enterally. Patients were included if they were intubated within 24 
hours of the onset of acute disease or surgery, were expected to be ventilated for more 
than 6 days, were not infected, receiving systemic antibiotics, did not have ARDS, 
myelosuppression or leukopaenia which might have obscured the diagnosis of 
pneumonia. The maximum period of observation was 14 days following intubation or 
discharge from the ICU, whichever occurred first. 
The patients were comparable in terms of age, sex, underlying disease, severity of 
illness determined by the simplified acute physiology score (mean of 12 in the control 
vs 13 in the SDD group), duration of treatment in the ICU (23 days in the control vs 18 
days) , period of ventilation (11 days in the control vs 16 in the SDD patients) , and 
diagnostic categories on admission. Central nervous system disease was common in 
both groups: there were 10 in each admitted with neurological disease, and 13 in the 
control and 14 in the SDD group had Glasgow coma scales of < 7. 6 patients in the 
control group died and in 5 the primary cause of death was related to neurological 
dysfunction, although at the time of death 3 patients were diagnosed as having 
pneumonia. In the treatment group there were 5 deaths, and 4 of these were also due to 
brain damage, but no patients had respiratory infections present either at or before the 
time of death. As a result of the high proportion of patients with cerebral damage, 17 
patients in the control and 15 in the treatment group were treated with steroids. 
Their choice of agents for the decontamination regimen was made because the 
predominating colonising organism in ventilated patients in the unit had previously been 
found to be Pseudomonas aeruginosa, which was sensitive to at least one of the two 
agents by disc-susceptibility testing: gentamicin covering at least 90% of 
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Staphylococcus aureus and the Enterobacteriaceae and 80% of the Pseudomonas 
aeruginosa isolates. 
The definition of pneumonia was a new "definite" infiltrate on the chest X-ray, together 
with increasing amounts of purulent tracheobronchial secretions, containing > 30 000 
granulocytes / microlitre and at least two further features: new febrile spikes > 
38.5°c, blood leukocyte count > 12 000/ml or < 4 000/ml, decrease of Pa02 
requiring an increase of the Fi02 of at least 0.15 to maintain oxygen tension. The 
infiltrate was considered to be definite if two independent radiologists, unaware of the 
treatment group confirmed the infiltrate which did not reverse after physiotherapy. 
"Febrile purulent tracheobronchitis" was defined by the emergence of purulent 
tracheobronchial secretions containing > 30 000 granulocytes/microlitre, together with 
clinical signs of infection ( new febrile spikes > 38.5°C) and these patients were also 
treated with antibiotics. The presence of a pathogen was used to only to define 
colonisation, but not to distinguish between colonisation and infection. 
Colonisation of the oropharynx by potential respiratory pathogens was observed in 95 % 
of the controls and 32 % of the treated patients, which was a significant difference. 
Enterobacteriaceae and/or Pseudomonas aeruginosa were detected in 85 % of the 
control and 16% of the treated patients. The colonisation patterns for the control 
patients showed an increase during hospitalisation, but declined in the treatment group. 
Similar patterns of colonisation were detected in the tracheobronchial system. 
14 (70%) of the control patients developed respiratory infections including 9 
pneumonias, but only 4 (21 % ) of the treatment group developed respiratory infections, 
including only one episode of pneumonia during the 14 day observation period. The 
respiratory infections in the treatment group were all preceded by colonisation of the 
airway, and in 87% there was also preceding oropharyngeal colonisation. The 
infections in the treatment group were all due to gentamicin-resistant Gram positive 
cocci or yeasts, and Gram negative rods were absent; ~owever, in the control patients, 
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while Gram negative bacilli predominated in 72 % of the isolates, the most common 
pathogen was Staphylococcus aureus. 
Antibiotic therapy was required in 14 (65%) of the controls and 6 (30%) of the SDD 
group which was statistically significant. There was one adverse reaction to the 
prophylactic regimen in the form of moderate diarrhoea, which occurred in 
approximately one third of patients. Pathogens resistant to the agents used in the 
prophylactic regimen occurred in 4 patients in both groups. No comment is made on 
the time relationship of these isolates to the duration of use of the decontamination 
regimen in the unit, or their relationship to each other. 
The small number of highly selected patients and unblinded nature of the study prevent 
conclusions being drawn from it. It is nonetheless of interest, because patients with 
neurological disease have not been reported in other studies 263,:?65 to be a group that 
stand to benefit from the use of selective decontamination, but the authors clearly found 
benefit in this study. 
v Ai"J UFFELEN ET AL Z66 reported the results of a prospective analysis of patients 
requiring longterm admission ( > 10 days of mechanical ventilation) to their general 
ICU in Groningen, Holland who received the same prophylactic regimen as that 
administered to patients in their ICU in the previously reported studies (Stoutenbeek 
and van Saene) 14,243,252, namely oral and enteral polymyxin E, amphotericin B, 
tobramycin and parenteral cefotaxime which, in this study. was administered until the 
oropharyngeal cultures ceased to grow Sraphylococcus aureus, Streptococcus 
pneumoniae, Haemophilus injluenzae and Branhamella catarrhalis. This group 
presumably formed part of the initial study of selective decontamination reported from 
Groningen, as these patients were enrolled in 1983, however, the data was reported 
separately in 1987, and not as a subanalysis. 
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27 patients, 6 of whom were admitted with primary infections, were evaluable (7 
trauma patients, 6 post abdominal surgery, 5 with neurological disease, 3 with chronic 
obstructive lung disease, 2 with adult respiratory distress syndrome and four others 
with Weil's disease, subarachnoid haemorrhage, tetanus and leukaemia). The mean 
duration of ICU stay in these patients was 30 days. 
60% of patients remained free of bacterial colonisation in the oropharynx and trachea 
throughout their ICU stay, while in those who were colonised on admission, the 
aerobic Gram negative bacilli were eliminated from the oropharynx within 3 days, and 
the lower airways were also subsequently cleared. The rectal surveillance swabs 
showed clearing of AGNB within 7 days in 82%, although in the remaining patients, 
colonisation persisted throughout their ICU stays . . 
All the primary infections were cleared by the parenteral cefotaxime, and during the 
one year study period , no nosocomial pneumonias were identified , although the 
definitions of infection are not specified in this paper. 
The study was reported as a pilot study of selective decontamination in this at-risk 
population group. As such , the numbers are too small for conclusions to be derived 
from it; nevertheless it is interesting to note that these authors found this technique of 
value in a population subgroup not demonstrated to benefit in other studies, such as the 
multicentre study reported by Gastinne et al 265. 
In another paper 248 reporting their experience with 27 patients from the same unit, 
van Uffelen et al demonstrated a correlation between the type and load of flora 
colonising the oropharynx and the tracheal flora: once a bacterial species had been 
isolated from the oropharynx in high concentrations. the identical organism was 
isolated in more than 50 % of patients from the trachea. 6 patients were reported to 
have acquired respiratory tract infections involving organisms from the oropharynx. 
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In this study, colonisation was defined as the appearance of any bacterial species in 
tracheal cultures, in the absence of purulent secretions or clinical evidence of infection. 
Bronchitis was defined as the presence of purulent secretions, but without clinical and 
radiological evidence of pneumonitis. A diagnosis of pneumonitis was made only when 
"unequivocal clinical or radiographic evidence of pulmonary parenchymal involvement 
was present." 
Once again the definitions and numbers of patients studied are inadequate, although the 
evidence confirms that of other authors who have demonstrated the importance of 
colonisation of the oropharynx and stomach in the pathogenesis of nosocomial lower 
respiratory tract infection. It was this study of 27 patients that instigated the much 
larger and more widely publicised studies on selective decontamination by the group at 
Groningen. 
In 1989, ULRICH ET AL 26? from the Hague in the Netherlands, studied the use of 
selective decontamination in a prospective randomised study , in a general ICU 
admitting a wide variety of diagnostic categories of patients, including general medical , 
surgical, neurological and neurosurgical patients, using a cheaper, modified regimen 
with norfloxacin, polymyxin E and amphotericin B as oropharyngeal and enteral 
agents, with systemic trimethoprim which was continued "until potentially pathogenic 
microorganisms could no longer be isolated from the oropharynx, respiratory or 
digestive tracts". If colonisation of the lower respiratory tract occurred in spite of the 
selective decontamination, antimicrobial treatment was started even in the absence of 
clinical evidence of infection. Control patients received peri-operative antibiotic 
prophylaxis and other antibiotics only when clinically indicated, and preferably with 
bacteriological substantiation. There was no minimum time limit for the duration of 
intubation or mechanical ventilation specified for evaluability in this study, however, 
the patients were required to have remained in the ICU for more than 5 days. 48 
patients were randomised to receive the SDD regimen and 52 were controls. 
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There were differences in definitions compared with other studies: all organisms 
isolated after the immediate admission specimens, being regarded as ICU acquired. 
Lower respiratory tract infection was defined by the presence of clinical and 
radiological signs of pulmonary infiltration, with fever and leukocytosis, and a dense 
growth on culture of sputum or tracheal aspirate. 
The two groups of patients were comparable in terms of sex, age, diagnostic categories 
and severity of illness, although there was a tendency for the patients who received 
SDD to have a more prolonged course in the ICU (16.9 days vs 13.4) , and duration of 
ventilation (10.7 vs 7.8 days). The mean simplified acute physiology score was slightly 
higher in the control group (12.4 vs 11.5) and 6 control patients vs only 3 who 
received SDD required haemodialysis. Antibiotic usage was slightly greater in the 
control group (mean antibiotic units 11.1 vs 10.6), and the patients in this group were 
also slightly younger (60 years vs 64.3). 
There was a significant reduction in oropharyngeal colonisation with the use of the 
SDD: both groups started off with 40% positive isolates for aerobic Gram negative 
bacilli, but after 7 days this had increased to 85 % in the control patients which 
persisted at this level, compared with only a 3 % incidence in the SDD group which 
declined to 0%. Gram positive organisms (predominantly Streptococcus faecalis and 
Staphylococcus epidermidis) were isolated from approximately 60% of both groups at 
admission, and this level was maintained in the SDD group, but rose to 80% in the 
control patients. Gram negative bacteria were isolated from the trachea in 24 % of the 
control and 41 % of the treatment group. but after 7 days, 67 % of the control group 
compared with only 26% of the treatment group were colonised. The same 
phenomenon of increasing colonisation by Gram positive cocci was observed in the 
trachea in both groups. 
The resistance patterns of the surveillance cultures were analysed , and resistance to the 
antibiotics in the decontamination regimen · was not noticeably more marked in the 
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treatment than in the control patients. There are unfortunately no details provided on 
the sensitivity profiles over the study period, and no comment is made as to whether 
the patterns of antibiotic resistance changed during the trial, as a result of the extensive 
and topical usage of antibiotics. 
40 patients in the control group (77 % ) developed 112 episodes of infection compared 
with 25 patients (52 % ) in the treatment group with 51 acquired infections. The 
incidence of Gram positive infections was similar in both groups (44 episodes in the 
control vs 41 in the treatment group). The incidence of Gram negative infections of the 
respiratory tract (6 % vs 44 %), urinary tract (4% vs 27 %) and catheter-related sepsis 
(0% vs 15 % ) was significantly lower in the SOD group. The number of infections due 
to Candida albicans was also significantly lower in the SOD patients. There were three 
patients in the treatment group who developed respiratory tract infections due to 
Pseudomonas aemginosa, apparently following successful initial decontamination. The 
authors invoke adherence mechanisms to explain colonisation of the trachea by-passing 
the usual initial stage of oropharyngeal colonisation , but suggest that decontamination 
of the patients' tracheostomy sites (all three had tracheostomies for prolonged 
ventilation) might have prevented these infections. 
Both the overall mortality (54 % vs 31 % ) and the "mortality attributable to sepsis" 
(15 % vs 0%) were significantly lower in the decontaminated patients; however, no 
criteria as to how the cause of mortality was determined are specified. 
The use of parenteral antibiotics did not di ffer significantly between the two groups, 
but the cost of bacteriological monitoring was noted to be higher in the control 
patients. The use of SOD did not shorten the duration of ICU stay, reduce duration of 
ventilation or antibiotic usage in this study, so cost benefit was not demonstrated. The 
different and cheaper agents in this study were felt to have been satisfactory substitutes 
for the conventional SOD regimen, although concern is expressed that the very low 
serum levels achieved with topical decontamination using an absorbable drug such as 
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norfloxacin might promote drug resistance. There were also three episodes of Gram 
positive infections which might have been prevented by cefotaxime and which were 
resistant to trimethoprim. 
This study is one of a select few which was able to report an improvement in mortality 
with the use of selective decontamination. Reservations about this study however do 
exist, as the patient numbers were small, the criteria for diagnosing infection were not 
sufficiently specific, the study was not blinded and the criteria for diagnosing a 
reduction in sepsis-related deaths are not provided. 
GODARD ET AL 268 reported in 1990 a double blind study of selective decontamination 
in their ICU in Lyon, France which admits all categories of patients. Only enteral 
decontamination was performed using tobramycin and polymyxin E; amphotericin B 
was administered to all patients. All patients admitted to the ICU during the trial period 
were enrolled, but there were 15 withdrawals (10 had received previous 
decontamination, 5 were not eligible because of gastro-oesophageal surgery) leaving 
181 evaluable patients, 97 of whom received decontamination (there were 4 
withdrawals in this group because of inadequate drug administration or treatment 
withdrawal) and 84 received placebo. 
The trial design was complex: the ICU is divided into two individually run subunits, 
and in the first 3 months of the study all patients in the one subunit received placebo, 
and all patients in the other subunit the active regimen; this was followed by a two 
month break during which no decontamination was performed, and then a further 3 
month period in which the treatment regimens in the two units were reversed. The 
rationale for this format was to avoid the carry-over effect causing misleading benefit 
in the placebo patients, or detracting from the benefit experienced by the 
decontamination in those who received the trial medication. 
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The two groups were fully comparable in terms of age, sex, diagnostic category and 
simplified acute physiology score (mean of 14.2 in the study group and 13.5 in the 
placebo patients). The patients did not require to be intubated at all for inclusion in the 
study, but there were similar numbers of ventilated and non-ventilated patients in both 
limbs of the study. The duration of intubation, ICU stay and the antibiotic requirements 
in the two groups were also similar. 
The definition of primary infection, was an infection acquired within 48 hours of 
admission; all subsequent infections were regarded as ICU-acquired. The criteria for 
the diagnosis of pneumonia were: new or progressive infiltrate on the chest radiograph, 
purulent sputum, fever > 38°c. leukocytosis > 10 000/ml. Protected specimen brush 
samples were taken on all patients who fulfilled the above criteria, and the diagnosis 
was retained if the brush specimen yielded > l 000 cfu/ml of a bacteria, or if a 
microorganism was cultured simultaneously from pleural effusion or blood culture and 
bronchial aspirate. 
The incidence of pnmary infections was similar m both groups: 56% in the 
decontaminated patients compared with 58 % in the placebo patients. Patients who 
underwent contaminated surgery or who were hospitalised after trauma all received 
intravenous antimicrobial prophylaxis. 
"ICU-acquired infections" appeared significantly later and recurred less frequently in 
the decontaminated patients, although there was no statistical difference in the 
frequency of infections between the two groups. No infections occurred in patients who 
stayed less than 8 days in the ICU in either group. All infections were reduced in the 
treatment group, but a statistically significant effect was only noted with pneumonia; 
there were no bacteriologically confirmed cases of pneumonia which occurred in the 
decontaminated group, compared with 8 cases in the placebo patients (due to 
Pseudomonas aeruginosa in 5, Haemophilus spp, Proteus spp and Staphylococcus 
aureus one each). Urinary tract infections in patients with indwelling catheters were the 
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most frequent site of acquired infection, and in both groups such infections were due to 
Gram negative bacilli and Gram positive cocci, and occurred in the third week of ICU 
stay. 
Among those who died, 6 untreated versus only one decontaminated patient, acquired 
at least one infection during their ICU stay. A similar difference was noted for the 
development of septic shock. There was a significant reduction in the number of ICU 
acquired infections due to Gram negative bacteria in the treatment group. In both 
groups, 15 % of Gram negative bacteria from surveillance cultures of rectal swabs were 
tobrarnycin resistant. No surveillance screening for colonisation of oropharyngeal, 
tracheal, gastrointestinal or urinary flora. was performed. 
25 % of ·the patients in both limbs stayed in the ICU for less than 48 hours; 55 % - 60% 
remained for more than one week. 
12 patients (12%) died in the decontamination group compared with 15 (18%) in the 
placebo group; thus, overall there was no significant reduction in mortality with this 
technique. With post hoc stratification, benefit from the decontamination was shown in 
those who stayed in the ICU for more than 7 days, or those with a mid-range SAPS. 
Interestingly, unlike other studies which suggested especial benefit for trauma patients 
from the use of SDD, no such benefit was demonstrated in this study where 41 patients 
received SDD, and a further 33 placebo; 34% of the SDD patients compared with 55% 
of the placebo developed infection in this subgroup. 
There was no dfect with the regimen on duration of ICU stay (although there was a 
non-significant trend with the mean in the decontaminated patients being 11 days vs 13 
in the placebo patients). The authors estimated that a one day reduction in ICU stay 
would have been sufficient to have paid for the intestinal decontamination for 50 days. 
The double blind nature of the study, and the differences in definitions, which were 
stricter than in many of the other trials, both combined to reduce the incidence of 
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pneumonia in the placebo limb to a mere 15 % , and the incidence of other infections 
was also much lower. Part of the problem when attempting to compare this study with 
others is that not all patients were intubated, which in itself might have caused a 
considerable reduction in the infection rate. The efficacy of the decontamination 
regimen is suggested by the reduction in Gram negative infections, but surveillance 
cultures would have been reassuring to confirm the efficacy of enteral decontamination 
alone. The study was possibly too short in duration, for resistance profiles to have been 
studied, but in the longterm, such information should be presented. It is interesting to 
note that this is yet another study where in spite of a significant reduction in the 
incidence of pneumonia, no effect on mortality, nor duration of hospital and ICU stay 
were demonstrated. 
GASTINNE ET AL in 1992 265 reported a multi-centre randomised, controlled trial of 
selective decontamination from France, which was designed to assess the efficacy of 
the regimen in improving survival, both in the ICU, and at 60 days after 
randomisation. 445 patients in 15 intensive care units were given placebo (225) or 
tobramycin , polymyxin E and amphotericin paste (220) to the oropharynx and an 
enteral suspension. No parenteral prophylaxis was used, but 72 % of the patients were 
receiving systemic antibiotics at the time of randomisation in any event. Enrollment 
criteria included mechanical ventilation for > 48 hours , but the patient should not have 
been intubated more than 48 hours before randomisation. Patients with drug overdoses, 
neutropaenia ( < 500 polymorphs/ml), or a simplified acute physiology score of more 
than 24 were excluded. The sample size of 600 patients was calculated to allow the 
detection of a 25 % reduction in mortality among the treated patients, assuming a 
mortality of 40% in the placebo group. 
Respiratory tract infections were classified as primary if they occurred within the first 
48 hours of admission, and thereafter as secondary and ICU acquired. Pneumonia was 
defined as all of the following: purulent tracheal aspirate, fever ( > 38.5°C), peripheral 
288 
289 
leukocytosis ( > 10 000/ml) , associated with a new and persistent infiltrate on the chest 
radiograph. Fibreoptic bronchoscopy with specimens obtained by brushing was 
recommended but not mandatory , and bacteriological documentation was not required, 
as it was thought that the topical antibiotics might interfere with the accuracy of 
cultures. Tracheobronchitis was defined by the presence of clinical signs, but the 
absence of a pulmonary infiltrate on the chest radiograph. 
The two groups were comparable in terms of the number and types of underlying 
diseases and diagnostic categories on admission; however, the simplified acute 
physiological score was higher in those randomised to receive SDD , there were also 
more males in this group , and there were more patients with more than one organ 
system failure on admission. 
Primary pneumonia occurred in 14 patients (9 in the placebo group compared with 5 in 
the SDD group). Pneumonia developed in 13% in the ICU within 30 days of 
enrollment (33 in the placebo group and 26 in the SDD group) , although pneumonia 
due to Gram negative bacilli was significantly reduced in the SDD patients. There was 
a trend toward an increase in the rate of staphylococcal pneumonia in those who 
received the active regimen (60% of patients with pneumonia in the treatment group 
had pneumonia due to this organism). 
There was no difference in the duration of ventilation, or mean duration of ICU 
admission between the two groups. 
170 of the 445 patients died in hospital , 88 in the SDD group and 82 in the placebo 
group; 142 of these deaths occurred in the ICU. The overall mortality rate in the ICU 
was 32% (34% in those who received SDD, compared with 30% in the placebo group), 
and the mortality rate at 60 days was similar. The 15-day and 30-day survival rates 
were 80 % in the placebo group vs 76 % in the treatment group and 74% vs 66% 
respectively. The estimated risk of death was 1.14 times higher in the treatment group. 
The costs of the antibiotics in the SDD group were 2.2 times higher than in the placebo 
patients. The daily cost of the SDD was $ 66.50 per patient and the mean total charge 
per patient was $ 694 ± 544. There was no difference in the mean total charge for 
systemic antibiotics during the stay in the ICU between the two groups; although the 
mean charge per patient for the antibiotics used to treat all episodes of respiratory tract 
infections was higher in the placebo group, this difference was not significant. 
The incidence of secondary pneumonia was low in this study (13 % in the placebo 
group). The diagnostic criteria were more clearly specified and much stricter than in 
many of the other studies, so it is difficult to compare the results between the centres. 
The double-blind nature of the study may also have helped to ensure a more reliable 
diagnosis. 
The population in this study may partly explain the discrepancy in the results with the 
use of SDD: 10% were admitted after emergency surgery, 25% with pneumonia, and a 
further 25 % were immunocompromised by chronic renal failure, HIV , or carcinoma. A 
high proponion were unconscious or had more than one organ system failure at 
admission, and almost half had a simplified acute physiology score of more than 13. 67 
patients (15 % ) were admitted following trauma which was documented to be a 
statistically significant adverse prognostic factor; however, in their discussion the 
authors comment that multiple trauma may be a subgroup that may stand to benefit 
from the use of SDD. Unfonunately no subgroup analysis is provided. 
\Vhile this study has overcome many of the drawbacks of previous studies in terms of 
methodology - it is double-blind, controlled , prospective and the numbers are 
sufficiently large; there are nonetheless a few problems with it: being a multicentre 
study, there is not the uniformity of practice, nursing etc which are encountered in a 
single centre study , and the contributions to mortality, and the infection rate from the 
various units are not specified. The other major criticism which could be levelled at this 
study is the complete absence of microbiological data: there is no mention of 
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surveillance samples, so that there is in fact no evidence that the patients were 
adequately decontaminated. No comment is made about the other patients in the unit 
who might possibly have caused cross-infection if they were overtly septic; the 
infection rate before the trial is not commented upon and the possibility of a carry-over 
effect from the decontaminated patients to the others which might have negated some of 
the benefit of the SDD is not mentioned. 
AERDTS ET AL 269 in 1990 reported a prospective. randomised three-limbed study of 
selective decontamination, in combination with initial cefotaxime, performed in an ICU 
in Nijmegen , Holland. There were two control groups, each with a different antibiotic 
policy to be used in the event of infection , thereby to determine the possible influence 
of antibiotics which affect colonisation resistance on the colonisation and infection rate. 
All patients who were expected to require mechanical ventilation for at least 5 days 
were included in the study , regardless of their underlying condition. After 
stratification, using the APACHE II score, the patients were allocated to one of the 
three treatment groups. In control group A, no antibiotic prophylaxis was provided, 
and only antibiotics, which were known to affect colonisation resistance were used, ( 
ampicillin, piperacillin , gentamicin and lincomycin being the preferred drugs); therapy 
being instituted on clinical evidence of infection. In control group B, patients also 
received antibiotics only if clinically indicated, however only antibiotics known to have 
no effect on colonisation resistance were used (cefotaxime, or cefuroxime in 
combination with gentamicin, and metronidazole if anaerobic infection was suspected). 
In group C, SDD using systemic prophylaxis with cefotaxime for the first 5 days, and 
oral and enteral decontamination with polymyxin E, norfloxacin and amphotericin B 
were given to all patients from admission until extubation; further infections were 
treated as in group B. This slightly different regimen from the more conventional 
polymyxin E , tobramycin and amphotericin B was used , because norfloxacin is not 
only cheaper than tobramycin, but' also theoretically safer, and the spectrum across 
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which tobramycin causes decontamination is narrower. Polymyxin E was used to 
increase the spectrum of activity against Pseudomonaceae against which norfloxacin 
was less active. 
All infections that were not present on admission but developed after this, were 
regarded as nosocomial. Lower respiratory tract infection was defined as : positive 
culture of the tracheal aspirate and a Gram stain showing many leukocytes, as well as 
the causative organism. In addition , two of the following three criteria had to be met: 
purulent appearance of the tracheal aspirate, peripheral leukocytosis > 12 000/ml or 
fever > 3gOc. 
88 patients were randomised on admission , but 24 were excluded because of premature 
discontinuation of ventilation. 56 patients thus were evaluable: A 18, B 21, C 17. The 
three groups were comparable in terms of age, sex, duration of intubation (25 days vs 
22 days vs 16 days), duration of ICU stay (30 days vs 25 days vs 23 days), and 
APACHE II score (mean 22.6, 23.4, 20.5) respectively. 
In patients in groups A and B, oropharyngeal colonisation with Haemophilus influenzae 
decreased during ICU stay, while in group C colonisation with this organism was 
eliminated, similarly Staphylococcus aureus colonisation of the oropharynx was 
eliminated in the patients in group C; yeasts were almost completely eliminated in this 
group, but colonisation with these organisms did not increase in any group with 
antibiotic therapy. 
Colonisation of the lower respiratory tract was present m 53 % of patients admitted 
without infection in groups A and B, and in 64% in group C. Gram positive cocci were 
the predominant organisms isolated. Lower respiratory tract colonisation was 
eliminated in all patients in group C by 5 days, but in 7 patients in the other 2 groups, 
colonisation later gave rise to infection. 
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Colonisation of the stomach with Gram negative bacilli was shown in 50% of patients 
in group A on admission, compared with 19% in group Band 29% in group C. These 
figures increased for groups A and B, but these organisms were virtually eliminated 
from the patients in group C. The number of patients colonised by Gram positive cocci 
and yeasts increased from 15 % on admission in the control groups to over 30%, but 
again colonisation with these organisms was virtually eradicated in group C. Although 
it took longer for rectal colonisation patterns to change, a similar phenomenon was also 
demonstrated. 
78 % of the patients in group A acquired lower respiratory tract infections, compared 
with 62% in group Band only one patient (6%) in group C. Almost all infections in the 
control groups were considered to be endogenous in origin, but the only infection in 
group C was thought to have been due to cross-infection. No details are provided of 
other sites of infection . 
94 % of the patients in group A and 100 % in group B were treated with systemic 
antibiotics, compared with only 65 % in group C. No emergence of resistance to 
cefotaxime was noted in this study, and no comment on the emergence of resistance to 
norfloxacin is made. 
The slightly different and arguably insufficient criteria to diagnose lower respiratory 
tract infection, the small number of patients in each limb and the unblinded nature of 
the study all make its interpretation difficult. There was nonetheless both a decrease in 
colonisation and lower respiratory tract infections in group C, associated with a small 
reduction in duration of stay, and duration of ventilation in these patients; although the 
APACHE II score in this limb was also the lowest. The small numbers make the 
unchanged mortality rate uninterpretable. 
It is interesting to note that, despite attempts to preserve normal colonisation resistance, 
the incidence of infections in group B was unaltered and colonisation with Gram 
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negative bacilli increased. This would suggest that it is not the use of antibiotics, that 
alter colonisation resistance, which influence the bacterial colonisation patterns in the 
critically ill. 
PALOMAR, BARCENILLA, ALVAREZ ET AL from Barcelona, compared the efficacy of 
preventing nosocomial pneumonia with the use of sucralfate in combination with 
parenteral decontamination using cefotaxime, with conventional decontamination, 
versus no prophylaxis. (Prevention of nosocomial pneumonia in ventilated patients 
using selective decontamination of the digestive tract, cefotaxime and sucralfate, 
Poster, ICC Berlin, 1991) They reported a prospective, randomised , multicentre (10 
hospitals) study of the two prophylactic regimens in the prevention of respiratory 
infections in ventilated patients admitted to the ICU. There was one control limb who 
received only antacids or H-2 blockers by nasogastric tube; a second group received 
selective oropharyngeal and enteral decontamination using polymyxin E, tobramycin 
and amphotericin B, plus parenteral cefotaxime for the first 4 days of ICU stay. In the 
third group, patients received cefotaxime and sucralfate for the period of intubation. 
87 patients were evaluable, 31 received antacids and no prophylaxis, 26 SDD, and 30 
sucralfate and cefotaxime. The patients were comparable in terms of age, sex 
distribution and APACHE II scores (17.4, 15.6, 17.2 respectively). The duration of 
ventilation in the three groups was similar (7.2, 10 and 9.4 respectively). Although the 
types of ICUs are not specified, the overwhelming majority of patients studied would 
appear to have been neurological, with only small representations of patients with 
primarily respiratory or other diseases. 
The diagnosis of nosocomial pneumonia was made using quantitative cultures obtained 
by bronchoalveolar lavage or protected specimen brush in half of the cases, but the 
definition of pneumonia was not specified further and patients were reported as having 
a high probability of having developed nosocomial pneumonia, which in an open study 
is possibly a dangerous way of introducing bias. 
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The overall incidence of secondary infection was reduced , by the introduction of some 
form of prophylaxis, although this did not achieve statistical significance. The infection 
rate in the control group was 80.6%, compared with 60% in those who received 
sucralfate and cefotaxime and 3 8. 5 % in the patients who received SD D. 
The incidence of nosocomial pneumonia was significantly reduced in the two groups 
who received some form of prophylaxis, compared with the control group (19.2 % 
SDD, 26. 7% in those who received cefotaxime and sucralfate, 58. l % in the control 
group). The nosocomial pneumonias that occurred in the groups who received 
prophylaxis developed later than those in the patients who received no prophylactic 
therapy. Staphylococci were the major cause of nosocomial pneumonias in all three 
groups; Gram negative organisms were the predominant cause of all nosocomial 
infections in the control group, while they were still more frequent pathogens than 
Gram positive infections in the sucralfate and cefotaxime group; however, in the SDD 
group, the vast majority of all nosocomially acquired infections were due to Gram 
positive organisms. 
The authors attributed the high incidence of staphylococcal infections encountered to 
the fact that "this organism is the most frequently encountered coloniser of patients 
with neurological disease", that there is a high prevalence of staphylococci in the ICUs 
studied (whether multiply resistant or otherwise and whether this incidence of infection 
is higher than previously is not mentioned) , lastly that the staphylococci are not 
sensitive to the agents used in the decontamination regimen. 
No mention is made of the effect of either form of prophylactic regimen on the 
resistance patterns, nor is any data provided to demonstrate the efficacy of the 
decontamination regimens in reducing colonisation with Gram negative and other 
pathogens. That this was achieved is nonetheless suggested by the differing spectrum of 
organisms causing infections in these two gro_ups. 
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There was however no difference in mortality between the three groups, except with a 
subanalysis of the trauma patients, in whom the mortality appeared significantly lower 
in those who received the conventional SDD regimen. 
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This study is once again flawed by its multicentred, open design , the small number of 
patients enrolled and the complexity of regimens evaluated, as well as the poor 
diagnostic criteria used. No data is provided as to whether any of the units studied were 
known to have problems with staphylococci prior to the study, or whether this was 
exacerbated by the introduction of SDD. The extremely high baseline infection rate of 
over 80% is not satisfactorily explained , nor is there any data provided as to whether 
all the infections emanated from one centre. It is thus difficult to be certain as to 
whether the high incidence of infection and its reduction in the two prophylactic groups 
was purely due to the fact that these two groups received more careful nursing than 
those in the control group. 
The use of selective decontamination to improve an infection rate of over 80% , when 
the problem is predominantly due to staphylococci, which are well recognised to be 
spread both endogenously and exogenously, must be questioned. The appropriateness of 
the agents selected, in view of the recognised sensitivity patterns of the staphylococci, 
is questionable. The effect this regimen might have had on the incidence and resistance 
patterns of both the staphylococci and other pathogens should surely have been of 
sufficient import for the data to have been provided. 
JACOBS, FO\VERAKER AND ROBERTS (Effectiveness of SOD and cefotaxime in an ICU 
with a policy encouraging low gastric pH. Poster, ICC, Berlin, 1991). Jacobs et al 
reported the results of a study of selective decontamination plus cefotaxime in a 
randomised controlled trial using oropharyngeal and enteral decontamination with 
polymyxin E, amphotericin B, and tobramycin in their ICU (no category of ICU-type 
specified). Enrollment _criteria for this study included an assessment of a ventilatory 
requirement exceeding 3 days . 
79 patients were enrolled, 36 received SDD and there were 43 in the control group. 
The two groups were comparable for sex, age, mean APACHE II score (17 in the SDD 
group compared with 18 in the control), duration of ICU stay (10 days in both groups), 
the use of steroids, H-2 antagonists, and mortality (39% vs 53%). The diagnostic 
categories on admission included sepsis ( 19 % vs 14), neurosurgery (58 % vs 4 7 % )and 
low cardiac output states (17% vs 40%) which were fairly equally distributed between 
the groups. 
The authors emphasise, what is often regarded as fairly standard ICU practice, that, in 
both groups , an attempt to maintain a low gastric pH was made by: the avoidance of H-
2 blockers, antacids, steroids; the administration of dopamine and sucralfate to prevent 
stress ulceration, and the use of intermittent enteral feeding. (How many patients 
received sucralfate is not specified, nor is there any mention of the very real concern 
that this drug may bind to enterally administered agents for decontamination, and 
thereby inactivate them 64). This study differs from other reported studies of SDD, 
however, in that daily measurements of gastric pH were made at midday, which was 
the end of the fasting period in the enterally fed patients. 
The diagnostic criteria for nosocomial pneumonia in this study included: alveolar 
infiltrates on more than two chest X-rays (the time interval is not specified), a rectal 
temperature of more than 38.4°C, moderate or copious purulent tracheal aspirate, a 
leukocyte count of more than 13 000/ml, and a heavy growth of organisms from 
tracheal aspirates before starting antibiotic therapy. 
Colonisation by the same organism of the oropharynx, trachea and stomach was 
prevented in those who received SDD, and this was significantly different from those in 
the control group; but the patients who were colonised at three sites in the control 
group were also observed to have an elevated gastric pH. The incidence of nosocomial 
pneumonia, in spite of the very non-specific diagnostic criteria in this study, was low: 
0 patients who rec~ived SDD and only 4 patients (10%) in the control population. The 
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controls were shown to have an elevated gastric pH, and were colonised by aerobic 
Gram negative bacilli. 14 % of the patients who received SDD and 16% in the control 
group developed nosocomial bacteraemias, and this was associated with an elevated 
gastric pH in all the control patients who developed bacteraemia. The mortality was not 
significantly different: 39 % in the SDD group and 53 % in the control group; the 
duration of ICU stay was similar in both groups of patients. 
The authors conclude by recommending routine gastric pH monitoring for ventilated 
patients, and suggest that if a low gastric pH cannot be maintained, selective 
decontamination should be instituted . This is a clearly inappropriate suggestion, as most 
studies would suggest that the benefit from SDD is derived by the early prevention of 
colonisation rather than awaiting for problems to arise. The possible beneficial effect of 
sucralfate on the control population , and its potential for inactivating the drugs and thus 
preventing decontamination in the SDD group, is not addressed in this study. 
No data is provided on the colonisation or resistance patterns or the microbial 
pathogens encountered during this study. As with so many of the other studies, the 
population studied is once again too small and the unblinded character, with rather 
loose definitions of infection prevents the data from significantly adding to the evidence 
either for or against SDD. 
BLAIR, 'WEBB, LoWRY, ARMSTRONG ET .-\L (Use of selective decontamination of the 
digestive tract (SDD) in an intensive care unit (ICU); an open prospective randomised 
concurrent controlled trial. Poster ICC, Berlin , 1991) from Belfast, reported a study of 
selective decontamination in which 331 patients were enrolled over an 18 month period 
in a regional ICU. The patients were stratified within 6 hours of admission into four 
groups according to their APACHE II score, and randomised to the control group or to 
receive a regimen of SDD comprising: oropharyngeal and enteral polymyxin E, 
tobramycin and amphotericin B, and parenteral cefotaxime for the first 4 days. There 
was no requirement for a minimum duration of ventilation or ICU stay. 
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161 patients were enrolled into the SDD group and there were 170 controls. The 
groups were comparable in terms of age, sex, episodes of primary infection, admission 
diagnosis, APACHE II score and sepsis score on admission. 
No definitions of infection or colonisation were provided. Colonisation of the trachea 
with aerobic Gram negative bacilli and yeasts was significantly reduced in the patients 
who received SDD, compared with the control group; there was a less marked effect on 
colonisation of the gastric aspirate, and no difference in colonisation of the rectum was 
noted. Rapid colonisation of all sites by coagulase negative staphylococci was observed 
in the patients who received SDD, especially of the stomach and trachea. 
Resistance to cefotaxime did not emerge during the study, but there was a trend 
towards tobramycin resistance developing in the patients who received SDD. 
Aminoglycoside resistant coagulase negative staphylococci appeared earlier in all sites 
of the SDD patients, and overall 79 % of isolates from such patients were tobramycin 
resistant compared with their later appearance in 60 % of isolates from the controls. 
The number of patients with secondary infections was significantly reduced in the SDD 
group, where 21 infections occurred in 126 patients (16.7%) compared with 40 
infections in the 130 controls (30. 8 % ) . Respiratory tract infections were also 
significantly reduced (10% in those who received SDD compared with 29% in the 
controls). The organisms causing infection in the two groups differed in that while 
there were very few infections attributed to aerobic Gram negative bacilli in the patients 
who received SDD, there were similar numbers of infections in both groups due to 
Gram positive organisms and yeasts. 
There was no difference in either duration of stay in the ICU nor mortality between the 
two groups, although there was a trend towards a reduction in mortality in the patients 
with mid-range and very high APA.CHE II scores. 
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The authors concluded that while they were able to demonstrate a reduction in the 
incidence of infection, morbidity and mortality were unaffected and the implementation 
of SDD would require rigourous infection control, particularly in view of the potential 
emergence of coagulase negative staphylococci. 
The patient population in this study is considerably larger, but there are certain flaws 
inherent to this study: the study is not blinded, the ICU population is not defined 
further than by a scoring system assessment , there are no definitions of infection 
provided and there is no cut-off time to distinguish between primary and secondary 
infections, nor is there any attempt to study the at-risk population who remained for 
sufficiently long in the ICU to develop nosocomial infection (which might have reduced 
the effective population size considerably). The efficacy of the technique of selective 
decontamination in reducing respiratory infections (and at other sites, although no 
further details are provided) is however well demonstrated, although once again it is 
remarkable to note the lack of effect on morbidity and mortality. 
FINCH. TOl\.fLINSON. HOLLIDAY ET AL (Use of selective decontamination of the digestive 
tract (SDD) plus systemic cefotaxime in the prevention of secondary sepsis in a 
medical/surgical intensive care unit. Poster, ICC, Berlin, 1991) reported a study of 44 
evaluable patients admitted to an open randomised trial of selective decontamination in 
their general ICU in Nottingham. In this study, randomisation was delayed for 60 - 72 
hours after admission to the ICU. The control patients were managed conventionally 
while those randomised to receive SDD were given parenteral cefotaxime for the initial 
4 days and gentamicin, amphotericin B and polymyxin E were applied to the 
oropharynx and enterally for the duration of ICU admission. 
The patients in both groups were comparable in terms of sex, age, admission 
diagnoses, the number of primary infections, and the simplified acute physiology 
scores. 
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No definitions of infection or colonisation were provided. Colonisation of the 
respiratory and upper gastrointestinal tract by aerobic Gram negative bacilli and yeasts 
was significantly reduced in the patients who received SDD, although this effect was 
less marked and not statistically significant in the lower gastrointestinal tract. 
Colonisation by Gram positive organisms initially decreased in both groups, but in the 
patients who received SDD these organisms tended to persist and even increased in 
number with time. Resistance to the agents used in the SDD regimen was detected in 7 
patients. 
The incidence of secondary infection was reduced in the patients who received SDD (7 
infections, or 35%, vs 12 infections, or 50%, in the control group), and their antibiotic 
requirements were also less. The duration of ICU stay was reduced, although this was 
not significant: 10 days vs 16 days in the controls. The mortality in both groups was 
high 65 % in the patients who received SDD vs 42 % in the controls, but this difference 
did not achieve statistical significance. 
This study is again marred by the small numbers , the absence of definitions of 
infection, and its unblinded design. Once again, the efficacy of SDD in reducing 
colonisation and infection is demonstrated, but little further benefit seems to have 
accrued from the use of the regimen- in this study. 
COCKERILL ET AL 270 from the Mayo Clinic reported a randomised controlled, but 
unblinded study, of selective decontamination using intravenous cefotaxime for the 
initial 72 hours , and oral and enteral gentamicin, polymyxin and nystatin for the 
duration of ICU stay, in their surgical and medical ICUs, over a three year period. 150 
patients who were thought likely to remain in the ICU for more than 3 days were 
randomised to the active and control groups, which each comprised 75 patients; 
patients who were infected or had received antibiotics within the 24 hours prior to 
randomisation were excluded. The aim of their study was to assess the efficacy of the 
regimen in preventing nosocomial infection. 
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Pneumonia was defined clinically and by laboratory evidence of infection localised to 
the lung. A new and progressive pulmonary infiltrate compatible with pneumonia, with 
purulent secretions, isolation of a potential pathogen, and fever, leukocytosis or both, 
were required. In two patients the diagnosis was not made until autopsy. 
Tracheobronchitis was defined as the presence of increased purulent endotracheal 
secretions requiring frequent suctioning and the presence of a potential pathogen. If 
pathogens were isolated without criteria for pneumonia or tracheobronchitis being met, 
colonisation was recorded. A 90% concurrence was achieved between two 
investigators, the one blinded, in the diagnosis of pneumonia. Bacteriuria was defined 
as colonisation of the urinary tract, unless the presence of fever, flank pain and 
leukocyte casts suggested pyelonephritis, or in patients without a urinary catheter, if 
dysuria and frequency with pyuria and bacteriuria suggested cystitis. The other 
definitions were fairly stanc:lard. 
The patient characteristics of the two groups were similar in terms of age, sex, the use 
of antacid therapy, and primary diagnoses. The severity of illness scores were also 
similar with a mean APACHE II of 18.3 vs 18.6 , ISS mean of 24 vs 24.8 respectively 
in the controls compared with the active group. 10 patients withdrew from the 
treatment group because of distaste for the oral paste, or diarrhoea, but these patients 
were nonetheless included in the analysis. 36 % of the controls and 35 % of the test 
patients remained in the ICU for less than 4 days. The total duration of hospital and 
ICU stay did not differ significantly between the two groups; however, the median 
duration of intubation was significantly shorter in the decontaminated patients (3 vs 5 
days p=0.022). 89% of the controls and only 80% of the decontaminated patient group 
were intubated at some stage of their ICU stay. 
Potential pathogens were reported to have been eliminated form the oropharynx of 67% 
of the test patients, and from the rectum in 55 % , although the time interval is not 
specified; the authors report that in those in which decontamination was not achieved, 
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the majority of patients had left the ICU within 4 days. Colonisation of the respiratory 
and urinary tracts was more frequent in controls than in the decontaminated patients (42 
vs 27 episodes p=0.01). Decontamination was reported to have had little effect on 
Gram positive cocci, but its effect on the incidence of these organisms as pathogens or 
the emergence of resistance were not commented upon. The antimicrobial resistance 
patterns of Gram negative bacilli in this institution are reported be low, but the 
resistance of isolates to gentamicin or third-generation cephalosporins was 11 % in 
controls vs 16% in the test patients. 
The control group were reported to be more likely to have fever while in the ICU, and 
such episodes were also more prolonged than in the test patients. A significant decrease 
in the number of days that parenteral antibiotics were administered when compared 
with the decontaminated patients was noted (9 days vs 4 days, p < 0.0001), only when 
the cefotaxime required by the protocol was excluded. 
The incidence of infectious episodes was significantly reduced in the decontaminated 
patients ( 12 episodes among 10 patients vs 36 episodes among 19 patients in the 
controls). This difference was noted to be especially marked for infections caused by 
the Gram negative bacilli: 3 episodes vs 23 (p < 0. 002) , and O bacteraemias compared 
with 10 (p= 0.004). The incidence of pneumonia was 5.3% in the controls vs 4% in 
the test patients, while the incidence of tracheobronchitis was 10.7% vs 1.3%. There 
were no episodes of urinary tract infection documented during the study period. 
16 of the 75 controls and 11 of the test patients died during their total period of 
hospitalisation. In 6 controls and 2 test patients, the patients either died with, or 
because of, infection. The calculated cost of SDD was $212 per patient. The authors 
suggest that, although they were not able to achieve statistically significant reductions 
in morbidity and mortality, the reduction in infections with the potential cost-saving 
that this, and the trend towards reduced morbidity and mortality, illustrate the benefit 
of the application of this technique in selected long-term patients in the ICU. 
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The authors have conducted a prolonged study (3 years) of selective decontamination 
using satisfactory definitions of infection, although the definition for tracheobronchitis 
is extremely non-specific. However, there are nevertheless difficulties with the 
interpretation of their results. 35 % of the patients did not remain in the ICU for as long 
as 4 days, and it has been well demonstrated that the enteral decontamination may take 
at least as long as this to achieve its goals of upper gastrointestinal decontamination. 
The effects that are being reported may thus largely be the result of the parenteral 
cefotaxime, but this is not addressed. When their statistics are applied to the much 
smaller number of patients remaining after 4 days, the same conclusions might not be 
applicable. The inclusion of non-intubated patients in this study, still further reduces 
the evaluable population, as these patients are recognised not to develop respiratory 
infections. The disparity in the number of patients requiring intubation and ventilation 
is also not adequately addressed , as this in itself would have biased the control group to 
a higher incidence of nosocomial respiratory tract infections. The exclusion of infected 
patients in this study, unfortunately also makes its comparison with other where this 
was a prerequisite for inclusion, studies difficult. 
\VINTER ET AL 271 reported a controlled trial of selective decontamination of the 
digestive tract performed in 91 patients in their general ICU in Bristol, whom they 
compared with 84 historical and 92 contemporaneous controls. The regimen consisted 
of topical polymyxin E, tobramycin and amphotericin B administered for the duration 
of ICU stay and parenteral ceftazidime administered for the initial three days only. 
Patients were enrolled if they were assessed as being likely to require ICU admission 
for more than 48 hours; patients in the two control . groups were comparable with the 
study patients in terms of age, sex , admitting diagnosis, median APACHE II (13 in the 
SDD patients, which was statistically higher than that in the historical controls), median 
ISS (25 in the SDD group), and median initial sepsis score (5 in the SDD group). 
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The criteria for diagnosing infection required two temperature spikes > 38.5°C within 
a 24 hour period, and a white cell count > 12 or < 4 x 109 /L. In addition, for the 
diagnosis of pneumonia, a positive bronchoalveolar lavage was regarded as essential, as 
well as the presence of two of the following: purulent sputum, new infiltrates on the 
chest radiograph or an increase of 0.15 in Fi02 to maintain equivalent oxygenation. 
Other definitions were fairly standard; no further attempt was made to differentiate 
between bronchial and parenchymal lung infection. 
18% of the SDD patients were primarily infected on admission to the ICU compared 
with 20% of the historical controls and 30% of the contemporaneous controls , which 
was significantly different; although the authors comment that there was no evidence 
that primary infection predisposed to the development of secondary infection. The 
incidence of secondary infection was significantly lower in the patients who received 
SDD ( 3 % vs 32 % in the historical and 35 % in the contemporaneous control groups , p 
< 0.01), although there was no difference in the timing of infections. The rate of 
colonisation with potential pathogens , particularly Gram negative bacilli, was 
significantly reduced at throat, gastric and rectal sites in the patients who received 
SDD, although there was no reduction of Gram negative bacteria in tracheal aspirates. 
Pseudomonas aeruginosa was the most frequently isolated pathogen, and the only 
pathogen identified as a cause of secondary infection in patients who received SDD. 
Significantly more (p < 0.01) Acinewbacrer spp isolates were recovered from rectal , 
throat and tracheal specimens of the patients in the contemporaneous control group, 
than from the other two groups. No patients developed infection or received antibiotics 
for possible infection caused by resistant bacteria, however. The antibiotic usage for all 
three groups was similar, although therapy with systemic amphotericin B was only used 
in the contemporaneous control group for two patients with aspergillus infection. 
The average duration of ICU stay was shorter in the patients who received SDD (6.38 
vs 7.3 in the historical and 7.97 days in the contemporaneous controls) , but this did not 
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achieve significance. 64 % of the SDD group survived to leave hospital, compared with 
60% of the historical and 56% of the contemporanous controls. There was no 
significant difference in overall mortality. The authors found that, when all patients 
were considered together, they were able to show a clear association between the 
incidence of infection and adverse outcome: 56 % of patients with primary infection 
died, compared with 35% without this problem; there was also an association between 
secondary infection and mortality (58% vs 37%). 
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The authors concluded that SDD provided an effective method for reducing the 
incidence of secondary infections, particularly in the subgroups of trauma patients, 
vascular surgery and long-stay patients. The technique was expensive in terms of drug 
costs , nursing time and microbiological surveillance. Although their results could not 
be interpreted as showing that SDD predisposed to secondary infection or colonisation 
by resistant bacteria, there was concern that the increased colonisation by Acinetobacter 
spp might be an indication of an alteration in the bacterial flora of the ICU as a result 
of the technique, reinforcing the importance of ongoing microbiological surveillance. 
This study incorporated sufficient patient numbers to provide useful information on the 
value of SDD, although the absence of blinding is unfortunate. The diagnostic criteria 
for infection differed from other studies, but incorporated a number of clinical 
parameters. It is of concern that the levels of antibiotics in the bronchial secretions 
achieved even with the topical agents in SDD, may be sufficient to have treated, rather 
than prevented , early secondary infections 272. A further criticism might be that the 
duration of ICU stay and intubation were not sufficiently clearly specified or used to 
allow the SDD to have taken effect. The mean duration of stay was only 6 days, at 
which stay the benefit of SDD is just becoming apparent, while the benefit of the 
parenteral agent may have reduced the incidence of early infections in these patients 
and thus contributed to the favourable results. 
6) Intestinal Decontamination to control nosocomial multi-resistant Gram negative 
bacilli 
BRUN-BUISSON ET AL 250 reported a study in 1989, performed in the medical ICU of 
their hospital in Paris, to assess the efficacy of intestinal decontamination in controlling 
an outbreak of intestinal colonisation and infection with multi-resistant 
Enterobacteriaceae, and to examine the effects of the regimen on endemic nosocomial 
infection rates. 
A 10-week prospective study was performed to assess the incidence and then an 8-week 
randomised, open trial of intestinal decontamination using consecutive and randomised 
controls followed. The study was conducted over two successive periods because of the 
possibility of a cross-over effect on nosocomial infections from the group given 
intestinal decontamination to the concurrent control group. The intestinal 
decontamination regimen consisted of neomycin, polymyxin E, and nalidixic acid, but 
no oropharyngeal nor parenteral prophylaxis were used, as these were thought to be of 
less clearly proven benefit and might have promoted the development of further 
organisms being resistant to the regimen used. All tracheally intubated patients received 
oropharyngeal disinfection with a povidone-iodine solution at least 3 times a day. 
Nosocomial infection was defined as any infection that was diagnosed during the ICU 
stay or within 48 hours of discharge. Pneumonia was defined as the occurrence of fever 
( > 38°C), peripheral leukocytosis ( > 10 000/ml) , purulent sputum or tracheal aspirate 
associated with a new and persistent infiltrate on the chest radiograph , and the culture 
of at least 109 colony forming units/I from a protected wedged catheter sample of 
bronchial secretions. The growth of at least 109 colony forming units/I and purulent 
sputum, with no definite or new infiltrate was diagnosed as tracheobronchitis. 
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Colonisation of the digestive tract with multi-resistant organisms was assessed in all 
patients by sequential rectal swab cultures, both during the study period and the month 
after the prophylaxis trial. 
Patients who stayed in the ICU for less than 48 hours were excluded from the study. 
124 patients (63 % of all admissions) were enrolled in the initial 10-week control 
period. 143 patients were admitted during the 8-week study period and, after exclusions 
because of low severity of illness score, or neutropaenia. 123 patients were included, of 
whom 68 were assigned to the control group and 65 to the decontamination regimen. 
The groups were demographically entirely comparable. 
On admission, a multi-resistant strain was detected on the rectal swab of two patients 
from the first study period , none from the control group and one from a 
decontaminated patient. More than 2 weeks elapsed between admission and first 
detection of multi-resistant Klehsiella pne11111011iae or other Enrerobacreriaceae in rectal 
swab specimens of patients acquiring colonisation by such organisms during their stay 
in the ICU. Multi-resistant strains were isolated from 19.6% of patients, at a mean of 
16 days after admission during the initial study period, 10 % of patients in the control 
group and only 2 % (1 patient) in the decontamination group. None of the patients 
admitted in the month following the trial, was colonised by multi-resistant 
Enterobacreriaceae. 
The overgrowth of at least one of the species possibly resistant to the intestinal 
decontamination regimen. was detected at least once in the stool specimens of 32 % of 
the control patients and 58 % of the decontaminated study patients, in whom 
overgrowth of Gram positive cocci was significantly more frequent when compared 
with the control group. The rectal concentration of Pseudomonas spp did not differ 
between these two groups. The strains of Enrerobacreriaceae (mostly Klebsiella 
pneumoniae) involved in the outbreak studied were remarkable by the presence of 
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transferable resistance to both third-generation cephalosporins and to most 
aminoglycosides, including amikacin. 
The digestive tract of the patients in the ICU was recognised to be an important 
reservoir of the epidemic strains, and an incidence of 20% in intestinal colonisation was 
documented during the initial period of monitoring , although about half of the 
colonised patients remained asymptomatic carriers only. In all the patients who 
developed infection due to these organisms, colonisation with the multi-resistant 
organism preceded detection of the organism clin ically by about 10 days. 
Most of the multi-resistant isolates were the same strain or Klebsiella pneumoniae, 
which suggested a major role for cross infection in addition to plasmid transfer; 
however, environmental studies failed to isolate the common source and, although hand 
transmission by the staff was considered the most likely method of transmission, and 
control measures were attempted, these were not successful until the attempt at 
eradication, using intestinal decontamination . The cross-over effect of the prophylactic 
regimen from the decontaminated patients to the control patients was anticipated by the 
investigators, and was well demonstrated by the reduced intestinal colonisation by 
resistant organisms in the control patients. compared with those in the initial study 
period. 
While the authors do not advocate intestinal decontamination as a substitute for 
recognised hygienic precautions in the prevention of infection, such as hand-washing, 
the isolation of infected patients. and a restricted antibiotic policy; there may be a role 
for a method such as this in controlling an outbreak of a multi-resistant organism, 
which at least circumvents the closure of an ICU. which is already a limited resource in 
any hospital. 
There was an incidence of secondary infection of 30.3% over the entire study period, 
and no significant difference was noted in the incidence of infections, or the 
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distribution of the organisms causing nosocomial infections, between the three groups. 
Pseudomonas spp infections tended, however, to be more common in the 
decontaminated patients than in the controls, whereas Enterobacteriaceae infections 
were more common in the controls than in the study patients. The duration between 
admission and infection was similar in all groups at 10 ± 4 .5 days. 
The authors acknowledge that the size of their study may have been too small to detect 
a significant reduction in the incidence of secondary infection ; however, if the results 
of other studies were reliable enough to be able to be extrapolated to their unit , a 
reduction in infection should have been seen . They suggest that the primarily medical 
population of their unit might have been a population group unlikely to benefit from 
selective decontamination, compared with the multiple trauma and postoperative 
patients where most benefit has been reported. 
The overall mortality rate in the ICU was 20 % m the patients rn the initial study 
period, 24% in the control patients and 22 % in the patients who received intestinal 
decontamination. It was thought that nosocomial infection contributed to death in 
similar proportions of each group (9%, 10%, 8.5% respectively), although the criteria 
for this were not specified. 
The authors conclude that while there may be a role for selective decontamination to be 
used for a limited period to control an outbreak of a resistant organism, they were 
unable to demonstrate any benefit from this technique in the prevention of endemic 
nosocomial infection , and that such use may not only not be cost-effective, but also 
potentially hazardous , because further bacterial resistance is likely to emerge. 
7) The Paediatric ICU 
ZOBEL ET AL 2?3 reported a study of selective decontamination performed in a 
paediatric ICU population who all required intubation, ventilation and ICU therapy for 
at least 4 days in their hospital in Graz , Austria. Patients were randomly assigned to 
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receive decontamination with oral and enteral polymyxin E, gentamicin and 
amphotericin B and parenteral cefotaxime, while the control group received 
perioperative prophylaxis and conventional therapy as indicated. 
The definition of a respiratory tract infection was the presence of purulent sputum with 
a positive culture and new pulmonary infiltrates on the chest radiograph, in association 
with pyrexia ( > 38.50C), and a white cell count > 14 000/ml or < 3 000/ml. 
The patients in both groups were comparable in terms of age, sex, body weight, 
severity of illness and therapeutic and monitoring expense. There was no significant 
difference between the groups in terms of duration of ICU stay, ventilation, nor 
systemic antibiotic therapy. 
The colonisation patterns resembled the other studies in that colonisation in both groups 
was similar on admission (24% in the treatment group, compared with 20% in the 
control); colonisation with Gram negative organisms gradually disappeared in the 
decontaminated patients , whereas in the control group colonisation with organisms such 
as Pseudomonas aeruginosa and Klebsiella ::,pp increased from 10 % to 52 % . In both 
groups the colonisation of the respiratory tract by Gram positive organisms increased, 
but Gram negative bacteria and yeasts were not found in the respiratory tract of the 
treatment group. Urinary tract colonisation was minimal in both groups. There was no 
development of resistance to the drugs used for decontamination during the trial. 
36% (10 patients) in the control group developed secondary infections (6 respiratory 
tract infections due to endogenous Gram negative organisms, 2 catheter related 
staphylococcal infections and one fungal and one staphylococcal septicaemia), 
compared with only 8 % (2 patients) in the treatment group, and both these infections 
were due to Staphylococcus aureus ( one tracheobronchitis and one catheter related 
infection). In all patients with respiratory infections, the infections were preceded by 
colonisation of the oropharynx. There were five deaths, 3 in the treatment group and 2 
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in the controls, all apparently because of multiple organ failure with low cardiac output 
states; however, without specifying how this was determined, "no patients died from 
uncontrolled infection". 
While this study again showed convincing eradication of colonisation by endogenous 
Gram negative organisms, with a lower incidence of infection due to such organisms in 
the decontaminated patients, the incidence of staphylococcal infections would appear to 
have been high in this unit. Whether this phenomenon was related to the SDD regimen 
used, which might promote the emergence of staphylococcus as a pathogen was not 
addressed. The microbiological data presented in this paper is limited. 
Once again, the unblinded nature of the study , the small numbers of patients, and 
differences in definitions prevent the conclusions from being definitive. 
8) The effect of selective decontamination on antibiotic resistance profiles 
There is much concern that the use of topical antibiotics may promote the emergence of 
resistance, particularly the widespread use of topical antibiotics in a prophylactic 
capacity. Much of the uncertainty over the role of selective decontamination has 
stemmed from the potential adverse effects that this regimen might exert on the ICU 
microbial flora, and routine microbiological surveillance has been recognised to be a 
sine qua non since the regimen was first instituted by Stoutenbeek et al 274. 
Nevertheless, most reported studies of SDD have failed to demonstrate a significant 
adverse effect on the aetiology and resistance patterns of the pathogens encountered 
following the use of SDD; the caveat being that in most cases the technique had 
possibly not been applied for sufficiently long for major effects to have become 
apparent; in some cases, they also have not been adequately looked for. 
That SDD must have some major effects on the bacterial flora would appear to be 
likely from the success that Brun-Buisson et al reported 249 with its use to eradicate 
multiply-resistant Gram negative bacilli from their ICU. 
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STOUTENBEEK ET AL 14,275 reported the effect of selective decontamination on the 
emergence of resistant bacteria, using data from 164 multiple trauma patients studied in 
their ICU over a 30 month period in their ICU. They found no increase in the 
percentage of patients with acquired drug-resistant Gram negative bacilli: 4 % of the 
strains of the 374 isolates were resistant to tobramycin; all strains, except for the 12 % 
of isolates which were Proteus spp, were sensitive to polymyxin E; Escherichia coli, 
K/ebsiella spp, and Proteus spp were invariably sensitive to cefotaxime. However, a 
"considerable" percentage of Pseudomonas spp, Acinetobacrer spp, Enterobacter 
cloacae and Citrobacter spp were found to be cefotaxime resistant. 96% of the flora 
present on admission were sensitive to cefotaxime, and the majority of cefotaxime-
resistant Gram negative organisms were considered to have been acquired within the 
hospital. 
35 % of patients acquired one or more different strains during their stay in the ICU, 
which were mostly isolated from the rectal swabs. The Gram negative organisms most 
frequently acquired included: Pseudomonas spp, Enterobacrer spp, Acinewbacter spp, 
and Proteus spp. Forty percent of these isolates were cefotaxime resistant, although 
none was resistant to the combination of antibiotics used in the enteral regimen. The 
majority of acquired organisms were isolated only once, but in 21 % secondary 
colonisation, usually of the rectum, followed, and in 66% of these cases, the organisms 
were subsequently eliminated by the enteral antibiotics. 10% of the gastrointestinal 
colonisation was with cefotaxime-resistant Gram negative organisms, but colonisation 
of the lower respiratory tract, urinary tract or wounds with cefotaxime-resistant Gram 
negative organisms was only found in 2 % . There was no increase in the incidence of 
cefotaxime-resistant strains, and the majority of organisms identified which were 
resistant to cefotaxime, were initially isolated in low concentration from the 
gastrointestinal tract, suggesting that they may already have been present from 
admission. There were eight strains of Gram negative bacilli which had previously been 
sensitive t~ cefotaxime which developed resistance, which the authors ascribed to the 
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presence of sub-inhibitory concentrations of cefotaxime in the faeces. These organisms 
were not resistant to the enteral antibiotics, however, and the "majority" were 
eliminated before clinical problems arose. 
Aminoglycoside resistance was not common in this study , which the authors explain by 
the fact that gentamicin and vancomycin are inactivated in the faeces, whereas the 
tobramycin, which they used instead , is not. The synergistic effect of the agents used in 
the enteral regimen and the preservation of the anaerobic flora were also invoked to 
explain this discrepancy. Resistance to polyrnyxin E did not occur during the study, 
other than in Proreus spp which is recognised to be intrinsically resistant to this 
antibiotic. 
The infections with resistant organisms included three wound infections with 
cefotaxime-resistant Gram negative bacill i (Emerohacrer cloacae, Pseudomonas 
aeruginosa and Acinerobacrer spp) , and one respiratory tract infection with 
Acinerobacrer spp. There were no secondary Gram negative urinary tract infections; 
however, before the addition of cefotaxirne to the reg imen. there were three cases of 
Gram negative septicaemia (Escherichia coli , Proreus mirabilis and Acinewbacter 
calcoaceti cus). 
This study is one of a very fev, which have reported in detail the effects of selective 
decontamination on the resistance patterns of the microbial flora. Unfortunately the 
regimen used was not uniform over the time period during which the study was 
conducted and cefotaxime was not routinely used for the whole period, so that the 
ultimate impact on resistance to this agent may have been underestimated. While the 
effect on colonisation of the . gastrointest inal tract by Gram negative organisms is 
extremely dramatic with the use of SOD. rhe authors do not address the other important 
issue of the potential adverse effects the regi men may have on the Gram positive flora, 
particularly the staphylococci. 
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ARMSTRONG ET AL 276 reported the effect of selective decontamination on the 
resistance patterns of Pseudomonads during their 18 month study of SDD in 331 
patients. Pseudomonads were isolated from 27% of the patients who received SDD and 
30% of controls. The respiratory tracts of 8 % and 9 % of patients, respectively, were 
colonised by Pseudomonads on admission, and although this incidence increased in 
both groups, there was a trend for this to be curtailed in the patients receiving SDD. 
There was a reduction in the incidence of clinical infections with this organism, despite 
the fact that the authors reported that the SDD patients appeared to act as a reservoir 
for persistent strains. The epidemiology of Pseudomonas aeruginosa did however 
appear to be influenced by the use of SDD, as the introduction of an aminoglycoside-
resistant strain to the ICU seemed to become more easily established, possibly due to 
the altered colonisation resistance of the patients and the tobramycin resistance of the 
organism. The question as to whether the frequency of infections due to Pseudomonas 
spp was actually increased due to the persistent reservoir that the SDD patients served 
to maintain is raised. Unfortunately the incidence of infections caused by this organism 
prior to the study is not presented, but this study does raise important issues which have 
not been adequately dealt with in other reports and for which the answers are at 
present, not available. 
Limited reports on the effect of SDD on the Gram positive organisms are available, 
although several studies have suggested that the use of the regimen is associated with an 
increase in colonisation and possibly infection by these organisms 256,273, Finch et al, 
Palomar et al 
NAU ET AL 277 reported that, following the introduction of SDD (parenteral cefuroxime 
for the initial 3-5 days, and enteral polymyxin E, amphotericin B and gentamicin) to 
their unit for the management of intubated neurological patients, there was an alarming 
increase in the incidence of cefuroxime and gentamicin resistant staphylococci, with a 
concomitant increase in gentamicin resistance amongst the Pseudomonaceae. There was 
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an increase rn methicillin-resistant staphylococci, and the gentamicin resistance was 
associated with amikacin resistance. They suggest that SOD is hazardous in selecting 
and inducing antimicrobial resistance, and abandoned the technique. 
KONRAD ET AL 278 reported similar findings in their study, where there was an increase 
in colonisation and infection caused by DNase negative staphylococci, an increase in 
methicillin- , cefotaxime- and tobramycin- resistant staphylococci, and cefotaxime-
resistant Enrerobacteriaceae and Pse11domo11ads in the patients receiving SDD. 
9) The antibiotic levels achieYed in the bronchial tree and serum during SDD. 
GASTINNE ET .-\L 272 reported a study in which they aimed to determine whether there 
were detectable levels of antibiotics in the bronchial secretions and serum of patients 
receiving SDD. Tobramycin and amphotericin B levels were determined every 3 days 
in the serum, tracheal aspirates, and distal bronchial secretions of 15 patients who 
received SOD and mechanical ventilation for more than 10 days. They showed that 
82 % of tracheal aspirates contained detectable levels of cobramycin, although the levels 
fluctuated widely, and that tobramycin levels were detectable in the serum of 50% of 
the specimens, as well as the distal bronchial secretions, particularly in those patients 
with renal impairment. The tobramycin level was frequently found to be above or near 
the MIC of common bacterial pathogens. and the MICs of the majority of pathogens 
that could be cultured were higher than corresponding drug levels. 
The authors point out that the presence of bactericidal antimicrobial concentrations 
within the bronchial secretions may prevent the development of nosocomial respiratory 
tract infections,_ by eliminating pre-existing colonisation in situ, rather than by merely 
exerting an effect on the gastrointestinal tract. Their findings are also of importance, 
because the definitions of respiratory tract infection used in many of the studies of SOD 
hinge on microbiological criteria, (both proximal culture of tracheal aspirate or the 
number of colony forming units obtained on culture of protected specimen brush 
samples), and thus may not be valid. Finally the nephrotoxic effects of persistent 
316 
samples), and thus may not be valid. Finally the nephrotoxic effects of persistent 
aminoglycoside administration need to be considered when this regimen is used for 
prolonged periods, if enterally administered tobramycin is able to achieve significant 
serum levels. 
10) Summary of Trials 
In the light of the above, selective decontamination has been demonstrated to have 
effects which include an unequivocal reduction in colonisation by Gram negative 
bacteria colonising the oropharynx and stomach, with a more variable effect on 
colonisation patterns of the lower gastrointestinal tract. The effect on yeasts is also 
more unpredictable. Many of the studies have reported a high incidence of infections 
due to Gram positive cocci, although none has reported outbreaks of resistant 
organisms with the use of this technique, albeit over limited periods, to date. All the 
studies have reported a reduction in respiratory tract infections, with a more variable 
effect on urinary tract and catheter related infections. 
Almost all the studies have indicated that, in spite of the reduction in infection, there 
was no associated benefit on morbidity and mortality. The costs of this technique are 
not insignificant, hence the attempts at developing regimens using cheaper agents with 
similar efficacy. 
The primary aim presumably, when embarking on the routine use of SDD, is to reduce 
morbidity and mortality through a reduction in secondary infections, but the majority of 
studies mentioned above have failed to do this conclusively through faults in study 
design including the use of different diagnostic criteria, many of which are too non-
specific to be considered reliable, or repeatable. The small patient numbers, 
uncontrolled, or unblinded studies, and post hoc stratification in an attempt to show 
benefit have prevented this technique from being able to be unreservedly accepted as a 
new and routine part of intensive care patient management. 
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As a result of the still questionable evidence on the benefit of selective 
decontamination, meta-analyses using the available evidence have been performed, as it 
is well recognised that to prove that any technique has a beneficial effect on mortality, 
requires vast numbers of enrolled patients. By combining the data of the published 
studies, it has been hoped that more conclusive results might be obtained. 
VANDENBROUCKE-GRAULS ET AL 279 published a meta-analysis of the effect of selective 
decontamination of the digestive tract on the incidence of respiratory tract infections 
and mortality in the intensive care unit in 1991. They evaluated 1489 patients who had 
been incorporated into 11 studies between January 1984 and December 1990, according 
to whether the study design used an historical control group of untreated patients or a 
randomised control. 
All the studies which were used in this meta-analysis have been reviewed above and 
include the publications by Stoutenbeek, Ledingham , Brun-Buisson , Hartenauer, 
Kerver, Ulrich , Tetteroo, Aerdts, Unertl and Mc Clelland, except for that of Konrad 
(published in German). As was mentioned when reviewing these papers, the studies are 
not homogeneous as some (Stoutenbeek, Ledingham, Konrad , Hartenauer, McClelland, 
Aerdts, Tetteroo) used initial parenteral prophylaxis with cefotaxime. 
The authors warn that the results of this meta-analysis need to be interpreted with 
caution, as the studies analysed all used the selective decontamination for different 
indications, in different patient groups and with different prophylactic regimens; they 
also point out that there may be unsuccessful studies which had not been analysed 
because they had not been published. They blame poor diagnostic criteria on the 
striking difference of the effect of this regimen on the incidence of infection and 
mortality. 
Selective decontamination in this meta-analysis was shown to have a significant effect 
on the frequency of respiratory tract infections, but its effect on mortality, however, 
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was not clearly shown. There was a 10% reduction in mortality in the historical control 
groups, with a confidence interval so wide that it ranged from a 33 % reduction to a 
25 % increase in mortality. Among the randomised and alternate trials, there was about 
a 33 % reduction in mortality, with the confidence interval ranging from a 50% 
decrease to a 10% increase. The studies of Stoutenbeek, using an historical control, and 
Ulrich, were largely responsible for this benefit; when these studies were removed 
from the meta-analysis, no benefit was found. The role of cefotaxime in these studies 
was not conclusively demonstrated. There was no difference in mortality in the studies 
in which parenteral antibiotic prophylaxis with this agent was provided, and those in 
which it was not given. 
LIBERATI AND BRAZZI from Milan (Meta-analysis of randomised controlled trials on the 
effect of Selective Decontamination of the Digestive Tract. SDD Trialists Group, 
submitted for publication) performed a meta-analysis of 22 randomised controlled 
studies published/unpublished since 1984. Altogether 4073 patients were analysed, of 
whom 2011 received active therapy and 2062 no treatment or placebo; in this group 
there were 1083 deaths. The endpoints of this study were pulmonary infections and 
overall mortality. Despite the wide heterogeneity of the trials analysed, this study once 
again confirmed that SDD significantly reduces pulmonary infections; however, the 
overall mortality was only marginally affected. 
According to their analysis, the pooled odds ratio for pulmonary infections was 0.38 
(95% CI= 0.32-0.45) , while that for mortality was 0.92 (95% CI= 0.79-1.06). A 
19% statistically significant relative reduction in the odds of death emerged, however 
when trials with a systemic antibiotic were added to the enteral decontamination 
regimen (2381 patients and 599 deaths) there was an odds ratio = 0. 81 (95 % CI = 
0.67-0.99). Using these estimates, 8 patients would need to be treated (range 7-9) to 
prevent one pulmonary infection and 27 patients (range 15-530) to prevent one death. 
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The authors emphasise that while this treatment has been shown to affect the incidence 
of pulmonary infections significantly, a properly conducted study with some 1500-2000 
patients, and using mortality as an endpoint, would be the ideal to identify the clinical 
relevance and cost-effectiveness profile of selective decontamination, and to determine 
which patient-mix is most likely to benefit from this technique. Their analysis suggests 
that both topical and parenteral agents are required for the technique to be effective. 
In general , the reviews of SDD have echoed doubts and caution rather than embracing 
the technique. van Dalen , as early as 1989 280 cautioned that "if the costs and the risk 
of the emergence of resistance are accepted, as well as the uncertainty of diagnostic 
accuracy in respiratory tract infections, SDD may be effective in patients requiring 
mechanical ventilation for more than 5 days." 
WEINSTEIN 281 reviewed the role of SDD following the reported successful eradication 
of a multiply-resistant Klebsiella spp strain with the use of this technique 250. While 
acknowledging that the results were difficult to explain, and there was still a potential 
risk of resistant organisms emerging, his conclusions were fairly positive, pending the 
results of definitive studies. He suggested that the regimen might be used in selected 
high risk groups, or as an empiric measure where other approaches had failed. 
REIDY ET AL 282,283 from Ledingham' s unit in Glasgow also reviewed the role of 
SDD and concluded that it had a definite role in ICU management, although which 
patient groups were most likely to benefit was not yet apparent, with the available 
studies. There was a suggestion that trauma patients and other long-stay groups were 
most likely to show benefit, however. They commented that, in spite of the variations 
in trial design, there was a "remarkable" consistency in the reported results from many 
centres. SDD was clearly demonstrated to reduce the rate of colonisation by aerobic 
Gram negative bacilli of the upper GIT and airway , with an associated reduction in the 
infection rate by these organisms, particularly secondary respiratory tract infections. By 
comparing the efficacy of the regimens in decontaminating the oropharynx, the authors 
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concluded that this is an important component of SDD, but that the importance of 
gastric decontamination is less well established. 
In the studies reviewed, no increase in antibiotic resistance by Gram negative 
organisms was detected, however, several centres did note an increased incidence of 
resistant Gram positive organisms, which resulted in infections in some centres. Cross-
infection between contaminated and decontaminated patients, which was part of the 
rationale for the consecutive design of some studies, however, did not seem to be an 
important consideration, as there was no substantial difference in the infection rate 
between these and concurrent trials. 
Reidy suggests that part of the reason for the failure of SDD to reduce mortality may 
be that the wrong group of patients was selected, because the number of patients 
recorded as dying from infectious causes is small; patients who are uninfected on 
admission and who are pre-selected as likely to require prolonged ventilation may also 
be at greater risk of brain death, or death from other underlying causes. The lack of 
evidence for a causal relationship between secondary infection and death is also cited as 
a potential explanation. Another potential mechanism which is invoked is that bowel 
endotoxin may be responsible for the development of multiple organ failure, and that 
the level of gastrointestinal decontamination achieved with SDD may not actually be 
sufficient to inhibit the endotoxin from still being formed and absorbed. 
With his interest in the gastrointestinal origin of endotoxin and its potential role in the 
induction of multiple organ failure, DIETCH 284 posed the question as to whether SDD 
failed to improve survival, because it was directed only at the pathogen, and not at 
improving the resistance of the host to infection. Bacterial translocation requires the 
disruption of the ecological balance of the normal intestinal microflora with bacterial 
overgrowth, or impairment of the host immune defences, or either the physical or 
physiological disruption of the function of the mucosa! barrier. He suggested that SDD 
could and would not alone be able to increase survival, because the studies had enrolled 
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mostly immunocompromised patients, with impaired intestinal barrier function, without 
addressing the underlying issues of preventing the mechanisms involved in bacterial 
translocation. 
GORIS ET AL l92 studied the effects of SDD on survival and organ function in an 
experimental model of sepsis with multiple organ failure. Their study is the only 
reported experimental model of the effect of SDD , and their findings both coincide 
with and contradict the conclusions reached by Deitch. They showed that SDD 
effectively prevented bacterial translocation of Enterobacteriaceae, with an associated 
decrease in the early mortality. However, the late mortality was unaffected, and 
seemingly unrelated to bacterial translocation. They suggested that SDD would be 
unlikely to have a major influence on mortality in patients, because therapy is 
introduced at a later stage than in the experimental model , thereby losing the advantage 
in a reduced early mortality; as a result of ileus, trauma or peritonitis , the therapeutic 
effect of SDD would also be likely to be still further delayed. The authors suggest that 
multiple organ failure and sepsis which are the major causes of death in the ICU are the 
result of a severe generalised autoinflammatory reaction to massive stimuli such as 
trauma, in which activated macrophages, rather than bacteria or endotoxins, play the 
dominant role. 
VAN SAENE ET AL 285 reviewed 16 controlled trials of selective decontamination that 
had been published prior to December 1990. They concluded that selective 
decontamination had generally been shown to reduce microbial carriage and acquired 
infections. They admitted that the benefit in terms of mortality had been less 
convincingly demonstrated, which they attributed to the fact that many of the patients 
in the studies had largely irreversible diseases and thus would have been unlikely to 
have shown significant benefit. 
Van Saene et al 286 commented on the controversy surrounding SDD in a "critical 
evaluation of the clinical, bacteriological and epidemiological benefits" ; the reviews 
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that had disputed the efficacy of the technique were hotly attacked, while any evidence 
in support of the regimen was eagerly grasped to argue in favour of this approach, 
which, they suggested should even be carried into the ward as part of prophylaxis for 
major surgery. The authors reviewed twenty studies available by 1991 and concluded, 
with no further evidence than has been provided in the previous chapters, that SDD was 
indicated for trauma patients, in certain elective surgical procedures including liver 
transplantation and oesophageal resection, and finally in the control of outbreaks of 
ICU infection. 
FINK 287 commented that future trials of SDD should p~eselect subgroups at high risk 
for mortality related to secondary infection , as the causes of mortality in the ICU were 
mostly a result of the underlying disease process, only a very select few dying as a 
result of acquired infection. He criticised physicians in North America for being slow 
to adopt the technique because of the cost constraints of this extremely expensive 
regimen. He acknowledged that the risk of the emergence of antimicrobial resistance 
was yet another strong detractor from the use of SDD, and in particular the risk of the 
emergence of gentamicin resistant enterococci and overgrowth with coagulase negative 
staphylococci was of great concern. If SDD were really of value, the benefits, 
measured by cost and mortality, might have been expected to have already been more 
evident and clinicians might require less persuasion to adopt SDD, rather than still 
awaiting the results of bigger and better trials. 
CRAVEN 288 provided one of the more recent editorials on the controversy over SDD. 
While commenting that almost all studies had shown a reduction in the incidence of 
respiratory tract infection, he cautioned that the diagnosis of nosocomial respiratory 
tract infection was difficult, and often unreliable; few studies had been able to show an 
improvement in mortality, morbidity as measured by duration of ICU stay or 
ventilation, or cost. While nosocomial infection increases mortality, he acknowledged 
that it was both difficult and controversial to segregate the mortality attributable to 
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infection. He felt that in view of the current lack of consensus on the role of SDD, the 
best regimen and the appropriate target population, the technique still needed to be 
regarded as experimental, and could not be recommended as a routine prophylactic 
strategy. In the interim, established infection prevention methods should continue to be 
carefully implemented. 
Part of the rationale for the use of selective decontamination has been that this 
technique may reduce the colonisation of patients and thus make it easier to maintain an 
uncontaminated environment in the ICU 229. This possible benefit would appear to be 
doubtful in view of the increasing evidence of the overgrowth of Gram positive bacteria 
associated with the use of SDD. Whether any study will ever be able to resolve 
convincingly the contribution that nosocomial infection plays in causing the death of an 
already critically ill patient is doubtful. 
7.U The Role of Selective Decontamination in the Prevention of Nosocomial 
Infection 
Despite almost a decade since SDD was introduced to the practice of critical care 
medicine, its role is still not clearly established , and the indications for its use remain 
controversial. There are several reasons for this: the regimens used in many of the 
studies have varied, with some studies including both parenteral and enteral agents, 
while others have used only enteral agents ; the controversy over the role of parenteral 
agents still not having been satisfactorily resolved. Even the agents used are not 
standardised. The ICU populations that have been studied have been different, allowing 
conclusions to be drawn as to subgroups that may potentially benefit from the 
technique. There is no uniformity in trial design and many of the studies have had 
inherent flaws such as post-hoc stratification and insufficient patient numbers, making 
any conclusions drawn suspect. The definitions of nosocomial infection are a further 
stumbling block in achieving consensus. There are as yet no standardised definitions for 
diagnosing nosocomial infection , and the diagnosis, particularly of nosocomial 
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pneumonia, is extremely difficult. The use of the protected specimen brush would 
appear to have superceded clinical definitions in many quarters, but what the 
microbiological cut-off should be in a patient who is receiving antibiotics is uncertain, 
particularly if the agents used in the SDD regimen are able to achieve therapeutic levels 
in the bronchial secretions and serum. In many of the studies, the distinction between 
colonisation and infection has not been adequately defined. While the majority of 
studies have shown a reduction in the incidence of nosocomial respiratory tract 
infections, the effects of SDD on morbidity and mortality remain less convincing. The 
data on the effect of SDD on the emergence of resistant micro-organisms remains 
controversial. While studies have not convincingly demonstrated an increase in the 
incidence of resistant aerobic Gram negative bacilli , there have been reports showing an 
increased incidence or persistence of Pseudomonas aeruginosa , and the adverse effects 
reported from several centres on organisms inherently insensitive to the agents in the 
regimen is of concern. Finally, the cost of the regimen is not insignificant, particularly 
when the drug costs, pharmacy and increased nursing time, as well as the considerable 
laboratory load imposed by the seemingly essential microbiological surveillance, are all 
taken into account. 
Stoutenbeek showed a reduction in the incidence of nosocomial respiratory tract 
infections, urinary tract infections, bacteraemias and wound infections 14, in the initial 
studies of the regimen. Ledingham was able to show a reduction predominantly in the 
incidence of respiratory tract infections, but no reduction in the incidence of 
bacteraemia 263 . Kerver reported a reduction in the incidence of bacteraemias, intra-
abdominal infections, as well as respiratory tract infections, but no effect on urinary 
tract infections 253 . Aerdts found that the incidence of respiratory tract infections was 
reduced, but was unable to confirm a reduction in the incidence of other types of 
nosocomial infection 269; this was also the experience of Tetteroo 260. The French 
studies 250,268 failed to find a significant reduction in the incidence of nosocomial 
infection. The majoritY. of other studies have reported a reduction in the incidence of 
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secondary respiratory tract infections, but have either not commented upon, or have not 
detected a significant reduction in the incidence of other types of infection. The implied 
consensus being that SDD may have some role in the prevention of respiratory tract 
infection, but that its effect at other sites is far from clear. 
In general, the reviews of SDD have echoed doubts and caution rather than embracing 
the technique. The conclusions at the first European Consensus Conference on SDD 
were that the use of this technique was able to reduce the incidence of nosocomial 
infection, particularly superinfection of the respiratory tract. However, there were no 
specific indications for its use, and there was no proven reduction of morbidity, 
duration of ICU stay, or mortality associated with its use; furthermore, there was no 
decrease in the costs of ICU therapy if this technique was employed. While 
acknowledging that the conclusions should not be considered definitive, the recently 
completed "Meta-analysis of randomised controlled trials on the effect of Selective 
Decontamination of the Digestive Tract" which has been submitted for publication, in 
which our study of SDD was included , showed a significant reduction in respiratory 
tract infections, and had a moderate effect on mortality. 
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CHAPTER 8. THE TREATMENT OF NOSOCOMIAL INFECTIONS IN THE 
ICU 
8.1. The treatment of nosocomial pneumonia 
The diagnosis of nosocomial pneumonia in the ventilated patient has been shown to be 
difficult, and requires a high index of suspicion. The importance of ongoing monitoring 
and surveillance of all parameters which may provide early indications of the 
development of infection at any site, cannot be over-emphasised , and is one of the 
mainstays of intensive care. The regular analysis of blood-gas, serum chemical and 
haematological parameters may provide early evidence of organ dysfunction , but 
microbiological surveillance cultures are the most valuable tool in providing ongoing 
information as to the prevailing bacterial flora, and thus serve as a useful guide in 
selecting the most appropriate empirical antibiotic therapy. This may then be modified, 
pending the culture results obtained by more specific diagnostic procedures, and thus 
avoiding delay at a critical phase. The importance of the Gram stain in guiding initial 
therapy should not be forgotten in guiding the selection of therapy. Numerous pus cells 
in association with a predominant organism, particularly if Gram positive, are likely to 
give an accurate guide to the type of antimicrobial therapy. 
The spectrum of pathogens causing nosocomial infection m the ICU, depends to a 
certain extent on the individual hospital, the specific ICU and patient population that is 
being considered; however, the majority of such infections are due to aerobic Gram 
negative bacilli including the Enrerobacreriaceae , particularly E.coli and Klebsiella 
spp, although Pseudomonas spp and Acinerobacter spp are also important, but may 
show more of a geographic variability. The staphylococci are also an important cause 
of nosocomial infection, and in patients who are immunocompromised or have received 
multiple courses of antibiotic therapy , the yeasts need to be considered. 
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The selection of antimicrobial agents for the therapy of nosocomial infections in the 
ICU, should follow the same principles as when choosing the most appropriate agent 
for therapy elsewhere. Once the patient has been hospitalised for more than 48 hours, 
the organism should be assumed to be hospital-acquired and the choice of antibiotic 
should take the resistance profiles and spectrum of pathogens into account. Because the 
patients are critically ill and there is no room for miscalculation, the tendency is to 
commence therapy with fairly broad spectrum drugs directed at the most likely 
causative organisms; once confirmatory evidence of the aetiological agent has been 
obtained, therapy can then be more specifically directed and unnecessary agents should 
be discontinued as soon as possible, to prevent the emergence of resistance 214. It is 
however important, in view of the critically severe nature of the patients' illness, that 
there be a minimum of delay in the initiation of therapy, as it has been demonstrated, 
both in the treatment of pneumonias due to Gram negative organisms 289 and 
bacteraemias due to Gram negative organisms 290 , that the achievement of early 
therapeutic aminoglycoside levels is a significant factor in determining outcome. While 
the measurement of aminoglycoside levels is a fairly simple and routine procedure, 
techniques are not as readily available for measuring the serum levels of other 
antimicrobials , but it would be fair to assume that a similar relationship must exist. 
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The choice of antimicrobial agent needs to be determined by the antibiotic policy laid 
down for the hospital and ICU. A close liaison between the teams of microbiologists 
and clinicians is helpful in formulating the most effective, early therapeutic strategies, 
in the often complex problems encountered in the ICU. The use of empirical antibiotic 
combinations such as beta-lactam agents in combination with aminoglycosides 291,292 
are widely used , because of the synergy , improved bactericidal effect, which is thought 
to impact on outcome 292, as well as the broad spectrum of cover such a combination 
provides. It is also thought that combination therapy may help in the prevention of 
antibiotic resistance. 
With the increasing prevalence of antimicrobial resistance, there is an ongoing search 
for new-lines of therapy, preferably containing new chemical entities which may bypass 
already established resistance mechanisms. The quinolones are a class of antibiotic that 
are currently being promoted , because of their pharmacokinetic and apparently good 
safety profile, wide spectrum of activity and relative novelty 247 ,293. The recently 
developed agent imipenem/cilastatin, combines a beta-lactam and cilastatin (an enzyme 
inhibitor that blocks the extensive renal metabolism of the drug) and has found a place 
in the ICU as a broad spectrum agent in the treatment of severe infections with minimal 
side-effects; it is particularly indicated for the treatment of nosocomial multi-resistant 
infections , but is expensive and needs to be kept as a last resort agent to preserve its 
therapeutic range of activity. 
(i) The treatment of pneumonias due to Gram negative organisms with aerosolised 
antibiotics 
Despite broad clinical experience with Gram negative pneumonia, there is no consensus 
about the optimal number of antibiotics for therapy , or the length of treatment. The 
response of nosocomial Gram negative pneumonia to appropriate antimicrobial therapy 
is recognised often to be poor; this has been attributed to poor penetration of the 
bronchial secretions by the aminoglycosides, even in the face of adequate serum levels, 
binding of these drugs within the bronchial tree, and a possible inhibitory effect of the 
low pH of purulent bronchial secretions. 
While the endotracheal administration of antibiotics for the prophylaxis of nosocomial 
pneumonia remains controversial as a result of the above studies, others have attempted 
a similar form of therapy for the treatment of established severe Gram negative 
bronchopneumonia, rather than as prophylaxis. The appeal of this form of therapy lies 
in its ability to place the antibiotic at the site of infection, while still theoretically 
avoiding the problems of systemic toxicity . 
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Klastersky et al 294 reported a study, conducted over a two year period in a 
neurosurgical ICU in Brussels, to evaluate the efficacy of endotracheally administered 
aminoglycosides as prophylaxis, or therapy, for Gram negative nosocomially acquired 
infections in intubated patients. 
Inclusion criteria for this study were the presence of a tracheostomy or endotracheal 
tube, a depressed level of consciousness and purulent sputum in which Gram negative 
bacilli were evident on smear, and which were cultured as the predominant organism; 
clinical and radiological signs of pulmonary parenchymal involvement, with fever and 
an increased white cell count, as well as a normal serum creatinine. The diagnosis of 
pneumonia further required the agreement of two separate observers. All patients 
received a minimum of four days of therapy , the mean in the active group being 7.3 
days vs 6. 9 days in the control. 
The study was a double-blind design with endotracheal administration of sisomicin or 
placebo being performed three times a day. All patients also received intravenous 
sisomicin and carbenicillin. A "favourable" response to therapy was regarded as an 
improvement in the clinical and radiological signs of bronchopulmonary infection, with 
the patient surviving the episode or dying from an unrelated cause at least 72 hours 
after the completion of therapy. Eradication of the organisms from the sputum was not 
a prerequisite for considering the response to therapy as favourable. 
There were 20 patients enrolled who received placebo and 18 who received sisomicin. 
The patients were comparable in terms of age, sex , and underlying disease. 
Colonisation by potentially pathogenic bacteria in the trachea occurred in 5 patients 
receiving placebo and in 7 treated with sisomicin; in all instances bar one, the organism 
was sensitive to sisomicin. A new clinical pulmonary superinfection occurred in 3 
patients receiving placebo and 4 treated with endotracheal sisomicin. 
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The levels of sisomicin in the serum and in bronchial secretions were measured in 17 
patients in both groups; the aminoglycoside levels in the bronchial secretions of those 
receiving endotracheal placebo were considerably lower than the serum levels, and 
were not found to be bactericidal at one hour after administration. In those who 
received endotracheal and systemic therapy, however, both serum and bronchial levels 
were higher, and the bronchial levels were bactericidal. By measuring the levels of 
sisomicin late in the course of therapy in some patients, the authors established to their 
satisfaction, that accumulation had not occurred. 
There was a favourable response to therapy in 45 % of the patients who received 
placebo, and 77% of those who received endotracheally administered sisomicin; this 
difference was significant. There were similar numbers of infections due to 
Pseudomonas aeruginosa in both groups, 50% of those in the placebo group responded 
to endotracheal administration of placebo plus systemic therapy, while 75 % showed a 
favourable response to endotracheal sisomicin. 
The majority of deaths were attributed to noninfectious complications; 4 (20%) of those 
receiving placebo died from their underlying disease, while a further 4 were thought to 
have died as a result of infection. There were no deaths in those receiving sisomicin 
that were attributable to infection, although 5 (28 % ) patients died from their underlying 
disease, and 4 of these were documented to have had infections with Pseu.domonas 
aeruginosa. 
The emergence of sisomicin resistant organisms was not detected, and the therapy was 
well tolerated. Although the numbers were small, this study also seemingly 
demonstrated an improvement in mortality with this form of therapy. However, the 
authors warn that this form of treatment should only be reserved for patients with 
documented Gram negative bacterial pneumonia, with careful microbiological 
surveillance to detect the possible emergence of drug resistant organisms; it is even 
recommended that patients receiving this form of therapy should be isolated. 
Brown et al 295 more recently reported a multi-centre, prospective, double-blind study 
to determine the efficacy and safety of endotracheal tobramycin in the treatment of 
Gram negative bacterial pneumonia. Patients were randomised to receive either 
tobramycin or placebo, administered endotracheally every 8 hours, as well as 
intravenous tobramycin and either cefazolin or piperacillin. 85 patients (45 in the study 
group and 40 in the placebo group) were enrolled, of whom 41 were fully evaluable. 
Diagnostic criteria for Gram negative bacterial pneumonia included an infiltrate on the 
chest radiograph, predominance of Gram negative organisms on Gram's stain of the 
tracheal aspirate in association with a predominance of leukocytes over squamous cells, 
grossly purulent tracheobronchial secretions, fever > 38°C on rectal measurement 
and/or a leukocyte count of more than 10 000/ml or less than 5 000/ml with a left shift. 
Patients receiving endotrachea1 tobramycin were more likely to have a bacteriological 
cure, and the pathogen was more often eradicated by endotracheally administered drugs 
than by those administered intravenously. Pathogens were eliminated in 56% of patients 
who received endotracheal tobramycin, compared with only 25% of those who received 
placebo which was statistically significant. The antibiotic serum levels in the two 
groups were similar, but had to be modified to maintain peak and trough levels. There 
was no more frequent emergence of drug resistance in the active group than in those 
who received placebo. However, analysis of the entire group demonstrated that 
symptomatic improvement, adverse events (including a worsening of renal function, 
and unexplained supraventricular tachycardia) and either clinical response or failure, 
occurred in a similar number of patients in both groups; the mortality was also not 
significantly different. 
The authors concluded that endotracheally administered antibiotics could be used as an 
adjunct to systemic antibiotic therapy in the treatment of pneumonia, with good 
tolerance and safety. 
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This study was performed over an 18 month period as a multicentre study yet only 
succeeded in enroling 41 fully evaluable patients; the impact of more widespread use of 
endotracheal tobramycin on antimicrobial resistance patterns within a single unit is not 
established and, in view of the evidence of antibiotic resistance patterns associated with 
other topical regimens, warrants further study. The small number of patients makes 
interpretation of this carefully conducted study difficult. It is difficult to envisage much 
role for an expensive adjunct to more conventional therapy, associated with an 
increased incidence of unexplained ~upraventricular tachycardia, where the results 
failed to demonstrate any clinical improvement or reduction in mortality. 
(ii) Other modalities 
The other modalities for the treatment of pneumonia in the ICU include supportive care 
in the form of specialised ventilatory techniques to ensure both adequate oxygen 
delivery and uptake, techniques such as positive airway pressure ventilation, 
physiotherapy and the use of bronchodilators. 
The use of immunotherapy in the form of monoclonal antibody preparations directed 
against endotoxin, tumour necrosis factor, interleukin I and other cytokine mediators of 
the inflammatory cascade, although still in its infancy, appears to be showing promise 
in opening up a new therapeutic avenue, in the management of nosocomial infections 
and other causes of overwhelming sepsis, which lead to the development of organ 
dysfunction; thereby aiming to prevent the spiral into multiple organ dysfunction to 
septic shock and death. Although all extremely important and interesting, they are 
beyond the scope of this thesis. 
8.2 The treatment of urinary tract infections 
In general it is not recommended that asymptomatic bacteriuria should be treated. 
However, Krieger et al 76 demonstrated that bacteriuria due to Serratia marcescens 
was associated with a high incidence of bacteraemia, and thus in such cases, earlier 
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therapy is probably indicated. There are no trials available looking at the most 
appropriate management of such clinical situations. 
With or without antimicrobial therapy, most cases of catheter-associated bacteriuria 
should disappear spontaneously on removal of the catheter. However, patients with 
catheter-associated bacteriuria are thought to have an increased incidence of post-
catheterisation symptomatic urinary tract infections; thus the use of antimicrobial 
therapy in patients with bacteriuria who are about to have their catheters removed may 
be appropriate. 
For the patient who develops symptoms and signs of bacteraemia, the physician needs 
to exclude other potential sources of sepsis, by culturing all potential sites, including 
the blood. If results of surveillance samples are available, these may be valuable in 
guiding initial empirical antibiotic therapy. The antibiotic selection needs to be based 
on the knowledge of the locally prevailing organisms and their sensitivity patterns. It 
would seem to be good practice to remove a potentially colonised and infected catheter, 
if infection or heavy colonisation are detected. 
8.3 The treatment of vascular catheter-related sepsis 
Despite careful attention to aseptic technique during the preparation and administration 
of intravenous solutions, the infusion and its apparatus are likely to continue to be 
needed to be considered as a potential source of sepsis. in the differential diagnosis of 
fever. There are no clinically distinguishing features to assist in the diagnosis, and a 
high degree of suspicion with a low threshold for the removal of all intravenous lines 
needs to be maintained to prevent the potentially serious sequelae that can follow 
catheter-related sepsis. The placement of the catheter for more than 48 hours, or the 
presence of phlebitis at the infusion site if noted, should both suggest that the 
intravenous line is a possible cause of infection - phlebitis is reported to be a feature in 
over half of all episodes of catheter-related septicaemias 80. 
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The most common organisms causing bacteraemias related to intravenous line 
infections are the Staphylococci, while Gram negative bacteria normally account for 
about one third of such cases 9o,93 . Multiply resistant coagulase negative staphylococci 
are becoming increasingly common causative organisms of line sepsis, particularly in 
patients who have already received antibiotic therapy, and accounted for 44 % of the 
organisms isolated in the study by Brun-Buisson et al 90, although they were less 
important in causing clinically significant infection. If it is suspected that the 
intravenous catheter is the source of sepsis and this organism is implicated, therapy 
with cloxacillin, fucidin, clindamycin or vancomycin should be commenced, and the 
catheter removed. 
One of the most serious complications of intravenous therapy is the development of 
suppurative thrombophlebitis. Patients with burns are the most susceptible, and this 
complication is frequently the cause of death in such patients. The diagnosis may go 
entirely unsuspected antemortem, as local signs of inflammation are reported to be 
absent in up to 70% of cases, and the signs and symptoms may only manifest 2 to 10 
days after the catheter has been removed SO. The clinical suspicion of this complication 
requires immediate surgical intervention. Antibiotic therapy should be based on the 
Gram's stain of pus obtained from the vein, but if this does not show organisms, initial 
antibiotic therapy should be initially directed against methicillin-resistant staphylococci 
and Gram negative bacteria. 
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PART TWO 
CHAPTER 9. ORIGINAL RESEARCH PROJECT 
A DOUBLE BLIND, PLACEBO CONTROLLED EVALUATION OF THE 
EFFICACY AND SAFETY OF CEFOTAXIME PLUS SELECTIVE 
DECONT~\ilINATION OF THE DIGESTIVE TRACT (SDD) Ai"10NG 
CRITICALLY ILL PATIENTS lN AN INTENSIVE CARE ENVIRONMENT 
Investigator 
J.M.J. Hammond 
Respiratory ICU 
Department of Medicine 
University of Cape Town and Groote Schuur Hospital 
Co-investigators: 
Professor P. D. Potgieter 
Head of Respiratory ICU 
Department of Anaesthetics 
University of Cape Town and Groote Schuur Hospital 
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Professor A.A.Forder 
Head of the Department of Medical Microbiology 
University of Cape Town and Groote Schuur Hospital 
Dr G.L.Saunders 
Department of Medical Micobiology 
University of Cape Town and Groote Schuur Hospital 
This study was sponsored by Roussel Laboratories . 
Introduction 
This study protocol was developed in 1988 , at which time many of the studies reviewed 
above had not yet been either performed or published. The study protocol which 
follows is the original protocol. which was used for the study which was performed 
from January 1989 to December 1990. 
9.1 Protocol 
Nosocomial infection is recognised to be a major cause of morbidity and mortality in 
patients requiring admission to the intensive unit. The overall incidence in our local 
respiratory ICU was reported to be 23.6 % 148 and , as in other centres, the most 
important site of such infection is the lower respiratory tract. 
337 
The majority of nosocomial infections are thought to be due to endogenous organisms, 
resulting from the aspiration of the secretions from the oropharynx and gastrointestinal 
tract, which have become colonised by resistant organisms from the hospital 
environment. Both the severity of the patient's illness and the excessive use of 
antimicrobial agents, alter the normal anaerobic flora of the gastrointestinal tract which 
usually provides colonisation resistance against colonisation with other more potentially 
pathogenic bacteria. The use of antacids and H-2 antagonists, which are often routinely 
used to prevent stress ulceration, also alter the protective acid barrier of the stomach 
and may thereby promote colonisation of the stomach and oropharynx. Studies using 
sucralfate rather than antacids or H-2 antagonists have reportedly reduced nosocomial 
respiratory infections from 34 % to 10.3 % 55 ,62. 
Recent studies using selective decontamination of the digestive tract (SDD) with 
preservation of the anaerobic flora, have shown marked reduction in gastrointestinal 
colonisation, where potentially pathogenic aerobic Gram negative bacteria are 
eliminated from the gastrointestinal tract with the use of non-absorbable antibiotics. 
The studies have been extended with inclusion of parenteral cefotaxime for the first 48 
hours of treatment, and more recent studies have shown a significant reduction in the 
incidence of nosocomial infections. However, the overall mortality has remained 
unchan°ed except in selected oroups such as trauma patients 243,263,296 e, ' 0 ' • 
The above studies support the use of these regimens in the intensive care unit to reduce 
the incidence of nosocomial infections. However, recommendations that they should be 
widely accepted were criticised in correspondence in the Lancet (Noone, Bunney, 
Inglis, Lancet 1988; 18 June : 1388-1389). All these previous studies had used 
historical controls rather than concurrent controls, which might have influenced the 
results, as it is well recognised that infections frequently follow cyclical changes which 
may be unexplained. A number of confounding factors , including the lack of control of 
H-2 antagonists may also have influenced the results; if the gastric acidity is controlled 
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there may be no further reduction in the nosocomial infection rate, colonisation or 
mortality in selected groups. These previous studies have shown no influence on the 
duration of stay in intensive care, and varying effects on the mortality. Other centres 
such as the Royal Free Hospital in London have achieved equivalent results with other 
regimens illustrating the need for results to be interpreted in the light of the prevailing 
conditions where the study was carried out. 
Similarly, this regimen, which is designed to prevent nosocomial infection, needs to be 
thoroughly evaluated in the environment where it will be used before becoming 
common practice, in order to ensure that it achieves its aims of reducing morbidity, 
mortality and the overall cost of intensive care. Furthermore, a revised study protocol 
using concurrent controls and avoiding earlier flaws in study design should eliminate 
the previous criticisms. 
2. Objectives 
The objective of this study is to determine the effectiveness of selective 
decontamination of the digestive tract in the prevention of secondary infections 
occurring after 48 hours of admission to the ICU, and within 48 hours of discharge 
from the ICU, in critically ill patients and to determine whether SDD is cost-effective 
in the management of seriously ill intensive care patients. This will be evaluated in 
terms of the incidence of morbidity and mortality , secondary infection and the 
additional costs incurred in the investigation and management of these secondary 
infections. 
3. Design 
This study is a double-blind placebo controlled comparative evaluation of the selective 
parenteral and enteral antisepsis regimen (SPEAR) in the prevention of acute secondary 
infections in critically ill patients in the ICU environment in the Groote Schuur 
Hospital, Cape Town. Patients will be entered to the trial on admission to the Unit. 
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4. Patient Selection 
4.1 Patient Inclusion Criteria 
4.1.1 Patients who are likely to be intubated for at least 48 hours and stay 5 days in the 
ICU should be included. The outcome in others excluded who meet entry criteria 
should be analysed separately. 
4.1.2 Those who fail to meet the entry criteria, after randomisation , will be excluded 
from analysis. 
4.2 Patient Exclusion Criteria 
The following patients will not be enrolled: 
4.2.1 Patients with a history of hypersensitivity to any of the investigational drugs, or a 
history of documented anaphylactic reactions to the penicillins. 
The patient can be withdrawn if the clinician feels it to be in the patient's own interest. 
5. Procedures 
5.1 Dosage and Administration 
Patients will be reviewed by a designated Critical Care staff member and allocated 
according to a randomised code list to either the test group or the control group. 
The SDD and cefotaxime will be administered as follows: 
a) SDD gel 5g (Amphotericin B 2 % , Polymyxin E 2 % and Tobramycin 2 % ) applied to 
the oral mucosa 6 hourly with a prefilled disposable syringe and spread evenly with a 
gloved finger , throughout the period of intubation and up to 48 hours after extubation. 
An identical placebo gel will be used in the placebo group. 
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b) SDD liquid 10 ml ( Amphotericin B 500 mg, Polymyxin E 100 mg, Tobramycin 80 
mg) delivered orally or per nasogastric tube 6 hourly. If a nasogastric tube is used, 
gastric suction will be discontinued one hour after each dose throughout the stay in the 
ICU. 
c) Cefotaxime lg intravenously 8 hourly administered on admission and continued for 
the full first 72 hours of the study. The dosage will be adjusted according to body 
weight in patients less than 50 kg : to 50 mg/kg body weight per day. All patients in the 
study (including the placebo group) wi ll receive cefotaxime or a previously prescribed 
antibiotic as mentioned in (d). 
d) Patients arriving in the ICU and already receiving an antibiotic (other than 
cefotaxime) will be kept on that antibiotic if the organism(s) involved show sensitivity. 
Patients on prophylactic antibiotics following surgery or trauma patients on antibiotics 
other than cefotaxime, will be changed to cefotaxime treatment. 
5.2 Concurrent Treatment 
Non-antimicrobial drug therapy may be administered concurrently, but must be 
recorded on the case report form . Probenecid and an timicrobial therapy (other than 
cefotaxime and the SDD antimicrobials) will be documented on the case report form. 
H-2 antagonists will be used in patients with known ulcer disease and evidence of overt 
gastrointestinal bleeding , and in other high risk patients (bums, severe head injuries 
and liver failure) . No other anti-ulcer preparations will be allowed. 
If antimicrobial therapy other than cefotaxime is indicated by clinical or 
microbiological findings , the oral decontamination therapy may be continued at the 
discretion of the physician. 
Inappropriate metronidazole should be discontinued and patients will remain on the 
trial, otherwise metronidazole may be continued. 
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Surgical procedures may be performed but must be documented on the case report 
form. 
6. Evaluation Criteria 
Objectives 
1. To determine the incidence of secondary infections occurring 48 hours after 
admission to the ICU. Hospital and community acquired organisms will be evaluated 
separately. 
2. To evaluate the effect of this regimen on the clinically significant isolates in the 
Unit. The resistance patterns of clinically significant isolates in the ICU from 12 
months preceding the trial will be compared with the last 12 months of the study 
period. 
3. To analyse mortality rates in: 
* death of patients staying longer than 5 days in the ICU 
* death of patients with an admission APACHE II score of < 17 , 17 - 30 , > 30. 
4. To evaluate total cost involved of antibiotics used during patient's stay in the ICU 
relating to 
* SDD regimen 
* treatment of secondary infection 
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6.1 Clinical Criteria 
A medical history will be taken and a complete physical examination will be performed 
on admission before SDD and cefotaxime therapy, to detect the clinical signs of any 
infection of the pulmonary system, the intravenous line, the urinary tract, soft tissue 
sepsis, or generalised septicaemia. (See Appendix for definitions). Evaluation of the 
severity of the illness according to the APACHE II score and organ failure will be 
calculated on admission. Injury severity scores will be calculated on admission in 
injured patients. During treatment, patients will be observed daily to evaluate their 
clinical status and to detect evidence of systemic or local infections. The physical 
examination ~ill be repeated within 48 hours after the completion of therapy. 
6.2 Laboratory Determinations 
Routine laboratory evaluation (haematology, chemistry, bacteriology) should be carried 
out as usual. 
6.3 Bacteriology 
6.3.1 Screening 
Aerobic bacterial cultures will be obtained from the oropharynx (properly taken swab), 
gastric aspirates (obtained via nasogastric tubes), rectum (faecally-soiled swab), urine, 
tracheal aspirates in intubated patients, and wounds (when present) on the day of 
admission , and twice weekly thereafter with specific identification of Enterococci, 
Acinetobacrer, Pseudomonas, Klebsiella spp, Staphylococcus aureus, Staphylococcus 
epidennidis and yeasts. Intravenous catheters will be cultured on removal. Colony 
counts for Gram positive and Gram negative bacteria and yeasts will be recorded. 
Cultures will be done twice weekly, on discontinuation of the study and 3 days after 
discharge from the Unit if the patient is still hospitalised. 
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6.3.2 Clinical 
When an acute infection is suspected clinically appropriate additional cultures will be 
obtained for the isolation, identification and sensitivity testing of the causative 
pathogen(s). The source of the cultures must be recorded on the case report form. 
Where multiple cultures of the same site are taken , it must be so indicated. 
All these results will be maintained on a daily updated log for screening cultures and 
clinical cultures. 
6.4 Sensitivity Testing 
Susceptibility testing of the pathogenic organism(s) to cefotaxime sodium will be 
determined by disc sensitivity using a 30 ug cefotaxime disc or by determination of the 
minimum inhibitory concentrations (MICs). As determined by the Kirby-Bauer method, 
organisms are susceptible to cefotaxime if the zone of inhibition is > 20mm. Disc 
sensitivity findings of 15 to 19 mm (intermediate zone) indicate that the organisms may 
be susceptible if a higher dosage of cefotaxime is used. A disc sensitivity finding of 
< 14mm indicates resistance to cefotaxime. The MIC breakpoints are sensitive at < 
16ug/ml and resistant at > 64 ug/ ml. Susceptibility testing will only be performed on 
pathogenic isolates (Eg in blood or otherwise sterile body fluids) and surveillance 
culture isolates from wounds, tracheal aspirates and urines when colony counts of 
bacteria exceed 103 organisms/ ml. 
7. Adverse Experiences 
Any adverse experience occurring during the study must be reported in the case report 
form. The investigator must state whether the cause of the adverse experience was 
related to the study drug, concurrent drug therapy , an underlying disease , a 
combination of these factors, or is unknown. Patients with an adverse experience will 
be carefully followed-up to determine the outcome. If a serious or alarming adverse 
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experience occurs which may be related to the study drug, therapy will be discontinued 
immediately and the patient will be treated accordingly. 
8. Institutional Review Committee 
In accordance with the Medicines Control Council of South Africa, the appropriate 
Ethical Committee must review this protocol. 
The Ethics Committee of the University of Cape Town approved the protocol. 
9. Informed Consent 
This should be given by the patient or a family member where indicated , prior to entry 
to the study. 
Prior to the commencement of the study , the protocol was altered to allow patients to 
be enrolled, if the attending physician who was not involved in the trial , agreed. At this 
stage, this technique was already an accepted form of prophylaxis, and none of the 
drugs used was experimental. This modification was accepted by the Ethical Review 
Committee. 
10. Confidentiality 
All personal information pertaining to patients during this study and in any subsequent 
reports will be kept confidential. Patients will be identified by their names, and by a 
patient number. 
11. Statistical Evaluation 
Statistical planning of the study involved the Department of Biostatistics at the Medical 
Research Council. It is planned to enrol 400 evaluable patients into the study, which 
should provide a sufficiently powerful model to show a statistical difference in 
mortality , as well as reductions in the inc~dence of infection and morbidity , based on 
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the current mortality and infection rate in the ICU and previously reported studies on 
SDD. With a confidence interval of 95 % and power of 80 % , a 50 % reduction in the 
mortality rate of 25 % should be demonstrated by enrolling 334 evaluable patients, 
while a 50% reduction in the infection rate from 23% should be able to be achieved 
with 370 patients. 
Data is to be gathered using a DBase IV programme data-base, and the statistical 
analysis will be performed using Epi-Info Stat-Cale (U.S.Department of Health and 
Human Services/Public Health Service/Centres for Disease Control, Atlanta, USA), 
and Statgraphics and these statistics would be complemented by the assistance of the 
Department of Biostatistics (Dr Carl Lombard) at the Medical Research Council. 
Statistical methods will include exact Chi-square testing for comparison of patients with 
multiple infections, Chi-square 2x2 tables for comparing two binomial proportions, and 
Fisher's exact test for small sample sizes, with t-testing for continuous variables, and 
confidence intervals where appropriate. 
Appendix 
DEFINITIONS OF INFECTION 
Endpoints for infection are defined as follows: 
I. A significant organism is a pathogenic organism(s) isolated in association with the 
following clinical infections: 
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a) Septicaemia: 
The clinical observation of all of the following: 
1) a rise or fall in the temperature 
2) a rise in the white cell count or a left shift in its morphology 
3) evidence of organ dysfunction such as hypoxaemia, renal dysfunction, hepatic 
dysfunction, central nervous system dysfunction etc. 
4) a positive blood culture. 
b) Nosocomial Pneumonia: 
A new radiological infiltrate on the chest X-ray occurring 48 hours after admission to 
the ICU with all of the following findings: 
1) purulent sputum with more than 25 leukocytes and less than 10 squames per low 
power field 
2) increased temperature > 38°c 
3) increased white cell count > 10 000/ml , an increasing white cell count ( > 2 000/ml) 
or a shift the morphology of the white cells 
4) respiratory or nosocomial pathogen cultured from the tracheal aspirate 
5) deterioration in gas exchange (Pa~ decrease of more than 2kPa) 
c) Bronchial infection was defined as all of the following: 
1) purulent bronchial secretions with more than 25 leukocytes per low power field 
2) increased temperature 
3) increased white cell count ( > 10 000/ml) or left shift 
4) respiratory or nosocomial pathogen cultured from secretions 
5) no radiological changes. 
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Colonisation of the bronchial tree was defined as the culture of the same organism on 
2 or more occasions without the signs of a systemic infection. 
d) Urinary tract Infection 
in the non-catheterised patient: 
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a urine culture yielding more than 100 000 colony forming units of aerobic bacteria, or 
fungi with dysuria and pyuria (> 10 white cells per high power field). 
in the patient who had either been catheterised for more than 48 hours before collection 
of the specimen or who was catheterised during the 48 hours prior to the collection of 
the specimen: 
bacteria in the urine 
white cells in the urine 
local or systemic signs of infection. 
Colonisation of the urinary tract was defined as the culture of the same organism on 
2 or more occasions without the signs of systemic infection. 
e) Wound Infection: positive culture of aerobic or anaerobic bacteria, or fungi, in the 
presence of pus draining or aspirated from a wound. 
O Abscess, Phlegmon or other fluid collection: a positive culture of aerobic or 
anaerobic bacteria, or fungi , obtained from a localised tissue collection. 
g) Sinusitis: clouding of a sinus on X-ray and clinical features of infection with 
isolation of bacteria ( aerobic or anaerobic) or fungi from an aspirate of the sinus or a 
nasal discharge in the presence of white cells. 
h) Enteritis : the isolation of enteric bacterial pathogens or Clostridium difficile toxin 
in the presence of diarrhoea or mucosa! changes on proctoscopic examination. 
i) Vascular catheter- related sepsis defined as all of the following: 
1) an increased temperature ( > 38°C) 
2) an increased white cell count ( > 10 000/ml) or a left shift in the white cell 
morphology 
3) defervescence of symptoms on the removal of the catheter 
4) with or without a positive catheter tip culture or blood culture 
5) with or without evidence of local inflammation. 
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Colonisation of an intravascular device was defined as a positive culture without 
signs of local or systemic infection. 
9.2: PRESL~TATION OF RESULTS 
9.2.1 Introduction 
The aim of performing this double-blind randomised study of selective decontamination 
was to evaluate accurately the efficacy of this technique in reducing the incidence of 
nosocomial infection, its associated morbidity and mortality , as well as its cost-
effectiveness and potential effects on the microbial flora. As outlined above, there have 
been numerous studies on selective decontamination, but the majority have not been 
blinded or have used historical control groups, with post hoc stratification to identify 
sub groups that might benefit from the use of this technique; the studies have also been 
too small to establish a conclusive role for this technique. 
9.2.2 Patients and l\'Iethods 
All patients admitted to the multi-disciplinary respiratory ICU who were considered to 
be at high risk of developing secondary infection, because of an expected duration of 
intubation of at least 48 hours, and an anticipated duration of stay of at least 5 days 
were included in this study. This assessment was made by the attending physician using 
guide-lines from previous analysis of admissions to this unit, which had showed that 
patients with asthma, overdoses and those admitted electively postoperatively, were 
unlikely to meet these criteria. Data was also collected on patients who were not 
enrolled, but who subsequently fulfilled the enrollment criteria, in order to seek 
selection bias and provide an additional control group; this data was analysed 
separate! y. 
Consent for enrollment to the trial was obtained from the patient, a close relative, or 
the responsible physician (who was not taking part in the study) if no-one else was 
available , as the study was not investigating a new drug , but designed to assess the 
efficacy of a regimen of drugs of established safety and efficacy. Only patients with a 
history of hypersensitivity to the study drugs, or of anaphylaxis to penicillin were 
excluded. The study was approved by the ethics committee of the University of c ·ape 
Town. 
On admission, patients were randomised by computer-generated numbers to groups 
receiving placebo or the SDD regimen , and either regimen was commenced within 6 
hours of admission. The regimen consisted of 2 ml methylcellulose gel containing 
amphotericin B 2 % , tobramycin 2 % and polymyxin E 2 % applied to the oral mucosa 
every 6 hours with a gloved finger (or an indistinguishable placebo) , and 10 ml of a 
solution of amphotericin B 500 mg, tobramycin 80 mg and polymyxin E 100 mg by 
mouth or nasogastric tube (or 10 ml of indistinguishable placebo solution). Nasogastric 
suction was discontinued for one hour after each dose of SDD. 
Cefotaxime lg 8 hourly was given intravenously to all patients for 72 hours; it was felt 
that the use of intravenous placebo instead. of the active antibiotic might have 
necessitated the withdrawal of excessive numbers of patients to establish whether they 
were receiving the active medication . Patients already receiving an antibiotic for a pre-
existing infection on admission to the ICU were continued on the antibiotic if the 
sensitivity patterns were appropriate, · or if the patient appeared to be responding; 
otherwise, if appropriate, cefotaxime was substituted. 
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No use of anti-cytokine therapy was made for the duration of the study. 
No routine prophylaxis against gastrointestinal bleeding was used. Ranitidine was used 
in patients with pre-existing ulcer disease or active gastrointestinal haemorrhage, and in 
those at high risk of gastrointestinal haemorrhage (from bums, liver failure or head 
injury). Sucralfate was not used for the duration of the study, because it is thought to 
bind to enteral medication and might thus have inactivated the drugs administered for 
decontamination, 64 and also because of its own antibacterial properties 59 which might 
have caused difficulty with the interpretation of results. 
The respiratory ICU, in which the study was conducted, comprises two units with a 
total of 10 beds and admits patients with medical, surgical, obstetric and gynaecological 
diseases, including patients who have sustained multiple trauma, although patients with 
primary head injuries are admitted to the neurosurgical ICU. 
Patients were fully examined on entry, an admission diagnosis was defined and the 
severity of illness was assessed according to the APACHE II 297, organ failure 298 
and injury severity scoring systems 299. Factors recognised as likely to affect the 
development of secondary infection 30,203, such as the presence of diabetes mellitus or 
other immunocompromising diseases, the presence of malnutrition, alcohol abuse, the 
use of steroid and other immunosuppressive therapy, and the use of antacids or H-2 
antagonists were documented specifically. 
In all intubated patients, nasogastric tubes were placed for the duration of ventilation. 
Patients were intubated via the nasal route unless there was a specific contraindication 
to this. In the majority of patients requiring intubation for more than 10 to 14 days, a 
tracheostomy was performed. 
Routine investigations included daily chest radiography during ventilation, laboratory 
evaluation of haematology, serum and urine chemistry; other investigations were 
performed as necessary. Clinical microbiological surveillance studies were performed 
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twice weekly and more often if indicated. Daily clinical examinations including 
monitoring for evidence of secondary infections were performed, and a careful note 
was made of all complications that developed while in the ICU. 
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Specific note was taken of factors and their duration which might predispose to the 
development of secondary infection while in the ICU, including the level of 
consciousness, the degree of sedation and mobilisation, the presence of bulbar 
dysfunction, the presence of ileus, and the use of invasive therapeutic and monitoring 
devices , such as intubation, ventilation , plasma exchange, dialysis, nasogastric 
drainage, total parenteral nutrition , which might have been required as part of 
management. Follow-up of all patients was continued until discharge from hospital. 
Nosocomial infection was diagnosed if signs developed more than 48 hours after 
admission to the ICU. The following definitions of infection were used: 
Septicaemia was diagnosed as the clinical observation of all of the following with no 
obvious localising site of infection: 
a positive blood culture 
a rise or fall in temperature ( > 38°c or < 35.5°C) 
a rise in white blood cell count ( > 10 000/ml) , or a left shift in its morphology 
evidence of organ dysfunction. Criteria for organ dysfunction were defined as follows: 
lung: Pa02 < 8kPa on 40% oxygen , or respiratory rate < 5/minute or > 49/minute, or 
PaC02 > 6kPa, or AaD02 > 46 kPa, or dependent on ventilator for > 4 days. 
kidney: urine output < 479ml/24 hours, or < 159ml/8 hours, or serum creatinine 
> 300 mmol/1, or serum urea > 20 mmol/1. 
liver:liver enzymes more than twice normal or total bilirubin > 50 mmol/1. 
central nervous system: unconscious with a Glasgow coma scale of < 6 without the use 
of sedatives for more than 24 hours 
haematological: white cell count < 1 000/ ml, or platelets 20 000/ml. 
cardiovascular: mean blood pressure < 49 m_m Hg , or pH < 7.24. 
Nosocomial pneumonia was defined as a new infiltrate on the chest radiograph more 
than 48 hours after admission to the ICU, purulent bronchial secretions with many 
leukocytes, temperature above 38°C, white blood cell count > 101011 , increasing or 
showing a left shift, substantial numbers of organisms shown by Gram staining of the 
tracheal aspirate, with a pure growth cultured from the tracheal aspirate, and a 
deterioration in gas exchange of 2kPa or more. 
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Bronchial infection was defined by the presence of all the features of pneumonia, 
except the radiographic changes. 
Urinarv tract infection in patients who had been catheterised for at least 48 hours before 
collection of the specimen, was defined by the presence of local or systemic signs of 
infection, with culture of bacteria or yeasts , and the presence of more than 108 white 
cells per litre of urine. 
Vascular-catheter related sepsis was defined as temperature above 38°C, white blood 
cell count above 1010;1 or left shift, with relief of signs on removal of the catheter; a 
positive catheter tip culture, blood culture, or the presence of local inflammation were 
not required for the diagnosis. 
If a nosocomial infection was diagnosed , appropriate cultures were taken for isolation, 
identification and sensitivity testing of the causative organisms. All central venous 
catheters were cultured on removal. The results of diagnostic and clinical surveillance 
samples were available to the clinicians. 
Aerobic cultures of oropharyngeal swabs, gastric aspirates, faecally soiled rectal swabs, 
urine, tracheal aspirates, wound swabs, or other secretions were taken on admission 
and then twice a week throughout the ICU stay; final specimens were taken 3 days after 
discharge from the ICU. To avoid carry-over of topical antibiotics from the SDD 
regimen, specimens were plated out, then placed in 10ml broth overnight to dilute any 
antibiotics present. Growth density was graded 1-5 by a semiquantitative method 243. 
Enterococci, Acinetobacter spp, Pseudomonas spp, Klebsiella spp, Staphylococcus 
aureus, Staphylococcus epidermidis and yeasts were identified and antibiotic sensitivity 
patterns tested by standard disc-diffusion methods. Enterobacteriaceae were identified 
to species. 
The clinical cause of death was characterised as unrelated, possibly related or definitely 
related to secondary infection; when possible these results were confirmed at autopsy. 
The costs of SDD and the additional costs of investigatioH and treatment of any 
episodes of nosocomial infection were recorded. 
Statistical analysis was done using the statistical programme "Statcalc" of Epi-Info 
(Version 5) (U.S.Department of Health and Human Sciences/Public Health 
Service/Centre for Disease Control U.S.A.); the "Statgraphics" programme and the 
Medical Research Council Department of Biostatistics (Dr Carl Lombard). Chi-square 
testing with 2x2 tables and 2x5 tables for categorical variables, Fisher's exact test for 
small sample sizes, contingency tables, Wilcoxon-rank, Student's t test for continuous 
variables and confidence intervals, were used where appropriate. 
9.2.3 Results 
Between January 1989 and December 1990, 719 patients were admitted to the 
Respiratory ICU, of whom 322 fulfilled the criteria for study entry on admission. 83 
were subsequently withdrawn: 3 for protocol violations (1 patient refused to continue 
with the enteral medication, 1 patient was suspected to have a drug allergy to the 
enteral medication, but was later found to have received placebo, and 1 patient was 
treated with sucralfate), and the remaining 80 because their duration of ICU stay was 
too short. 28 of those excluded, none of whom developed infection, died within 5 days 
of admission. There were, in addition, 36 patients who were not initially included, but 
who were subsequently found to have satisfied the study criteria; their data was 
analysed separate! y. 
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The various groups were similar in terms of baseline characteristics (Table Seven). 
Table Seven - Baseline Characteristics** 
SDD 
group 
n=l 14 
Mean age 43.5 
± 15.5 
Male/female 67/47 
Race 
Black 33 
White 20 
Mixed 61 
APACHE II 13.9 
SD ± 8.4 
Organ 1.29 
failure* ± 0.55 
ISS 28.9 
± 14.0 
*By Knaus'criteria 298 
± values are standard deviation 
ISS: Injury Severity Score 299 
Placebo Withdrawn 
group 
n=125 n=83 
43.5 42.7 
± 16.5 ± 16.3 
69/56 47/36 
32 ? -_) 
21 16 
72 42 
14.0 16.9 
± 7. 1 ± 10.2 
1.34 1.45 
± 0.55 ± 0.85 
28.4 20.5 
± 13.5 ± 11.5 
Suitable but 
not included 
n=36 
46.3 
± 16.6 
14/22 
7 
3 
26 
14.8 
± 8.9 
1.25 
± 0.56 
32.7 
± 11.9 
** No statistical difference between rhe acrive and control groups, or "suitable" group 
was found, using Chi square, Srudent's rand conringency rabies where appropriare. 
The medical diagnoses and surgical categories of che patients are shown in Table Eight. 
The diagnoses are similar in . all groups, other than the patients who were suitable, 
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where there were more asthmatics and other disease categories not normally thought 
likely to lead to prolonged ICU admission. 
Table Eight: Diagnosis on Admission 
SDD Placebo Withdrawn Suitable 
114 125 83 36 
Medical 59 77 53 20 
Asthma 4 1 1 8 
COAD 3 5 11 0 
Pneumonia 12 24 7 3 
ARDS 4 9 4 0 
Other resp 9 6 9 0 
Neurological 12 19 9 4 
Cardiovascul 3 1 2 1 
Poisoning 0 0 3 1 
Other di seas* 12 12 7 1 
Surgical 16 15 15 3 
Cardiothorac 1 2 1 1 
General surg 10 10 7 0 
Obst & gynae 5 '") ,., 4 0 
Orthopaedic 0 1 3 2 
Trauma 39 33 15 13 
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SDD Placebo Withdrawn Suitable 
Other diseases* 
Septicaemia 7 9 0 1 
Connect Tis 2 1 2 0 
Glomneph 2 0 1 0 
Hypothermia 1 0 0 0 
35% burns 0 1 0 0 
Liver fail 0 1 2 0 
Leukaemia 0 0 1 0 
Septic abort 0 0 l 0 
No significant difference between the 4 groups, using Chi square and contingency 
tables. 
The prevalence of pre-existing disease and the incidence of other immunocompromising 
factors during ICU stay were similarly distributed between the SDD and placebo 
groups (Table Nine) 
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Table Nine: Underlying disease and Immunocompromising Factors 
SDD Placebo Withdrawn Suitable 
n= 114 n=125 n=83 n=36 
Cyclophos 1 1 1 0 
Cytotoxic 0 0 1 0 
Medrol 1 l 1 0 
Pred >40mg 1 2 3 2 
Pred <40mg 7 6 4 6 
Total drugs 10 10 10 8 
Carcinoma 5 2 5 0 
Diabetes 8 10 7 5 
Conn tiss dis 1 4 2 0 
Malnutrition 11 10 6 2 
Obese 11 19 9 6 
Alcohol abuse 20 35 17 7 
Peptic ulcer 6 7 5 2 
Shocked on adm 16 11 10 3 
Emerg surg 9 8 5 0 
Infected 
on admission 59 76 30 26 
(Cylophos =cyclophosphamide, cytotoxic = antineoplastic chemotherapy, pred = 
prednisone, conn riss dis = connective tissue disease) 
Malnutrition and obesity were judged clinically. 
Alcohol abuse was defined as > 4g alcohol/day: (> I boule wine!> 4 tots!> 5 
beers/day). 
Shocked on adm (admission) was defined as a sysrolic blood pressure for less than 
70mm Hg for more than one hour. 
Univariate statistical analysis of rhe factors porentially predisposing to infection was 
pe,fonned using Chi-square, Manrel-Haenszel, Phi Coefficient and contingency tables, 
but failed to demonstrate any d{fference between rhe active and placebo groups. 
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Other factors predisposing to nosocomial infection were also distributed with equal 
frequency between the active, placebo and suitable groups (Table Ten). 
The neurological status was assessed according to the following schema: 
1. Orientated: fully responsive and aware of surroundings 
2. Confused: inappropriate response 
3. Unconscious: not responding to verbal commands 
4. Comatose: not purposeful response to pain (i.e . Glasgow coma scale < 6) 
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Table Ten: Factors Predisposing to Secondary Infection in the ICU* 
SDD Placebo Withdrawn Suitable 
n= 114 n=l25 n=83 n=36 
Albumin< 30mmol/l 77 83 34 17 
Coma day 3 34 49 12 16 
Coma4 ,, -,..) 30 17 10 
Bulbar dysfunct 9 5 1 0 
Bedbound > 5 days 81 96 6 30 
Ulcer 27 33 15 3 
Femoral line 11 9 1 3 
lieus > 5 days 41 36 3 8 
TPN 32 44 6 10 
Enteral feed 96 117 46 31 
* No statistical difference between the groups H1as demonstrared using Chi square. 
Coma day 3 was a neurological grade ~ 3 for 3 days 
Coma 4 was a neurological grade of 4 at any stage (Glasgow coma scale < 6). 
Bulbar dysfunction was documented according ro whether the patient was able to 
swallow his secretions or required denral sucrion and/or a vocal aid added to the 
tracheostomy. 
Bedbound > 5 days: Mobility of rhe patient was documented as to whether the patient 
was able to be mobilised w a chair within 5 days. 
Ulcer therapy: denotes whether the patienr required ranitidine for suspected or proven 
gastrointestinal bf eeding. 
Femoral line: denores the presence of an inrravenous femoral catheter for access, 
dialysis, plasma exchange etc. The risk of carherer-relared sepsis is highest at this site. 
Ileus > 5 days denotes patients who required prolonged nasogastric drainage for 
persistent ileus for more than 5 days. 
TPN denotes parients who received rota/ parenreral nutrition. 
Enteralfeed denotes patients who were enrerally fed via rhe nasogastric tube. 
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The following table documents the ventilatory therapy (Table Eleven) and again shows 
that there were no differences between the two groups that might have favoured the one 
developing infection over the other. 
Table Eleven: Ventilatory Therapy 
SDD Placebo 
n=l 14 n=125 
; 
IPPV(no) 9 6 
CPPV(no) 105 119 
Trache(no) 39 -,., )"-
ETT(days) 7.6 8.0 
± 5.4 ± 5.2 
Trache(days) 22.1 17.7 
± 16.1 ± 13.8 
± = plus or minus standard deviation. 
IPPV denotes intermittent positive pressure venrilarion 
CPPV denotes continuous positive pressure venrilarion 
Trache denotes tracheostomy 
ETT denotes endotracheal tube 
Withdrawn 
n=83 
10 
71 
5 
2.3 
I ± 1.1 
29.0 
± 42.5 
Suitable 
n=36 
6 
30 
11 
7.5 
± 4.8 
18.8 
± 14.8 
No statistical difference could be demonsrrared between rhe active and placebo groups, 
using Chi-square and Student's t rests. 
Numerous devices and life-support . procedures are recognised to be significant 
predisposing factors associated with the development of nosocomial infection. Of these, 
haemodialysis, plasmapheresis , central lines, particularly for the administration of TPN 
and pulmonary artery catheters, are recognised to be important. The frequency of their 
use was equally distributed in both groups, as is indicated in Table Twelve. Enteral 
feeds were used in significantly more patients in the placebo group, may have a 
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protective effect on the intestinal mucosa, but may also contribute to infection by 
introducing exogenous organisms, increasing gastric pH and facilitating aspiration. 
Table Twelve: Invasive Procedures used in the ICU* 
SDD Placebo 
n=114 n=l25 
Haemodialys 8 11 
Plasmapheres 5 4 
Chest drain 37 42 
Art. line 56 76 p=0.09 
Central line 88 107p=0.13 
Periph line 114 125 
PA cath 75 80 
TPN 32 44 p=0. 29 
Enteral feed 96 l l 7p=0.03 
Haemodialys denotes haemodialysis. 
Plasmapheres denotes plasmapheresis. 
Art line denotes arterial line. 
P.A.cath denotes pulmonary artery catheter. 
Withdrawn 
n=83 
1 
0 
11 
32 
48 
83 
43 
6 
I 46 
Suitable 
n=36 
1 
0 
11 
12 
23 
36 
25 
10 
31 
* No statistical difference was demonstrared between rhe acrive and placebo groups 
using Chi square tests. 
There was no significant difference in the number of patients who developed secondary 
infections between the active and placebo groups using Chi-Square (p=0.1714) , 
categorical variables 2x5 (p=0.1368), exact Chi-square test (p=0.0523); however, 
when the Wilcoxon-rank test was used , ranking the number of infections per patient, it 
was possible to show a statistical benefit in the active group (p=0.0465). 
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The incidence of all infections (other than abscesses) but including respiratory tract 
infections, did not differ significantly between the placebo and active groups. The types 
of infection are shown in Table Thirteen. There were very few secondary infections 
encountered in the withdrawn group, as a result of the short duration of stay in the 
majority. In the suitable group, the incidence of secondary infection resemble that of 
the placebo group, reflecting the absence of selection bias, in spite of these patients 
requiring more prolonged admission than had been anticipated. 
Abscesses occurred significantly more frequently in the placebo group. The aetiological 
agents causing the abscesses in the placebo group were : £. coli 2, S. aureus 3, 
Enterobacter spp 1, Candida albicans 4; in the active group there was only one soft 
tissue infection due to S.aureus. These abscesses were mainly intra-abdominal and, 
because of the small numbers involved, the significance of this finding is questionable. 
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Table Thh1een: Types of Infection 
SDD Placebo Withdrawn Suitable 
n=l14 n=125 n=83 n=36 
Infections: 
Total no 44 64 5 16 
No of patients* 31 44 p=0.17 2 11 
(%) (26) (34) (2) (33) 
Pneumonia 8 8 1 1 
Bronchial 15 20 3 10 
Sinusitis 2 0 0 0 
Septicaemia 7 10 0 1 
IV catheter 6 9 0 1 
Urinary tract 3 5 0 3 
Abscess* 1 10 p=0.057 0 2 
Wound 2 2 0 0 
* p values with Chi-square testing. 
Table Fourteen shows the total number of organisms causing infection in the various 
groups. There were fourteen infections which were caused by multiple pathogens. 
There was a significantly higher incidence of Gram positive infections in the patients 
who received SDD (p=0.003, Chi-Square testing), whereas in the placebo group, the 
incidence of Gram negative infections, especially infections caused by the 
Enterobacteriaceae, was significantly increased (p=0.022 and p=0.034, respectively). 
The suitable group again is shown to mirror the placebo group. 
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Table Fourteen: Organisms causing Infection 
SDD Placebo Withdrawn Suitable 
Gram positive 27 22 0 4 
p=0.003 
S.aureus 15 9 0 3 
S. epidermidis 11 7 0 1 
Enterococcus 0 3 0 0 
S. milleri 1 1 0 0 
Other strep 0 "') 0 0 ,_ 
Gram negative 16 42 4 14 
p=0.022 
Enterobacteria 4 19 0 7 
p=0.034 
E.coli 0 7 0 3 
Klebsiella spp 2 5 0 2 
Proteus spp 1 1 0 0 
Emerobacter 1 6 0 2 
Pseudomonas sp 2 5 2 0 
Acinetobacre r 10 15 2 6 
H. influenzae 0 2 0 1 
M. cararrhalis 0 1 0 0 
Candida 1 5 0 0 
Viruses 0 1 0 0 
Other 1 1 0 2 
Table Fifteen demonstrates the organisms causing bronchial infections. There were no 
infections due to the Enterobacteriaceae in the SDD group, however, the number of 
infections due to S.aureus and the non-fermenters was similar in both groups. There 
were no infections caused by Streptococcus pneumoniae in either group, presumably as 
a result of the 72 hours of cefotaxime, although such infections were not encountered in 
the "suitable but not included" group either. 
Table Fifteen: Organisms causing bronchial infections 
SDD Placebo Withdrawn Suitable 
S.aureus 7 5 0 2 
S. epidermidis l 0 0 0 
H. injluenzae I 0 l 0 l 
M. cararrhalis 0 1 0 0 
E.coli 0 1 0 0 
Klebsiella'spp 0 1 0 0 
Pseudomonas sp 1 3 1 0 
Enterobacter 0 2 0 1 
Acinetobacter 6 7 2 6 
Other 0 0 0 1 
Table Sixteen illustrates the organisms causing nosocomial pneumonia. Although the 
incidence of pneumonia was similar in both SDD and placebo groups , a pattern of 
causative organisms similar to those causing the bronchial infections is again seen. It is 
interesting to note that in the group receiving SDD, S. epidermidis, an organism not 
usually associated with pneumonia was considered to be the infecting agent in four 
cases of respiratory tract infection . Acinerobacrer spp , a non-fermenting Gram negative 
organism, endemic to our ICU was the most common pathogen in all groups , and 
appeared to be uninfluenced by this regimen of SDD. 
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Table Sixteen: Organisms causing pneumonia 
SDD Placebo Withdrawn Suitable 
S.aureus 3 1 0 0 
S. epidermidis 3 0 0 0 
H. injluenzae 0 1 0 0 
M. catarrhalis 0 1 0 0 
Klebsiella spp 0 1 0 1 
Pseudomonas sp 0 1 1 0 
Enrerobacter 0 0 0 1 
Acinerobacrer 2 3 0 0 
Other 0 1 0 0 
Table Seventeen shows the organisms causing septicaemia. While a pattern and 
spectrum of pathogens similar to other sites was seen in both groups, it is interesting to 
note that an episode of fungaemia did occur in a patient receiving SDD. 
Table Seventeen: Organisms causing Septicaemia 
SDD Placebo Withdrawn Suitable 
S.aureus 2 2 0 0 
S. epidermidis 1 2 0 0 
E.coli 0 1 0 0 
Klebsiella spp 1 2 0 l 
Pseuaomonas sp 1 0 0 0 
Enterobacter 0 1 0 0 
Acinetobacrer 2 2 0 0 
Candida 1 2 0 0 
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Table Eighteen illustrates the pathogens identified in episodes of catheter related sepsis. 
The expected predominance of Gram positive infections is seen in both groups. 
Table Eighteen: Organisms causing IV catheter related sepsis 
SDD 
S.aureus 1 
S. epidermidis ,., ., 
Enterococcus 0 
Other strep 0 
Klebsiella spp 1 
Ente robacte r 0 
Acinerobacter 0 
Placebo 
0 
4 
2 
Withdrawn 
0 
0 
0 
0 
0 
0 
0 
Suitable 
0 
0 
0 
0 
0 
0 
0 
Table Nineteen illustrates the aetiological agents identified in episodes of urinary tract 
infection. Such infections were extremely uncommon. It is important to note however, 
that episodes of heavy Candida/ colonisation of the bladder were all treated by 
amphotericin B bladder washes, which may have eliminated these infections. 
Table Nineteen: Organisms causing urinary tract infections 
S. epidermidis 
E.coli 
Ente robacte r 
Proteus spp 
SDD 
1 
0 
1 
1 
Placebo 
3 
0 
1 
Withdrawn 
0 
0 
0 
0 
Suitable 
0 
2 
0 
0 
Table Twenty shows the organisms responsible for other episodes of infection. There 
were only two episodes of sinusitis, despite nasotracheal intubation being the norm, and 
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both occurred in patients receiving SDD. There were two soft tissue infections in the 
SDD group, while, as mentioned previously there were significantly more abscesses in 
the placebo group. 
Table Twenty: Other Sites of Infection 
SDD Placebo Withdrawn Suitable 
S.aureus 2 3 0 0 
S. epidermidis 2 0 0 0 
Enterococcus 0 1 0 0 
S. milleri 1 1 0 0 
Other strep 1 1 0 0 
E.coli 0 2 0 0 
Enterobacrer 0 1 0 0 
Pseudomonas sp 0 1 0 0 
Acinetobacter 0 1 0 0 
Candida 0 3 0 0 
Other 0 1 0 0 
Pre-admission colonisation by aerobic Gram negative bacilli of the gastrointestinal tract 
was similar in both groups; in the SDD group , clearance of aerobic Gram-negative 
bacilli from the gastrointestinal tract was effective. Approximately 30% of the 
surveillance cultures of the stomach and oropharynx on admission, showed colonisation 
by aerobic Gram negative bacilli. The clearance of organisms from these sites with 
SDD occurred within approximately 72 hours of admission, whereas, the rectum, 
which was colonised in 90% of instances, took from two to three weeks to achieve a 
90% reduction. There was a progressive increase in colonisation with aerobic Gram 
negative bacilli of the upper gastrointestinal tract in the placebo group. See Figure 
Two. 
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Fig. 2 Gastrointestinal Surveillance Samples 
Enterococcal colonisation of the oropharynx became more common during the ICU stay 
in both groups. On admission, 16% and 10% of oropharyngeal samples from the SDD 
and placebo groups, respectively, were colonised with enterococci. By week two, 30% 
and 32 % were colonised and after 4 weeks, 41 % of samples in both groups were 
colonised. There was a similar increase in methicillin-resistant S. aureus colonisation, 
but it was significantly greater in the SDD than placebo group (SDD 0% on admission, 
10% at 2 weeks, 13% at 4 weeks, vs placebo 2%,4%,5% ; p<0.005, Fisher's test). 
This surveillance data was withheld from the clinical staff for the duration of the study 
to prevent unblinding, and prejudice the diagnosis of infection by influencing the 
clinicians. 
The effects of SDD on complications developing while in the ICU, morbidity and 
mortality are shown in Tables Twenty-one and Twenty-two. There were no differences 
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between the two groups in the incidence of complications, mean duration of ICU stay, 
hospital stay, or outcome. Most deaths were due to multiple organ system failure. 
The incidence of multiple organ failure was similar in both groups, suggesting that the 
use of SDD did not protect against development of multiple organ failure, in spite of a 
significant reduction of the load of aerobic Gram negative bacilli in the gastrointestinal 
tract. 
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Table Twenty-one: Complications while in the ICU* 
SDD Placebo Withdrawn Suitable 
n=114 n=125 n=83 n=36 
Adverse drug react 
Trial drug 0 0 0 0 
Other drug 3 ,.., 0 0 .) 
Other complications 
GIT bleed I I 8 2 0 
Hepatic failure · 12 14 1 3 
Cardiac failure 
-+ l l 1 
' 
Renal fai I u re 7 7 1 0 
Haematol failure 4 3 I I 0 
CNS (coma) 7 3 1 1 
Shock (SBP < 70mmHg) 8 2 10 1 
Aspiration gastric 2 ! I 0 0 
Aspiration feed 4 3 1 0 
Pulmonary embolus 0 0 l 1 
Pneumothorax 3 6 l 0 
Other vent comp 0 0 0 5 
Failed wean 10 14 l 4 
Diarrhoea 19 I 20 1 1 
I 
Venous thrombosis 8 I 7 3 3 
Other 0 2 2 2 
Total no complies 104 99 24 17 
No (%)of patients -+6(40) -+9( 39) 15 ( 18) 11(30) 
* There was no srarisrical d.(/ference herween rhe acrive and placebo groups using Chi-
square testing. 
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There was no overall effect of SDD on mortality (see Table Twenty-two). When the 
patients in the active and placebo groups were analysed according to severity of illness . 
as calculated by the APACHE II score, the mortality was 13 % for those with APACHE 
II scores of less than 17 (SDD 9/78 vs 11/77), 22.5% for those with APACHE II 
scores between 17 and 30 (9/33 vs 9/ 4 7) and all those with an APACHE II of more 
than 30 died (3/3 and 2/2). There was no difference in mortality in any of these 
categories of severity of illness. 
Table Twenty-Two: Effect of SDD on morbidity and mortality 
SDD Placebo Withdrawn Suitable 
n= 114 n= 125 n=83 n=36 
.Mean stay(days) 
In ICU 16.2 16.8 4.8 15.2 
± 14.3 ± 12.3 ± 13.2 ± 12.8 
In hospital 29.9 31.9 14.6 30.4 
± 25.0 ± 22.2 ± 25.0 ± 31.3 
Deaths 
In ICU 14 15 25 2 
In hospital 7 6 3 2 
Total 21 21 28 4 
(%) (18) (17) (34) ( 11) 
± values denotes standard deviation 
There was no statistical difference berween the acrive and placebo groups for any of the 
above variables using chi-square and student's t testing. A significant difference in the 
incidence of secondary infection was however demonstrated in the patients who 
developed multiple infections using contingency rabies. 
The cause of death was categorised according to the main organ system failure which 
was clinically thought to have resulted in death. Respiratory failure and the sequelae of 
septicaemia, which occurred equally frequently in both groups, were the major causes. 
In a number of patients in both groups, death occurred following withdrawal of therapy 
when the outcome was determined to be hopeless. 
The relationship to nosocomial infection was assessed clinically and at autopsy, where 
possible. 3 deaths in each group were assessed as being directly attributable to 
secondary infection , and in a further 9 deaths , this was thought to have been a possible 
contributory factor. 
Autopsies were performed in 11 of the patients in the active and placebo groups ( 3 in 
the active and 8 in the placebo group). In all these patients , the clinical diagnosis of 
secondary infection was confirmed at autopsy , with 3 deaths being directly attributable 
to secondary infections with Pseudomonas spp and Acinerobacrer spp being the 
pathogens in one of these patients, and in two no organisms were identified. In a 
further four patients, nosocomial infections were considered to be a contributory cause 
of death, and this was not determined ante-mortem in only one of these patients. In five 
of these patients , autopsy suggested that the death might have been preventable: two of 
these patients were found to have undiagnosed disseminated tuberculosis, one died of 
staphylococcal septicaemia which had developed in hospital prior to ICU entry, and 
two patients died of ICU acquired infections. This may have been misleading, as 
autopsy was more likely to have been performed in those cases where the exact cause 
of death was uncertain. 
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Table Twenty-Three: Causes of Death 
SDD Placebo Withdrawn Suitable 
Cause of death 
Cardiac 2 1 3 0 
Neurological 1 1 6 2 
Respiratory 5 5 6 2 
Septicaemia 4 7 6 0 
Active support 
withdrawn 6 7 5 1 
Other 3 0 2 1 
Total 21 2 1 28 4 
Relationship to noso, ~omial infect on 
Definite 3 3 0 1 
Possible 4 5 0 0 
Unrelated 14 13 28 3 
There was no statistical difference between rhe active and placebo groups using chi-
square testing. 
The costs of applying the technique of SDD include the costs of the topical and 
parenteral antibiotics , as well as the nursing time required to apply the technique, and 
the cost of microbiological surveillance, which is recommended to detect potential 
outbreaks of resistance. The reduction of antibiotic use for the treatment of secondary 
infections, with the attendant reductions in morbidity and mortality are hoped to 
produce cost-benefit from the use of SDD. Table Twenty-four indicates the measurable 
costs of antibiotics in all groups. The costs of treating secondary infection were 
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significantly higher in the SDD patients, probably as a result of the significant 
increased prescription of vancomycin that was required . 
Table Twenty-Four: Antibiotics used and Costs for treating and preventing 
Infection 
SDD Placebo Withdrawn Suitable 
Acyclovir 0 l 0 0 
Amikacin 5 14 p=0.32 1 4 
AmphotericinB l 4 0 0 
Ampicillin l 1 0 1 
Ceftazidime 2 3 1 0 
Ceftriaxone 2 7 p=0. 4 0 1 
Clindamycin l 1 0 1 
Cloxacillin 9 8 0 3 
Cotrimoxazole 10 18 p=0.84 1 6 
Erythromycin 2 0 0 0 
Fucidin 1 0 0 0 
Gentamicin 0 6 0 1 
Imipenem l 2 0 2 
Penicillin 3 0 0 0 
Piperacillin 0 6 1 0 
Quinolones 0 3 1 0 
Tobramycin l 1 l 0 
Vancomycin 15 9 p=0.01 1 1 
State cost*(R) 24 015 33 337 l 259 3 363 
Total/patient** 1 710 266 15 93 
Private cost* 47 308 59 491 3 283 8 167 
Cost of SDD* 171 000 0 - -
* Cost in rands at prices currem during rhe years I 989-1990 
** Totallpariem denotes mean cost of SDD and amibiotics for secondary infections, at 
state rates for all patients. 
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9.2.4 Discussion 
In this trial of selective decontamination, 239 patients at high risk of nosocomial 
infection were fully evaluable in terms of criteria of duration of stay, and our protocol. 
No significant reduction in the infection rate in the active group was able to be 
demonstrated , either in the group as a whole , or in the various subgroups previously 
reported as being particularly likely to benefit from the use of this regimen, apart from 
in the patients with mid-range APACHE II scores. There was also no reduction in 
morbidity, as measured by the duration of ICU and hospital stay , complications , 
mortality or costs. Overall, 14 % of deaths were assessed as being directly attributable 
to secondary infection, but this figure was not improved by the use of SDD. While it is 
acknowledged that the numbers of patients studied were probably too small for a 
significant improvement in mortality to have been achieved , despite such a finding 
having been reported in two studies 14,267, these findings have not been confirmed in 
meta-analysis 279 and the relationship between secondary infection and death may in 
fact be too tenuous for such benefit ever to be convincingly demonstrated. 
The use of strict clinical definitions for the diagnosis of infection may have resulted in 
a lower reported incidence of infection in this study , but because of the concurrent and 
double-blind nature of the study, the effect would have been the same on both groups; 
this study design would thus have eliminated bias in the diagnosis of secondary 
infection which , is difficult, as has been discussed extensively in the previous sections, 
and dependent on subjective interpretation. The definitions in many of the reported 
studies of SDD have a heavy microbiological weighting, with rather loose clinical 
criteria; the net result being that the reported rates of nosocomial infection are far 
higher than previous studies reporting the incidence of secondary infection 5. The 
definitions used in this study are also not necessarily the gold standard for diagnosing 
secondary infection, and may also be criticised. However, they were found to be 
workable, clinical definitions without the heavy microbiological weighting and its 
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attendant problems, so common to many of the studies of SDD, and if criticism should 
be levelled, it would be that there was a tendency for the over-diagnosis of nosocomial 
infection. These definitions were also not excessively invasive, nor was exotically 
expensive equipment required; and they were easy to apply on a day to day basis, 
which, in the longterm would have improved their reliability. Indeed, these definitions 
are still regularly used to define episodes of nosocomial infection in the Respiratory 
ICU. Both clinical and microbiological confirmation were required to establish a 
definitive diagnosis of secondary infection. 
The use of concurrent controls avoided the potential influence that outbreaks of 
infection, changes in the infection rate, treatment, and the nursing workload might have 
had on the results if the study had used either historical or consecutive time periods. 
The similar results for the patients who were found to have fulfilled admission criteria 
but were not enrolled (the so-called "suitable" group), also demonstrates the absence of 
a possibility of selection bias. Similarly, inclusion of the "withdrawn group" (48 SDD, 
35 placebo) in an intention-to-treat analysis, still showed no beneficial effect of SDD; 
the overall mortality then being 23 % in the SDD group and 21 % in the placebo group. 
Only 3 patients who satisfied the duration of stay criterion were withdrawn, and their 
inclusion in the analysis did not affect the results. The remainder did not receive SDD 
for sufficiently long to have benefited from it, or to have been at significant risk for the 
development of secondary infection, and so have not been included in the main 
analysis. 
A further possible explanation for our negative findings is that our infection rate is 
lower than many previously reported studies of SDD 253.264,269,278. The statistical 
power of our study was sufficient to have detected a 12 % reduction in the incidence of 
infection with 80 % certainty and 95 % confidence intervals, despite our initially low 
infection rate. The high nurse to patient ratio, a modern working environment with the 
beds widely spaced, and a strictly enforced antibiotic policy are possible reasons for 
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this low infection rate. It is widely accepted that long-term immobilisation, especially 
after multiple trauma, is associated with increased morbidity 70. the 
immunosuppressant effects of hypnotic agents is also well known 26. For several years 
we have had a policy of using the minimum of sedation necessary for patient 
management and comfort in our ICU, and have encouraged early mobilisation of our 
patients, with the use of vigorous physiotherapy 222 . It is possible that all these factors 
may help to prevent the development of infections. 
Surveillance cultures showed effective decontamination m all patients who received 
SDD, but the incidence of infection was not significantly reduced; however among the 
placebo group, there were significantly more infections due to Enterobacreriaceae and 
other Gram negative organisms. The incidence of Gram positive infections was 
significantly higher in the SDD-treated patients, which may be due to an increase in 
colonisation by the staphylococci, which are not sensitive to the agents used in the 
decontamination regimen. The most common infectious agents were multi-resistant 
bacteria, including Acinerobacrer spp and, especially m the active group, 
Staphylococcus aureus and Staphylococcus epide1midis. Although fewer SDD-treated 
than placebo-treated patients had infections caused by Acinerobacter spp, the difference 
was not significant. Very few of these organisms are sensitive to the antibiotics used for 
SDD. 
The mode of infection seems to be less straightforward than has been suggested 
previously m reports promoting the use of SOD. Endogenous infections from 
organisms colonising the patient's own gastrointestinal tract are undoubtedly important, 
but their role may have been over-emphasized300-302; results of administration of 
topical antibiotic prophylaxis to the respiratory tract are conflicting 222 ,233, and the 
idea that colonisation is probably one step away from infection is possibly over-
simplistic. Most of our patients had no evidence of gastrointestinal colonisation before 
the infective episodes; thus exogenous infections from the patient's skin or cross-
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infection, are the most likely routes, especially for organisms such as S aureus, S 
epidermidis, or Acinetobacter spp. A possible criticism of this study design is that the 
effect of SDD might result from its influence on the environment rather than on the 
individual 229, suggesting that the control group might have had a reduced incidence of 
infection as a spin-off from the overall reduced bacterial load. The incidence of 
secondary infection was noted not to have differed from that reported previously from 
the unit 148 so that this would seem extremely unlikely. We were also unable to show 
~ross-infection with aerobic Gram negative bacteria, and all patients , including those in 
whom infection developed, had evidence of effective bowel decontamination. 
All patients in the trial received cefotaxime; this agent eliminates organisms such as 
Streptococcus pneumoniae and Haemophilus injluenzae which tend to cause early 
nosocomial infections 17,263. In a study using cefoxitin prophylaxis to prevent 
nosocomial pneumonia, there was no demonstrable reduction in infection 17, so it is 
unlikely that cefotaxime would have had an important role in this way. 
There has been concern that increased use of topical antibiotics with the SDD regimen 
may lead to the development of infections with S. aureus and enterococci, which are 
not sensitive to the agents used; and may even exert pressure on sensitive organisms to 
acquire resistance. We have shown an increase in colonisation of the gastrointestinal 
tract with enterococci in both groups, although these organisms did not cause many 
infective episodes. Methicillin-resistant S aureus colonisation increased significantly in 
the SDD group, resulting in more infections. It might be possible to address this 
difficulty by use of a different regimen 142, although the use of topical vancomycin 
with it attendant high cost might promote the development of greater resistance 
amongst the staphylococci, which would be of extreme concern. 
Although SDD may reduce the incidence of infection slightly, it has no effect on 
morbidity or mortality and adds substantially . to the cost of ICU care, in terms of 
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antibiotics, microbiological surveillance and nursing time. From the results obtained in 
this study its use cannot be recommended for routine prophylaxis in the general ICU. 
9.3 : Sub-Group Analyses 
Analyses of the various subgroups, particularly patients with multiple trauma and mid-
range APACHE II scores, previously reported by Ledingham 263 and Stoutenbeek 274 
to benefit from this technique, as well as patients with primary neurological disease and 
a comparison with patients infected on admission versus those who were uninfected on 
admission are discussed in the following sections. 
9.3.1 Neurological disease 
Introduction 
Patients with neurological disease are recognised to be at particularly high risk for the 
development of nosocomial infection in the ICU, because their stay is often prolonged, 
and ventilatory support is needed for protracted periods of time. Their protective 
reflexes, particularly bulbar and upper airway reflexes may be impaired as part of their 
disease or in association with a depressed level of consciousness; steroids, plasma-
exchange and other immunosuppressive agents play a major part in the therapy of 
patients with neurological disease, and stress ulcer prophylaxis also, in the form of 
antacids and H-2 antagonists, may further serve to predispose to the development of 
infection. 
Patients and Methods 
These patients are a subset determined a priori of the total study on selective 
decontamination. The protocol and methods are therefore identical to the parent study. 
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Results 
40 patients with neurological disease and respiratory failure were included in the study 
of selective decontamination. Their demographic features are shown in the following 
table. 
Table Twenty-five : Demographic Features of Patients with Neurological Disease 
SDD Placebo Withdrawn 
No of patients 13 20 7 
~1ean age 38.5 ± 14.4 40.5 ± 18.4 41.8 ± 14.8 
Sex (male:female) 7:6 6: 14 5:2 
Mean APACHE II 9.7 ± 5.4 12.5 + 7.7 25.4 ± 11.4 
l\-lean organ failure 1.2 ± 0.4 1.5 ± 0.6 2.3 ± 0.9 
Glasgow coma scale 13.8 10.8 5.1 
The placebo and SDD groups were fully comparable in terms of age and sex 
distribution. The severity of illness parameters (APACHE II (p =0.2), organ failure 
score and Glasgow coma scale) were not significantly different. 
The patients who were withdrawn had a higher APACHE II and Glasgow coma score 
and all but one had primary central nervous system disturbance, either from trauma or 
hypoxic brain damage, with a consequently higher mortality. They were all withdrawn 
because of failure to meet the criteria of duration of intubation and ICU stay, and have 
not been included in the analysis , as there were no infections and the SDD had not 
been given sufficient time to be effective. Even when included in the analysis , they do 
not affect the results. 
382 
The spectrum of neurological diseases that required ICU admission during the trial is 
shown in Table Twenty-Six. 
Table Twenty-Six : Spectrum of Neurological Diseases 
SDD Placebo Withdrawn 
Status epilepticus 1 3 2 
Myasthenia gravis 1 2 0 
Guillain-Barre 4 6 1 
Tetanus 4 ') 0 ... 
Meningoencephalitis 2 3 1 
Coma 1 4 3 
The distribution of the different neurological diseases, and the number of patients who 
were immunosuppressed for the management of their disease, were equally represented 
in both groups. The distribution of associated underlying disease, and other 
compromising factors occurred in a small number of patients only - Table Twenty-
Seven. 
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Table Twenty-Seven: Underlying diseases predisposing to infection 
SDD Placebo, 1ithdrawn 
Carcinoma 1 0 0 
Immunosuppressing drugs 3 3 1 
Plasma exchange 4 3 0 
Diabetes mellitus I 2 1 
Peptic ulcer disease 0 0 0 
H-2 antagonists 2 5 0 
Malnourished 2 4 3 
Alcohol abuse 2 4 5 
Antibiotic on admission 4 8 2 
Comatosed 5 10 6 
Unconscious for 3 days 7 11 4 
Bulbar dysfunction 8 6 0 
Bedbound > 5 days 8 17 0 
The neurological srarus was assessed according to rhe following schema: 
1. Orienrated: fully responsive and aware of surroundings 
2. Confused: inappropriare response 
3. Unconscious: nor responding to verbal commands 
4. Comatose: no purposeful response ro pain (i.e. Glasgow coma scale < 6) 
Bu/bar dysfunction was documenred according ro whether the patient was able to 
swallow his secretions or required dental suction and/or a vocal aid added to the 
rracheostomy. 
Bedbound > 5 days: Mobiliry of the patienr was documented as to whether the patienr 
was able ro be mobilised to a chair within 5 days. 
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The overall incidence of infection in patients with neurological disease, who required 
intubation for more than 2 days and stayed in the ICU for at least 5 days, was 46.1 % in 
the SDD group and 31.5% in the placebo group , with an overall incidence of 37.5% 
for this subgroup, compared with only 30% for all evaluable patients. The various 
types of infection documented during the patients ' stay are shown in Table Twenty-
Eight. 
Table Twenty-Eight: Efficacy of SDD 
SDD Placebo Withdrawn 
Infections total 11 10 0 
Patients infected 6 6 0 
Bronchial 6 3 
Pneumonia 2 1 
UTI 0 3 
IV catheter 2 1 
Septicaemia 0 2 
Other 1 0 
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The organisms causing secondary infection in the different groups are shown in Table 
Twenty-Nine. While there are too few infections for there to be any statistically 
significant differences, it is noteworthy that there were no infections due to Escherichia 
coli in the SDD group. 
Table Twenty-Nine: Organisms causing infection 
SDD Placebo 
Staphylococcus aureus 5 4 
Staphylococcus epidennidis 2 2 
Pseudomonas spp 2 0 
Escherichia coli 0 3 
Acinerobacrer spp 0 1 
Unknown 1 0 
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Diarrhoea proved to be the most common complication, but was self-limiting, and 
usually responded to altering the feeds; this as well as other complications were equally 
distributed in both groups. (Table thirty.) All patients were routinely anti-coagulated 
using subcutaneous heparin, and anti-embolism stockings were worn; monitoring for 
venous thrombo-embolism was performed clinically. 
Table Thirty: Complications 
SDD Placebo Withdrawn 
Gastrointestinal haemorrhage 0 1 0 
Hepatic failure 0 1 0 
Renal failure 0 1 0 
Haematological failure 0 1 0 
Gastric aspiration 1 1 0 
Aspiration of feeds 0 0 0 
Venous thrombosis I 0 0 
Pulmonary embolism 0 0 0 
Ventilatory complications 0 0 0 
Diarrhoea 5 5 0 
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The duration of ventilation was longer in the SDD group, but this was not significant 
(p=0.075); however, the duration of tracheostomy was prolonged in the SDD group 
(p=0.0025). The duration of ICU and hospital stay appeared to be more prolonged in 
the patients who received SDD, however this did not achieve statistical significance, 
nor was there any difference in mortality. 
Table Thirty-One: Ventilatory Therapy, Morbidity and Mortality 
SDD Placebo Withdrawn 
Duration (days) 
IPPV 27.9 ± 19.9 16.1 ± 16.7 2.5 ± 1.1 
Tracheostomy* 39.3 ± 22.3 14.8 ± 20.1 0.5±1.1 
ICU stay 30.1 ± 22.5 20.6 ± 17.7 2.6 ± 0.9 
Hospital stay 49.3 ± 31.9 40.0 ± 33.4 10.9 ± 8.4 
Mortality 15% 15% 75% 
* Duration of tracheosromy p = 0. 0025, Student's r resr,· remaining values for the SDD 
and placebo groups were not significanrly different using Srudenr's t testing. 
DISCUSSION 
Neurological diseases requiring longterm ventilation are reported to be complicated by 
respiratory infections in 35 - 67% of cases , and infection contributes to death in 33 % of 
patients with tetanus. 224-226 A recent multivariate analysis of critically ill patients in 
a multicentre study showed pneumonia to be an independent risk factor for death and 
found the presence of neuromuscular disease and impairment of airway reflexes on 
admission, to be risk factors for the development of infection. 186 Such patients are 
also at particularly high risk of developing secondary infection because of their 
unusually protracted stay in the ICU. Impaired muscle function and immobility 
predispose to atelectasis; depressed protective reflexes and impaired bulbar function 
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render these patients susceptible to aspiration; endotracheal tubes, tracheostomies and 
central lines as well as longterm urinary catheterisation, by breaching host defences, 
increase the risk of nosocomial infection. 30 Immunosuppression and plasmapheresis, 
which are used in the management of patients with acute inflammatory demyelinating 
polyneuropathy (Guillain-Barre Sydrome) and myasthenia gravis, and the profound 
sedation used in the management of tetanus , may reduce humoral defences and increase 
the risk of such patients developing infection. 26 
There have been no studies evaluating the SOD regimen 10 patients requiring ICU 
admission for neurological disease. However, such patients might be expected to show 
especial benefit from such a prophylactic regimen. The higher incidence of secondary 
infection in patients with neurological disease was confirmed in this study, where the 
incidence of secondary infection was 37.5 %, whereas , in the parent study, in patients 
with other diseases requiring admission who fulfilled similar criteria for analysis, the 
incidence was 30%. There were no secondary infections in the patients in the group 
that were withdrawn from the study; they were not included as an "intent to treat 
group" , because although they had been randomised , their short duration of ICU stay 
made them at low risk for the development of secondary infection . 
We were unable to reduce the incidence of secondary infection with SDD, nor were 
any deaths related to secondary infection. Although patient numbers are small, because 
of the increased risk of infection in this group and their prolonged ICU stay, this study 
probably includes sufficient patients to make these negative findings important. 
Our patients represent the usual spectrum of neurological diseases requiring longterm 
ventilatory support and, although the numbers are small , the distribution in the groups 
is similar; all other features also make them entirely comparable. The severity of 
illness does not appear to have favoured the development of infection in the active 
group, as the APACHE II score was actually higher in the placebo group. The 
Glasgow coma scale was lower in the placebo group which also might have been 
expected to have put this group at increased risk of infection. The duration of 
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ventilation, ICU stay and hospital stay were not significantly different in the 2 groups. 
Although the duration of tracheostomy was longer in the active group, the number of 
respiratory tract infections did not appear to be influenced by this, as the majority of 
infections occurred within 25 days; only one bronchial infection and one pneumonia 
developed later in each group. The timing of onset of infections was similar in both 
groups and most infected patients had more than one episode of infection. 
The most common organisms causing infection in both groups were Staphylococcus 
aureus and Sraphylococcus epidermidis which are frequent causes of nosocomial 
infection; colonisation with these organisms may even be increased by the use of SDD. 
A recent study from Spain in patients with head injuries requiring admission to a 
neurosurgical ICU, has shown that the most frequent pathogens in patients with a 
Glasgow coma scale of less than 9 are the staphylococci 303. Marked regional 
differences with endemic organisms may occur in different ICUs, which may also 
influence the effects of SDD. In our unit, colonisation by Acinetobacter spp., 
frequently resistant to tobramycin, was shown in surveillance cultures to be unaffected 
by SDD. The route of infection with these organisms is usually from the skin, but 
intestinal decontamination may actually promote their growth in the gut. 
The concurrent design of our trial simultaneously allowed decontaminated and non-
decontaminated patients in the ICU. This may have led to cross infection and increased 
infection in the SDD group; however, it was not possible to demonstrate spread from 
patient to patient. It may also be argued that by reducing the load of AGNBs in the 
ICU with SDD, there may have been some benefit to the control group. This is 
particularly relevant in this group of patients who are exposed to the ICU environment 
for prolonged periods, with the implied risk of colonisation by unit-pathogens. These 
potential drawbacks in the study design were clearly outweighed by the advantages of 
the concurrent blinded nature of the study, which made the diagnosis of infection more 
reliable and eliminated possible observer bias. 
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Reusser et al 300 were unable to demonstrate that gastric colonisation played a role in 
the development of nosocomial infection in neurosurgical patients requiring mechanical 
ventilation. Although our patients were primarily medical, rather than surgical, the role 
of exogenous infections may help to explain the lack of efficacy of this regimen 
demonstrated in our study. 
The microbiological surveillance, which must be performed for early detection of 
antibiotic resistance, the increased nursing and laboratory workload , and the additional 
drugs all add .::onsiderably to the cost of hospitalisation. While the theoretical benefits 
of reducing nosocomial infections and preventing patient complications with the use of 
SDD are extremely attractive, this study has been unable to confirm any benefit in 
patients with neurological disease; such techniques as strict asepsis , hand-washing , 
care of ventilatory apparatus and respiratory care must continue to be the cornerstones 
of prophylaxis. 
9.3.2 Trauma patients 
Introduction 
Patients who have sustained multiple trauma are generally regarded as being "clean" on 
admission and thus form an ideal group for the primary prevention of secondary 
infection. These patients have been demonstrated in many studies to be particularly 
susceptible to secondary infection , because of extremely suppressed host immune 
responsiveness , and in studies using historical controls with post hoc stratification 
263 ,274, trauma has been described as being an area where selective decontamination 
is of especial benefit. 
Patients and Methods 
This section reports a subgroup selected a priori as being at high risk of secondary 
infection who have been shown to benefit from the use of SOD with both a reduction in 
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nosocomial infections and mortality 263,274. The same protocol as described in detail 
above in section 9. 1, was used. 
Approximately 30% of all admissions to our respiratory ICU are secondary to trauma. 
Our hospital is the major hospital and referral centre in a city with an estimated 
population of over 2 million inhabitants. The majority of trauma patients admitted to 
our ICU are victims of motor vehicle accidents - most of these being pedestrians. The 
delay from the time of injury to the time of hospital admission was usually not more 
than 4 to 5 hours, and ICU admission followed within 3 to 4 hours after resuscitation 
and definitive treatment in our accident unit. 
Trauma patients admitted to our ICU had predominantly blunt chest trauma and 
multiple injuries, that required intermittent positive pressure ventilation. Many had 
associated limb, head , and abdominal injuries, mostly due to motor vehicle accidents; 
however, those with predominant head injuries were treated in a separate neurosurgical 
ICU and were not included in this study. All thoracic trauma patients referred to our 
hospital requiring ICU therapy would have been admitted to our respiratory ICU and 
included in this study. Only one patient with extensive burns of 35 % body surface area, 
who was randomised to receive placebo, was admitted to the study (the other burns 
patients requiring ICU management received treatment in our isolation ICU, where the 
study of SDD was not conducted). 
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Eighty seven trauma patients were randomised on admission and entered into the study. 
The demographic details of the two groups show that the patients were fully 
comparable in terms of age, sex, severity of illness, and are shown in Table Thirty-
Two. 
Table Thirty-Two: Demographic Details of Trauma Patients 
SDD Placebo \,Vithdrawn 
Number of patients 39 33 15 
Mean age 40 38.7 39.9 
ISS 29.5 ± 13.8 29.5 ± 13.5 21.6 ± 11 
APACHE II 9.8±6.1 10.5 ± 5.8 10.1 ± 6.5 
Organ failure 1.2 ± 0.4 1.1 ± 0.3 1.3 ± 1 
Those patients in the withdrawn group did not meet the criteria for full evaluation of 
the study, because their durations of ICU stay or intubation were too short; there was 
one patient in whom it was decided to break the code because of suspected drug allergy 
- he was found to be receiving placebo. One further patient, who would not tolerate the 
application of the oral gel, also had to be withdrawn; however , when these patients 
were included in the overall analysis, they did not affect the results. 
393 
The presence of pre-existing factors which might have predisposed to the development 
of infection was documented, and are shown in Table Thirty-Three. The only factors 
which were maldistributed and likely to predispose to infection, would have favoured 
the development of more infections in the placebo group. 
Table Thirty-Three: Factors predisposing to infection 
SDD Placebo 
n=39 n=33 
Carcinoma 0 0 
Immunosuppressing drugs 0 0 
Diabetes mellitus 2 0 
Malnutrition 
I 3 5 
Albumin < 30/ mmol/1 23 19 
Alcohol abuse 7 15 p=0.02* 
Peptic ulcer disease 1 0 
H-2 antagonists 5 6 
Glasgow coma scale 12.3 ± 4.2 12.7 ± 3.6 
Bedbound > 5 days 30 24 
Shocked on admission 0 4 p=0.08* 
Emergency surgery 7 3 
* Statistical analysis by Chi-square resting 
Alcohol abuse was defined as > 4g alcoholldav: (> J bortle wine!> 4 rots!> 5 
beers/day). 
Shocked on adm (admission) was defined as a systolic blood pressure for less than 
70mm Hg for more than one hour. 
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The complications experienced during ICU stay are shown in Table Thirty-Four and 
were equally distributed in both groups. 
Table Thirty-Four: Complications 
SOD Placebo 
Gastrointestinal haemorrhage 2 1 
Hepatic failure 5 4 
Cardiac failure 1 I 0 
I 
Renal failure 2 1 
Shock (SBP < 70) 1 1 
Aspiration 2 1 
Pneumothorax 0 1 
Ventilatory complications 6 5 
Diarrhoea 
I 
6 1 
Venous thrombosis 1 1 
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The overall incidence of secondary infection in the subgroup of trauma patients was 
slightly lower (27%) , than for all patients enrolled in the study (30%), but the 
difference in incidence between those who received SOD (28.2 % ) and placebo (33.3 % ) 
was not significant. The distribution and the various types of secondary infection 
occurring are shown in Table Thirty-Five. One patient from the placebo group, who 
was withdrawn from the study because of possible drug toxicity , developed infections. 
Table Thirty-Five: Efficacy of SOD 
SOD Placebo Withdrawn 
No of patients infected 11 11 1 
% patients 28. 2 33.3 6.6 
Bronchial 4 5 2 
Pneumonia 6 l 1 
Urinary tract infection 2 1 0 
IV catheter related 2 2 0 
Septicaemia 2 3 0 
Other 1 4 0 
Total infections 17 16 3 
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The organisms causing infection in the groups are shown in Table Thirty-Six. The 
majority of infections in those who received the active regimen were due to 
Staphylococcus aureus and Staphylococcus epidermidis. 
Table Thirty-Sb:: Organisms causing secondary infection 
SOD Placebo \Vithdrawn 
I 
Staphylococcus a:u-eus 
-+ 4 0 
Staphylococcus epidermidis 6 1 0 
Enterobacteriaceae 2 5 1 
Acinetobacter spp 3 1 1 
Other Gram -ve l 1 0 
Other Gram + ve l 2 0 
The organisms causing pneumonia m the active and placebo groups are shown in 
Figure Three. There were six patients in the active group and one in the placebo who 
developed pneumonia; the organisms causing pneumonia in the active group included 
Staphylococcus epidermidis 3, Acinerobacrer 2, one patient in the placebo group 
developed pneumonia caused by Haemophilus injluenzae and a patient who was 
withdrawn developed a pneumonia due to Pseudomonas aeruginosa. Bronchial 
infections were caused by Staphylococcus aureus in 3 patients in each group, 
Acinetobacrer spp in one patient in each group, Srreprococcus pneumoniae in one and 
Mora.xella cararrhalis in one in the active and placebo groups respectively; there were 
two bronchial infections in the patients who were withdrawn caused by Acinetobacter 
spp and Pseudomonas aeruginosa. 
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Fig.3 Organisms causing Pneumonia 
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Surveillance cultures demonstrated that colonisation of the gastrointestinal tract by 
aerobic Gram negative bacilli was effective (Figure Four). 
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Colonisation of ~he gastrointestinal tract by the majority of organisms unaffected by the 
agents used as part of the decontamination regimen , however, was shown to increase 
progressively. Colonisation by methicillin-resistant Staphylococcus aureus increased 
signficantly in the active group at all sites (p=0.0002), particularly in the oropharynx 
(p=0.0006) during ICU stay (Figure five). 
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Persistently high levels of colonisation with Staphylococcus epidermidis were seen at all 
sites. (Figure Six) 
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Gastric and oropharyngeal colonisation by the enterococci occurred in 18.3 % of 
patients on admission and increased in both groups to 56.2 % at three weeks, while 
rectal colonisation was maintained in 83. 7% of all patients. (Figure 7). 
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The duration of mechanical ventilation was similar, and although the duration of 
tracheostomy was more prolonged in the active group, this did not achieve statistical 
significance. The duration of ICU and hospital stay was similar in both active and 
placebo groups. Two deaths in each group were assessed as being directly attributable 
to secondary infection. In the patients who received SDD, there were 5 deaths (in 1 
active treatment was discontinued because of primary neurological injury, there was 1 
patient with a cardiac and 1 with a neurological cause of death), while in the placebo 
group, active treatment was discontinued in the third fatality. In the withdrawn group, 
active treatment was withdrawn in one, and there was an additional neurological death. 
Table Thirty-Seven: Ventilatory Therapy, Morbidity and Mortality 
SDD Placebo Withdrawn 
Duration (days) 
IPPV 6.5±4.1 5.9 ± 2.9 2.4 ± 1.1 
Tracheostomy 18.2 ± 12.1 13.4 ± 8.6 19.8 ± 14.8 
ICU stay 15.5 ± 12.5 14.2 ± 9.7 11.3 ± 29.6 
Hospital stay 26.3 ± 18.5 25.5 ± 16.3 20.2 ±43.3 
Mortality 12.8% 9% 13.3% 
DISCUSSION 
This study of selective decontamination has been unable to show any reduction in the 
incidence of secondary infection, in this subgroup of trauma patients, there was also no 
reduction in the duration of ICU or hospital stay, nor other parameters of morbidity; 
the mortality also was similar, with death attributable to secondary infection occurring 
in 2 patients in each group. These findings are surprising as our patient population is 
similar to many studies which have shown a reduction in secondary infection, although 
only a few have been able to show any effect on mortality .14,263,267 Most of 
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studies have, however, compared selective parenteral and enteral decontamination with 
no antibiotic regimen, whereas in this study, selective decontamination of the digestive 
tract only is being evaluated, as both limbs received cefotaxime for 72 hours (all 
enrolled patients received systemic prophylaxis with cefotaxime, as the administration 
of a parenteral placebo would have resulted in too many patients having to be 
withdrawn because of unblinding). The cefotaxime may have reduced the incidence of 
early-onset secondary infection in this study , as only 2 patients who received the active 
regimen developed infections within the first 5 days of admission (sinusitis and 
nosocomial pneumonia) compared with 3 who received placebo (septicaemia, wound 
infection and a bronchial infection). An early study by Stoutenbeek274 using an 
enteral regimen alone showed only a moderate effect until cefotaxime was added to the 
initial regimen , to eliminate early onset pneumonia and achieve early decontamination. 
Another possible explanation for the lack of efficacy of selective decontamination , may 
have been the inclusion of both decontaminated and contaminated patients in the same 
unit, necessitated by the blinded nature of the study , but this is unlikely to have had a 
major influence as there were no episodes of overt cross-infection detected 278. 
Intestinal decontamination invariably takes a few days and thus, with the usual rapid 
patient turnover in any ICU , there will always be this reservoir of organisms in patients 
who are not fully decontaminated. 
The surveillance cultures confirmed effective gastrointestinal elimination of aerobic 
Gram negative bacilli in the active group and few infections resulted from the 
Enterobacreriaceae. A high rate of colonisation by Sraphylococcus epidermidis was 
seen in all patients. Increased colonisation by methicillin resistant Sraphylococcus 
aureus was noted in the patients who received the active regimen and , although the 
incidence of infection with this organism was similar in both groups, this was of 
concern. An increase in colonisation with Acinerobacrer :,,pp and Enrerococci was also 
noted in both groups. The infections caused by Sraphylococcus aureus and 
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Acinerobacrer spp were not necessarily preceded by gastrointestinal colonisation, 
particularly in the case of Acinetobacrer spp, suggesting that other routes of infection, 
or alterations in adherence mechanisms, may have played a role. 33 
It is of interest that the overall rate of secondary infection in multiple trauma patients 
(29%) during the study period , was lower than the 43 % previously reported from our 
unit in this group of patients 148 - which is again still considerably lower than the 
incidence in many of the studies where selective decontamination of the digestive tract 
has been reported to be of benefit. This difference may have been due to a reduction in 
the incidence of early onset pneumonia by the use of cefotaxime in both limbs of our 
trial, and also the use of strict clinical criteria for diagnosis. The exceptionally high 
incidence of secondary infection reported in the controls of some of the 
studies253 ,264,269 may have been due to the open nature of the studies and the 
predominantly microbiological definitions. The reduction in colonising organisms in 
surveillance cultures with the use of selective decontamination is striking. This 
reduction, whether real or due to the "carry-over effect of the topical antibiotics", may 
influence the interpretation of tracheal cultures and lead to the under-diagnosis of 
infection. 
A recent study of selective decontamination of the digestive tract using vancomycin, 
polymyxin B and neomycin in selected surgical patients showed a significant reduction 
in infection but no influence on mortality. 17 With a similar regimen in our patient 
population, staphylococcal infections might have been prevented; however, it is 
unlikely that infections with Acinerobacrer spp would have been prevented. Selective 
decontamination of the digestive tract may, however, show more positive benefits if the 
antibiotic regimens are specifically chosen to deal with the problem organisms specific 
to the unit or hospital. 
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The negative results of this study do not support the routine use of selective 
decontamination of the digestive tract in trauma patients in a polyvalent ICU with a low 
incidence of secondary infection. 
9.3.3 Mid-range APACHE II 
Introduction 
Patients with APACHE II scores ranging between l 6 and 31 have been shown in 
several studies 14,263 to benefit from the use of selective decontamination. The 
severity of illness which falls into this range may preselect certain disease categories, or 
a subset of patients in whom, with no further complications, the outcome is likely to be 
favourable. Should they , however, develop infective complications, these may 
significantly adversely affect their outcome. Although there is no evidence to support 
the above theory, this subset was prospectively chosen for subanalysis. 
Patients and Methods 
There were 103 patients enrolled in this study who fulfilled this criterion; 33 in the 
SDD group and 47 who received placebo were suitable for subanalysis. The details of 
the protocol and methods are identical to those described previous! y. 
Results 
The demographic features of these patients are shown in Table Thirty-eight. The 
severity of illness as measured by the various scoring systems was similar for both 
SDD and placebo groups. 
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Table Thirty-eight: Demographic features of Patients with mid-range APACHE II 
scores. 
SDD Placebo Withdrawn Suitable 
No of patients 33 47 23 8 
Age 51 46.6 42.9 54. 1 
± 13 .6 ± 17 ± 19 ± 18.5 
Male:female 19: 14 28: 19 14:9 3:5 
Mean APACHE II 22. l 20.6 22 .9 22.4 
± 4.2 ±3.3 ± 3.5 ±4 
Mean organ 1.6 1.6 1. 9 1.4 
failure ± 0.7 ± 0.6 ± 1.1 ± 0.7 
Mean ISS n=S n=lO n=2 n=l 
33.6 25.5 27.5 34 
Glasgow coma 11.5 11.5 11 12.5 
score ± 4.3 ± 4.3 ± 5.1 ± 4.1 
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The diagnostic categories of the patients with mid-range APACHE II scores are shown 
in Table Thirty-Nine. There were more patients in the placebo group admitted with 
pneumonia and neurological disease, however, this did not achieve statistical 
significance. 
Table Thh1y-nine: Diagnostic Categories of Patients with mid-range APACHE II 
SDD Placebo Withdrawn Suitable 
Asthma/resp 7 4 I 6 3 
I ARDS 0 5 '1 0 
I Pneumonia* 5 14 1 1 
Cardiovascular l l 2 1 
General Surgery 5 I 6 I 2 0 
I 
Neurological 2 6 4 l 
Trauma 5 7 3 1 
Other disease 8 4 3 1 
* Pneumonia p=0.28 chi-square resr 
Possible factors predisposing to the development of secondary infection are shown in 
Table Forty. These factors were uniformly distributed , apart from previous infections, 
which favoured the development of infection in the placebo group. 
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Table Forty: Underlying or Predisposing Factors for the Development of Infection 
SDD Placebo Withdrawn Suitable 
In hospital* 
>48 hrs 11 19 10 3 
Infect on adm 21 31 9 7 
Infect past month** 2 18 5 3 
Carcinoma 0 2 4 0 
Immune supp drug 5 2 4 0 
Cytotoxics 0 0 2 0 
Cylophosphamide l 0 0 0 
Steroids 4 1 0 0 
Connect tissue 
disease l 2 0 0 
Diabetes 5 5 2 2 
Obesity 4 6 l 2 
Malnourished 1 6 l 0 
Albumin < 30 23 31 10 4 
Alcohol abuse 8 1-i 7 1 
Peptic ulcer 1 3 '} 0 .;., 
H-2 blockers 12 17 8 0 
Shocked 
on admission 8 6 6 2 
Emerg surgery 4 5 3 1 
Bedbound > 5 days 23 41 3 8 
Bulbar dysfunct 0 '} 0 0 ,_ 
Comatosed 9 16 8 2 
Unconsc 3 days# 14 27 5 4 
* Hospitalised for more rhan 48 hours before admission ro the ICU: p=0.6 Chi-square 
test 
** Infections in rhe pasr monrh prior ro ICU admission p=0.002 Chi-square test 
# Unconscious.for 3 days: p= 0.27 Chi-square resr 
The neurological srarus was assessed according ro rhe.fiJ//owing schema: 
1. Orientared: fully responsive and aware of' surroundings 
2. Confused: inappropriare response 
3. Unconscious: not responlling ro verbal commands 
4. Comarose: no putpos~ful response ro pain (i .e. Glasgow coma scale < 6) 
Bulbar dysfunction was documenred according ro wherher the patient was able to 
swallow his secrerions or required denral .rncrion and/or a vocal aid added to the 
rracheosromy. 
Bedbound > 5 days: Mobility of rhe pariem was documenred as ro wherher the patient 
was able to be mobilised ro a chair wirhin 5 days. 
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The amount of invasive therapeutic and monitoring required by both groups, which 
might have influenced the incidence of infection , was similar, and is shown in Table 
Forty-one. The duration of ventilation, tracheostomy, ICU and hospital stay were 
similar for both groups. 
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Table Fo11y-One: Invasive Therapy 
SDD Placebo 
No of patients 33 47 
Duration IPPV 11.6 11.8 
±11.2 ±8 
Tracheostomy n=lO n= 25 
19.2 16.8 
Duration* 16.6 19.3 
ICU (days) ± 14 ± 12.2 
Duration** 30.4 35. l 
hospital (days) ± 27.7 ± 21.3 
Haemodialysis 6 8 
TPN* 10 22 
TPN >5 days 14 18 
Enteral feedino** ;::, 27 42 
Plasmapheresis 1 0 
Chest drain 9 12 
Arterial line 18 34 
Central line 28 44 
Peripheral line 33 47 
Pulmonary artery# 23 32 
catheter 
* Duration ICU sray p= 0.36 Srudenr's r resr 
** Durarion hospiral sray p = 0.42 Srndenr 's r resr 
* TPN p= 0.21 Chi Square resr . 
**Enteralfeeding p=0.52 chi-square resr 
# Pulmona,y emery carherer p =0. 92 Chi-square resr 
Withdrawn 
23 
4.3 
± 6.1 
n=3 
45 
9.2 
± 25 
18 .2 
± 36.6 
l 
4 
3 
11 
0 
3 
13 
14 
23 
13 
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Suitable 
8 
7.9 
± 12.3 
n=2 
17 
12.4 
± 12.3 
21.8 
± 19.1 
1 
l 
l 
7 
0 
1 
3 
5 
8 
3 
The development of complications while in the ICU occurred with equal frequency in 
both SDD and placebo groups and these are demonstrated in Table Forty-two. 
Table Forty-Two: Complications 
SDD Placebo Withdrawn Suitable 
GIT bleed 6 6 2 0 
Hepatic failure 8 7 1 1 
Cardiac failure 2 1 1 0 
Renal failure 4 4 0 1 
Haem failure 3 -+ 0 0 
CNS coma 5 0 0 0 
Shock (Sbp < 70) 5 0 6 0 
Pneumothorax 2 2 1 0 
Failed wean 3 7 1 0 
Diarrhoea 6 9 1 1 
Ven. thrombosis ., 2 1 0 ., 
Other 4 6 1 0 
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Table Forty-three illustrates the types of secondary infections. There was no significant 
difference in the incidence of infection between the SDD and placebo groups. 
Table Forty-three: Types of Infections 
SDD Placebo Withdrawn Suitable 
No of patients* 10 21 2 3 
Bronchial 6 8 3 2 
Pneumonia 3 3 1 1 
IV catheter 1 6 0 0 
Urinary catheter 0 2 0 0 
Septicaemia 2 7 0 0 
Other 1 4 0 0 
Total 13 30 4 ,., j 
* No of parienrs infecred p=O. 28 Chi-square resr 
The distribution of the pathogens causing infection is demonstrated in Table Forty-four. 
Infections caused by the Emerobacreriaceae and yeasts , occurred predominantly in the 
placebo group. 
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Table Forty-Four:Organisms causing infection 
SDD Placebo Withdrawn Suitable 
H. influenzae 0 l 0 0 
S. aureus 4 5 0 l 
S. epidermidis "I 7 0 0 ., 
Escherichia coli 0 4 0 0 
Klebsiella spp l 2 0 1 
Proteus spp 0 l 0 0 
Emerobacrer 0 2 0 0 
Acinerobacrer spp 5 4 ') 1 
I Pseudomonas spp 0 1 0 2 
Candida 0 3 0 0 
Enrerococcus 0 l 0 0 
Other streprococci 0 I l 0 0 
Other 0 I 1 0 0 
There was no statistical difference between the mortality in the active and placebo 
groups (Table Forty-five). 
Table Forty-Five: Mo11ality 
SDD Placebo Withdrawn Suitable 
No of patients 33 .+7 23 8 
Mortality in ICU 6 7 11 1 
in hospital 3 2 l 1 
% total deaths* 27.3 19.2 52. l 25 
* Overall morraliry p=0.55 chi-square resring 
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Discussion 
Ledingham et al 263 identified the patients with mid-range APACHE II scores (17-33 
inclusive), with post-hoc stratification, as a group in whom the mortality was 
significantly reduced by the use of selective decontamination; the mortality rate was 
43% in this group, compared with 58% in the control group. The mid-range APACHE 
II score selected by Ledingham is possibly too high, as it includes patients with scores 
of over 30, where the outcome is always very poor. Survival with an APACHE II 
score of over 30 may relate more to the disease process itself. and be unlikely to be 
significantly influenced by therapy. An APACHE II score of 17-30 was accordingly 
selected a priori for analysis in our study , where only 2.8% of patients had APACHE 
II scores of over 33. In our patients, even using Ledingham' s higher mid-range 
APACHE II scores (17-33), the overall mortality was only 32.4%, which is 
significantly lower. It is possibly because of the lower mortality rate that no significant 
difference with the use of SDD could be demonstrated in this study. 
The infection rate was also similar in both groups , although infections with organisms 
sensitive to the SDD regimen occurred more frequently in the placebo group. Although 
statistical significance was not achieved in the reduction of the incidence of secondary 
infection with SDD, there was a trend in this direction. A number of infections caused 
by the staphylococci occurred in both groups. suggesting that enteral elimination of the 
Enterobacreriaceae is not sufficient to prevent secondary infections altogether, and that 
the exogenous route of pathogenesis of secondary infection remains important. 
9.3.4 : Surgical Patients 
Introduction 
Post-operative and other surgical categories may also stand to benefit from the use of 
SDD259. Although this group of patients was not large enough in this study to provide 
any conclusive results, this subgroup is presented for completeness. 
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Patients and Methods 
This subgroup of patients was part of the study on selective decontamination, the 
methods and protocol were therefore identical to that described above. Selective 
decontamination was commenced on admission to the ICU, following surgery. Routine 
perioperative antimicrobial prophylaxis was used where indicated . 
There were no patients undergoing surgery who met enrollment criteria who were not 
included in the study i.t there is no "suitable group". 
Results 
Similar numbers of patients were enrolled into both groups , however, the patients in 
the placebo group tended to have a higher APACHE II score; the patients were 
otherwise comparable . 
Table Fo11y-six: Demographics of General Surgical Patients 
SDD Placebo Withdrawn 
No of patients 10 10 7 
Age 56.8 ± 15 58 .3 ± 16.3 51.1 ± 16.8 
Male: female 4:6 4:6 2:5 
Hospitalised 4 4 4 
>48 hours 
APACHE 12.8 ± 4.9 16. 1 ± 7.1 12.9 ± 9 
Organ failure 1 ± 0.5 l.2 ± 0.4 1.4 ± 0.5 
415 
Potential factors thought to predispose to infection were equally distributed in both 
active and placebo groups, and are shown in Table Forty-seven. 
Table Fmty-Seven: Factors Predisposing to Infection 
SOD Placebo Withdrawn 
Infected 
on admission 4 5 2 
Carcinoma l l 0 
Immunsupp drugs ! 1 1 
Steroids 1 1 1 
Diabetes 3 1 1 
Obesity 4 2 2 
Malnourished 0 2 0 
Alcohol abuse 1 1 I 2 
Peptic ulcer 2 4 2 
Shocked on adm ') 3 0 ,. 
Emerg surg 9 8 5 
Albumin < 30 mmol/1 10 10 3 
Bedbound > 5 days 6 7 1 
H-2 blocker 6 6 4 
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This group of patients received numerous invasive monitoring and therapeutic 
modalities, which were however, equally distributed between the two groups. Table 
Forty-eight. 
Table Fo11.y-eight: Invasive and Other Therapy 
SOD Placebo Withdrawn 
Haemodialysis 1 0 0 
TPN 7 I 8 1 
En teral feed ~ 7 2 
Plasmapheresis 0 1 0 
Chest drain 0 1 1 
Arterial line 7 8 5 
Central line 10 10 7 
Periph line 10 10 7 
Pulmonary a cath 8 5 2 
TPN >5days 8 6 1 
Duration (days) 
IPPV 8.7 ± 4.4 9.2 ± 6. 4 2.1 ± 1.2 
Tracheostom y n= 1 19 n=6 11.9 n=O 
417 
The patients admitted to the Respiratory ICU following surgery, were largely 
emergency and non-elective cases, and the numerous complications reflect the severity 
of their disease , which is not accurately conveyed by the relatively low APACHE II 
scores on admission. Table Forty-nine. 
Table Forty-Nine: Complications in ICU 
SDD Placebo Withdrawn 
GIT bleed "') 1 1 .. 
Hepatic failure "') .., 0 -
-
Cardiac failure 1 0 0 
Renal failure .., 0 0 .. 
CNS coma 3 0 0 
Shock(Sbp < 70) "') 0 1 .. 
Failed wean 0 2 0 
Diarrhoea 0 3 0 
Ven thrombosis 0 I 0 
Other 0 l 1 
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The morbidity for patients in the placebo group was higher in this subgroup, and the 
patients remained in both the ICU and hospital for significantly longer; however, the 
mortality in both groups was similar. 
Table Fifty-Two: Morbidity and Mo11ality 
SOD Placebo Withdrawn 
Duration 13. 1 20.7 3.4 
in ICU ±8.8 ± 13.3 1.9 
Duration 2'.2.6 -1-0.2 * 17.5 
in Hospital ± 12.9 ~ 16.8 10.8 ..!.. 
Mortality 
in ICU 1 1 1 
in hospital 2 I 0 
Overall 30% 20 % 14.3% 
* p = 0.017.fordijferencefrom acrive subgroupfordurarion in hospiral. 
Discussion 
This subgroup of patients is unfortunately too small for any meaningful conclusions to 
be drawn. It is also not possibly representative of the patients admitted to a general 
surgical ICU for elective post-operative care . The lack of infections due to 
Enrerobacreriaceae and yeasts in the SOD group suggests that t~e regimen may have 
been of benefit in preventing this type of infection, however, the greater incidence of 
staphylococcal infections is of concern. 
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9.3.5: Patients infected within the previous month of admission to the ICU 
Introduction 
Viral infections are well known to cause immunosuppression and to alter the indigenous 
colonising flora by alterations in bacterial adhesion 46. More recently, a number of 
studies have reported an increase in incidence of repeated infections, following severe 
pneumonia requiring hospitalisation 304. Infections in the month prior to admission to 
ICU were regarded as a potential major risk factor for the development of nosocomial 
infection. These patients were selected a priori to be analysed as a subset, in order to 
determine if the possible breach in adherence mechanisms and consequent 
predisposition to infection might be demonstrated to be prevented by SDD. 
Patients and "fethods 
This subset was determined from the history taken on admission to the ICU. 95 patients 
fulfilled criteria for inclusion in this subgroup, and a further 11 patients not enrolled 
proved to have been suitable, and are shown separately. Previous antibiotic 
administration was documented. The protocol was identical to that described 
previous! y. 
421 
Results 
The demographic details of the patients who fulfilled criteria for inclusion in this 
subgroup are shown in Table Fifty-three. The patients' characteristics were similar in 
both groups. 
Table Fifty-Three: Demographics of Patients recently infected 
SOD Placebo Withdrawn Suitable 
No of patients 30 46 19 11 
Age 41.3 45.2 42.8 52.5 
± 12 ± 17.7 ± 18.2 ± 10.9 
Male:female 13: 17 24:22 6: 13 2:9 
Hospital > 48 hrs 19 ? -_) 11 5 
Rec'd antibiotics* 30 42 16 8 
Community acq* 20 34 12 8 
Nosocomial * 10 12 7 3 
APACHE II 14.2 15. 1 17.3 13.5 
± 8.5 ± 7.1 ± 11 ± 3.9 
Organ failure 1.5 1.5 1.5 1 
± 0.7 ± 0.7 ± 0.7 ± 0.4 
ISS (n=3) (n =2) (n = 1) (n=3) 
20.3 45.5 9 18.3 
* Number of parien.rs who had already received anribimic rherapy, and whether the 
infecrion was acquired in rhe communiry or hospira/. 
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The risk factors which might have influenced the development of secondary infection 
were equally distributed in both groups and are shown in Table Fifty-four. 
Table Fifty-four: Underlying Factors Predisposing to Infection 
SDD Placebo Withdrawn Suitable 
No of patients 30 46 19 11 
Carcinoma 2 2 2 0 
Immunosupp drugs 0 4 2 3 I 
Cyclphos 0 l 0 0 
Steroids 0 3 2 3 
Diabetes 2 5 2 3 
Conn tissue dis 0 , l 0 ., 
Obesity 3 0 1 2 
Malnourished 6 5 l 1 
Alcohol abuse 6 12 3 1 
Other l l 0 0 
Peptic ulcer l ') 1 1 ,_ 
Shocked on adm 7 3 3 1 
Emerg surg 7 6 1 0 
Albumin <30 22 37 12 5 
Bedbound > 5days* 21 39 l 9 
I H-2 blocker 8 12 3 1 
p=O. 208 Chi-square resr 
The admitting diagnoses of the patients are shown in Table fifty-five. The numbers are 
small, and there is no statistical difference between the SOD and placebo groups. 
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The admitting diagnoses of the patients are shown in Table fifty-five. The numbers are 
small, and there is no statistical difference between the SDD and placebo groups. 
Table Fifty-Five: Diagnostic Categories of Patients admitted with Infection 
SOD Placebo Withdrawn Suitable 
No of patients 30 46 19 11 
Respiratory dis . 4 7 6 4 
Pneumonia* 5 13 4 1 
ARDS 2 4 l 0 
Cardiovasc I 0 0 1 
Surgery 7 6 3 1 
Neurological 3 6 2 0 
Other dis 6 8 '") 1 
Trauma 3 '") 1 3 
"" 
*p = 0.37 Chi-square resring 
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Equally frequent use was made of therapy which might have influenced the 
development of secondary infection in both groups; apart from the use of chest drains, 
which were inserted more frequently into the placebo patients. The data is shown in 
Table Fifty-six. This difference in the use of chest drains might have influenced the 
incidence of secondary infection, however, no empyemata were encountered and chest 
drains appear to be an infrequent source of infection. 
Table Fifty-SLx: Invasive and other therapy 
SDD Placebo Withdrawn Suitable 
No of patients I 30 46 19 11 
Haemodial ysis 4 6 0 0 
TPN 14 22 0 2 
En teral feed 25 42 9 11 
Chest drain* 3 16 0 4 
Arterial line 21 31 8 4 
Central line 30 46 19 11 
Peripheral line 30 46 19 11 
Pulm art cath 24 31 10 9 
TPN >5 days 16 19 0 1 
Duration IPPV 7.5 9.8 2.4 8.9 
± -L7 ± 5.4 ± 1.3 ± 7.9 
Tracheostomy n=7 n= 19 n=l n=2 
21.3 1-+.4 ") 29.5 ~ 
± 24.6 ± 13.7 
* p = 0. 03 Chi-square res ring. 
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The complications that occurred while in the ICU and which might have contributed to 
the development of secondary infection are shown in table Fifty-seven. 
Table Fifty-Seven: Complications Developing in ICU 
SDD Placebo Withdrawn Suitable 
No of patients 30 46 19 11 
GIT Bleed 1 4 0 0 
Hepatic failure 3 7 0 1 
Cardiac fai lure 0 1 1 0 
Renal failure 0 2 0 0 
Haem failure 2 2 I 0 0 
CNS coma 1 I I 0 0 
Shock(SBP < 70) 2 0 3 1 
Gastric aspirat l 1 0 0 
Pneumothorax l 4 0 0 
Failed wean l 5 0 3 
Diarrhoea* 4 10 0 2 
Ven thrombosis 2 2 0 1 
Other 3 2 0 1 
* p= 0.53 Chi-square cesring 
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The types of infection in the two groups are demonstrated in Table Fifty-eight. 
Respiratory tract infections again predominated , but there was no statistical difference 
between the SDD and placebo patients. 
Table Fifty-Eight: Types of Secondary Infection 
SDD Placebo Withdrawn Suitable 
No of patients 30 46 19 11 
No of infections 8 19 I 0 8 
I 
No of patients* 5 I [5 0 4 
Bronchial 3 7 0 5 
Pneumonia 1 2 0 1 
IV cath 1 ') 0 1 
-
Urinary cath 0 0 0 1 
I 
Septicaemia 2 4 0 0 
Abscess 1 6 0 0 
* p= 0.2 Chi-square resring 
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The pathogens caus111g infection are illustrated in Table Fifty-nine. There was a 
predominance of staphylococcal infections and infections caused by Acinetobacter spp. 
Table Fifty-Nine: Organisms causing Infection 
SDD Placebo ·withdrawn Suitable 
S. aureus 4 5 0 l 
S epidennidis I 3 0 l 
Enrerococcus I 0 
.., 0 0 
E. coli 0 1 0 l 
Klebsiella Jpp 0 1 0 l 
Enterobacrer 0 1 0 0 
Pseudomonas Jpp 1 2 0 0 
Acinerobacrer :,p .., 6 0 3 
Candida 0 3 0 0 
Other 0 1 0 l 
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The morbidity, as measured in terms of duration of ICU and hospital stay, was similar 
in both active and placebo groups; there was also no significant difference in mortality. 
(Table Sixty). 
Table Sixty: Morbidity and Mortality 
SDD Placebo Withdrawn Suitable 
ICU stay 15.2 18.2 2.9 17.5 
± 14.5 ± 11.9 ± 1.3 ± 13 
Hospital stay 32.5 32.3 17. 7 31.5 
± 21.4 ± 17.5 ± 27.9 ± 20.7 
Mortality 
in ICU# ... 10 9 1 .) 
in hosp 3 ..., 1 0 .) 
Total 20% 28.3% 52.6% 9% 
# p= 0.309 Chi square test 
Discussion 
This group of patients who had a history of recent infection, comprise a large subset 
(95 patients) of those admitted to the study of selective decontamination. The factors 
likely to predispose to secondary infection. particularly a greater incidence of alcohol 
abuse, lower serum albumin, and more invasive procedures occurred more frequently 
in the placebo group. This group also had twice as many patients admitted with primary 
pneumonia. A large proportion of patients in both groups had already received prior 
antibiotic therapy. The incidence of infections appeared to be higher in the placebo 
patients, although this did not achieve statistical significance, and the outcome of this 
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subset would suggest that no conclusive benefit from the use of SDD is found, even in 
patients with potentially abnormal bacterial adherence mechanisms. 
When all the patients in the study are combined , no difference in the number of patients 
who developed secondary infections who had previously been infected, compared with 
the group as a whole (p =0. 65) could be demonstrated. suggesting that this factor may 
not play an important role. 
9.3.6 Patients infected on admission to the ICU 
Introduction 
A major proportion of patients admitted to the ICU are admitted with infection and the 
mortality in these patients is appreciably higher than for other disease categories. These 
patients have been excluded from many previous studies of SDD either by study design 
261,270, or by selecting groups unlikely to be primarily infected Eg multiple trauma or 
post-surgical cases. In this study, these patients were specifically included and 
prospectively gathered to evaluate the efficacy of selective decontamination in reducing 
morbidity and mortality in this high risk group. 
Patients and Methods 
This study was a prospectively selected subgroup of the parent study on selective 
decontamination, using the protocol and methods described previously. 164 patients 
fulfilled criteria for enrollment and subanalysis, and a further 27 were suitable, but 
were not enrolled to the study on ICU admission. 
The antibiotics that were used to treat the infections present on admission were 
continued, unless cefotaxime could be substituted; other agents thought to have an 
adverse effect on colonisation resistance were avoided if possible. 
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Results 
The patients in the SDD and placebo groups were comparable in terms of demographic 
features. About 20-30% of all infections present on admission were acquired in 
hospital, and were equally distributed in both groups. Table Sixty-one. 
Table Sixty-One: Demographic Details of Patients Infected on Admission 
SDD Placebo Withdrawn Suitable 
No of patients 59 76 29 27 
Age 42.4 45.8 43 46.6 
±15.2 ± 16.8 ± 16.4 ±15.7 
Male:female 27:32 30:45 18: 11 18:9 
Hospit > 48hrs 29 36 12 9 
Community acq 47 64 23 21 
Nosocomial 12 12 6 6 
Inf ec past 1/ 12 29 43 29 24 
APACHE 15.2 15. 1 20.8 14.1 
± 8.3 ± 7.3 ± 11.7 ± 6.6 
Organ failure 1.4 1.4 1.8 1.7 
± 0.6 ± 0.6 ± 1.1 ± 0.7 
Hospit > 48 hrs: hospiralisedfor more rhan 48 hours before ICU admission 
Community acqu, Nosocomial : Communiry or Nosocomial origin of infections present 
on ICU admission. 
Infec past 1/12: Infecrion in monrh prior ro ICU admission. 
* p=0.42 Chi-square resr. 
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The diagnostic categories of the patients are shown in Table Sixty-two. The various 
diseases were not significantly differently distributed between the two groups. 
Table Sixty-Two: Diagnostic Categories of Patients Admitted with Infection 
SOD Placebo Withdrawn Suitable 
No of patients 59 76 29 27 
ARDS 3 5 1 6 
Respiratory dis 11 7 6 3 
Surgery 9 12 3 2 
CVS 2 0 0 0 
Neurological 8 9 4 3 
Other 6 9 5 2 
Pneumonia* 12 23 7 3 
Trauma 8 11 3 8 
* p =0.26 Chi-square test 
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Factors thought likely to predispose to the development of secondary infection were 
equally distributed between the active and placebo groups, except for immobilisation: 
significantly more patients in the SDD group had more prolonged immobilisation. 
Table SLxty-Three: Factors Potentially Predisposing to the Development of 
Secondary Infection 
SDD Placebo Withdrawn Suitable 
No of patients 59 76 I 29 27 
Carcinoma .i ..., 2 0 
-
Immunosup drugs 5 ..., 2 5 
-
Diabetes 4 6 3 4 
Conn tiss dis 0 3 1 0 
Malnutrition 10 8 3 0 
Obesity 4 8 ..., 6 
Alcohol abuse* 13 'r _.) 6 4 
Peptic ulcer 3 6 ..., 2 ,_ 
Shocked 12 9 4 2 
Emergency surg 10 12 5 2 
Albumin< 30mmol/l 43 60 20 14 
Bedbound > 5days# 42 33 5 12 
H-2 blocker 15 22 6 3 
* p= 0.23 Chi-square test 
# p = 0.002 Chi-square test 
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The invasive and therapeutic monitoring procedures including ventilatory requirement 
during ICU stay are shown in Table Sixty-four and were equally distributed between 
both groups, apart from a significantly increased requirement for total parenteral 
nutrition in the placebo group. 
Table SLxty-Four: Invasive Therapeutic and \'Ionitoring Procedures 
SDD Placebo Withdrawn Suitable 
No of patients 59 76 29 27 
Dialysis 6 9 1 1 
TPN* 17 38 4 7 
Enteral feed 49 69 14 23 
Plasmapheresis l 2 0 0 
Chest drain 10 24 2 6 
Arterial line 31 51 13 10 
Central line 47 71 22 18 
Peripheral line 59 76 29 43 
Pulm an cath 43 51 11 16 
TPN >5 days* 21 30* 3 5 
Duration IPPV 12.7 13.6 34 10.2 
± 13.8 ± 11.3 ± 5 .2 ± 10 
Tracheostomy (n=21) (n=34) (n=2) (n=7) 
21.9 19 .8 8.9 14.7 
:!-p = 0. 02 Chi-square resr 
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Complications occurred with equal frequency in both groups and are shown in Table 
Sixty-five. 
Table Sixty-Five: Complications developing in the ICU 
SOD Placebo Withdrawn Suitable 
No of patients 59 76 29 27 
GIT bleed 6 7 1 0 
Hepatic fmlure 6 10 1 2 
Cardiac fmlure 0 I 0 0 
Renal failure 2 6 0 0 
Haem fmlure 2 3 0 0 
CNS coma 2 2 0 0 
Shock (SBP < 70) 3 I 7 1 
Gastric aspirat 2 1 0 1 
Feed aspiration 1 ,.., 10 0 
--
Pulmon embolus 0 0 0 0 
Pneumothorax 2 5 1 0 
Other vent comp 0 0 0 0 
Fmled wean* 2 10 1 5 
Diarrhoea 12 17 1 3 
Ven thrombosis 3 2 0 1 
Other 7 7 I 2 
* p = 0.09 Chi-square re.wing 
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There were significantly more infections in the placebo group, and these occurred at all 
sites. (Table Sixty-six). 
Table Sixty-Six: Types of Infection 
SDD Placebo Withdrawn Suitable 
No of patients 59 76 29 27 
No of patients,;: 13 32 2 9 
No infections 19 -+9 -+ 16 
Bronchial 7 13 '"I 10 .) 
Nosocom pneumon. 1 7 l 1 
IV catheter 5 7 0 0 
Septicaemia 
-+ 7 0 0 
UTI 0 3 0 3 
Other 2 9 0 0 
* p = 0. 023 Chi-square rest 
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Gram positive infections occurred with equal frequency in both groups, however, there 
was a significantly increased frequency of all Gram negative infections in the placebo 
group (p=0.02). No infections were caused by the Enterobacteriaceae in the SDD 
patients, whereas there were 12 infections in the placebo group (p =0.03). 
Table SLxty-Seven: Organisms causing Secondary Infection 
SOD Placebo Withdrawn Suitable 
S.aureus 7 5 0 2 
S. epidem1idis 4 5 0 l 
Streptococci 0 I 0 0 
Ente rococcus 0 3 0 0 
H. injluen:a<! 0 1 0 1 
E.coli 0 6 0 3 
En.terobacrer spp 0 3 0 1 
Klebsiella spp 0 3 0 1 
Pseudomonas spp 1 4 2 0 
Acinerobacrer jp 6 9 2 5 
Candida spp 0 3 0 0 
Other 1 2 0 1 
437 
The morbidity and mortality were similar in both active and placebo groups, although 
there were more deaths in the ICU in patients who did not receive SDD. The 
relationship of death to secondary infection was assessed as: "definite" in 3 patients in 
the placebo group, "possible" in the 2 patients who received SDD and 4 who received 
placebo, and "unlikely" in the remainder. 
Table Sixty-Eight: Morbidity and Mo11ality 
SOD Placebo Withdrawn Suitable 
No of patients 59 76 29 27 
ICU stay 17.5 18 .8 7.8 14 
± 15.5 ± 13.9 ± 22.4 ± 10.9 
Hospital stay 32.7 34 .2 17.6 31.21 
± 23.8 ± 21 ± 34. l ± 34.6 
ICU deaths* 5 11 14 l 
Hospital deaths 5 6 1 l 
% Mortality 17% 22.3% 51.7% 7.4% 
* p = 0.42 Chi-square testing 
Discussion 
It has been suggested that part of the explanation for the lack of efficacy of SDD in 
units admitting predominantly medical patients 265 , has been that such patients are 
often primarily infected and thus less likely to demonstrate benefit from the use of 
SDD. These patients form a considerable proportion of the patients requiring admission 
to the medical ICU. However, in our study significant benefit has been demonstrated 
from the use of this technique in this subgroup , whereas no benefit was found in either 
the surgical or trauma subgroups. This suggests that there must be another explanation 
438 
for the failure of SDD to reduce the incidence of nosocomial infection, morbidity or 
mortality in medical patients. 
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The overall incidence of secondary infections was not higher in primarily infected 
patients (29. 3 % ) compared with the entire study group; however, the incidence was 
significantly reduced in those who received SDD (22 % ), with complete elimination of 
the Enterobacreriaceae as nosocomial pathogens. In spite of this reduction in the 
incidence of secondary infection. there was no signi fi cant effect on morbidity or 
mortality. When the causes of death were analysed , however, only two deaths in the 
SDD patients were related to secondary infection , compared with seven in the placebo 
group; in the placebo group , three of these deaths were directly attributable to 
secondary infection, while in four , nosocomial infection played a contributory role. 
Had the numbers been larger, this might have achieved statistical significance. 
The organisms identified in the three placebo patients as responsible for death were 
Candida spp in one, Candida spp and Sraphylococcus aureus in another, and 
Enterococcus in the third. This suggests that the use of amphotericin B in the 
prophylactic regimen may be extremely important, particularly in patients who receive 
prolonged therapy with broad-spectrum antibiotics. The overgrowth of Sraphylococcus 
aureus and Enrerococcus in the gastrointestinal surveillance samples of all patients may 
have resulted from the use of SDD and contributed to the higher incidence of infections 
caused by those organisms inherently resistant to the agents used in the regimen. 
Some authors have suggested that the reservoir of microorganisms in uncontaminated 
patients may have explained the lack of efficacy shown in some studies; however, even 
in those studies where infected patients were excluded, but nevertheless treated within 
the same ICU, effective decontamination was reported 263 ,264,268 . This suggests that 
treating decontaminated and undecontaminated patients in the same unit, plays no part 
in the incidence of secondary infection. 
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More studies evaluating the efficacy of SDD in infected patients , particularly using 
enteral antifungal prophylaxis alone, or in combination with drugs which will also 
prevent staphylococcal infections, are clearly required to assess its potential benefits. 
The potentially lethal consequences of systemic fungal infections, and its difficulty of 
diagnosis may well be sufficient to justify even costly therapy with enteral amphotericin 
B in certain at-risk groups of patients. However, the greater ease in detecting 
staphylococcal superinfection and the concern over the emergence of further 
antimicrobial resistance in the Gram positive organisms may mitigate against the use of 
anti-staphylococcal prophylactic regimens. 
9.3. 7 Patients with Primary Pneumonia 
Introduction 
Patients with primary pneumonia requiring ICU admission have a particularly high 
mortality (29%) 141 . These patients usually require prolonged ventilation, and 
antibiotic therapy for a number of weeks. Pneumonia itself has been shown to 
predispose to further episodes of respiratory tract infection 304 and this may apply to 
secondary infection occurring during the hospital stay. This subgroup who thus may be 
at particular risk for the development of secondary infection, has not previously been 
assessed with regard to the efficacy of selective decontamination. 
Patients and Methods 
This prospectively selected subgroup formed part of the parent study on selective 
decontamination , and the protocol and methods were thus identical. Primary pneumonia 
was defined as an acute febrile illness , with clinical signs of consolidation and crackles 
and radiological opacification , in patients who had not been hospitalised in the previous 
month. 
Results 
Forty-four patients fulfilled criteria for inclusion in this subgroup, and there were a 
further three who were suitable but not included. There was no difference between the 
SDD and placebo groups, as is demonstrated in Table Sixty-nine. The patients who 
were withdrawn were unable to be included because they did not meet the criterion for 
duration of ICU stay or intubation (6 early deaths). 
Table Sixty-Nine: Demographic Details of Patients with Pneumonia 
SOD 
No of patients* 12 
Age 43.2 
± 13. l 
Male: female 
Hospit > 48hrs 
APACHE** 
Organ failure 
* p =0.09 Chi-square rest 
** p = 0.25 Srudenr's r resr 
8:4 
6 
14.6 
± 6.4 
1.4 
± 0.7 
Placebo 
24 
45.7 
±18.3 
16:8 
13 
17. l 
± 5.9 
1.5 
± 0.6 
Withdrawn Suitable 
8 3 
56.9 47 
± 14.4 ± 3.5 
2:5 1 :2 
1 3 
27.4 15 
± 13.7 2.65 
I. 7 1 
± l 0 
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The factors which have previously been described as predisposing to the development 
of secondary infection were equally distributed between the active and placebo groups. 
(Table Seventy). There were more patients who were shocked on admission included in 
the SDD group, but because of the small numbers in the study, this did not achieve 
statistical significance. 
Table Seventy: Possible Predisposing Factors to the Development of Secondary 
Infection 
SDD Placebo Withdrawn Suitable 
No of patients* 12 24 8 3 
Carcinoma 1 1 1 0 
Immunosup drugs 1 2 0 0 
Diabetes 1 2 3 0 
Conn tiss dis 0 1 0 0 
Malnutrition 2 1 1 0 
Obesity 2 2 0 0 
Alcohol abuse 5 8 5 1 
Peptic ulcer 1 1 2 0 
Shocked* 4 1 2 0 
Albumin < 30 10 20 4 3 
Bedbound > 5days 7 22 0 2 
* p = 0.06 Chi-square test 
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The use of invasive and therapeutic monitoring procedures whilst in the ICU was of 
equal frequency in both SOD and placebo groups. (Table Seventy-one). 
Table Seventy-One: Invasive Therapeutic and Monitoring Procedures 
SDD Placebo Withdrawn Suitable 
No of patients* 12 24 8 3 
Dialysis 2 3 0 0 
TPN 4 15 1 0 
Enteral feed 11 .., ., 3 3 
--
Plasmapheresis 0 0 0 0 
Chest drain 3 10 l l 
Arterial line 7 19 4 0 
Central line 10 23 4 3 
Peripheral line 12 24 7 3 
Pulm art cath 9 18 3 3 
TPN >5 days 3 12 0 1 
Duration IPPY 11. 1 12.8 1.9 19.3 
± 9.7 ±5 .6 ± 1.2 ± 16.2 
Tracheostomy (n=4) (n=9) 0 
16.3 17.2 0 
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Complications occurred infrequently in both groups. Five patients developed 
pneumothoraces, related to positive pressure ventilation.(Table Seventy-Two) 
Table Seventy-Two: Complications Developing Within the ICU 
SOD Placebo Withdrawn Suitable 
No of patients* 12 24 8 3 
GIT bleed l 3 0 0 
Hepatic failure 2 3 0 0 
Cardiac failure 0 1 1 0 
Renal failure I .., 0 0 ,._ 
Haem failure 0 2 0 0 
CNS coma 0 l 0 0 
Shock (Sbp < 70) 0 l .., 0 -
Gastric aspirat 0 0 0 0 
Feed aspiration 0 l 0 1 
Pulmon embolus 0 0 0 0 
Pneumothorax l 4 0 0 
Other vent comp 0 0 0 0 
Failed wean 2 .., 0 0 
Diarrhoea 1 6 0 0 
Ven thrombosis 1 0 0 0 
Other ') l 0 0 
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Only one nosocomial infection occurred in the patients who received SDD, compared 
with 10 infections in the placebo group. Five of the infections in the placebo group 
were respiratory. Table Seventy-three. 
Table Seventy-Three: Types of Secondary Infection 
I 
SDD Placebo Withdrawn Suitable 
No of patients* 12 24 8 3 
No of patients* 1 8 0 1 
Infections 1 10 0 1 
Bronchial I 3 0 1 
Nosocom pneum 0 2 0 0 
IV catheter 
I 
0 , 0 0 .) 
Septicaemia 0 ") 0 0 
* p = 0.24 Chi-square test 
The organisms causing infection are shown in Table Seventy-Four. Infections were 
predominantly caused by Gram negative bacilli. 
Table Seventy-Four: Organisms Causing Secondary Infection 
SDD Placebo Withdrawn Suitable 
S. epidennidis 0 1 0 0 
Enrerobacrer 0 1 0 0 
Klebsiella spp 0 I 0 0 
Pseudomonas :-ipp 0 2 0 0 
Acinerobacrer spp 1 2 0 1 
Candida :-ipp 0 I 0 0 
Other 0 I 0 0 
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Morbidity and mortality were similar for active and placebo groups, although 
unfortunately the numbers are too small for meaningful comparison. 
Table Seventy-Five: Morbidity and Mortality 
SDD Placebo Withdrawn Suitable 
No of patients* 12 24 8 3 
ICU stay 18 17. 7 2.1 22.7 
± 16.1 ± 11.3 ± 1.2 ± 16.9 
Hospital stay 32.3 35.4 5.9 41 
± 22.3 ± 20.4 ± 8.6 ± 22 .5 
ICU deaths 0 5 6 0 
Hospital deaths 1 l 0 0 
Mortality# 8.3% 25 % 75% 0% 
# p = 0. 45 Chi-square rest 
Discussion 
Only one patient in the SDD group died: this patient's therapy was withdrawn because 
of hypoxic brain damage sustained following cardiac arrest on intubation and prior to 
ICU admission. Four of the twelve patients enrolled to the SDD group were shocked 
on admission, compared with only one in the control group: this alone, although not 
statistically significant. should have predisposed to a higher mortality rate in this group, 
as shock in pneumonia has been shown to be a poor predictor of outcome (Hammond , 
unpublished data). There was a total of 13 deaths, of which six occurred early from 
respiratory failure or multiple organ failure· in the withdrawn group. There were six 
deaths in the placebo group of which one was definitely related to secondary infection 
(Candida septicaemia), and one possibly related to secondary infection. 
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Although 47 patients with pneumonia were admitted over the study period, only 36 met 
criteria for analysis, and these numbers are insufficient to show statistically relevant 
differences. It is however very suggestive that SDD exerted a protective effect in 
patients with pneumonia, and may prevent mortality, as two of the patients in the 
placebo group died from secondary infection. 
9.4 Microbiological Surveillance during SDD 
Introduction 
While the use of antimicrobial prophylaxis with SDD has been shown to reduce the 
incidence of secondary infection 261,263 ,274 , mortality has not been influenced 279, 
and there has been concern that the longterm application of topical and systemic 
antibiotics may lead to the development of increasing antimicrobial resistance. 
Surveillance cultures thus form an important and integral part of the technique 263. 
Previous studies have suggested that SDD has very little influence on the resistance 
patterns of aerobic Gram negative bacilli 275,276, although most of the studies have 
not monitored the resistance patterns of the microorgansisms for prolonged periods. 
There are reports to suggest that the overgrowth of organisms not susceptible to the 
agents used in the decontamination regimen may be promoted by SDD, and that the 
incidence of infections due to Staphylococcus aureus, coagulase negative staphylococci 
and enterococci may actually increase 305. 
This section reports the results of surveillance cultures taken during the double-blind 
randomised study of selective parenteral and enteral decontamination in our respiratory 
intensive care unit over a two year period. The clinical results suggested that although 
the incidence of infections caused by the Enterobacteriaceae was significantly reduced, 
infections due to staphylococci actually increased in those who received the trial drugs, 
with a resultant non-significant reduction in the overall incidence of nosocomial 
infection. 305 
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Patients and Methods 
This double-blind randomised placebo controlled trial of selective decontamination of 
the digestive tract (SDD) was performed in the two five-bedded open plan units of the 
Respiratory ICU of our hospital, admitting all categories of medical, surgical and 
trauma patients. All patients who were expected to be intubated for more than 48 hours 
and to remain in the ICU for more than 5 days, were randomised on admission, by 
computer generated numbers, to receive either the active decontamination regimen (2 
ml methylcellulose gel containing 2 % wt/vol each of tobramycin, polymyxin E and 
amphotericin B, applied to the oropharynx with a gloved finger 6 hourly; 10 ml of an 
enteral solution containing amphotericin B 500 mg, tobramycin 80 mg and polymyxin 
E 100mg, 6 hourly by mouth or nasogastric tube) or indistinguishable, inert, placebo 
compounds. Both groups of patients received intravenous cefotaxime lg 8 hourly for 
the first 72 hours of admission. The study was approved by the ethics committee of the 
University of Cape Town. 
322 patients were enrolled, but 83 patients were withdrawn (3 protocol violations, 80 
with too short a duration of stay) and these withdrawals have not been included in the 
microbiological surveillance analysis. 239 patients were suitable for analysis: 114 
received the active regimen and 125 placebo; the patients in the two groups were fully 
comparable in terms of age, sex distribution ratio , disease categories and severity of 
illness parameters. 
All ICU and laboratory staff were blinded until the end of the trial. The results of 
microbiological surveillance cultures were not reported to the clinical staff or diagnostic 
section of the microbiological laboratory, as they were expected to reveal a difference 
between verum and placebo groups. A diagnosis of infection was made on the basis of 
clinical evaluation and diagnostic microbiological specimens only. 
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Microbiological surveillance specimens included swabs from the oropharynx and the 
rectum, samples of urine and aspirates of gastric and tracheal secretions. These 
specimens were obtained on admission and then twice weekly, being taken shortly 
before the morning administration of medications. Collection of the gastric and 
tracheal secretions continued until extubation, whilst the remaining specimens were 
collected throughout ICU admission, and final specimens was taken three days after 
discharge from the ICU. 
Processing of specimens was as follows: Gram-stains and semiquantitative leucocyte 
counts were carried out on the samples of urine and tracheal aspirate specimens in the 
diagnostic section of the microbiology laboratory. Urines were cultured 
semiquantitatively on MacConkey agar, while tracheal aspirates were plated onto boiled 
blood, 5 % horse blood and MacConkey agars. After processing and interpretation, 
these cultures were passed to the surveillance section. Gastric aspirates and swabs from 
the oropharynx were cultured as for tracheal aspirates, but in addition were plated onto 
sodium azide-aesculin agar and Saboraud' s agar. Rectal swabs were cultured in the 
same way but without a boiled blood agar plate. 
To minimise the effect of any residual antimicrobial, these swabs (or swab of the 
gastric aspirate fluid) were inoculated into 10ml amounts of brain-heart infusion broth. 
These swabs were subcultured when absence of growth on the agar plates indicated 
such an effect. All incubations were in air overnight at 37°C, except for the boiled 
blood agar plates which were incubated in 5-10% CO2. 
Morphologically distinct colonies were identified by standard methods 306_ 
Susceptibility testing was by the disc diffusion method. Isolates of Pseudomonas 
species were tested for susceptibility to piperacillin, ceftazidime, gentamicin, 
tobramycin and amikacin, while other AGNB and non-fermenters were tested for 
susceptibility to amoxycillin, cefamandole, cefotaxime, gentamicin , tobramycin, 
amikacin, co-trimoxazole and chloramphenicol. 
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Tobramycin resistant isolates of non-fermenters (usually one morphologically distinct 
isolate per patient) were stored on Dorset egg slopes at room temperature. Where these 
non-fermenters were identified as Xanthomonas or Flavobacterium species, polymyxin 
susceptibility was determined by multi-point inoculation of agar containing up to 1000 
mg/L polymyxin B. 
Definitions. 
Aerobic Gram negative bacilli (AGNB) were Emerobacreriaceae and P. aentginosa. 
An organism was "acquired" when no prior specimen from the same site grew an 
organism with the same identification and susceptibility profile. 
"Colonisation" was the isolation in two or more consecutive specimens from the same 
site of organisms with the same identification and susceptibility profile. 
Pseudomonas aemginosa was assumed resistant to cefotaxime and Proteus, Providencia 
and Morganella species were assumed resistant to polymyxin 275. 
Resistant AGNB were these bacteria and Enrerobacteriaceae resistant to cefotaxime or 
tobramycin on susceptibility testing. 
"Infection" was diagnosed using strict clinical and microbiological criteria and was 
defined as secondary infection when signs developed more than 48 hours after 
admission to the ICU 305 
Statistical analysis. 
The presence of organisms isolated from the various specimens was analysed in 
intervals determined by the duration of ICU stay. 263 These intervals were: On 
admission, 8-72 hours, 3-7 days, second week, third week and fourth to eighth weeks. 
The numbers of samples, isolates or patients were the denominators for proportions 
263,275,277,278 The difference between proportions was tested by chi-squared 
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without Yate's correction, or Fisher's exact test (alpha= 0,05) and, where relevant, 
95 % confidence intervals for the difference between proportions were obtained. 
Results 
Specimens for microbiological surveillance were obtained from 239 patients (Verum: 
114 Placebo: 125). The specimens were equally distributed between the two groups. 
with a total of 3806 gastrointestinal specimens, a mean of 15.2 verum and 16.6 placebo 
specimens per patient. Tracheal aspirates totalled 1207 (V5.1, P5.0) and arinary 
specimens 947 (V3.9, P4). 
Colonisation of the gastrointestinal tract by AGNB in the decontaminated patients was 
significantly reduced , but not completely eliminated. with early clearance being evident 
in the oropharyngeal and gastric surveillance samples within 3 days, while requiring a 
week or longer to achieve a similar degree of rectal clearance. (Figures 8, 9, and 10) 
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Colonisation of the gastrointestinal tract by AGNB that had been present from 
admission occurred infrequently in all patients. Those who were treated with SDD had 
significantly less gastrointestinal colonisation (V: 0, 16 P: 0,32 p < 0,005). None of 
the organisms which persisted as colonisers caused infection. 
Tracheal and gastric colonisation by AGNB remained at very low levels in the active 
group, but increased significantly in the placebo group with more prolonged duration of 
stay The progression from colonisation of the digestive tract by AGNB acquired in the 
ICU, to colonisation of the trachea, with the subsequent development of secondary 
lower respiratory tract infections was only detected in placebo patients (V: 0 P: 7 p < 
0,01). (Figure Eleven) The acquisition , colonisation and infection that occurred with 
AGNB in the patients during their ICU stay are shown in Figure Twelve. 
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In all secondary lower respiratory tract infections caused by _P. aeruginosa, in the 
patients who received the active regimen , the organisms were either present in the 
trachea from admission, or acquired directly into the trachea, without evidence of prior 
gut colonisation. (Figure Twelve). 
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P. aeruginosa was less common in the digestive tract of verum patients when measured 
as isolates from specimens, but when measured by colonisation of patients, (V: 4 P: 
12) this difference was not significant. 
The 1174 non-fermenters isolated were identified as: Acinerobacter species (809), 
Xanthomonas maltophilia (195), Flavobacterium species (57) and non-aeruginosa 
pseudomonads. Non-fermenters were isolated with equal frequency from both groups 
of patients. These organisms were mainly isolated from tracheal aspirates (740 versus 
354 specimens from other sites), but were uncommon until 8-72 hours after admission. 
The isolation of non-fermenters from other sites was uncommon in patients who 
received SDD (V: 0,047 P: 0, 142 p < 0,0001). Acquired tracheal colonisation by 
Acinetobacter species was common, usually became evident during the first week of 
admission, (85/108 patients) and occurred throughout the trial. Acinetobacter species 
caused equal numbers of lower respiratory tract infections in both groups of patients 
and was the most common Gram negative organism resulting in unit-acquired 
colonisation and infection. The respiratory tract was the most frequent site of infection 
caused by this organism and, as with Pseudomonas spp, preceding gastrointestinal 
colonisation was not identified, suggesting an alternative route of acquisition. (Figure 
Thirteen). 
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Most secondary lower respiratory tract infections were caused by "community-
acquired" respiratory pathogens, particularly methicillin sensitive Staphylococcus 
aureus and , in placebo patients, Haemophilus species. The acquisition of Streptococcus 
pneumoniae and Moraxel/a catarrhalis after admission to the ICU was uncommon, and 
did not lead to either colonisation or infection (Figure Fourteen). 
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Both the acquisition and colonisation by "community-acquired" respiratory pathogens 
were more common in placebo than verum patients (p < 0,05). In neither group of 
patients were episodes of "early" hospital-acquired infection (48 hours to 5 days after 
admission) attributable to "community-acquired" pathogens such as Streptococcus 
pneumoniae, Moraxella cararrhalis, or Haemophilus spp. 
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Colonisation of the gastrointestinal tract by DNase negative, methicillin- resistant and 
sensitive staphylococci showed an increase in all patients, but this was significantly 
greater in those who received SDD. (Figure Fifteen). 
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The majority of secondary lower respiratory tract infections were due to methicillin 
sensitive Staphylococcus aureus (Figure Fourteen). There were no identified outbreaks 
of methicillin-resistant staphylococcal infection during the study period, however, there 
was an increase in both colonisation and infection with this organism in the patients 
who received the active regimen . (Figure Sixteen) . 
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There were significantly more Gram postive infections caused by all the staphylococci 
in the patients who received SOD, than in the placebo group (26 infections vs 16, p= 
0.003); in some of these the route was gastrointestinal, but in others direct acquisition 
via the exogenous route played a role . 
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The overgrowth of yeasts was controlled by the use of SDD. The topical application of 
amphotericin B almost complettely abolished colonisation by yeasts in the 
decontaminated patients; there was however no difference in the incidence of infection 
caused by Candida albicans in the two groups, and in one decontaminated patient 
infection which failed to respond to amphotericin B was detected. (Figure 
Seventeen). G/1/dida a!bicans was identified in two patients who died from secondary 
infection acquired in the ICU. 
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The enteral amphotericin decontamination was sufficient to eliminate virtually all 
urinary fungal colonisation. The low incidence of fungal infection in the placebo 
patients may have been partly due to active topical oropharyngeal and urinary anti-
fungal therapy commenced whenever significant and persistent colonisation was noted 
in the clinical samples. The effect of SDD on urinary tract colonisation and infection is 
illustrated in Figure Eighteen. 
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The use of SDD appeared to have no influence in promoting overgrowth or infection by 
enterococci. Increasing colonisation of the gastrointestinal tract by enterococci occurred 
to a similar extent in all patients throughout the patients'stay: 16% of SDD patients 
were colonised on admission, and this increased to 30% by the second week, and 41 % 
of patients were colonised by the fourth week. In the placebo group, 10% were 
colonised on admission, 32 % by week 2, and 41 % after four weeks. There were three 
enterococcal infections which occurred in the placebo group: one IV catheter related 
infection which lead to death and two abscesses. (Figure Nineteen) . 
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The percentage of resistant Gram negative organisms increased in both groups from 
soon after admission.(Figure Twenty). 
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When comparing the total number of resistant isolates, there was a significant increase 
of resistant Gram negative isolates in the placebo group (Figure Twenty-One). 
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Although no increase in antibiotic resistance by the AGNB was seen in the SDD group, 
in the placebo group a significantly increasing number of isolates resistant to 
tobramycin and cefotaxime was found. (Figure Twenty-Two) 
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The isolation of both cefotaxime and tobramycin resistant Enterobacteriaceae was less 
common in the digestive tract of patients receiving SDD, whether measured as isolates 
from specimens or as colonisation of patients (cefotaxime resistant, tobramycin 
susceptible V: 2 P: 20 p< 0,001 and tobramycin resistant V: 2 P: 19 p< 0,001 ). 
(figure Twenty-Three) 
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The respiratory tract was identified by surveillance cultures as the source of Gram-
negative septicaemia in six patients. In the one verum patient without a respiratory 
source, acquired rectal colonisation by a cefotaxime and robramycin resistant Klebsiella 
pneumoniae preceded the septicaemia by 10 days. 
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Proteus, Providencia and Morganella species, which are intrinsically resistant to 
Polymyxin, were isolated with equal frequency in both groups and the colonisation of 
patients was also similar in both groups (V: 6 P: 8). In three patients who received 
SDD, these isolates were also found to be Tobramycin resistant. There was only one 
respiratory tract infection in a patient receiving SOD that could have been attributed to 
prior gut colonisation with Proreus mirabilis; this was an episode of sinusitis related to 
a nasogastric tube caused by a tobramycin sensitive organism. (Figure Twenty-four) 
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The majority of non-fermenters were resistant to the agents used in the decontamination 
regimen, apart from polymyxin E; most isolates of these organisms (92 % ) were 
resistant to cefotaxime. Although tobramycin resistant Acinerobacrer species were 
isolated less often in the patients who received SOD (V: 0.46 P: 0 ,59 p < 0,0005) 
colonisation (V: 27 P: 34) was not significantly different. Most isolates of other non-
fermenters (94 % ) were resistant to tobramycin. All isolates of Flavobacterium species 
were resistant to 1000 mg/L polymyxin. Acquired tracheal colonisation by 
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Xanthomonas maltophilia and Flavobacterium species was recognised more often in the 
second year of the trial (9/14 and 11/12 patients, respectively). Colonisation by X. 
maltophilia occurred equally in both groups of patients, and, although colonisation by 
Flavobacterium species was more common in verum than placebo patients (V: 8 P: 4), 
the difference was not significant. X. maltophilia was responsible for one catheter-
related (verum) and one respiratory (placebo) infection. No infections were attributed 
to Flavobacterium species. 
Methicillin resistant Staphylococcus aureus (MRSA) were more commonly acquired in 
the ICU in patients who received SDD, whether measured as total isolates, or as 
number of patients with colonisation (isolates in consecutive specimens from the same 
site: V: 16 P: 7 p< 0,025). However, secondary infections caused by MRSA were 
not more common in verum patients (V: 7 P: 5). 
Contamination of urine with yeasts and AGNB was less common in verum patients (V: 
6 P: 34 p<0,001, Figure Eighteen). Urinary tract infection was infrequent. In 50% 
of the 8 patients who developed urinary tract infection, rectal isolation of the causative 
AGNB was noted to precede infection. 
Discussion 
The aim of this detailed microbiological surveillance was to detect the effects of SDD 
on colonising and pathogenic flora, and to monitor for the emergence of antibiotic 
resistance and overgrowth by organisms not susceptible to the agents used in the 
decontamination regimen. 
Our study design differed from the other studies of SDD in that patients in both the 
active and placebo groups were given intravenous cefotaxime for 72 hours following 
admission. Cefotaxime was given to both groups to avoid the frequent unblinding 
which might otherwise have been necessary, because of uncertainty as to whether the 
patients were receiving an antibiotic. The absence of early infections by "community" 
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pathogens may have been due to the initial effect of the systemic cefotaxime 
administered to all patients. This may be one of the reasons why our study of SDD 
failed to demonstrate a significant reduction in the number of patients with secondary 
infections. A recent paper 17 using cefoxitin prophylaxis to prevent the development 
of early onset pneumonia in patients requiring mechanical ventilation, however, failed 
to find any benefit from its use, suggesting that this alone was not the reason. 
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Despite successful clearance of the Enterobacteriaceae from the gastrointestinal tract of 
decontaminated patients, and the clear reduction in incidence of nosocomial infections 
caused by this group of organisms, the overall incidence of secondary infections was 
not significantly reduced in the patients who received SDD. There may be several 
reasons for this: 1) the primarily low incidence of secondary infections caused by the 
Enterobacteriaceae in our patient population, 2) the increased incidence of Gram 
positive infections in the decontaminated patients, 3) continuing infections caused both 
by the Pseudomonads and other non-ferrnenters and 4) routes other than the 
gastrointestinal tract contributing significantly to infection. 
The overall incidence of nosocomial infection in our ICU during the two year period of 
SDD was 23.2 % . The incidence of secondary infections caused by the 
Enterobacteriaceae was 29. 7 % in the placebo group 305; the year prior to the 
commencement of the SDD study, 30 % of nosocomial infections in the ICU were 
caused by Enterobacteriaceae (unpublished data). Although significantly higher than 
the incidence in the decontaminated patients (9.1 %), this incidence is far lower than the 
incidence of over 80 % reported in the studies where the most dramatic benefit from 
SDD was found 253,264,269,278. 
Direct acquisition and colonisation of the trachea by sensitive organisms did occur in 
the patients who were decontaminated. Pseudomonas aeruginosa was the most 
important cause of such episodes and was isolated primarily from this site. Primary 
colonisation of the trachea by this organism is thought to occur because of bacterial 
adherence mechanisms 33, which facilitate its adherence to the epithelium with 
resultant colonisation of the lower respiratory tract. Certainly, SOD appears to have 
had no influence in preventing this organism from causing respiratory tract infection, 
nor did it prevent gastrointestinal colonisation. The incidence of infections caused by 
this organism was not significantly different in the active and placebo groups (2 vs 5 
infections). 
Amongst the other non-fermenters, Acinetobacter spp was the most common pathogen, 
resulting most commonly in respiratory tract infections. This organism was not 
frequently isolated from surveillance samples of the gastrointestinal tract, and as with 
P. aeruginosa was frequently primarily isolated from the respiratory tract; its route of 
spread is generally accepted to be exogenous, and although less is known about its 
adherence to the epithelium of the lower respiratory tract, it appears that selective 
decontamination is not an effective way of preventing secondary infection with this 
organism. This organism was the most frequently isolated Gram negative pathogen, and 
appears to be increasing in importance as an opportunistic nosocomial pathogen in the 
ICU. This may well have contributed to the limited efficacy of SDD. 
The significance of gastric colonisation and its relationship to secondary respiratory 
tract infection with both the Enterobacteriaceae and other Gram negative organisms has 
been questioned 39,300; and mechanisms of direct tracheal or oropharyngeal 
acquisition and infection have been suggested to be of greater importance than may 
have been recognised by the protagonists of SDD. Our findings would support this. 
Although the number of staphylococcal infections was significantly higher in the 
decontaminated patients, when comparing methicillin-resistant, methicillin-sensitive and 
DNase negative infections, the numbers were too small individually to achieve 
significance. This increase in infections with Gram positive organisms diminished the 
positive effect of SDD on the overall incidence of secondary infections. Whilst the 
staphylococcal infection rate was not excessively high in our unit, a much higher rate 
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of infection with this organism has been found in neurosurgical patients 199 during a 
study of SDD. The infections due to these organisms in our study were not necessarily 
related to gastrointestinal colonisation, and although gastrointestinal colonisation with 
these organisms actually increased during the study period. In many cases the route of 
infection appeared to have been via direct acquisition of these organisms. 
There was concern that the use of SDD might promote an outbreak of methicillin-
resistant Staphylococcus aureus infections; however, methicillin-resistant 
staphylococcal infections occurred with equal frequency in both groups, and no 
outbreaks were identified. It is nevertheless of concern that this increasing colonisation 
by resistant organisms might eventually have resulted in infection if the regimen had 
been continued for much longer. The use of alternative agents in the decontamination 
regimen to address the problem of staphylococcal infection has been reported to be 
successful 142. The potential induction of resistance to vancomycin with the topical, 
prophylactic use of this drug however, needs careful evaluation. 
Surveillance cultures showed a significantly increased incidence of both cefotaxime and 
tobramycin resistance by the non-fermenters in both groups, but there was also an 
increase in resistance to these agents by the Enterobacceriaceae isolated from the 
placebo group; however, during the trial period, there was no increase in the incidence 
of antibiotic resistance by the AGNB in early surveillance cultures. There were no 
outbreaks of multi-resistant organisms during the trial of SDD, or in the subsequent 12 
months. 
Topical amphotericin B proved highly effective in eliminating yeasts from both the 
gastrointestinal and urinary tracts. There were fewer systemic infections with Candida 
albicans in the patients who received the active regimen; however, this reduction was 
not significant. The incidence of fungal infection in the placebo limb may have been 
reduced with the use of topical therapy, whenever colonisation was clinically detected. 
The high mortality and difficulty in diagnosis associated with systemic fungal 
infections, may be a sufficient reason for the more general use of topical antifungal 
prophylaxis, despite the expense and controversial role of amphotericin Bin SDD. 
Gastrointestinal surveillance cultures were of little value in detecting microorganisms 
likely to cause infection at other sites; however, the value of the surveillance cultures 
of tracheal aspirates was highlighted by their having detected in advance the presence 
of colonising organisms, which subsequently gave rise to the development of 
respiratory tract infections or septicaemias. The routine use of tracheal and urinary 
surveillance should help to predict the early development of infection and its likely 
aetiology, and assist in the choice of appropriate therapy. 
9.5 Antibiotic resistance patterns and the long-term effects of selective 
decontamination 
We recently reported the effect of the use of amikacin as the primary aminoglycoside 
on antibiotic resistance profiles in our ICU 34, during this time of increased amikacin 
usage, the rate of amikacin resistance increased from 8.5 % to 39. 6 % with an associated 
increase in resistance to the other aminoglycosides. There has been much concern 
internationally that the use of selective decontamination, where clinically important 
antibiotics are used prophylactically and topically , might likewise have a detrimental 
effect on microbial resistance patterns. Surveillance cultures have been an integral part 
of the majority of studies on SDD, and assessment of resistance patterns during the use 
of SDD have shown no increase in the incidence of resistance in Gram negative 
organisms to the agents used. A number of studies have shown some increase in the 
number of organisms, not sensitive to the regimen, which has further heightened 
concern about the potential long-term effects of SDD 263,275,276,305. None of these 
studies was designed to demonstrate, over an extended time period, the influence of 
SDD on the overall antimicrobial resistance patterns. 
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This prospective study compares the resistance patterns before the introduction of SDD 
with those obtained during the two year period of the trial of SDD, and those during 
the subsequent year, in an attempt to evaluate the effect of SDD on the long-term 
antibiotic resistance patterns in the ICU. 
Methods 
All patients admitted to the respiratory ICU were included in this four year study from 
January 1988 through December 1991. The clinical features and episodes of 
nosocomial infection were documented in a similar manner to those reported during the 
study of SDD. 
Nosocomial infection was diagnosed if signs developed more than 48 hours after 
admission to the ICU. The following definitions of infection were used: 
Septicaemia was diagnosed as the clinical observation of all of the following with no 
obvious localising site of infection: 
a positive blood culture 
a rise or fall in temperature ( > 38°c or < 35 .5°C) 
a rise in white blood cell count ( > 10 000/ml), or a left shift in its morphology 
evidence of organ dysfunction. Criteria for organ dysfunction were defined as follows: 
lung: PaQi < 8kPa on 40% oxygen, or respiratory rate < 5/minute or > 49/minute, or 
PaCQi > 6kPa, or AaD02 > 46 kPa, or dependent on ventilator for > 4 days. 
kidney: urine output < 479ml/24 hours, or < 159ml/8 hours, or serum creatinine 
> 300 mmol/1, or serum urea > 20 mmol/1. 
liver: liver enzymes more than twice normal or total bilirubin > 50 mmol/1. 
central nervous system: unconscious with a Glasgow coma scale of < 6 without the use 
of sedatives for more than 24 hours 
haematological: white cell count < 1 000/ml, or platelets 20 000/ml. 
cardiovascular: mean blood pressure <49 mm Hg, or pH < 7.24. 
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Nosocomial pneumonia was defined as a new infiltrate on the chest radiograph more 
than 48 hours after admission to the ICU, purulent bronchial secretions with many 
leukocytes, temperature above 38°C, white blood cell count > 101011 , increasing or 
showing a left shift, substantial numbers of organisms shown by Gram staining of the 
tracheal aspirate, with a pure growth cultured from the tracheal aspirate, and a 
deterioration in gas exchange of 2kPa or more. 
Bronchial infection was defined by the presence of all the features of pneumonia, 
except the radiographic changes. 
Urinary tract infection in patients who had been catheterised for at least 48 hours before 
collection of the specimen, was defined by the presence of local or systemic signs of 
infection, with culture of bacteria or yeasts, and the presence of more than 108 white 
cells per litre of urine. 
Vascular-catheter related sepsis was defined as temperature above 38°c, white blood 
cell count above 101011 or left shift, with relief of signs on removal of the catheter; a 
positive catheter tip culture, blood culture, or the presence of local inflammation were 
not required for the diagnosis. 
If a nosocomial infection was diagnosed, appropriate cultures were taken for isolation, 
identification and sensitivity testing of the causative organisms. All central venous 
catheters were cultured on removal. 
Routine surveillance cultures of tracheal aspirates m intubated patients and unne 
samples, as well as from other clinically relevant sites, were performed twice weekly 
and when clinically indicated, in addition to the surveillance cultures taken as part of 
the study on SDD. 
Clinically significant bacterial isolates only were considered for analysis, and resistance 
patterns of organisms deemed to be colonisers were excluded. A clinically significant 
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bacterial isolate was defined as a culture of an organism accompanied by clinical 
evidence of systemic infection which required antibiotic treatment. Repeated culture of 
the same organism was recorded as the initial specimen only, and all organisms 
considered to be colonisers or contaminants were disregarded. The method used to 
determine resistance for the initial period was that of Stokes and Ridgway306,307, 
using a 10 microgram aminoglycoside disc which was subsequently changed to the 
Kirby-Bauer method, where 30 ug aminoglycoside discs were used 308. 30ug discs of 
cephalosporin were used throughout the study. 
Results 
The demographic data of the patients admitted to the Respiratory ICU over the three 
time intervals studied are shown in the Table Seventy-six. Although similar numbers of 
patients were admitted over the four years , and there was no statistical difference in 
age, in the year post SDD, there was an unexplained increase in the number of women 
admitted, and the APACHE II score was significantly lower than in the year prior to 
SDD. The duration of tracheostomy was shorter in the year after SDD. There was 
however no difference in the number of patients who required ventilation or other 
invasive procedures, and the overall mortality for the three time periods was similar. 
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Table Seventy-Six :Patient profiles and invasive procedures 
Pre-SDD SDD Post-SDD 
No of patients 406 719 403 
Age 42.7 41.4 40 
± 18.2 ± 16.5 ± 17.9 
Male: female 208: 198 371:348 193:210 
APACHE 14.3* 13.3 12.9* 
± 8.3 ± 8.1 ± 6.8 
Ventilated 75.9% 79.6% 76.9% 
Duration ETT 5.1±4.8 5.2 5 ± 3.8 
Tracheostomy n=68 n= 132 n=75 
18. 1 18.3 12.9 
ICU stay 9.6 9.9 9.1 
± 13.3 ± 11.6 ± 10.8 
PA catheter 61 115 62 
Mortality 14.5% 13.9% 13.4% 
* Student's t rest p=0.0088 comparing APACHE II pre and post SDD. 
The incidence of different diseases requiring ICU admission was also similar and is 
shown in Table Seventy-seven. 
Table Seventy-Seven: Incidence of disease requiring ICU admission 
Pre SDD SDD Post-SDD 
No of patients 406(%) 719( % ) 403(%) 
Asthma 46(11.3) 72(10) 30(7) 
Pneumonia 62(15) 87(12) 50(12) 
ARDS 21(5) 65(9) 34(8) 
COPD 18(4) 29(4) 15(4) 
Other lung dis. 37(9) 62(9) 37(9) 
Neurologic dis. 39(10) 54(8) 40(10) 
Overdose/poison 34(8) 43(6) 26(6) 
Elective surgery 41(10) 63(9) 45(11) 
Blunt chest trauma 44( 11) 112(16) 47(12) 
Other disease 64(16) 132(18) 79(20) 
The number of patients who received antibiotics during the three time intervals is 
shown in table Seventy-eight. The differences in antibiotics used over the time intervals 
studied, were largely the result of drug studies (a quinolone was studied as part of a 
Phase III study in the year pre-SDD), or owing to hospital policy and cheaper tenders 
for antibiotics. Cefotaxime usage during the SDD interval was higher, as this antibiotic 
was often continued for therapeutic purposes, if microbial sensitivities were appropriate 
over this time period; thereafter, however, the drug was no longer available on hospital 
code and other cephalosporins were substituted , so that overall cephalosporin usage 
remained similar. The overall antibiotic prescribing over the three time i'ntervals was 
thus comparable. 
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Table Seventy-Eight : Number of Patients for whom antibiotics were prescribed 
d . th t d SDD t d . d urmg . e pre, pos an s u 1y per10 s 
Pre SDD SDD Post SDD 
No of patients 406 719 403 
Penicillin 119 187 148 
Ampicillin 69 67 58 
Cotrimoxazole 40 74 49 
Gentamicin 2 55 127 
Amikacin 135 160 37 
Cefamandole 0 1 0 
Cefoxitin 0 1 0 
Cefuroxime 1 0 5 
Cefotaxime 52 195 1 
Ceftriaxone 11 106 77 
Ceftazidime 14 15 10 
Piperacillin 9 14 5 
Imipenem 1 8 3 
Quinolone 26 8 18 
Cloxacillin 57 97 59 
Fucidin 3 10 11 
Macrolides 39 60 43 
Vancomycin 25 48 28 
Metronidazole 83 176 117 
TB drugs 16 46 28 
Amphotericin B 8 14 12 
Nystatin 4 3 1 
Acyclovir l 4 3 
Other 28 18 12 
Total no.antibiotics 743 1367 852 
(Other: chloramphenicol, tetracycline, nalidixic acid) 
The overall incidence of nosocomial infection was not statistically different during any 
of the time periods studied, although the incidence of respiratory tract infections was 
significantly higher in the year following SOD than during the two year SDD study 
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period. There were no clusters of nosocomial infection during any of the time periods, 
and the incidence of infection was considered to be the usual pattern with no 
exceptional increases. No outbreak of nosocomial infections with resistant organisms 
was identified and the incidence of different pathogens was similar during all the 
intervals that were monitored. (Table Seventy-Nine). 
Table Seventy-Nine: Incidence of Nosocomial Infection 
Pre-SDD SDD Post-SDD 
No of patients 406 719 403 
Respiratory 42 68* 55* 
Septicaemia 23 35 17 
Urinary tract 13 18 16 
Endocarditis 0 l 1 
Other 2 10 5 
Total infections 80 132** 94 
* Chi-square: p=0.039 difference between incidence of respiratory tract infections 
during SDD and year post SDD. 
** p= 0.055 difference between overall incidence of nosocomial infections during and 
afterSDD. 
The clinically significant bacterial isolates obtained during the study periods are shown 
in Table Eighty. There was a significantly increased number of clinically significant 
organisms isolated in the year following SDD compared with the SDD period 
(p=0.0005), and the year preceding SDD (p=0.024); however, there was no 
difference in the incidence of infection between the year preceding SDD and the SDD 
period (p =0.43). The increase in the different types of pathogens in the year following 
SDD was proportional. 
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Table Eighty : Clinically Significant Bacterial Isolates 
Pre-SDD SDD Post-SDD 
Gram positive 49 79 44 
S. pneumoniae 12 5 5 
S.aureus 25 42 29 
S. epidermidis 7 23 8 
Enterococcus 3 6 2 
S.milleri 1 1 0 
Other strep. 1 2 0 
Gram negative 69 111 95 
E.coli 6 10 12 
Klebsiella spp 19 16 12 
Proteus spp 1 3 7 
Enterobacter 1 12 4 
Serratia spp 0 0 2 
Acinetobacre r 21 45 36 
Pseudomonas spp 9 15 13 
H. influenzae 10 9 6 
M. catarrhalis 2 1 3 
Candida 10 13 9 
Viruses 0 2 0 
Other l 6 12 
The resistance patterns of the clinically significant isolates cultured are shown in Table 
Eighty-one. Tobramycin resistance in the year following SDD was unfortunately not 
tested , except for Pseudomonas spp. 
Table Eighty-One: Resistance patterns of organisms causing clinical infection, 
cultured 48 hours after ICU admission. 
Pre-SDD 
Organism Isol 
AGNB 28 1 
Tobramycin 
Amikacin 
Gentamicin 1 ? 
Cephalosporin-
Cotrimoxazole 
Amoxycillin 
Pseudomonas 2 
Tobramycin 
Amikacin 
Gentamicin 
Ceftazidime 
Piperacillin 
Acinetobacrer 20 
Tobramy5n 
Amikacin 
Gentamicin 
Cephalosporin 
Cotrimoxazole 
S.aureus 
Tobramycin4 
23 
Amikacin 
Penicillin 
Cloxacillin 
Vancomycin 
Cotrimoxazole 
S.eQidermidis 2 
Tobramycin 
Amikacin 
Penicillin 
Cloxacillin 
Vancomycin 
Cotrimoxazole 
AGNB : En.rerobacteriaceae 
N. T. = nor. rested 
Resist 
17.8% 
4% 
18% 
25% 
32% 
86 % 
0 
0 
0 
11 % 
11 % 
-
60 % 
95 % 
100% 
5% 
48% 
17 % 
100% 
48 % 
0% 
30 % 
N.T. 
20% 
100% 
60 % 
0% 
60% 
Cephalosporin : ceforaxime, cefr.riaxone. 
1 p=0.44 2 p=0.02 
3 p=0.000037 4 p=0.19 
SDD Post-SDD 
Isol Resist Isol Resist 
38 36 
23.1 % N.T. 
5% 3% 
5% 8% 
26% 3% 
39% 39 % 
82% 86 % 
14 11 
8% 8% 
7% 0 
7% 15 % 
14% 8% 
14% 8% 
45 35 
- -
51 % 6% 
98 % 91 % 
100% 100% 
0% 6% 
39 26 
38 % 23% 
36 % 23% 
90 % 92% 
38% 23% 
0% 0% 
23% 15% 
22 
.a 
N.T. N.T. 
68 % N.T. 
95 % 100% 
64% 62% 
0% 0% 
77% 100% 
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Discussion 
This four year clinical study in which a similar population of 1528 patients were 
admitted to the respiratory ICU, has shown a very consistent pattern of nosocomial 
infections and causative organisms, with no major changes in antimicrobial resistance 
patterns, despite the extensive use of antimicrobial prophylaxis with topical and 
systemic therapy. It is however interesting to note that the incidence of respiratory tract 
infections was higher in the year subsequent to SDO than during the trial period. The 
reasons for this are not clear, and there was no statistical difference between the 
incidence of respiratory infections during and before SOD. 
There was no discernible increase in the microbial resistance patterns of clinically 
significant isolates, as a result of selective decontamination. The number of isolates of 
specific organisms tested during the three time intervals studied was similar, confuming 
that there were no outbreaks of any particular organism. A decrease in resistance to the 
cephalosporins and gentamicin was noted in the period following SDD, which was 
almost certainly attributable to the change in the method of sensitivity testing. A similar 
resistance pattern was also seen in isolates from the rest of the hospital over the same 
time period. 
The level of aminoglycoside resistance by the Enterobacreriaceae, following SDD, was 
unfortunately not tested for tobramycin, and the level of gentamicin resistance in this 
case may be unhelpful, as resistance to the aminoglycosides may occur independently. 
86% of isolates of Enrerbacreriaceae were resistant to amoxycillin, 39% to 
cotrimoxazole, 8 % to gentamicin and l isolate only to amikacin and ceftriaxone. 
Antimicrobial resistance of Pseudomonas spp following SOD to tobramycin, 
ceftazidime and piperacillin was detected in 8 % of isolates , while 15 % of isolates were 
resistant to gentamicin, and all were sensitive to amikacin. Previous studies 276 have 
suggested that SOD may alter adherence mechanisms and the colonisation resistance of 
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patients, allowing an increased colonisation and possibly infection with this organism. 
In our study, this problem was not encountered, as colonisation was uncommon and in 
the few infections that did occur, the organism was either present on admission, or 
acquired directly into the trachea. In this long-term surveillance, no influence on 
aminoglycoside resistance was detected. 
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All isolates of Acinetobacter spp, which was the most commonly isolated Gram 
negative organism other than the Enterobacteriaceae, were resistant to ceftriaxone, 
91 % to gentamicin, and only 6% to amikacin and cotrimoxazole. These resistance 
patterns were seen both during SDD and in the year preceding and after the study, 
demonstrating no adverse effects with the use of SDD, despite its inherent lack of 
sensitivity to the regimen (apart from polymyxin E). A previous study 271 has 
expressed concern that SDD might promote the incidence of infections with this 
organism, and although the incidence of nosocomial infections with this agent is high, 
no long-term effects relating to SDD could be found. It appears that this organism is 
emerging as a consistently important ICU pathogen, unrelated to the use of SDD. 
Despite the increase noted in gastrointestinal colonisation by methicillin resistant 
staphylococci, with an associated higher frequency of infections caused by S aureus in 
the patients who received the active decontamination regimen during the SDD trial 
period, the percentage of clinically significant methicillin-resistant isolates did not 
increase with SDD. Reassuringly, in the year after SDD the number of clinically 
significant methicillin-resistant isolates of S aureus was actually lower than previously, 
so that there would appear to have been no long-term adverse effects on the Gram 
positive flora in the ICU. There has previously been concern that the use of SDD might 
cause such major disturbances to the microbial flora of the ICU that its former 
equilibrium might not be restored. This study would suggest that once SDD has been 
withdrawn, the potential problem with Gram positive organisms, intrinsically resistant 
to the agents used in SDD, subsides to its previous level 277,278_ 
Despite major concern that the long-term effects of SDD might adversely affect the 
"ecological" balance of the microbial flora within the intensive care unit, this study has 
demonstrated that there would appear to be no immediate or long-term sequelae 
associated with this prophylactic regimen . 
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CHAPTER 10 CONCLUSION 
For over a decade attempts at reducing the incidence of nosocomial infection in the 
ICU with the technique of selective decontamination of the digestive tract have been 
attempted, yet its role remains controversial. This is not surprising, as the reported 
incidence of secondary infection varies widely between different populations and 
institutions; no conformity in the diagnostic criteria for secondary infections has been 
achieved, and the actual influence of secondary infection on morbidity and mortality in 
ventilated patients remains unknown, further contributing to the dilemma. 
Attempts to elucidate the pathogenetic mechanisms involved, have lead to the 
recognition of the important role of colonisation of the host, leading to endogenous 
infection. 5 The natural progression from this greater understanding of the role of the 
gastrointestinal tract in the pathogenesis of nosocomial infection, was the emergence of 
selective decontamination of the digestive tract, using non-absorbable oropharyngeal 
and enterally administered, prophylactic antibiotics. 
Initial attempts using enteral prophylaxis alone by Stoutenbeek et al 243, failed to 
reduce the incidence of early onset nosocomial pneumonia, until parenteral cefotaxime 
was added for the initial few days of ICU admission. With a combination of parenteral 
and enteral prophylaxis, the Groningen group reported a dramatic reduction particularly 
in the incidence of secondary respiratory tract infection from over 80% to less than 
20% 274. Especial benefit was shown in patients who had sustained multiple trauma14; 
subsequently Ledingham et al 263 confirmed these results and showed a reduction in 
mortality in this subset of patients. While initial studies reported reductions in the 
incidence of all types of secondary infections, particularly of the respiratory and 
urinary tracts, subsequent emphasis has largely been on the prevention of respiratory 
tract infection. 
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The previous adverse experience encountered with the use of aerosolised polymyxin 
233, and the inherent resistance of physicians to the use of topically administered 
antimicrobial prophylaxis, for fear of the development of resistance, has resulted in 
there having been at least a further twenty to thirty reported studies, with varying 
success. Meta-analysis 279 of the effect of selective decontamination of the digestive 
tract on the incidence of respiratory tract infections and mortality, where the technique 
had been used for varying indications in different patient groups, with either historical 
or concurrent controls, and different prophylactic regimens, found a significant 
reduction of the frequency of respiratory tract infections, but the effect on mortality 
was not clearly shown. The studies of Stoutenbeek 274 , using an historical control 
group, and Ulrich 267, were largely responsible for any reduction in mortality, and 
when these studies were excluded from the meta-analysis, no benefit was found. 
Criticism of all these studies was the accuracy of diagnosis of secondary pulmonary 
infection, particularly in ventilated patients , and the lack of uniformity in the 
definitions. 
More recently, the publication of two large, double-blind studies has shown less 
convincing benefit from the use of SDD in both medical patients 265, and in the 
general ICU, where a large subgroup of trauma patients 30S was included. Although 
these studies showed a trend towards a reduction in infection, particularly with 
En.terobacteriaceae, in the 684 patients reported the reduction in secondary infection 
did not achieve statistical significance. Microbiological surveillance was only reported 
in one of these studies and demonstrated effective clearance of AGNB from the 
digestive tract; no episodes of pneumonia followed oropharyngeal colonisation with 
AGNB in the decontaminated patients. Although the infections with aerobic Gram 
negative bacilli were virtually eliminated, infection with non-fermenters persisted, and 
Staphylococcal infections increased significantly in the decontaminated patients, so that 
there was no overall benefit. There was a complete absence of early onset pneumonia 
( < 5 days), possibly because both trial groups received cefotaxime, which may also 
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have effectively reduced the observed benefit of decontamination, and thereby 
supporting Stoutenbeek' s early observation that initial use of a parenteral agent was 
essential 243 . 
Many of the studies which have shown maximal benefit from the use of SDD, have 
used control groups, with an exceptionally high incidence of pneumonia ( 40-80%) 
14,253,278. Previous descriptive studies of ICU infection have shown the incidence of 
nosocomial pneumonia to be much lower, than that reported with SDD, with an 
incidence of approximately 20 % 30, 148. This suggests that in the trials of SDD, there 
was , a priori , an exceptionally high incidence of both exogenous and endogenous 
nosocomial infection; any trial under such circumstances, particularly if not blinded, 
would have been likely to have shown benefit. While the reduction in infection could 
have been directly attributed to SDD, other peripheral phenomena such as awareness, 
improved hand-washing and aseptic techniques fostered by the routine imposed by the 
regimen may also have contributed significantly. 
Another important detractor from the benefit shown in these studies, is the recognised 
inadequacy of the diagnosis of pneumonia in ventilated patients. This difficulty is best 
recognised in the setting of ARDS, where 29 % of patients with ARDS were 
misdiagnosed as having pneumonia, and 36 % of cases of nosocomial pneumonia were 
misdiagnosed as ARDS until autopsy 1?5. SDD is well recognised to signficantly 
reduce colonisation of the upper airway and oropharynx , and this, combined with the 
suppressive effects of oral antibiotics on microbiological cultures 272 , may influence 
the incidence of nosocomial pneumonia, particularly if the diagnosis is dependent on 
quantitative cultures. 
The protected specimen brush has become widely accepted as the gold standard for the 
diagnosis of pneumonia, yet its sensitivity of only 70% makes it unreliable as a clinical 
means for the diagnosis of pneumonia 112. Once again it relies heavily on quantitative 
cultures, which may be signficantly affected by the carry-over effects of high dose oral 
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aminoglycosides and polymyxin . The levels in serum and bronchial secretions have 
been shown to exceed the MIC for Enterobacteriaceae, following the administration of 
SDD 272. 
The best way to minimise bias in the diagnosis of ventilator-associated pneumonia in 
clinical trials , is with the use of well defined clinical criteria, which should include the 
presence of purulent tracheal secretions, a new pulmonary infiltrate on the chest 
radiograph , an increasing white cell count, fever and a deterioration in oxygen 
exchange, in well designed , controlled and preferably double-blind studies. While the 
high specificity of the protected specimen brush ensures an accurate aetiological 
diagnosis, its lower sensitivity makes it less valuable in clinical trials evaluating 
therapeutic and preventative modalities l 10, l l l , 115 . The treatment of bronchial 
infection , which usually precedes pneumonia, is essential to ensure optimal outcome, 
while awaiting the development of parenchymal involvement, may prejudice survival. 
In this setting , the use of routine surveillance cultures of tracheal secretions, may 
provide an early indication of the progression from colonisation to respiratory 
infection . 
The more recent studies which have shown no benefit, suggest that while the gut is 
important as a source of endogenous infection , either by colonisation of the oropharynx 
and aspiration or possible translocation , other mechanisms, particularly enhanced 
bacterial adherence 51 , may play a more major role when the gut has been 
decontaminated. This seems to be relevant with altered patterns of infection with 
Pseudomonas aeruginosa 276 and Acinetobacter spp 147. In addition , part of the 
normal flora , which is eliminated by decontamination , may also be important in 
colonisation resistance. Its removal may account for increasing colonisation by 
enterococci and staphylococci , which has been encountered in a number of studies; this 
may lead to an increased incidence of infection by these organisms. The use of 
alternative agents in the decontamination regimen may obviate some of these problems. 
that the incidence of both Gram negative and staphylococcal pneumonia was reduced by 
using enteral vancomycin, neomycin and vancomycin, although the long-term effects 
on antimicrobial resistance remain of concern. Despite careful microbiological 
surveillance conducted during most of the studies of SDD, there has, to date, been very 
little antimicrobial resistance reported by the aerobic Gram negative bacteria to the 
agents used in the regimen 275,276. Few of the studies have monitored the resistance 
patterns of the Gram positive organisms, but in those studies that have analysed this, 
there has been concern that there may be an increasing incidence of both methicillin 
resistant and sensitive Sraphylococcus aureus and coagulase negative staphylococci 
277,278,305 Long-term follow-up, on discontinuation of SDD, has shown that 
disturbances in the microbial flora and its resistance patterns should revert to their 
previous levels. 
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The relationship between nosocomial infection and death may be indirect, and related 
to the development of multiple organ failure. This may be related to the release of 
cytokines or endotoxin from the bowel or the site of infection. It was postulated that the 
reduction in the bacillary load in the gastrointestinal tract achieved with SDD might 
reduce the translocation of endotoxin from the gut during periods of ischaemia, and 
thus not only reduce the incidence of nosocomial infections, but also prevent the 
development of mutiple organ failure. This hypothesis has however not been confirmed 
in any of the studies of SDD, as no reduction in mortality nor the incidence of multiple 
organ failure has been observed despite effective bowel decontamination.255,305 
The cost of SDD in terms of drug costs, pharmacy time, nursing time for the 
application of the medication, and microbiological surveillance, which is considered an 
essential part of the regimen, all add considerably to the expense of hospitalisation with 
little obvious benefit in terms of morbidity and mortality and would question the 
wisdom of widespread use of this technique. SDD has, however, been successfully 
used to curtail the spread of multiply-resistant Enr.erobacreriaceae 249. There may also 
be a role for elements of the SDD regimen, in particular, the use of topical antifungal 
therapy may be effective in preventing systemic superinfection with yeasts in 
susceptible patients 257 ,258 ,309 . 
490 
CHAPTER 11 BIBLIOGRAPHY 
1. Duguid JP, Marmion BP, Swain RHA. Mackie and McCartny: Medical 
Microbiology. 13th ed. Edinburgh: Churchill Livingstone, 1978: 
2. Eickhoff TC. Nosocomial Infections. N Engl J Med 1982; 306: 1545-1546. 
3. Eickhoff TC. Nosocomial infections - a 1980 view: progress, priorities and 
prognosis. Am J Med 1981; 70:381-388. 
4. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of 
hospitalised patients. N Engl J Med 1969; 281: 1137-1140. 
5. Johanson WG, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory 
infections with Gram negative bacilli: the significance of colonisatiion of the 
respiratory tract. Ann Intern Med 1972; 77:701-706. 
6. Schimpff SC, Miller RM, Polkavetz SH, Hornick RB. Infection in the severely 
traumatised patient. Ann Surg 1974; 179:352-357. 
7. Le Frock JL, Ellis CA, Weinstein L. The impact of hospitalisation on the 
aerobic fecal microflora. Am J Med Sci 1979; 277:269-274. 
8. Brown RB, Hosmer D, Chen C, et al. A comparison of infections in different 
ICUs within the same hospital. Crit Care Med 1985; 13,no6:472-476. 
9. Daschner FD, Frey P, Wolff G, Baumann PC, Suter P. Nosocomial infections 
in intensive care wards: a multicentre prospective study. Intensive Care Med 
1982; 8:5-9. 
491 
10. Craven DE, Kunches LM, Lichtenberg DA, et al. Nosocomial Infection and 
Fatality in Medical and surgical intensive care unit patients. Arch Intern Med 
1988; 148: 1161-1168. 
492 
11. Daschner FD. Cost effectiveness in hospital infection control - lessons for the 
1990s. J Hosp Infect 1989; 13:325-326. 
12. Clasener HAL, Yollaard EJ. Yan Saene HKF. Long term prophylaxis of 
infection by selective decontamination in leukopenia and in mechanical 
ventilation. Rev Infect Dis 1987; 9,no2:295-328. 
13. Guiot HFL, Yan der Meer JWM, Van Furth R. Selective antimicrobial 
modulation of human microbial flora: infection prevention in patients witn 
decreased host defense mechanisms by selective elimination of potentially 
pathogenic bacteria. J Infect Dis 1981; 143:644-654. 
14. Stoutenbeek CP, Van Saene HKF, Miranda DR, Zandstra DF. The effect of 
selective decontamination of the digestive tract on colonisation and infection rate 
in multiple trauma patients. Intensive Care Med 1984; 10: 185-192. 
15. van Saene H.K.F., Stoutenbeek C.P .. Zandstra D.F. Eleven Important 
Definitions, 1991 First European Consensus Conference on Selective 
Decontamination. 
16. Bone RC. Sepsis , the sepsis syndrome, multi-organ failure: a plea for 
comparable definitions. Ann Intern Mecf 1991; 114:332-333. 
17. Mandelli M, Mosconi P, Langer M, Cigada M. Prevention of pneumonia in an 
intensive care unit : a randomised multicentre clinical trial. Crit Care Med 
1989; 17:501-505. 
18. Gorbach SL, Barza M, Giulano M, Jacobus NV. Colonisation Resistance of the 
human intestinal microflora: testing the hypothesis in normal volunteers. Eur J 
Clin Microbiol Infect Dis 1988; 7:98-102. 
19. Wells CL, Maddaus MA, Jechorek RP, Simmons RL. Role of intestinal 
anaerobic bacteria in colonisation resistance. Eur J Clin Microbiol Infect Dis 
1988; 7: 107-113. 
20. Van Saene HKF, Stoutenbeek CP, Zandstra DF, Gilbertson AA, Murray A, 
Hart CA. Nosocomial infections in severely traumatised patients: magnitude of 
problem, pathogenesis, prevention and therapy. Acta Anaesthesiol Belg 1987; 
38:347-353. 
21. Geddes DM. Infection versus Colonisation. Intensive Care Med 1990; 
l 6s3: s20 l -s205. 
22. Niederman MS, Rafferty TD, Sasaki CT, Merrill WW, Matthay RA, Reynolds 
h Y. Comparison of bacterial adherence to ciliated and squamous epithelial cells 
obtained from the human respiratory tract. Am Rev Respir Dis 1983; 127:85-
90. 
23. Niederman MS, Merrill WW, Ferranti RD. Nutritional status and bacterial 
binding in the lower respiratory tract in patients with chronic tracheostomy. Ann 
Intern Med 1984; 100:795-800. 
493 
24. Todd TRJ, Franklin A, Mankinen-Irvin P, Gurman G, Irvin RT. Augmented 
bacterial adherence to tracheal epithelial cells is associated with Gram-negative 
pneumonia in an intensive care unit population. Am Rev Respir Dis 1989; 
140: 1585-1589. 
25. Harada R, Repine JE. Pulmonary Host Defense Mechanisms. Chest 1985; 
87:247-252. 
494 
26. Stevenson GW, Hall SC, Rudnick S, Seleny FL, Stevenson HC. The effect of 
anesthetic agents on the human immune response. Anesthesiology 1990; 72:542-
552. 
27. Gil-Egea MJ, Pi-Sunyer MT, Verdaguer A, Sanz F, Sitges-Serra A, Torre 
Eleizegui L. Surgical Wound Infections: Prospective study of 4 468 Clean 
Wounds. Infection Control 1987; 8:277-280. 
28. Haley RW, Culver DH, Morgan WM, White JW, Emor TG, Hooton TM. 
Identifying patients at high risk of surgical wound infection: a simple 
multivariate index of patient susceptibility and wound contamination. Am J 
Epidemiol 1985; 121 :206-215. 
29. Cross AS, Roup B. Role of respiratory assistance devices rn endemic 
nosocomial pneumonia. Am J Med 1981 ; 70: 681-685. 
30. Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe 
WR. Risk factors for .pneumonia and fatality in patients receiving continuous 
mechanical ventilation. Am Rev Respir Dis 1986; 133:792-796. 
31. Berendt RF. Relationship of method of administration to respiratory virulence 
of Klebsiella pneumoniae for mice and squirrel monkeys. Infect lmmun 1978; 
20:581-583. 
32. Nickel JC, Ruseka I, Wright JB. Tobramycin resistance of Pseudomonas 
aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob 
Agents Chemother 1985; 27:619-624. 
33. Niederman MS , Craven DE, Fein AM, Schultz DE. Pneumonia in the critically 
ill hospitalised patient. Chest 1990; 97: 170-181. 
34. Hammond JMJ, Potgieter PD, Forder AA, Plumb H. Influence of amikacin as 
the primary aminoglycoside on bacterial isolates in the intensive care unit. Crit 
Care Med 1990; 18:607-610. 
35. Kerver AJH, Rommes JH, Mevissen-Verhage EAE. et al. Colonisation and 
infection in surgical intensive care patients -a prospective study. Intensive Care 
Med 1987; 13:347-351. 
36. White R, Dilworth P. Pneumonia in Hospital. Br J Dis Chest 1988; 82: 121-
126. 
37. Meduri GU. Ventilator associated pneumonia m patients with respiratory 
failure: a diagnostic approach. Chest 1990; 97: 1208-1219. 
495 
38. Graybill JR, Marshall L W, Charache P, Wallace CK, Melvin VB. Nosocomial 
Pneumonia : a continuing major problem. Am Rev Respir Dis 1973; 108: 1130-
1140. 
39. Schwartz SN, Dowling JN, Benkovic C. Sources of Gram negative bacilli 
colonising the tracheae of intubated patients. J Infect Dis 1978; 138:227-231. 
496 
40. Potgieter PD, Tinker J, Warren DE, Hambraeus A. The Influence of Design on 
Nosocomial Infections in ICUs. HOST 1992; 6:8-10. 
41. Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of 
alternative hand-washing agents in reducing nosocomial infections in intensive 
care units. N Engl J Med 1992; 327:88-93. 
42. Goldmann D, . Larson E. Hand-washing and nosocomial infections. N Engl J 
Med 1992; 327: 120-122. 
43. Preston GA, Larson EL, Stamm WE. The effect of private isolation rooms on 
patient care practices, colonisation and infection in an Intensive Care Unit. Am 
J Med 1981; 70:641-645. 
44. Cobley M, Atkins M, Jones PL. Environmental contamination during tracheal 
suction. Anaes 1991; 46:957-961. 
45. Valenti WM, Trundell RG, Bentley DW. Factors predisposing to orophayngeal 
colonisation with Gram-negative bacilli in the aged. N Engl J Med 1978; 
298: 1108-1111. 
46. Ramirez-Ronda CH, Fuxench-Lopez Z, Nevarez M. Increased pharyngeal 
bacterial pharyngeal colonisation during viral illness. Arch Intern Med 1981; 
141: 1599-1603. 
47. Glover J, Jolly L. Gram negative colonisation of the respiratory tract in post-
operative patients. Am J Med Sci 1971; 261:24-26. 
48. Johanson WG, Higuchi JH, Chauduri TR, Woods DE. Bacterial adherence to 
epithelial cells in bacillary colonisation of the respiratory tract. Am Rev Respir 
Dis 1980; 121:55-64. 
49. Hasty D, Simpson WA. Effect of fibronectin and other salivary macromolecules 
on the adherence of Escherichia coli to buccal epithelial cells. Infect Immun 
1987; 55:2103-2109. 
50. Niederman MS, Ferranti RD, Ziegler A, Merrill WW, Reynolds hY. 
Respiratory infection complicating long-term tracheostomy: the implication of 
persistent Gram negative tracheobronchial colonisation. Chest 1984; 85:39-44. 
51. Niederman MS, Mantovani R, Schoch P, Pappas J, Fein AM. Patterns and 
routes of tracheobronchial colonisation in mechanically ventilated patients: the 
role of the nutritional status in colonisation of the lower airway by Pseudomonas 
species. Chest 1989; 95?: 155?-161. 
52. Atherton ST, White DJ. Stomach as source of bacteria colonising respiratory 
tract during artificial ventilation. Lancet 1978; iv:968-969. 
497 
53. Huxley EJ, Viroslav J, Gray WR, Pierce AK. Pharyngeal aspiration in normal 
adults and patients with depressed consciousness. Am J Med 1978; 64:564-568. 
54. Du Moulin GC, Paterson DG, Hedley-Whyte J, Lisbon A. Aspiration of gastric 
bacteria in antacid treated patients: a frequent cause of postoperative 
colonisation of the airway. Lancet 1982; 1:242-245. 
55. Tryba M. Risk of acute stress bleeing and nosocomial pneumonia in ventilated 
intensive care unit patients : sucralfated versus antacids. Am J Med 1987; 
83s3b: 117-124. 
56. Heyland D, Mandell LA. Gastric colonisation by Gram -negative bacilli and 
nosocomial pneumonia in the ICU patient. Chest 1992; 101:187-193. 
57. Ruddell WSJ, Axon ATR, Findlay JM, Bartholomew BA, Hill MJ. Effect of 
gastric cimetidine on the gastric bacterial flora. Lancet 1980; i:672-674. 
58. Pingleton SK, Hinthorn DR, Liu C. Enteral nutrition m patients rece1vmg 
mechanical ventilation: multiple sources of tracheal colonisation include the 
stomach. Am J Med 1986; 80:827-832. 
59. Tryba M, Mantey-Stiers F. Antibacterial activity of sucralfate in human gastric 
juice. AmJMed 1987; 83s3b:125-127. 
60. Inglis TJJ. Pulmonary Infection in Intensive Care Units. British Journal of 
Anaesthesia 1990; 65: 94-106. 
498 
61. Snepar R, Poporad GA, Romano JM, Kobasa WD , Kaye D. Effect of 
cimetidine and antacid on gastric microbial flora. Infect Immun 1982; 36:518-
524. 
62. Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated 
patients given sucralfate as compared with antacids or histamine type 2 
blockers. N Engl J Med 1987; 317:1376-1382. 
63. Cook DJ , Laine LA, Guyatt GH, Raffin TA. Nosocomial pneumonia and the 
role of gastric pH: a meta analysis. Chest 1991; 100:7-13. 
64. McCarthy DM. Drng therapy: Sucralfate. N Engl J Med 1991; 325: 1017-1025. 
65. A'Court C, Garrard CS. Nosocomial pneumonia m the intensive care unit: 
mechanisms and significance. Thorax 1992; 47:465-473. 
66. Langer M, Mosconi P, Cigada M, Mandelli M. Long term respiratory support 
and risk of pneumonia in critically ill patients. Am Rev Respir Dis 1989; 
140:302-305. 
67. Reinarz JA, Pierce AK, Mays BB, Sanford JP. The potential role of inhalation 
therapy equipment in nosocomial pulmonary infection. J Clin Invest 1965; 
44:831-839. 
68. Inglis TJJ, Millar MR, Jones JG , Robinson DA . Tracheal tube biofilm as a 
source of bacterial colonisation of the lung. J Clin Microbiol 1989; 274:2014-
2018. 
499 
69. Inglis T.J.J. Colonisation of the Ventilated Airway 1990, MD Thesis, Leeds 
University. 
70. Seibel R, Laduca J, Hassett JM, et al. Blunt multiple trauma (ISS 36),femur 
traction, and the pulmonary failure septic state. Ann Surg 1985; 202:283-295. 
71. Behrman SW, Fabian TC, Kudsk KA , Taylor JC. Improved outcome with 
femur fr~ctures : early versus delayed fixation. J trauma 1990; 30:792-798. 
72. Caplan ES, Hoyt NJ. Nosocomial sinusitis. JAMA 1982; 647:639-643. 
73. Im SWK, Fung JPH , So SY, Yu DYC. Unusual dissemination of 
pseudomonads by ventilators. Anaes 1982; 37: 1074-1077. 
74. Irwin RS, Demers RR, Pratter MR, et al. An Outbreak of Acinetobacter 
Infection Associated with the Use of a Ventilator Spirometer. Resp Care 1980; 
25:232-237. 
75. Leu HS, Kaiser DL, Mori M, Woolson RF , Wenzel RP. Hospital-acquired 
pneumonia attributable mortality and morbidity. Am J Epidemiol 1989; 
129: 1258-1267. 
76. Krieger JN, Kaiser DL, Wenzel RP. Urinary tract etiology of bloodstream 
infections in hospitalised· patients. J Infect Dis 1983; 148:57-62. 
77. Finkelberg Z, Kunin CM. Clinical evaluation of closed unnary drainaage 
systems. JAMA 1969; 207: 1657-1662. 
500 
78. Warren JW. Nosocomial urinary tract infections. In: Mandell GL, Douglas RG, 
Bennett JE, eds. Principles and practice of Infectious Disease. 3rd ed. New 
York: Churchill Livingstone, 1990:2205-2215. 
79. Quercia R.A, Hills SW, Klimek JJ, et al. Bacteriologic contamination of 
intravenous infusion delivery systems in an Intensive Care Unit. Am J Med 
1986; 80:364-368. 
80. Maki DG, Goldmann DA, Rhame FS. Infection control in intravenous therapy. 
Ann Intern Med 1973; 79:867-887. 
81. Ryan JA, Abel RM, Abbott WM, et al. Catheter complications m total 
parenteral nutrition. N Engl J Med 1974; 290:757-761. 
82. Collignon P, Sorrell TC, Uther JB. Prevention of sepsis associated with the 
insertion of intraavenous cannulae: the experience in a coronary care unit. Med 
J Aust 1985; 142:346-348. 
83. Maki DG, Ringer M. Evaluation of dressing rgimens for prevention of infection 
with peripheral intravenous catheters: Gauze, a transparent polyurethane 
dressing, and an iodophor dressing. JAMA 1987; 258:2396-2403. 
84. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. Catheter related sepsis: 
Prospecitve, randomised study of three methods of long-term catheter 
maintenance. Crit Care Med 1990; 18:1073-1079. 
85. Samsoondar W, Freeman JB, Coultish I, Oxley C. Colonisation of intravascular 
catheters in the intensive care unit. Am J Surg 1985; 149:730-731. 
501 
86. Rhame FS, Maki DG, Bennett JV. Hospital Infections. Boston: Little Brown, 
1979:433-442. 
87. Miller JJ, Venus B, Mathru M. Comparison of the sterility of longterm central 
venous catheterisation using single lumen , triple lumen, and pulmonary artery 
catheters. Crit Care Med 1984; 12:634-637. 
88. Linder LE, Curelaru I , Gustavsson B. Material thrombogenicity in central 
venous catheterisation:A comparison between soft , antebrachia catheters of 
silicone elastomer and polyurethane. J Parenter Enteral Nutr 1984; 8:399-406. 
89. Kelly CS , Ligas JR , Smith CA, Madden GM, Ross KR , Becker DR. Sepsis due 
to triple lumen central venous catheters. Surg Gynecol Obstet 1986; 163: 14-16. 
90. Brun-Buisson C, Abrouk F , Legrand P, Huet Y, Larabi S, Rapin M. Diagnosis 
of central venous catheter related sepsis: critical level of quantitative tip 
cultures. Arch Intern Med 1987; 147:873-877. 
91. Goldman DA, Maki DG. Infection control in total parenteral nutrition. JAMA 
1973 ; 223: 1360-1364. 
92. Press OW, Ramsey PG, Larson EB. Hickman catheter infections in patients 
with malignancies. Medicine (Baltimore) 1984; 63 : 189-200. 
93. Forgacs IC, Eykyn SJ, Bradley RD. Serious infection in the Intensive Therapy 
Unit: a 15 year study of bacteraemia. Quart J Med 1986; 60:773-779. 
502 
94. Sheagreen JN. Significance of blood culture isolates of Staphylococcus 
epidermidis. Arch Intern Med 1987; 147:635. 
95. Fiddian-Green RG, Baker S. Nosocomial pneumonia in the critically ill: product 
of aspiration or translocation? Crit Care Med 1991; 19:763-769. 
96. Deitch EA. The role of intestinal barrier failure and bacterial translocation in 
the development of systemic infection and multiple organ failure. Arch Surg 
1990; 125: 403-404. 
97. Deitch EA. Intestinal bacterial translocation rn sepsis. Highlights from 
infections in surgery 1992; 
98. Veterans Affairs Total Patenteral Nutrition Cooperative Study Group . 
Perioperative Total Parenteral Nutrition in surgical patients. N Engl J Med 
1991 ; 3325:525-532. 
99. Guedon C, Schmitz J, Lerebours E. Decreased brush border hydrolase activities 
without gross morphological changes in human intestinal mucosa after 
prolonged total parenteral nutrition of adults. Gastroenterology 1986; 90:373-
374. 
100. Levine GM, Deren JJ , Steiger E, Zinno R. Role of oral intake in maintenance 
of gut mass and disaccharide activity . Gastroenterology 1974; 67:975-982. 
101. Alverdy JC , Aoys E, Moss GS. TPN promotes bacterial translocation from the 
gut. Surg 1988; 104: 185-190. 
503 
102. Souba W, Herskowitz K, Salloum RM, Chen MK, Austgen TR. Gut glutamine 
metabolism. J Parenter Enteral Nutr 1990; 14:s45-s50. 
103. Jacobs S, Chang RW, Lee B, Bartlett FW. Continuous enteral feeding: a major 
cause of pneumonia among ventilated intensive care unit patients. J Parenter 
Enteral Nutr 1990; 14:353-356. 
104. Tobin MJ, Grenvik A. Nosocomial Jung infection and its diagnosis. Crit Care 
Med 1984; 12:191-199. 
105. Andrews CP, Coalson JJ, Smith JD, Johanson WG. Diagnosis of Nosocomial 
Bacterial Pneumonia in Acute Diffuse Lung Injury . Chest 1981; 80:254-258. 
106. Winterbauer RH, Hutchinson JF, Reinhardt N, et al. The use of quantitative 
cultures and antibody coating of bacteria to diagnose bacterial pneumonia by 
fibreoptic bronchoscopy. Am Rev Respir Dis 1983; 128:98-103. 
107. Wilkinson PJ, Ball AJ, Gillespie WA, Orton VS. Routine laboratory assessment 
of postoperative chest infection: a prospective study. J Clin Path 1977; 30:417-
420. 
108. Torres A, Puig de la Bellacasa J , Xaubet A, et al. Diagnostic value of 
quantitative cultures of bronchoalveolar lavage and telescoping plugged 
catheters in mechanically ventilated patients with bacterial pneumonia. Am Rev 
Respir Dis 1989; 140:306-310. 
109. Meduri GU. Introduction to the Consensus Conference on Ventilator-Associated 
Pneumonia. Chest 1992; 102sl:55Js-552s. 
504 
110. Wunderink RG, Mayhall CG, Gibert C. Methodology for Clinical Investigation 
of Ventilator-Associated Pneumonia; Epidemiology and Therapeutic 
Intervention. Chest 1992; 102sl:580s-588s. 
111. Pingleton SK, Fagon JY, Leeper KV. Patient Selection for Clinical 
Investigation of Ventilator-Associated Pneumonia; Criteria for Evaluating 
Diagnostic Techniques. Chest 1992; 102sl :553s- 556s. 
112. Chastre J. Prospective evaluation of the protected specimen brush for the 
diagnosis of pulmonary infections. Am Rev Respir Dis 1984; 130:924-929. 
113. Bartlett JG, Alexander J, Mayhew J, Sullivan-Sigler N, Gorbach S. Should 
fibreoptic bronchoscopy aspirates be cultured? Am Rev Respir Dis 1976; 
114:73-78. 
114. Donowitz GR, Mandell GL. Acute Pneumonia. In: Mandell GL, Douglas RG, 
Bennett JE, eds. Principles and Practice of Infectious Diseases. 3rd ed. New 
York: Churchill Livingstone, 1990:540-555. 
115. Meduri GU, Chastre J. The Standardisation of Bronchoscopic Techniques for 
Ventilator-Associated Pneumonia. Chest 1992; I02s:557s-564s. 
116. Baselski VS, El-Torky M, Coalson JJ, Griffin JP. The Standardisation of 
Criteria for Processing and Interpreting Laboratory Specimens. Chest 1992; 
I02sl :571s-579s. 
505 
117. Wimberley N, Faling U, Bartlett JG. A fiberoptic bronchoscopy technique to 
obtain uncontaminated lower airway secrections for bacterial culture. Am Rev 
Respir Dis 1979; 119:337-343. 
118. Baughman RP, Thorpe JE, Staneck J, Rashkin M, Frame PT. Use of the 
protected specimen brush in patients with endotracheal or tracheostomy tubes. 
Chest 1987; 91:233-236. 
119. Torres A, Puig de la Bellacasa J, Rodriguez-Roisin R, Jimenez de Anta MT, 
Agusti-Vidal A. Diagnostic value of telescoping plugged catheters in 
mechanically ventilated patients with bacterial pneumonia using the Metras 
Catheter. Am Rev Respir Dis 1988; 138: 117-120. 
120. Torzillo PJ, McWilliam DB, Young IH, Woog RH, Benn R. Use of protected 
telescoping brush system in the management of bacterial pulmonary infection in 
intubated patients. Br J Dis Chest 1985; 79: 125-131. 
121. Chastre J, Fagon JY, Soler P, et al. Diagnosis of nosocomial bacterial 
pneumonia in intubated patients undergoing ventilation: comparison of the 
usefulness of bronchoalveolar lavage and the protected specimen brush. Am J 
Med 1988; 85:499-506. 
122. Fagon JY, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in 
ventilated patients: use of a protected specimen brush and quantitative culture 
techniques in 147 patients. Am Rev Respir Dis 1988; 138:110-116. 
506 
123. Fagon JY, Chastre J, Do mart Y, et al. Nosocornial pneumonia m patients 
receiving continuous mechanical ventilation. Am Rev Respir Dis 1989; 
139:877-884. 
124. Faling LJ. A tale of two brushes. Chest 1981; 79:155-156. 
125. Zavala DC, Schoell JE. Ultrathin needle aspiration of the lung in infectious and 
malignant disease. Arn Rev Respir Dis 1981; 123: 125-131. 
126. Ha Pham L, Brun-Buisson C, Legrand P, et al. Diagnosis of nosocornial 
pneumonia in mechanically ventilated patients: companson of a plugged 
telescoping catheter with the protected specimen brush. Arn Rev Respir Dis 
1991; 143: 1055-1061. 
127. Bates JH, Campbell GD, Barron AL, et al. Microbial aetiology of acute 
pneumonia in hospitalised patients. Chest 1992; 101:1005-1012. 
128. Faling LJ. New advances in diagnosing nosocomial pneumonia m intubated 
patients: editorial. Arn Rev Respir Dis 1988; 137:253-255. 
129. Johanson WG, Seidenfeld JJ, Gomez P, De Los Santos R, Coalson JJ. 
Bacteriologic diagnosis of nosocornial pneumonia following prolonged 
mechanical ventilation. Arn Rev Respir Dis 1988; 137:259-264. 
130. Meduri GU, Wunderink RG, Leeper KY. Management of bacterial pneumonia 
in ventilated patients: protected bronchoalveolar lavage as a diagnostic tool. 
Chest 1992; 101:500-508. 
507 
131. Meduri GU, Beals DH, Maijub AG, Baselski V. Protected bronchoalveolar 
lavage: A new bronchoscopic technique to retrieve uncontaminated distal airway 
secretions. Am Rev Respir Dis 1991; 143:855-864. 
132. Johanson WG. Ventilator-Associated Pneumonia: light at the end of the tunnel? 
Chest 1990; 97: 1026-1027. 
133. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis 
of ventilator associated pneumonia by bacteriologic analysis of bronchoscopic 
and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis 
1991; 143: 1121-1129. 
134. Pugin J, Auckenthaler R. Delaspre 0. van Gessel E, Suter P. Rapid diagnosis 
of Gram negative pneumonia by assay of endotoxin in bronchoalveolar lavage 
fluid. Thorax 1992; 47:547-549. 
135. Davidson M, Tempest B, Palmer DL. Bacteriologic diagnosis of acute 
pneumonia. Comparison of sputum, transtracheal aspirates and lung aspirates. 
JAMA 1976; 235: 158-163. 
136. Wunderink RG, Russell GB, Mezger E, Adams D, Popovich J. The diagnostic 
utility of the antibody coated bacteria test in intubated patients. Chest 1991; 
99:84-88. 
137. Salata RA, Lederman MM, Shlaes DM, et al. Diagnosis of nosocomial 
pneumonia in intubated, intensive care unit patients. Am Rev Respir Dis 1987; 
135:426-432. 
508 
138. Wunderink RG, Woldenburg LS, Zeiss J, Day CM, Ciemins J, Lacher DA. 
The radiologic diagnosis of autopsy-proven ventilator associated pneumonia. 
Chest 1992; 101 :458-463. 
139. Winer-Muram HT, Rubin SA, Ellis JV. Guidelines for Reading and Interpreting 
Chest Radiographs in Patients Receiving Mechanical Ventilation. Chest 1992; 
102s 1 :565s-570s. 
140. Bartlett JG, O'Keefe P, Tally FP, Louie T, Gorbach SL. Bacteriology of 
hospital acquired pneumonia. Arch Intern Med 1986; i46:868-871. 
141. Potgieter PD, Hammond JMJ. Etiology and Diagnosis of Pneumonia Requiring 
ICU Admission. Chest 1992; 101:199-203 . 
142. Pugin J, Auckenthaler R, Lew DP, Suter PM. Oropharyngeal decontamination 
decreases incidence of ventilator associated pneumonia: a randomised , placebo 
controlled double blind clinical trial. JAMA 1991; 265:2704-2710. 
143. Pagon JY , Chastre J , Trouillet JL, Doman Y, Scheimberg A, Dame C. 
Evaluation of patients suspected of having nosocomial pneumonia: are invasive 
procedures necessary for accurate decision making?(abstract). Am Rev Respir 
Dis 1988; 137:A219. 
144. Maki D, Weise CE, Sarafin HW. A semiquantitative culture method for 
identifying intravascular catheter-related infection. N Engl J Med 1977; 
296: 1305. 
509 
145. Henderson DK. Bacteremia due to percutaneous intravascular devices. In: 
Mandell GL, Douglas RG, Bennett JE, eds. Principles and Practice of 
Infectious Diseases. 3rd ed. Boston: Churchill Livingstone, 1990:2189-2199. 
146. Mosca R, Curtas S, Forbes B. The benefits of isolator cultures in the 
management of suspected catheter sepsis. S urg 1987; 102: 718-723. 
147. Haley RW, Schaberg DR, Crossley KB , Yon Allmen SD, Mc..Gowan JE. Extra 
charges and prolongation of stay attributable to nosocomial infections: a 
prospective interhospital comparison. Am J Med 198 l ; 70:51-58. 
148. Potgieter PD, Linton DM, Oliver S, Forder AA. Nosocomial infection in a 
respiratory intensive care unit. Crit Care Med 1987; 15:495-498. 
149. Jimenez P, Torres A, Rodriguez-Roisin R, et al. Incidence and aetiology of 
pneumonia acquired during mechanical ventilation. Crit Care Med 1989; 
17:882-885. 
150. Ruiz-Santana S, Jimenez AG, Esteban A, et al. ICU pneumonias: a multi-
institutional study. Crit Care Med 1987; 15:930-932. 
151. Gross PA, Neu HC, Aswapokee P, Yan Antwerpen C, Aswapokee N. Deaths 
from nosocomial infections: Experience in a university hospital and a 
community hospital. Am J Med 1980; 68:219-223 . 
152. Bryan CS, Reynolds KL. Bacteremic nosocomia1 pneumonia. Am Rev Respir 
Dis 1984; 129:668-671. 
510 
153. Mock CN, Burchard KW, Hasan F, Reed M. Surgical intensive care unit 
pneumonia. Surg 1988; 104:494-499. 
154. Nielsen SL, Roder B, Magnussen P, Engquist A, Frimodt-Moller N. 
Nosocomial pneumonia in an intensive care unit in a Danish University 
Hospital: Incidence, Mortality and Aetiology . Scand J Infect Dis 1992; 24:65-
70. 
155. Rello J , Quintana E, Ausina V. et al. Incidence, etiology and outcome of 
nosocomial pneumonia m mechanically ventilated patients. Chest 1991; 
100:439-444. 
156. Thorp JM, Richards WC, Telfer ABM. A survey of infection in an intensive 
care unit. Anaes 1979; 34:643-650. 
157. Chandrasekar PH, Kruse JA, Mathews MF. Nosocomial infection among 
patients in different types of intensive care units at a city hospital. Crit Care 
Med 1986; 14:508-510. 
158. Torres A, Aznar R, Gatell JM, et al. Incidence, Risk, and prognosis factors of 
nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 
1990; 142:523-528. 
159. Montgomery AB ," Stager MA, Carrico CJ , Hudson LD. Causes of mortality in 
patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1985; 
132:485-489. 
511 
160. Campbell GD, Coalson JJ, Johanson WG. The effect of bacterial superinfection 
on lung function after diffuse alveolar damage. Am Rev Respir Dis 1984; 
129:974-978. 
161. Haley RW, Hooton TM, Culver DH, Stanley RC, Emori TG. Nosocomial 
infections in U.S. Hospitals 1975-1976: estimated frequency by selected 
characteristics of patients. Am J Med 1981; 70:947-959. 
162. Donowitz LG, Wenzel RP, Hoyt JW. High risk of hospital acquired infection in 
the ICU patient. Crit Care Med 1982; 10:355-357. 
163. Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill 
patients with nosocomial bloodstream infections. Chest 1991; 100:164-167. 
164. Detsky AS, Baker JP, O'Rourke K, Goel V. Perioperative Parenteral Nutrition: 
A Meta-Analysis. Ann Intern Med 1987; 107: 195-203. 
165. Wenzel RP. Preoperative Antibiotic Prophylaxis. N Engl J Med 1992; 326:337-
339. 
166. Kaiser AB. Antimicrobial proophylaxis m surgery. N Engl J Med 1986; 
315:1129-1138. 
167. Crossley K, Gardner LC. Antimicrobial Prophylaxis m Surgical Patients. 
JAMA 1981; 245:722-726 . 
168. Shapiro M, Townsend TR, Rosner B, Kass EH. Use of antimicrobial drugs in 
general hospitals: patterns of prophylaxis. N Engl J Med 1979; 301:351-355. 
512 
169. Bergquist EJ, Murphey SA. Prophylactic antibiotics for surgery. Med Clin 
North Am 1987; 71:357-368. 
170. Hunt TK. Surgical Wound Infections: an overview. Am J Med 1981; 70:712-
718. 
171. Stone HH. Basic principles in the use of prophylactic antibiotics. J Antimicrob 
Chemo 1984; 14sB:33-37. 
172. Polk HC, Lopez-Meyer JF. Postoperative wound infection; a prospective study 
of determinant factors and prevention. Surg 1969; 66:97-103. 
173. Burke JF. The effective period of preventive antibiotic action in experimental 
incisions and dermal lesions. Surg 1961; 50: 161-168. 
174. Ronald AR. Antimicrobial prophylaxis in surgery. Surg 1983; 93:172-173. 
175. Green JW, Wenzel RP. Postoperative wound infection: a controlled study of the 
increased duration of hospital stay and direct cost of hospitalisation. Ann Surg 
1977; 185 :264-268. 
176. Guglielmo BJ, Hohn DC, Koo PJ, Hunt TK, Sweet RL, Conte JE. Antibiotic 
Prophylaxis in Surgical Procedures. Arch Surg 1983; 118:943-955. 
177. Burdon DW. Principles of antimicrobial prophylaxis. World J Surg 1992; 
6:262-267. 
513 
178. Classen DC, Scott Evans R, Pestotnik SL, Horn SD, Menlove RL, Burke JP. 
The timing of prophylactic administration of antibiotics and the risk of surgical 
wound infection. N Engl J Med 1992; 326:281-286. 
179. Allgower M, Durig M, Wolff G. Infection and Trauma. Surg Clin North Am 
1980; 60: 133-144. 
180. Goris RJA, Draaisma J. Causes of death after blunt trauma. J Trauma 1982; 
22:141-146. 
181. Schmipff SC, Miller RM, Polakavetz S, Hornick RB. Infection in the severely 
traumatised patient. Ann Surg 1974; 179:352-357. 
182. Harkness GA, Bentley DW, Roghmann KJ. Risk factors for nosocomial 
pneumonia in the elderly. Am J Med 1990; 89:457-463. 
183. Kinnear WJM, Finch RG, Macfarlane JT. Nosocomial lower respiratory tract 
infections in surgical wards. Thorax 1990; 45: 187-189. 
184. Eykyn SJ, Gransden WR, Phillips I. The causative organisms of septicaemia 
and their epidemiology. J Antimicrob Chemo 1990; 25sC:41-58. 
185. Celis R, Torres A, Gatell JM , Almela M, Rodriguez-Roisin R, Agusti-Vidal A. 
Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest 
1988; 93:318-324. 
186. Mosconi P, Langer M, Cigada M. Epidemiology and risk factors of pneumonia 
in critically ill patients . European Journal of Epidemiology 1991; 7:320-327. 
514 
187. Deppe SA, Kelly JW, Thoi LL, et al. Incidence of colonisation, nosocomial 
pneumonia and mortality in critically ill patients using a Trach Care closed 
suction system versus an open suction system: Prospective randomised study. 
Crit Care Med 1990; 18: 1389-1393. 
188. Rogers LA, Osterhout S. Pneumonia following tracheostomy. Am Surg 1970; 
59:39-46. 
189. Bresalier RS, Grendell JH, Cello JP, Meyer AA. Sucralfate suspension versus 
titrated antacid for the prevention of acute stress related gastrointestinal 
hemorrhage in critically ill patients. Am J Med 1987: 83s3B:110-116. 
190. Lacroix J, Infante-Rivard C, Jenicek M, Gauthier M. Prophylaxis of upper 
gastrointestinal bleeding in intensive care units: a meta-analysis. Crit Care Med 
1989; 17:862-869. 
191. Fiddian-Green RG. The potential for monitoring gastric intrmucosal pH to 
reduce the costs of critical care. In: Vincent JL, ed. Yearbook of Intensive Care 
and Emergency Medicine. Berlin: Springer-Verlag, 1992:259-268. 
192. Goris RJA, van Bebber IPT, Mollen RMH , Koopman JP. Does selective 
decontamination of the gastrointestinal tract prevent multiple organ failure? 
Arch Surg 1991; 126:561-565. 
193. Moiraghi A, Castellani Pastoris M, Barra! C, et al. Nosocomial legionellosis 
associated with use of oxygen bubble humidifiers and underwater chest drains. J 
Hosp Infect 1987; 10:47-50. 
515 
194. Grayston JT, Diwan VK, Cooney M, Wang SP. Community and hospital 
acquired pneumonia associated with Chlamydia TWAR infection demonstrated 
serologically. Arch Intern Med 1988; 149:169-173. 
195. Sanford JP. Lower respiratory tract infections. In: Bennett JV, Brachman PS, 
eds. Hospital Infections. Boston: Little ,Brown, 1986:385-422. 
196. Andrews BE, Bartlett CRL. Connolly CK , et al. Community acquired 
pneumonia in adults in British hospitals in 1982-1983: a survey of aetiology , 
mortality , prognostic factors and outcome. Quart J Med 1987; 62: 195-220. 
197. Johanson WG , Seidenfeld J, Gomez P, De Los Santos R, Coalson JJ. 
Bacteriologic diagnosis of nosocomial pneumonia following prolonged 
mechanical ventilation. Am Rev Respir Dis 1988; 137:259-264. 
198. Crouch TW, Higuchi JH , Coalson JJ , Johanson WG. Pathogenesis and 
prevention of nosocomial pneumonia in a nonhuman primate model of acute 
respiratory failure. Am Rev Respir Dis 1984; 130:502-504. 
199. Hong-Hao Hsieh A, Bishop MJ , Kubilis PS , Newell OW, Pierson DJ. 
Pneumonia following closed head injury. Am Rev Respir Dis 1992; 146:290-
294. 
200. Espersen F, Gabrielsen J. Pneumonia due to Sraphylococcus aureus during 
mechanical ventilation . J Infect Dis 1981 ; 144: 19-23. 
516 
201. Stevens RM, Teres D, Skillman JJ, Feingold DS. Pneumonia in an Intensive 
Care Unit. Arch Intern Med 1974; 134: 106-111. 
202. Silver DR, Cohen IL, Weinberg PF. Recurrent Pseudomonas aeruginosa 
Pneumonia in an Intensive Care Unit. Chest 1992; 101:194-198. 
203. Tran DD, Groeneveld J, Van der Meulen J, Nauta JJP, Strack van Schijndel 
RJM , Thijs LG. Age, chror:ic disease, sepsis, organ system failure and 
mortality in a medical intensive care unit. Crit Care Med 1990; 18:474-479. 
204. Seidenfeld JJ , Pohl DF, Bell RC, Harris GD , Johanson WG. Incidence, site and 
outcome of infections in patients with the adult respiratory distress syndrome. 
Am Rev Respir Dis 1986; 134: 12-16. 
205. ACCP/SCCM consensus committee , Bone RC. American College of Chest 
Physicians/Society of Critical Care Medicine Consensus Conference: 
Definitions for sepsis and organ failure and guidelines for the use of innovative 
therapies in sepsis. Crit Care Med 1992; 101: 1644-1655. 
206. Mylotte JM, Beam TR. Comparison of Community-acquired and Nosocomial 
Pneumococcal bacteraemia. Am Rev Respir Dis 1981 ; 123: 165-168. 
207. Caplan ES, Hoyt N. Infection Surveillance and control m the severly 
traumatised patient. Am J Med 1981 ; 70:638-640. 
208. Machiedo GW, LoVerme PJ, McGovern PJ , Blackwood JM. Patterns of 
mortality in a surgical intensive care unit. Surg Gynecol Obstet 1981; 152:757-
759. 
517 
209. Meijer K, Van Saene HKF, Hill JC. Infection control in patients undergoing 
mechanical ventilation: traditional approach versus a new development -
selective decontamination of the digestive tract. Heart Lung 1990; 19: 11-20. 
210. Haley RW, Culver DH, White JW. The efficacy of infection surveillance and 
control programs in preventing nosocomial infections in university hospitals. 
Am J Epidemiol 1985; 121:182-205. 
211. Inglis TJJ, Sproat LJ, Hawkey PM, Knappert P. Infection control in intensive 
care units: U.K. national survey. British Journal of Anaesthesia 1992; 68:216-
220. 
212. Albert RK, Condie F. Hand-washing patterns in medical intensive care units. N 
Engl J Med 1981; 304:1465-1466. 
213. Garner JS, Favero MS. CDC guidelines for the prevention and control of 
nosocomial infections. Am J Infect Control 1986; 14: 110-129. 
214. Hamilton-Miller JMT. The emergence of antibiotic resistance: myths and facts 
in clinical practice. Intensive Care Med 1990; 16s3:s206-s21 l. 
215. Weinstein RA, Kabins SA. Strategies for prevention and control of multiple 
drug-resistant nosocomial infection. Arn J Med 1981; 70:449-454. 
216. Weber DJ, Wilson B, Rutala WA, Thomann CA. Manual ventilation bags as a 
source for bacterial colonisation of intubated patients. Am Rev Respir Dis 1990; 
142:892-894. 
518 
217. Flournoy DJ, Plumlee CJ, Steffee RL. Volume Ventilator as a vehicle of 
airborne bacterial contamination from patients. Resp Care 1980; 25:57-60. 
218. Nauseef WM, Maki DG. A study of the value of simple protective isolation in 
patients with granulocytopaenia. N Engl J Med 1981; 304:448-453. 
219. Burke JF, Quinby WC, Bondoc CC , Sheehy EM, Moreno HC. The contribution 
of a bacterially isolated environment to the prevention of infection in seriously 
burned patients. Ann Surg 1977; 186:377-387. 
220. Klein BS, Perloff WH, Maki DG . Reduction of nosocomial infection during 
paediatric intensive care by protective isolation. N Engl J Med 1989; 320:1714-
1721. 
221. Madge P, Paton JY, McColl JH, Mackie PLK. Prospective controlled study of 
four infection-control procedures ot prevent nosocomial infection with 
respiratory syncytial virus. Lancet 1992; 340: 1079-1083. 
222. Turner JS, Potgieter PD , Springhorn H, Briggs S. Patients' recollection of ICU 
experience. Crit Care Med 1990; 18:966-968. 
223. Torres A, Serra-Batlles J , Ros E, et al. Pulmonary Aspiration of Gastric 
Contents in Patients Receiving Mechanical Ventilation: the effect of body 
position. Ann Intern Med 1992; 116:540-543. 
224. Beale EO, Miller MT. The Guillain- Barre syndrome A review of admissions to 
an intensive care unit over 8 years. S Afr Med J 1985; 67:10-12. 
519 
225. Edmondson RS, Flowers MW. Intensive care in tetanus : management 
complications and mortality in 100 cases. Br Med J 1979; 1:1401-1404. 
226. Trujillo M, Castillo A, Espana JV, Guevara P, Eganez H. Tetanus in the adult: 
intensive care and management experience with 233 cases. Crit Care Med 1980; 
8:419-423. 
227. Apte NNf, Karnad DP, Medhekar TP, Tilve GH, Morye S, Bhave GG. Gastric 
colonisation and pneumonia in intubated critically ill patients receiving stress 
ulcer prophylaxis: A randomised, controlled trial. Crit Care Med 1992; 20:590-
593. 
228. Simmons BP, Wong ES. CDC Guidelines for the prevention and control of 
nosocomial infections: Guideline for the prevention of nosocomial pneumonia. 
Am J Infect Control 1983; 11:230-244. 
229. Miranda DR, Van Saene HKF, Stoutenbeek CP, Zandstra DF. Environment and 
costs in surgical intensive care unit : The implication of selective 
decontamination. Acta Anaesthesiol Belg 1983; 3,September:223-232. 
230. Allen KD, Green HT. Hospital outbreak of multiresistant Acinetobacter 
anitratus: an airborne mode of spread? J Hosp Infect 1987; 9:110-119. 
231. Rodriguez-Roldan JM, Altuna-Cuesta A, Lopez A, et al. Prevention of 
nosocomial lung infection in ventilated patients: use of an antimicrobial 
pharyngeal nonabsorbable paste. Crit Care Med 1990; 18:1239-1242. 
520 
232. Klick JM, Du Moulin GC, Hedley-Whyte J, Teres D, Bushnell LS, Feingold 
DS. Prevention of Gram negative bacillary pneumonia using polymyxin aerosol 
as prophylaxis. J Clin Invest 1975; 55:514-519. 
233. Feeley TW, Du Moulin GC, Hedley-Whyte J, Bushnell LS, Gilbert JP, 
Feingold DS. Aerosol Polymyxin and pneumonia in seriously ill patients. N 
Engl J Med 1975; 293:471-475. 
234. Johanson WG, Seidenfeld J, De Los Santos R, Coalson JJ, Gomez P. 
Prevention of nosocomial pneumonia using topical and parenteral antimicrobial 
agents. Am Rev Respir Dis 1988; 137:265-272. 
235 . Faling U. Advances in Preventing Nosocomial Pneumonia Part II. Am Rev 
Respir Dis 1988; 137:256-258. 
236. Burke J, Jacobson J, Garibaldi R. Evaluation of daily meatal care with poly-
antibiotic ointment in prevention of urinary catheter-associated bacteriuria. J 
Urol 1983; 129:331-334. 
237. Schaeffer AJ , Story KO, Johnson SM. Effect of silver 
oxide/ trichloroisocyanuric acid antimicrobial unnary drainage system of 
catheter-associated bacteriuria. J Urol 1988; 139:69-73. 
238. Garibaldi RA, Burke JP , Britt MR. Meatal colonisation and catheter-associated 
bacteriuria. N Engl J Med 1980; 303: 3 316-318. 
521 
239. Garibaldi RA, Mooney BR, Epstein BJ. An evaluation of daily bacteriologic 
monitoring to identify preventable episodes of catheter-associated urinary tract 
infection. Infection Control 1982; 3:466-470. 
522 
240. Olson ME, Lam K, Bodey GP, King EG, Costerton JW. Evaluation .of 
strategies for central venous catheter replacement. Crit Care Med 1992; 20:797-
804. 
241. Bradley JA, Hamilton DNH, Brown MW, Cance W, Jackson VS, Ledingham 
IMA. Cellular defense in critically ill surgical patients. Crit Care Med 1984; 
12:565-570. 
242. Jackson GG. Considerations of antibiotic prophylaxis in nonsurgical high risk 
patients. Am J Med 1981; 70:467-473. 
243. Stoutenbeek CP, Van Saene HKF, Miranda DR, Zandstra DF, Langrebr D. The 
effect of oropharyngeal decontamination using topical nonabsorbable antibiotics 
on the incidence of nosocomial respiratory tract infections in multiple trauma 
patients. J Trauma 1987; 27:357-364. 
244. van der Waaij D. Evidence of immunoregulation of the composition of intestinal 
microflora and its practical consequences. Eur J Clin Microbiol Infect Dis 1988; 
7: 103-106. 
245. Goldin BR, Lichtenstein AH, Gorbach SL. The roles of the intestinal flora. In: 
Shils ME, Young YR , eds. Modern Nutrition in Health and Disease. 7th ed. 
Philadelphia: Lea and Febiger, 1988:500-515. 
246. Young LS. Antimicrobial prophylaxis in the neutropaenic host: lessons of the 
past and perspectives for the future. Eur J Clin Microbial Infect Dis 1988; 7:93-
97. 
247. Wolfson JS, Hooper DC. Overview of Fluoroquinolone Safety. Am J Med 
1991; 9ls6A:sl53-s161. 
248. Van Uffelen R, Yan Saene HKF, fidler V, Lowenberg A. Oropharyngeal flora 
as a source of bacteria colonising the lower airways in patients on artificial 
ventilation. Intensive Care Med 1984; 10:233-237. 
249. Brun-Buisson C, Legrand P, Rauss A. et al. Oral digestive tract 
decontamination (SDD) to control an outbreak of multiresistant Gram negative 
bacilli . Effect on endemic nosocomial infections. Intensive Care Med 1988; 14 
supplement 311: 
250. Brun-Buisson C, Legrand P, Rauss A, et al. Intestinal decontamination for 
control of nosocomial multiresistant Gram negative bacilli : study of an 
outbreak in an ICU. Ann Intern Med 1989; 110: 873-881. 
251. Goris RJA , Draaisma J. Death after blunt injury. Injury 1982; 14:7-10. 
252. Van Saene HKF, Stoutenbeek CP, Miranda DR, Zandstra DF, Langrehr D. 
Recent advances in the control of infectiion in patients witb thoracic injury. 
Injury 1986; 17:332-335. 
523 
253. Kerver AJH, Rommes JH, Mevissen-Yerhage EAE, et al. Prevention of 
colonization and infection in critically ill patients: a prospective randomised 
study. Crit Care Med 1988; 16: 1087-1093. 
254. Hartenauer U, Thulig B, Diemer W, et al. Effect of selective flora suppression 
on colonisation, infection, and mortality in critically ill patients : a one year, 
prospective consecutive study. Crit Care Med 1991; 19:463-473. 
255. Cerra FB, Maddaus MA, Dunn DL. et al. Selective Gut Decontamination 
Reduces Nosocomial Infections and Length of Stay but Not Mortality or Organ 
Failure in Surgical Intensive Care Unit Patients. Arch Surg 1992; 127: 163-169. 
256. Wiesner RH. Selective bowel decontamination for infection prophylaxis in liver 
transplantation patients. Transplant Proc 1991; 23: 1927-1928. 
257. Rolando N, Harvey F, Brahm J. Prospective study of bacterial infection in acute 
liver failure. Hepatology 1990; 11 :49-53. 
258. Rolando N, Harvey F, Brahm J. Fungal infection: a common, unrecognised 
complication of acute liver failure. J Hepatol 1991; 12 : 1-9. 
259. Tetteroo GWM, Wagenvoort JHT, Ince C, Bruining HA . Effects of selective 
decontamination on Gram negative colonisation, infections and development of 
bacterial ·resistance in esophageal resection. Intensive Care Med 1990; 
16s3:s224-s228. 
524 
260. Tetteroo GWM, Wagenvoort JHT, Castelein A, Tilanus HW, Ince C, Bruining 
HA. Selective decontamination to reduce Gram negative colonisation and 
infections after oesophageal resection. Lancet 1990; l: 704-707. 
261. Tetteroo GWM, Wagenvoort JHT, Bruining HA, Tilanus HW. A randomised 
study to the efficacy of selective decontamination in patients undergoing 
oesophageal resection, and it's epidemiological effects. Intensive Care Med 
1988; 14 supplement 311: 
262. McClelland P, Murray AE, Willians PS, et al. Reducing sepsis m severe 
combined acute renal and respiratory failure by selective decomtamination of 
the digestive tract. Crit Care Med 1990; 18:935-939. 
263. Ledingham IMA, Alcock SR. Easraway AT, McDonald JC, McKay IC, 
Ramsay G. Triple regimen of selective decontamination of the digestive tract, 
systemic cefotaxime, and microbiological surveillance for prevention of 
acquired infection in intensive care. Lancet 1988; l :785-790. 
264. Unertl K, Ruckdeshel G, Selbmann HK, et al. Prevention of colonisation and 
respiratory infections in long term ventilated patients by local antimicrobial 
prophylaxis. Intensive Care Med 1987; 13: 106-113. 
265. Gastinne H, Wolff MD, Delatour F, Faurisson F, Chevret S. A controlled trial 
in intensive care units of selective decontamination of the digestive tract with 
nonabsorbable antibiotics. N Engl J Med 1992; 326:594-599. 
525 
266. Van Uffelen R, Rommes JH, Van Saene HKF. Preventing lower airway 
colonisation and infection in mechanically ventilated patients. Crit Care Med 
1987; 15:99-102. 
267. Ulrich C, Harinck-de Weerd JE, Bakker NC, Jacz K, Doornbos L, de Ridder 
VA. Selective decontamination of the digestive tract with norfloxacin in the 
prevention of ICU aquired infections : a prospective randomized study. 
Intensive Care Med 1989; 15:424-431. 
268. Godard J, Guillaume C, Reverdy M-E. et al. Intestinal decontamination in a 
polyvalent ICU A double blind study. Intensive Care Med 1990; 16:307-311. 
269. Aerdts SJA, Clasener HAL, Van Dalen R, van Lier HJJ , Vollaard EJ, Festen J. 
Prevention of bacterial colonisation of the respiratory tract and stomach of 
mechanically ventilated patients by a novel regimen of selective decontamination 
in combination with initial systemic cefotaxime. J Antimicrob Chemo 1990; 
26sA:59-76. 
270. Cockerill FR, Muller SR, Anhalt JP , et al. Prevention of Infection in Critically 
Ill Patients by Selective Decontamination of the Digestive Tract. Ann Intern 
Med 1992; 117:545-553. 
271. Winter R, Humphreys H, Pick A, MacGowan AP , Willatts SM, Speller DCE. 
A controlled trial of selective decontamination of the digestive tract in intensive 
care and its effect on nosocomial infection . J Antimicrob Chemo 1992; 30:73-
87. 
526 
272. Gastinne H, Wolff M, Lachatre G, Boiteau R, Savy FP. Antibiotic levels in 
bronchial tree and in serum during selective digestive decontamination. 
Intensive Care Med 1991; 17:215-218. 
273. Zobel G, Kuttnig M, Grubbauer HM, Semmelrock HJ, Thiel W. Reduction of 
colonisation and infection rate during pediatric intensive care by selective 
decontamination of the digestive tract. Crit Care Med 1991; 19: 1242-1246. 
274. Stoutenbeek CP, Van Saene HKF, Miranda DR, Zandstra OF. A new technique 
of infection prevention in the intensive care unit by selective decontamination of 
the digestive tract. Acta Anaesthesia! Belg 1983; 3, September:209-221. 
275. Stoutenbeek CP, Van Saene HKF, Zandstra DF. The effect of oral non-
absorbable antibiotics on the emergence of resistant bacterial in patients in an 
intensive care unit. J Antimicrob Chemo 1987; 19:513-520. 
276. Armstrong PJ, Barr JG, Webb CH, Blair PH, Rowlands BJ. Epidemiology of 
Pseudomonas aeruginosa m an intensive care unit using selective 
decontamination of the digestive tract. J Hosp Infect 1992; 20: 199-208. 
277. Nau R, Ruchel R, Mergerian H, Wegener U, Winkelman T, Prange HW. 
Emergence of antibiotic resistant bacteria during selective decontamination of 
the digestive tract. J Antimicrob Chemo 1990; 25: 881-883. 
278. Konrad F, Schwalbe B, Heiderich P, Schmitz JE, Ahnefeld FW. Bacterial 
colonisation and respiratory tract infections in long term ventilated patients 
under conventional antibiotic treatment and selective decontamination of the 
digestive tract (SDD). Intensive Care Med 1988; 14:abstract 3. 
527 
279. Vandenbroucke-Grauls CMJE, Vandenbroucke JP. Effect of select1.ve 
decontamination of the digestive tract on respiratory tract infections and 
mortality in the intensive care unit. Lancet 1991; 338:859-862. 
280. Van Dalen R. Selective decontamination in ICU patients: benefits and doubts. 
In: Vincent JL, ed. Update in intensive care and emergency medicine. 14th ed. 
Berlin: Springer Verlag , 1991 :379-386. 
281. Weinstein RA . Selective intestinal decontamination - an infection control 
measure whose time has come? Ann Intern Med 1989 ; 110: 853-854. 
282. Ramsay G. Reidy JJ. Selective decontamination in intensive care practice: a 
review of clinical experience. Intensive Care Med 1990; 16s3:s217-s223. 
283. Reidy JJ, Ramsay G. Clinical trials of selective decontamination of the digestive 
tract :review. Crit Care Med 1990; 18: 1449-1456. 
284. Deitch EA. Selective decontamination of the gut - is it enough? Crit Care Med 
1990; 18: 1043-1044. 
285. Van Saene HKF, Stoutenbeek CP, Stoller JK. Selective decontamination of the 
digestive tract in the intensive care unit: current status and future prospects. Crit 
Care Med 1992; 20:691 -703. 
286. Van Saene HKF, Stoutenbeek CP , Hart CA. Selective decontamination of the 
digestive tract in intensive care patients: a critical evaluation of the clinical, 
bacteriological and epidemiological benefits. J Hosp Infect 1991; 18:261-277. 
528 
287. Fink MP. Selective digestive decontamination: A gut issue for the nineties. Crit 
Care Med 1992; 20:559-562. 
288. Craven DE. Use of Selective Decontamination of the Digestive Tract - is the 
light at the end of the tunnel red or green? Ann Intern Med 1992; 117:609-611. 
289. Moore RD, Smith CR, Lietman PS. Association of Aminoglycoside Plasma 
Levels with Therapeutic Outcome in Gram-Negative Pneumonia. Am J Med 
1984; 77:657-661. 
290. Moore RD, Smith CR, Lietman PS. The association of aminoglycoside plasma 
levels with mortality in patients with Gram negative bacteraemia. J Infect Dis 
1984; 149:443-448. 
291. Moellering RC, Eliopoulos GM, Allan JD. Beta-Lactam/Aminoglycoside 
Combinations: Interactions and Their Mechanisms . Am J Med 1986; 80sC:30-
34. 
292. Klastersky J. Concept of empiric therapy with antibiotic combinations: 
indications and limits. Am J Med 1986; 80:2-12. 
293. Potgieter PD. Pefloxacin therapy for nosocomial infections in the intensive care 
unit. J Antimicrob Chemo 1990; 26sB: 83-89. 
294. Klastersky J, Carpentier-Meunier F, Kahan-Coppens L, Thys JP. 
Endotracheally administered antibiotics for Gram negative bronchopneumonia. 
Chest 1979; 75:586-591. 
529 
295. Brown RB, Kruse JA, Counts GW, Russell JA, Christou NV, Sands ML 
Double blind study of endotracheal tobramycin in the treatment of Gram 
negative bacterial pneumonia. Antimicrob Agents Chemother 1990; 34:269-
272. 
296. Stoutenbeek CP, Van Saene HKF, Miranda DR, Zandstra DF, Langehr D. 
Nosocomial Gram-negative pneumonia in critically ill patients: a 3 year 
experience with a novel therapeutic regimen. Intensive Care Med 1986; 12:419-
423. 
297. Knaus WA, Draper EA, Wagner DP, ·Zimmerman JE. APACHE II: a severity 
of disease classification. Crit Care Med 1985; 13: 818-829. 
298. Knaus WA, Draper EA, Wagner DP. Prognosis in acute organ system failure. 
Ann Surg 1985; 202:685-690. 
299. Baker SP, O'Neill B, Haddon W, Long WB. The injury severity score: a 
method for describing patients with multiple injuries and evaluating emergency 
care. J Trauma 1974; 12: 187-196. 
300. Reusser P, Zimmerli W, Scheidegger D, Marbet GA, Buser M, Gyr K. Role of 
Gastric Colonisation in Nosocomial Infections and Endotoxaemia: A 
Prospective Study in Neurosurgical Patients on Mechanical Ventilation. J Infect 
Dis 1989; 160:4 14-421. 
530 
301. Martinez-Pellus AE, Ruiz J, Garcia J, San Miguel MT, Seller G, Bru M. Role 
of Selective Digestive Tract Decontamination(SDD) in the Prevention of 
Nosocomial Pneumonia (NP): Is gastric decontamination necessary? Intensive 
Care Med 1992; 18:2218-221. 
302. Cade JF, McOwat E, Siganporia R, Keighley C, Presneil J , Sinikas V. 
Uncertain relevance of gastric colonisation in the seriously ill. Intensive Care 
Med 1992; 18:210-217. 
303 . Rello J, Ausina V, Castella J, Net A, Prats G. Nosocomial Respiratory Tract 
Infections in Multiple Trauma Patients: Influence of level of consciousness with 
implications for therapy. Chest 1992; 102:525-529. 
304. Hedlund JU , Ortqvist AB, Kalin M, Scalia-Tomba G, Giesecke J. Risk of 
pneumonia in patients previously treated in hospital for pneumonia. Lancet 
1992; 340:396-397. 
305. Hammond JMJ , Potgieter PD , Saunders GL , Forder AA. Double-blind study of 
selective decontamination of the digestive tract in intensive care. Lancet 1992; 
340:5-9. 
306. Cowan ST. Manual for the identification of medical bacteria. 2nd ed. 
Cambridge: Cambridge University Press , 1974: 
307. Lorian V. Antibiotics in Laboratory Medicine 2nd edition pg 61 , Williams and 
Wilkins, 1986 
531 
308. NCCLS Antimicrobial Susceptibility Testing, 3rd edition, Vol 10, no 7 
American National Standards Institute, 1991. 
309. Wiesner RH. The incidence of Gram negative bacterial and fungal infections in 
liver transplant patients treated with selective decontamination. Infection 1990; 
18 suppl 1:sl9-s21. 
532 
